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ABSTRACT
A close relationship exists between sleep and epilepsy. While many forms of epilepsy 
may be influenced by the sleep-wake cycle, this phenomenon is particularly evident in 
frontal lobe epilepsy where affected individuals may experience seizures exclusively 
during sleep (nocturnal frontal lobe epilepsy, NFLE). In this thesis, three aspects of 
the relationship between sleep and frontal lobe epilepsy are examined.
Firstly, serotonergic neurotransmission across the human sleep-wake cycle was 
studied using the novel PET ligand l8F-MPPF, a serotonergic 5HT ia receptor 
radioligand sensitive to endogenous serotonin release. Fourteen individuals with 
narcolepsy underwent l8F-MPPF PET scans during sleep and wakefulness. The study 
demonstrated a 13% increase in l8F-MPPF binding potential (p<0.01) during sleep, 
indicating a reduction in serotoninergic neurotransmission, in line with existing 
animal data.
Secondly, the characterisation of benign, non-epileptic parasomnias and their 
distinction from nocturnal frontal lobe seizures was addressed in two studies.
The first comprised an analysis of the historical features of these conditions, and 
included the development and validation of a clinical scale for the diagnosis of 
nocturnal events. The second comprised a detailed semiological analysis of a series 
of parasomnias recorded on video-EEG monitoring, and a statistical comparison with 
seizures in NFLE. Although similarities between NFLE and parasomnias were 
observed, the results provide an evidence base for the confident distinction of these 
disorders.
Finally, the familial form of NFLE (autosomal dominant nocturnal frontal lobe 
epilepsy, ADNFLE) is associated with mutations in genes for nicotinic acetylcholine 
receptor subunits, but recognised mutations account for only a minority of reported 
cases. The last study presented here is a clinical and genetic analysis of two large 
families with an unusually severe ADNFLE phenotype. Affected individuals had 
refractory epilepsy and increased rates of mental retardation and psychiatric disorders
4
and, in one family, linkage studies suggest a previously unrecognised underlying 
mechanism.
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LEGEND OF VIDEO CLIPS
(ALL VIDEO CLIPS ACCOMPANY CHAPTER 13)
VIDEO 13.1 Parasomnia, triggered by a snore, with brief apparent fear and 
vocalisation, followed by apparently purposeful fumbling with nearby objects. The 
subject was asleep by electrographic criteria throughout the episode.
VIDEO 13.2 Brief segment of a prolonged period of arousal behaviour triggered by 
a door slam. Low amplitude tremor is seen at times during the event, (reported 
historically by his mother as ‘jerking’).
VIDEO 13.3 Nocturnal frontal lobe seizure,with clear dystonic posturing, but 
commencing with several seconds of arousal behaviour. This arousal is 
indistinguishable from the onset of many parasomnias.
VIDEO 13.4 Seizure in NFLE, with vocalisation and apparent fear. Note the 
abrupt onset and offset, and the minimally interactive quality of speech and 
behaviour.
VIDEO 13.5 Prolonged ‘mixed’ event, showing a mixture of parasomnia behaviour 
types, and waxing and waning quality. Offset is indistinct; the subject appears to 
fully waken, but the exact point at which the event ends is unclear.
VIDEO 13.6 Postictal behaviour mimicking parasomnias. The seizure itself is quite 
subtle, with eye opening and repeated left arm flexion and extension. The video 
clip shows the last few seconds of the seizure, which was associated with a robust 
ictal rhythm. This is followed be postictal behaviour with sitting forward, 
searching, fumbling with EEG electrodes and some oral automatisms. The 
behaviour looks very similar to many parasomnias.
VIDEO 13.7 Brief segment of normal arousal behaviour in a parasomnia. The 
subject rouses, looks around and mumbles; other than the prolonged duration of the 
behaviour, and electrographic sleep patterns on EEG, this is normal arousal.
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VIDEO 13.8 Segments of a prolonged parasomnia. Onset is with confused 
mumling and swearing, with some non-agitated motor behaviour. This alternates 
with emotional distress through the event. At one point, tremor and some low 
amplitude myoclonic jerks are seen.
VIDEO 13.9 Non-agitated motor behaviour. The subject sits forward, and licks his 
hands in an apparently purposeful manner during sleep.
VIDEO 13.10 Early somnambulism. The subject stands but is restricted by EEG 
leads and does not leave the bed.
VIDEO 13.11 Fearful and distressed speech, with clear interaction, during a 
prolonged parasomnia.
VIDEO 13.12 Apparently fearful behaviour at arousal, with the patient backing 
away from an unseen object, but without vocalisation. This rapidly settles to non- 
agitated behaviour.
VIDEO 13.13 Tearful and anguished behaviour during a parasomnia.
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ABBREVIATIONS AND GLOSSARY OF TERMS
l8F Fluorine radioisotope used in PET scanning
5-HT Serotonin
5H T ia Serotonin (5-HT) 1A receptor
ACh Acetylcholine
ADNFLE Autosomal dominant nocturnal frontal lobe epilepsy
ASDA American Sleep Disorders Association
Bmax Maximum concentration of receptor sites
BP Binding potential
C a Arterial concentration of tracer in PET kinetic modelling
CHRNA2 Neuronal nicotinic acetylcholine receptor alpha 2 subunit
gene
CHRNA4  Neuronal nicotinic acetylcholine receptor alpha 4 subunit
gene
CHRNB2 Neuronal nicotinic acetylcholine receptor beta 2 subunit
gene
CRH Corticotrophin releasing hormone
CT Computed tomography
DRN Dorsal raphe nuclei
EEG Electroencephalogram
EM G Electromyography
EOG Electrooculography
FDG Fluorodeoxyglucose
FLE Frontal lobe epilepsy
FLEP scale Frontal lobe epilepsy and parasomnias scale
GABA Gamma-amino butyric acid
Glu Glutamate
IGE Idiopathic generalised epilepsy
ILAE International League Against Epilepsy
Ki Arterial input function in PET kinetic modelling
Kd Equilibrium dissociation constant of a ligand
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LC Locus coeruleus
LDT Lateral dorsal tegmental nucleus
LOD Log of the odds
LO R Line of response
M PPF 4-2 '-(methoxy-phenyl)-1 -[2 '-(N- 2 "-pyridinyl)-p-
fluorobenzamido]ethlpiperazine 
M RI Magnetic resonance imaging
M t Concentration of tracer in brain in PET kinetic modelling
nAChR Nicotinic acetylcholine receptor
NFLE Nocturnal frontal lobe epilepsy
NOR Noradrenaline
NREM Non-rapid eye movement
PET Positron emission tomography
PPT Pedunculopontine tegmental nucleus
PSG Polysomnography
Ro Kj ratio between reference tissue and tissue of interest
RBD REM behaviour disorder
rCBF Regional cerebral blood flow
REM  Rapid eye movement
SPECT Single photon emission computed tomography
VEM Video EEG monitoring
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Chapter 1. Historical Perspective
CHAPTER 1 
HISTORICAL PERSPECTIVE
1a. Early writings
A relationship between sleep and epilepsy has been recognised since antiquity. 
Some of the earliest writings on epilepsy are from Ancient Greece, and the term 
‘epilepsy’ is derived from the Greek verb epilamhanein, meaning ‘to seize’ or ‘to 
attack’. In a volume of his collection of medical writings entitled ‘On the Sacred 
Disease’, written around 400 BC, Hippocrates rejected the commonly held belief 
that seizures were manifestations of divine or demonic possession (Temkin, 1994). 
He proposed a physiological rather than a supernatural basis for seizures, and 
stated that the allegedly divine character of epilepsy was a shelter for the 
fraudulent practices of magicians and charlatans. He therefore emphasised the 
importance of diet and drugs in the treatment of epilepsy, as opposed to exorcism, 
and recognised the importance of regular sleep in the prevention of seizures. 
Patients should “spend the day awake and the night asleep. If this habit be 
disturbed, it is not so good.. ..worst of all is when he sleeps neither night nor day” 
(Temkin, 1994). Other influential physicians from Ancient times also noted the 
relationship between seizures and sleep. Aristotle declared that “sleep is like 
epilepsy and, in a sense, actually is a seizure of sorts. Accordingly, the beginning 
of this malady takes place with many during sleep, and their subsequent habitual 
seizures occur during sleep and not in waking hours” (Aristotle, 350 BC). Galen, 
whose teachings formed the cornerstone of Western medicine until the 
Enlightenment in the 17th century, warned against sleeplessness, and Aretaeus (2nd 
century AD) emphasised the need for regular sleep patterns in his complex health 
regimes for sufferers of epilepsy (Temkin, 1994).
In ancient writings, a distinction was drawn between epilepsy and other events 
arising from sleep such as parasomnias, although the conditions were often linked. 
Hippocrates reported “people groaning and shouting in their sleep....others jump 
from their bed and run outside and remain out of their mind until they wake, when 
they are as healthy and sane as they were before” (Temkin, 1994). Soranus (2nd
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century AD), on the other hand, stated that untreated nightmares would result in 
epilepsy, and Posidonius taught that “what epileptics suffer in their attacks when 
awake, sufferers from incubus undergo in their sleep’(Temkin, 1994).
In the Middle Ages, however, medical beliefs and practices became heavily 
influenced by the rise of Christianity, and the rational observation of the Greeks 
and Romans was replaced by religiosity and mysticism. Epilepsy, along with 
parasomnias and madness, was often considered to be the result of demonic 
possession, and was widely known as “the falling evil”. The term incubus, which 
is now associated with an adult parasomnia, was coined in this era and derives 
from the Latin ‘incubo’ meaning ‘to lie upon’. An incubus was a lascivious male 
demon which would possess mortal women as they slept, sexually assaulting 
them. These demons were of considerable concern to the medieval church, and 
were discussed in the writings of St Augustine (354-430 AD) and Thomas 
Aquinas (1225-1274 AD). Likewise, the demonic nature of epilepsy seems to 
have been confirmed in a famous passage from the Gospel of St Mark, (ix 14-29) 
in which Jesus drives out a ‘foul spirit’ from a possessed boy. In this passage, the 
father of the possessed boy describes how his son ‘Hath a dumb spirit; and 
wheresoever he taketh him, he teareth him: and he foameth, and gnasheth with his 
teeth, and pineth away....and oftentimes it hath cast him into the fire, and into the 
waters, to destroy him’. Jesus witnesses such an attack, and rebukes the spirit, 
driving it out of the boy. The description sounds very much like a seizure, and the 
interpretation given in the Gospel was widely accepted by the Church. In the third 
century AD, the Christian theologian Origen wrote ‘W e... believe the Gospel in 
the point that this disease, in those affected with it, is obviously brought about by 
an unclean dumb and deaf spirit’ (Temkin, 1994). Such views prevailed, and the 
treatment for epilepsy therefore was based on regimes of prayer and fasting, often 
in conjunction with bleeding, purging, vomiting and, in severe cases, trephining.
Little progress was made until the Enlightenment in the 17th and 18th centuries 
heralded a return to a rational and methodological approach to medicine.
Landmark discoveries in the field of medicine were made in this period, such as 
William Harvey’s demonstration of cardiovascular circulation, and physicians 
began to emphasise the importance of detailed descriptions and systematic
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classification of diseases. The principles of clinical neurology began to develop at 
this time under Thomas Willis and Thomas Sydenham, and new theories of 
epilepsy began to develop. Willis hypothesised that in seizures a ‘spasmodic 
copula’ distilled from the blood to the brain causing the animal spirits there to 
explode, manifesting as a seizure (Willis, 1684). This concept of an explosion of 
animal spirits in the brain was a new way of explaining epilepsy, and clearly an 
advance from a scientific perspective, but was only one of a variety of theories 
circulating at that time. Unfortunately, while these ideas resulted in a change in 
the conceptualisation of epilepsy, they were not accompanied by any significant 
improvement in therapeutics.
1 b. Emergence of modern concepts
By the 19th century the practice of clinical neurology was well established. The 
work of Hughlings Jackson led to a concept of epilepsy which gradually gained 
widespread acceptance. He drew upon both an increasing physiological 
knowledge at the time and careful clinical descriptions of seizures, defining 
epilepsy as “a chronic disorder in which there are recurring, sudden, excessive, 
and rapid discharges of grey matter of some parts of the brain, the clinical 
manifestations of which are determined by the anatomical site in the brain of the 
discharge” (Jackson, 1873). Considerable work on the relationship of seizures to 
sleep was undertaken on institutionalised patients in this period. In a seminal 
study of 840 such patients, William Gowers reported that 21% had seizures 
exclusively at night, 42% exclusively in the day, and the remaining 37% in either 
day or night (Gowers, 1885). In this era of painstaking clinical evaluation and 
diagnosis, there was considerable debate as to whether parasomnias such as 
confusional arousals and sleepwalking represented variants of nocturnal epilepsy 
or were separate conditions altogether. While some authors distinguished between 
sleepwalking and epilepsy (Echeverria, 1879), others were less sure. Prichard, for 
example, believed that epilepsy, somnambulism and incubus were similar 
afflictions, and stated “where they do not coexist with epilepsy they often seem to 
stand in the place of it” (Temkin, 1994). With only clinical observation as a 
guide, there was significant doubt as to the possible epileptic nature of these and
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many other ‘minor’ symptoms such as vertigo, chorea and cataplexy, which 
Gelineau reported in his description of narcolepsy in 1880 (Gelineau, 1880).
1c. Development of electroencephalography
Towards the turn of the century, there was increasing interest in the importance of 
electricity in the functioning of the brain. The discovery of spontaneous, 
continuous and recordable electrical currents in the brain was made by Richard 
Caton in 1875. Caton studied the brains of rabbits and monkeys, investigating the 
electrical response to external sensory stimulation. He reported that ‘in every 
brain hitherto examined, the galvanometer has indicated the existence of feeble 
electric currents...of variable direction”. (Caton, 1875, 1877). Meanwhile the 
physicians Fritsch and Hitzig in Berlin had demonstrated that electrical 
stimulation of the brains of dogs produced replicable motor responses in certain 
areas of the brain, and in some animals this stimulation resulted in epileptic 
seizures (Fritsch, 1963). Together, these findings implicated electrical activity in 
both the normal function of the brain and in seizures and were a prelude to the 
most important technical development in epileptology and sleep medicine, the 
invention of the electroencephalogram. The Austrian psychiatrist Hans Berger 
published the first of a series of papers entitled ‘Uber das Elektroenkephalogram’ 
in 1929 (Friedlander, 2001). Berger himself noted changes in the EEG during 
sleep, and these changes were subsequently divided into ‘stages’ by Loomis et al 
in 1939. In the 1960s this was modified and standardised into the sleep staging 
system used today (Rechstaffen, 1968). In the interim, the discovery of rapid eye 
movement (REM) sleep by Aserinsky and Kleitman in 1953 had revolutionised 
the concept of sleep; it was no longer thought of as simply a passive state of brain 
inactivity, but rather as an active, dynamic process.
The EEG was rapidly established as an important tool in the evaluation of patients 
with epilepsy, revealing characteristic electrical ‘epileptiform’ discharges in many 
subjects. In addition, it soon became apparent that the clinical relationship 
observed between sleep and epilepsy had an EEG correlate. Gibbs and Gibbs 
reported activation of epileptiform discharges in sleep (Gibbs, 1947), although it 
was subsequently recognised that, while NREM sleep was an activator, REM
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sleep suppressed generalised epileptiform discharges (Sato et al., 1973). 
Subsequently Rodin demonstrated the activating potential of sleep deprivation on 
the EEG (Rodin, 1962).
1d. Neurotransmitters and sleep
While the electroencephalogram revolutionised the study of the neurophysiology 
of sleep and epilepsy, animal studies from the 1930s started to shed light on the 
neurochemical changes that occur in the brain during sleep. Bremer’s early 
transection studies identified the brainstem as a critical region for control of sleep 
and conscious state (Baghdoyan, 2002), and subsequent work by Jouvet amongst 
others identified serotonin and noradrenalin as essential neurotransmitters in the 
regulation of the sleep-wake cycle (Jouvet, 1969). The development of 
microelectrode and microdialysis technologies led to significant progress in this 
field, and other neurotransmitters involved in this process were subsequently 
identified, including acetylcholine, histamine, dopamine, and GABA. The 
‘reciprocal interaction hypothesis’ was proposed by Hobson in 1975 to describe 
the relationships between these neurotransmitters during the sleep-wake cycle 
(Hobson, 1975), and remains widely accepted today. However, almost all data on 
the neurochemical changes in sleep are based on animal studies, as 
methodological limitations have hampered attempts to investigate this area in the 
human brain to date.
1e. Frontal lobe epilepsy and its relationship to sleep
These scientific discoveries, among others, resulted in major advances in the 
understanding of physiological and pathophysiological aspects of sleep and 
epilepsy. In the field of epilepsy, characteristic electroclinical patterns were 
delineated for both generalised and partial epilepsies. Characteristic frontal lobe 
seizure patterns, such as supplementary motor area (SMA) seizures, were 
recognised through the intraoperative electrical stimulation studies of Wilder 
Penfield and colleagues in the 1940’s and 1950’s (Penfield, 1951, 1954), in 
conjunction with the clinical studies of Ajmone-Marsan (Ajmone-Marsan and 
Ralston, 1957). However, the full spectrum of seizures seen in frontal lobe
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epilepsy (FLE) was not fully appreciated for considerably longer. This was due in 
part to the bizarre and unusual semiology often seen with FLE, but also largely 
because many frontal lobe seizures are not associated with ictal changes on scalp 
EEG. Frontal lobe seizures were often confused with pseudoseizures when 
occurring in wakefulness, and with parasomnias in sleep. Lennox and Lennox 
recognised “running fits” which they considered to be a rare form of epileptic 
seizure, difficult to distinguish from a parasomnia. This led them to remark that 
“The unconsciousness of an epileptic seizure is a mystery which is compounded 
when it is combined with the unconsciousness of sleep” (Lennox, 1960).
The particular relationship between sleep and frontal lobe epilepsy began to 
emerge with the development of video EEG monitoring. In 1981 Lugaresi and 
Cirignotta described 5 patients with nocturnal episodes characterised by limb 
posturing and dyskinetic movements which were brief but occurred many times 
per night (Lugaresi and Cirignotta, 1981). These episodes were not associated 
with interical or ictal EEG abnormalities and occurred exclusively in stage 2 of 
sleep, leading the authors to suggest that this was a new form of movement 
disorder which they called Nocturnal Paroxysmal Dystonia (NPD). However, 
evidence soon started to accumulate indicating an epileptic basis to NPD 
(Meierkord et al., 1992). Increased recognition of the spectrum of frontal lobe 
seizure semiology (Williamson et al., 1985), in conjunction with placement of 
additional zygomatic and sphenoidal electrodes in some NPD patients (Tinuper et 
al., 1990), established that NPD was in fact a form of frontal lobe epilepsy, which 
was subsequently termed nocturnal frontal lobe epilepsy (NFLE). The phenotype 
of NFLE has subsequently been well described (Provini et al., 1999), and a 
number of features have been identified that allow the differentiation of NFLE 
from parasomnias (Zucconi and Ferini-Strambi, 2000). The importance of formal 
video EEG monitoring in diagnosing these conditions is, however, still widely 
acknowledged (Provini et al., 2000; Zucconi and Ferini-Strambi, 2000).
More recently it was recognised that NFLE can be inherited as an autosomal 
dominant condition (Autosomal Dominant Nocturnal Frontal Lobe Epilepsy, 
ADNFLE) (Scheffer et al., 1994). Mutations have now been identified in the 
genes coding for the a4 and 02 subunits of the a402 nicotinic acetylcholine
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receptor in some families with ADNFLE (Steinlein et al., 1995), but, the majority 
of affected families do not carry these mutations (Combi et al., 2004) suggesting 
that ADNFLE is a clinically and genetically heterogeneous disorder.
While there has been enormous progress in the understanding of frontal lobe 
epilepsy and its relationship to sleep, there remain many areas of this relationship 
which are poorly understood. These range from the underlying neurochemical 
changes of sleep which apparently precipitate frontal lobe seizures, to clinical 
difficulties in the diagnosis of paroxysmal sleep-related events, and the full 
clinical and genetic spectrum of ADNFLE. This thesis is an attempt to address 
some of these aspects.
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CHAPTER 2 
THE NEUROBIOLOGY OF SLEEP
Introduction
Although sleep has fascinated philosophers and writers for millennia, modem 
scientific study in this area dates back only 40 or 50 years. During this time our 
understanding of the physiological processes underlying sleep has advanced 
considerably through both animal studies and human research, the latter having 
been greatly facilitated by the development of polysomnography (PSG). This 
technique, which allows the monitoring of various physiological parameters in the 
sleeping subject, is now the principal technology used in sleep medicine. In this 
chapter I will review the basic phenomena of normal sleep, and the associated 
physiological changes as measured by polysomnography. I will then discuss the 
neurochemical processes which are responsible for the regulation of sleep stages, 
as well as the chronobiological mechanisms which influence them, before going 
on to describe their neurophysiological consequences. Finally, I will briefly 
discuss some of the theories relating to one of biology’s greatest unsolved 
mysteries: the function of sleep.
Section 2.1. Sleep: basic phenomena
Sleep is usually defined as a reversible behavioural state of perceptual 
disengagement from, and unresponsiveness to, the environment (Carskadon, 
2004). For centuries it was considered to be a passive state, in which the brain 
was ‘turned o ff , and essentially characterised only by an absence of wakefulness. 
While this concept, summarised in the ancient Greek proverb ‘sleep and death are 
brothers’, existed for millennia, it is now recognized that sleep is in fact an active, 
complex, and highly regulated process.
2.1a. The Stages of Sleep
Three distinct states of consciousness are recognized in humans and most animals: 
wakefulness, non rapid eye movement (NREM) sleep, and rapid eye movement
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(REM) sleep. These are defined according to established polysomnographic 
criteria (Rechstaffen, 1968), and are based on electroencephalographic and other 
physiological parameters.
Wakefulness. The EEG of adults in relaxed wakefulness with eyes closed is 
characterized by posterior rhythmic alpha activity. This pattern is attenuated by 
eye opening or attention, when the EEG shows a low voltage, mixed frequency 
‘activated’ or ‘desynchronized’ pattern.
N RE M  sleep. NREM sleep is subdivided into four stages (stages 1 to 4) which 
reflect the ‘depth’ of NREM sleep and are characterized by increasing 
synchronization of the EEG. In stages 1 and 2 (often referred to as ‘light’ sleep), 
increasing background theta activity is seen on the EEG, along with sleep 
transients such as vertex waves, sleep spindles and K complexes. In stages 3 and 
4 (often referred to as ‘slow wave sleep’), increasing amounts of high amplitude 
delta activity are seen; sleep transients such as spindles are seen less frequently in 
these stages. The stages of NREM sleep are defined distinctly on 
polysomnographic criteria, but in fact represent a continuum of a single process. 
During the progression though NREM stages 1 to 4, arousal thresholds increase 
corresponding to ‘deeper’ sleep (Williams et al., 1964). The metabolic rate of the 
brain decreases, such that in slow wave sleep it is about 70% of normal waking 
levels (Maquet et al., 1992; Maquet, 1995). EMG tone gradually declines in 
NREM sleep, although is not lost completely and limb movements remain 
possible (Chase, 2004). The metabolic rate of the body as a whole reduces by 5 - 
17% (White et al., 1985; Ryan et al., 1989), and physiological changes consistent 
with this reduced metabolic activity (with functional prevalence of 
parasympathetic influences) are observed. Heart rate and blood pressure are 
reduced and stabilized (Coccagna et al., 1971); ventilation, although somewhat 
unstable during light sleep (Trinder et al., 1992), decreases and becomes highly 
stable in slow wave sleep with reduced rate but a slight increase in tidal volume 
(Birchfield et al., 1959). Thermoregulatory function is maintained in a fashion 
similar to that in quiet wakefulness (Glotzbach and Heller, 1976), although body 
temperature is downregulated (Parmeggiani et al., 1971). Overall, NREM sleep is
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conceptualized as a regulating but relatively inactive brain in a resting but 
movable body.
R E M  sleep. In contrast to NREM sleep, the EEG during REM sleep is 
characterized by activation and ‘desynchronisation’, such that it resembles the 
patterns seen in wakefulness. This is accompanied by muscle atonia (resulting 
from brainstem-mediated inhibition of spinal motoneurons) and bursts of rapid eye 
movements. While REM sleep is not usually subdivided in clinical practice, 
physiologically it is recognized that there are two forms of REM sleep. ‘Tonic’ 
REM sleep (when the eyes are still) has physiological features which are present 
throughout the REM sleep period; phasic REM sleep, on the other hand, is 
characterised by episodic physiological changes which accompany rapid eye 
movements. In both tonic and phasic REM, muscle atonia is accompanied by a 
cessation of thermoregulation (Glotzbach and Heller, 1976), such that body 
temperature drifts towards environmental temperature (Glotzbach and Heller, 
1976). During phasic REM, marked irregularities of heart rate, blood pressure and 
respiratory rate are seen at this time, in contrast to the marked regulation of 
NREM sleep (Birchfield et al., 1959; Coccagna et al., 1971). The phasic features 
of REM sleep appear to be generated by ponto-geniculo-occipital (PGO) spikes, 
which are high amplitude potentials, originating in the pons and propagating to the 
lateral geniculate nucleus and on to the occipital cortex and the nuclei of 
extraocular muscles (Morrison and Bowker, 1975). They are not usually visible in 
humans, but have been widely studied in feline sleep. The cerebral metabolic rate 
in REM sleep, as measured using FDG-PET, is significantly greater than in 
NREM and is comparable to that during wakefulness (Maquet, 1995; Maquet et 
al., 1996). Overall, REM sleep is conceptualized as a highly active brain in a 
paralysed body.
2.1b. Sleep architecture
The stages of NREM and REM sleep do not occur randomly, but alternate 
throughout the night with a distinct pattern and structure known as the sleep 
architecture (Figure 2 .1). Sleep is entered through NREM sleep, and REM sleep 
does not occur until 80 minutes or more of NREM. NREM and REM sleep then
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ARCHITECTURE OF SLEEP
AWAKE
REM SLEEP-
STAGE 1 -
STAGE 2 -
STAGE3-
STAGE4-
HOURS OF SLEEP
Figure 2. I. Hypnogram o f normal sleep architecture in a young adult. Normal sleep follows 
a well-organised pattern, with cycles o f NREM and REM sleep; the longest periods o f NREM 
sleep are in the early cycles, wheras REM sleep predominates in the later cycles in the sleep 
period. Typical EEG patterns (on a PSG timescale) are shown on the left. From Culebras, A 
(Ed). Handbook of Clinical Neurology. Boston, Butterworth-Heinemann, 1996, p35.
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alternate throughout the night; the cycle has a period of around 90 minutes, with 
typically 4 to 6 cycles per night. Slow wave sleep (stage 3 and 4 NREM sleep) 
predominates in the first third of the night, but occupies less time as the night 
progresses. Later periods of NREM sleep are largely composed of stage 2 sleep.
In early cycles the duration of REM sleep is relatively brief, but these episodes 
become progressively longer as the night progresses, and REM sleep predominates 
in the last third of the night (Zeman and Reading, 2005). Early periods of REM 
are largely tonic, with phasic REM being seen later in the night (Aserinsky, 1969). 
Overall, REM sleep constitutes about 20-25% of sleep time; of the 75-80% 
making up NREM, 15-30% is slow wave sleep (Carskadon, 2004). The relative 
distributions of REM and NREM appear to be related to changes in body 
temperature across the night.
Sleep architecture may be influenced by many factors. The most common factor 
is age; foetal and neonatal sleep is largely REM sleep, but the amount of REM 
sleep then drops off through the first few months of life, from when it remains 
essentially constant throughout life. Infants and children have increased quantities 
of slow wave sleep compared to young adults; the quantity of SWS declines 
through adulthood and is often almost absent by old age, particularly in men 
(Redline et al., 2004), when arousals become increasingly frequent. Temperature, 
circadian rhythm disturbances (such as jet-lag), drugs and disease (both primary 
sleep disorders and numerous neurological and other medical conditions) may all 
disrupt the normal sleep architecture (Carskadon, 2004).
2.1c. Dreaming
The association of dreams and mental activity with different sleep states has been 
largely deduced from sleep laboratory studies, in which subjects are woken from 
different sleep stages and asked to describe any dream imagery present at the time. 
An early and robust finding from such studies was the now widely-known 
association between REM sleep and dreaming (Dement and Kleitman, 1957). 
However, subsequent studies have confirmed that around 80% of wakings from 
REM sleep are associated with dream recall, they have also demonstrated that 25- 
50% of wakings from NREM sleep are associated with dream reports (Foulkes,
39
Chapter 2. Neurobiology o f Sleep
1962; Nielsen, 2000). Dream recollections from REM sleep are longer, more 
vivid, emotional, and dramatic, and have a more bizarre quality than NREM 
dream reports, which are typically brief, thought-like and mundane (Hobson et al., 
2000). There is some debate as to whether the same processes are at work in these 
states or whether NREM and REM dreams are in fact produced by different 
cerebral mechanisms; it is also possible that apparently NREM-associated dreams 
are remembered from prior REM periods. Some researchers have proposed that 
brief periods of ‘covert’ REM sleep (which are too brief to reach FSG staging 
criteria) within NREM sleep may be responsible for NREM dreaming (Nielsen, 
2000). So while dreams are most strongly associated with REM sleep, the role of 
NREM sleep in dreams is less clear and remains a source of some controversy.
Section 2.2. The neurochemical basis of sleep
While the physiological changes of sleep can be measured in humans using 
polysomnography, the neurochemical mechanisms underpinning them have been 
established through alternative methods, principally animal studies. Sleep-wake 
state is regulated through a variety of neurochemically distinct neural systems, the 
nuclei of which are located in the brainstem, diencephalon and basal forebrain. 
There is considerable interaction between these systems, and most send extensive 
projections throughout the brain through which they exert diffuse modulatory 
effects on brain function (Figure 2.2). The sleep-wake state of the organism 
ultimately depends on the balance and interplay of these distinct but highly 
interconnected systems. In this section I will describe each system individually 
before going on to discuss the interactions involved in the regulation of sleep and 
wakefulness.
2.2a. Neurotransmitters involved in the regulation of sleep
Glutamate. Glutamate is the major stimulatory neurotransmitter in the brain and 
has a key role in the maintenance of wakefulness (Jones, 2003); glutamate 
antagonists, such as ketamine, have sedative or anaethetic properties (Mayer and 
Westbrook, 1987). Glutamate is found in high concentrations in the brainstem 
reticular formation, a loose collection of neurons extending from the caudal
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medulla to the midbrain. The reticular formation receives inputs from a wide 
number of sensory systems and sends excitatory projections to subcortical 
structures, particularly the intralaminar and midline thalamic nuclei. These 
excitatory projections play a critical role in thalamocortical activation, which 
produces the ‘desynchronized’, low amplitude EEG pattern seen in wakefulness 
(Steriade, 2005).
Gamma-Aminobutyric Acid (GABA). GABA, the major inhibitory 
neurotransmitter in the brain, also plays an important role in the regulation of 
sleep; drugs which enhance GABAergic transmission, such as benzodiazepines, 
have sedative properties. GABAergic neurons are distributed throughout the 
brainstem and basal forebrain. Within the reticular formation, they appear to 
inhibit the excitatory glutamatergic neurons (Jones, 1995). In the thalamic 
reticular nucleus, which plays a key role in the generation of sleep spindles, 
GABA-mediated inhibition appears to be a fundamental prerequisite of slow wave 
sleep and the cortical deafferentation that accompanies it (Steriade, 2004). In the 
ventrolateral preoptic area of the hypothalamus (VLPO), GABA-containing 
neurons send inhibitory projections to the tubomammilary nucleus (histamine), 
dorsal raphe nuclei (serotonin) and locus coeruleus (norepinephrine) (Sherin et al., 
1998). Release of GABA in these regions is lowest in wakefulness, intermediate 
during NREM sleep, and highest in REM sleep; it therefore seems likely that 
GABA release from the VLPO area is directly involved in the modulation of sleep 
through effects on the NOR, histamine and 5-HT systems (Nitz and Siegel, 1997; 
Nitz and Siegel, 1997).
Serotonin (5-hydroxytryptophan, 5-HT). The serotonergic system is comprised 
of several neuronal groups, the somas of which form dorsal and median raphe 
nuclei (RN). These nuclei are located in a medial saggital plane extending from 
the medulla to the midbrain, and give rise to extensive efferent projections which 
extend to all areas of the brain, as represented in Figure 2.2 (Azmitia and Segal,
1978). Serotonin is implicated in the modulation of a wide range of behavioural 
functions including the sleep-wake cycle, affect, cognition and motor function 
(Veasey et al., 1995; Fornal et al., 1996; Meneses, 1999; Ursin, 2002). This 
diversity of functional effects is not a function of RN firing patterns, which are
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Neocortex
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To spinal cord
Figure 2. 2 Schematic representation o f the nuclei and projections o f the serotonergic 
system. Although serotonergic nuclei are located almost exclusively in the raphe nuclei 
in the brainstem, they send projections to almost all regions o f the CNS.
42
Chapter 2. Neurobiology o f Sleep
simple and reflect their ancient phylogenetic roots (Peroutka and Howell, 1994), 
but result from the large number of serotonergic receptor subtypes which have 
different structural and operational characteristics (Hoyer et al., 2002). The sleep- 
wake effects of serotonin appear to be mediated primarily through 5HT)A receptors 
(Bjorvatn and Ursin, 1998), which are distributed widely throughout the central 
nervous system (Hoyer et al., 2002); 5-HT binding to 5HT| A receptors may occur 
at the synapse, or on more distant receptors (including autoreceptors) in a ‘non- 
synaptic' fashion. Although a role for serotonin in sleep has been postulated for 
many years on the basis brain stem transection studies (Bremer, 1937; Jouvet, 
1967), the current understanding of its role has only emerged through 
technological advances in the last three decades. Landmark electrophysiological 
studies performed in intact, unanaesthetised cats established that serotonergic 
neurons had clear state-dependant discharge patterns. When electrodes were 
positioned to record the discharge patterns of single dorsal raphe neurons over a 
seven day period, the neurons were observed to fire at their highest rate during 
wakefulness, with rates slowing during NREM sleep and discharges ceasing 
completely during REM sleep (McGinty and Harper, 1976; Trulson and Jacobs,
1979). Subsequent microdialysis studies confirmed that serotonin release in 
forebrain areas is highest in wakefulness, reduced during NREM sleep and lowest 
in REM sleep, thus paralleling the single cell discharge patterns (Wilkinson et al., 
1991; Portas and McCarley, 1994; Portas et al., 1998; Strecker et al., 1999). In 
addition to these findings, systemic administration of 5-HT)A agonists (such as 8- 
OH-DPAT) and selective serotonin reuptake inhibitors (SSRIs, such as fluoxetine) 
increase wakefulness and reduce REM sleep (Sharpley et al., 1996; Bjorvatn et al., 
1997). Taken together, this evidence indicates that serotonin promotes 
wakefulness and inhibits REM sleep; these are commonly referred to as ‘REM- 
o ff  properties.
Norepinephrine (noradrenaline, NOR). Norepinephrine-synthesising neurons are 
located principally in the locus coeruleus (LC) which lies in the dorsorostral pons. 
Like serotoninergic neurons, these send diffuse projections to the cortex and other 
regions including hippocampus, thalamus and hypothalamus (Foote et al., 1983). 
NOR appears to have ‘REM -off effects on the sleep-wake cycle, similar to those 
of serotonin, and the neurons of the locus coeruleus display similar firing
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properties to those of the raphe nuclei (Hobson et al., 1975; Aston-Jones and 
Bloom, 1981). In other words, they are active during wakefulness, less active 
during NREM sleep and quiescent during REM (Foote, 1980; Aston-Jones, 1981). 
Furthermore, stimulation of the norepinephrinergic system promotes wakefulness 
and EEG activation (Berridge and Foote, 1991; Cape and Jones, 1998) wheras 
inhibition of the system leads to a reduction in fast activity and arousal patterns on 
EEG (Berridge et al., 1993). While NOR, in concert with 5-HT, plays an integral 
role in the initiation and maintenance of wakefulness, it appears to have some 
specific properties. There is evidence that NOR promotes enhanced attention to 
important stimuli, and may therefore have a role in maintaining wakefulness in 
stressful or interesting situations (Jones, 1991; Berridge and Waterhouse, 2003); 
for example, NOR deficient mice have been shown to have normal sleep-wake 
patterns, but fall asleep more quickly than normal mice after periods of mild stress 
(Hunsley and Palmiter, 2003).
Histamine (HA). Histaminergic neurons are located exclusively in the 
tubomammilary nucleus in the posterior hypothalamus and project to practically 
all brain regions (Brown et al., 2001). Like NOR and 5-HT - releasing neurons, 
they have a ‘REM-off’ firing pattern (highest in wakefulness, lower in NREM 
sleep and very low in REM sleep) and appear to promote wakefulness (Steininger 
et al., 1999). Pharmacological studies provide further evidence for the wake- 
promoting properties of histamine, with administration of histamine Hi receptor 
antagonists resulting in increases in both REM and non-REM sleep in 
experimental settings (Monti et al., 1986; Lin et al., 1988), and reducing sleep 
latency in clinical practice (Roehrs et al., 1984). Histamine Hi receptor agonists 
have the opposite effect, increasing wakefulness and reducing REM and NREM 
sleep (Monti et al., 1986). Findings in histamine-deficient mice suggest that HA 
may be particularly important in the initiation of wakefulness from sleep, as well 
as the maintenance of wakefulness in potentially soporific situations (Parmentier 
et al., 2002).
Dopamine. Dopamine is the most abundant monoamine in the brain, and is 
organized into three main systems: the nigrostriatal, mesocorticolimbic and 
tuberoinfundibular systems. While its effects on movement, motivation and
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reward are well recognized, its role in sleep is less clear (Rye, 2004). There is 
evidence that dopamine promotes wakefulness, but the mechanisms by which it 
does so are not well understood. For example, dopamine agonists clinically tend 
to promote wakefulness, wheras antagonists increase sleepiness and sleep 
(Nicholson and Pascoe, 1990). Most individuals with Parkinson’s disease 
complain of disordered sleep (Clarenbach, 2000), and the link between 
Parkinson’s disease and REM sleep behaviour disorder has suggested a role of 
dopamine in the regulation of REM sleep. Furthermore, the stimulants 
amphetamine and methylphenidate appear to exert their effects largely or 
exclusively through effect on the dompaminergic system (Kuczenski and Segal, 
1997, 2001). Despite these findings, however, experimental studies of 
dopaminergic neuronal firing rates and extracellular dopamine concentration 
(measured by microdialysis) have demonstrated no change in either parameter 
across the sleep-wake cycle (Miller et al., 1983; Shouse et al., 2000). So, while it 
is widely accepted that dopamine can promote arousal, further work is needed to 
clarify the mechanisms by which it does so.
Acetylcholine (ACh). Cholinergic neurons are located in two main regions in the 
central nervous system which project to different regions. Firstly, the 
pedunculopontine (PPT) and laterodorsal tegmental (LDT) nuclei, located in the 
pons, send projections to the pontine reticular formation, the basal forebrain, the 
thalamus (particularly the midline and intralaminar thalamic nuclei) and the 
hypothalamus (Armstrong et al., 1983; Steriade et al., 1988). Secondly, a group of 
cholinergic nuclei is located in the basal forebrain (nucleus basalis, substantia 
innominata, nuclei of the diagonal band, and septum), and these send widespread 
projections to the hippocampus, amygdale and entire cerebral cortex (Mesulam et 
al., 1983). During wakefulness and REM sleep, cholinergic neurons in these 
regions activate thalamocortical signaling, leading to low amplitude 
desynchronised EEG patterns (Detari and Vanderwolf, 1987; Steriade et al.,
1990).
There is considerable evidence to support a fundamental role for acetylcholine in 
the generation of REM sleep. Cholinergic neurons are active in wakefulness, 
becoming less active during NREM sleep, but increasingly active again during
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REM sleep (Szymusiak et al., 2000; Vazquez and Baghdoyan, 2001). Direct 
injection of cholinomimetics into the pontine reticular formation produces an 
REM-like state in animals, an effect which is site dependant and blocked by the 
muscurinic antagonist atropine (Baghdoyan, 1997). Administration of muscurinic 
receptor antagonists cause reduced vigilance and EEG slowing (a feature of 
NREM sleep), as does Alzheimers disease, a condition characterized by loss of 
cholinergic neurons (Jeong, 2004). Lesions in the PPT/LDT and the basal 
forebrain nuclei have differing consequences: destruction of the LDT/PPT results 
in loss of REM sleep, wheras lesions in the basal forebrain result in EEG slowing 
and reduced vigilance (Stewart et al., 1984; Jones, 2003), implying some 
independence of function between the regions. It is hypothesized that broad 
control of sleep-wake state is governed through the PPT/LDT; however, these 
send extensive projections to the basal forebrain nuclei, through which 
thalamocortical activation is facilitated, leading to the characteristic EEG 
appearances in REM sleep and wakefulness (Steriade, 2005).
Hypocretin (Orexin). Hypocretin is a peptide neurotransmitter which was 
discovered by two groups independently in 1998 (de Lecea et al., 1998; Sakurai et 
al., 1998). Two forms of hypocretin are recognized, hypocretin 1 and hypocretin 2 
(Hcrt-1 and Hcrt-2), which arise from a common precursor, preprohypocretin 
(Taheri et al., 2002). Hypocretin-producing neurons are located in the dorsal and 
lateral hypothalamus, particularly in the perifomical area; they project widely 
throughout the brain but particularly to hypothalamus, amygdala, septum, and 
monoaminergic centres involved in sleep regulation (including locus coeruleus, 
raphe nuclei, and tubomamillary nuclei) (Taheri et al., 2002). The importance of 
hypocretin in the regulation of sleep and wakefulness became apparent with the 
discovery of a mutation in the hypocretin receptor Hcr-2 gene in a population of 
narcoleptic dogs (Lin et al., 1999). It was subsequently discovered that about 90% 
of patients with narcolepsy-cataplexy have undetectable hypocretin levels in their 
CSF (Nishino et al., 2000), and human postmortem studies of the brains of 
individuals with narcolepsy show a marked loss of hypocretin neurons (Peyron et 
al., 2000; Thannickal et al., 2000). The clinical picture of narcolepsy-cataplexy, 
combined with in vivo and in vitro studies, have led to the concept of hypocretin 
as an arousal promoting peptide which stabilizes the awake state.
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The major anatomical connections between hypocretin neurons and brainstem 
monoaminergic centres, combined with in vitro studies demonstrating a clear 
excitatory effect of hypocretin on raphe, locus coeruleus and tubomammilary 
nuclei, strongly suggest that hypocretin is an excitatory peptide able to act on 
multiple systems involved in the sleep wake cycle (Sherin et al., 1996; Hagan et 
al., 1999; Brown et al., 2001; Taheri et al., 2002). Furthermore, hypocretin- 
producing neurons are active during wakefulness and less active during NREM 
sleep (Kiyashchenko et al., 2002); CSF hypocretin levels are at their lowest at the 
end of sleep, increase progressively throughout the awake period, and are highest 
just prior to sleep onset (Fujiki et al., 2001); and hypocretin levels are increased by 
sleep deprivation (Yoshida et al., 2001). These properties have led to the 
suggestion that hypocretin may counteract increasing sleep propensity that builds 
up during normal wakefulness and sleep deprivation (Nishino, 2003). This would 
be concordant the clinical picture of hypocretin deficiency in narcolepsy, in which 
patients are characteristically refreshed by sleep, but after an hour or two awake 
start to be overcome by irresistible sleepiness (Overeem et al., 2001).
2.2b. NREM, REM and the reciprocal interaction hypothesis
All the systems described above, and probably more, are involved in the 
regulation of the sleep-wake state. There is no single and discrete ‘sleep centre’; 
rather, behavioural state is determined by interconnections and interactions 
between these systems.
The reciprocal interaction model was first proposed in 1975 to describe the 
changes in cholinergic and aminergic neurotransmitter system which lead to the 
alternating patterns of REM and NREM sleep (Hobson et al., 1975). In this model 
it is proposed that during wakefulness, activity in the reticular activating system 
(predominantly cholinergic and glutametergic), under the influence of the activity 
of serotonergic and norepinephrinergic tone, results in thalamocortical activation 
and the awake state. At this time, specific cholinergic ‘REM-on’ neurons, also 
located in the brainstem LDT and PPT are inhibited by projections from the 
serotonergic and norepinephrinergic ‘REM -off neurons in the LC and RN; these 
nuclei send serotonergic and norepinephrinergic projections diffusely to the cortex
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and elsewhere where they have an activating effect, but also project heavily to the 
‘REM-on’ cholinergic system where they exert a tonic inhibitory influence. As 
NREM sleep develops, the firing rate of ‘REM -off neurons decreases, leading to 
increasing thalamocortical hyperpolarisation and the establishment of NREM 
sleep. As NREM sleep deepens, the ‘REM -off’ neurons eventually fall silent, at 
which point cholinergic ‘REM-on’ neurons are released from inhibition. Activity 
in these neurons generates the thalamocortical activation and skeletal muscle 
atonia of REM sleep (Figure 2.3).
The reciprocal interaction model is still held to be essentially correct, with 
considerable support from experimental evidence (Berridge and Foote, 1991; 
Portas and McCarley, 1994; Szymusiak et al., 2000). Unsurprisingly, however, it 
appears to be an oversimplification, with additional intermediate steps and other 
neurotransmitters involved. For example, it seems that the initial decline in 5-HT 
and NOR tone in NREM is mediated by GABA release from the VLPO (Nitz and 
Siegel, 1997), with hypocretin having a contrary effect (Brown et al., 2001).
Other neurotransmitters such as histamine have also been shown to be involved in 
the sleep-wake process, and it is likely that some neurotransmitters (such as 
hypocretin) have more than one function. Nevertheless, the model appears 
essentially sound, and remains the basis of the current understanding of the 
neurochemistry of sleep.
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PPT/LDT
(Acetylcholine)
BRF
(Glutamate)
DRN
(serotonin)
(Norepinephrine)
VLPO
(GABA)
Dorsolateral
hypothalamus
(hypocretin)
‘REM on’ ‘REM off’
Figure 2. 3 Summary o f the principle neurotransmitter systems involved in sleep 
regulation. Rapid eye movement (REM) sleep depends on the balance between two mutually 
antagonistic systems, 'REM on ’ and ‘REM off,  which are themselves under the influence of 
other systems including GABAergic inputs from VLPO and hypocretin from the dorsolateral 
hypothalamus.
Abbreviations: VLPO = ventrolateral preoptic area; DRN = dorsal raphe nuclei; LC -locus 
coeruleus; PPT = pedunculopontine tegmental nucleus; LDT = laterodorsal tegmental 
nucleus; BRF = brainstem reticular formation
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2.2c. Other aspects of sleep regulation: the interaction of 
homeostatic and circadian processes.
Sleep regulation -  the 2 process model. While the neurophysiologic mechanisms 
discussed above describe the neurochemical basis of sleep regulation, they do not 
account for homeostatic and circadian influences in the regulation of sleep. For 
example, the tendency for increased sleep drive and prolonged recovery sleep 
following sleep deprivation is widely accepted both through scientific study and 
individual human experience, but this is not well explained by way of the 
reciprocal interaction hypothesis. Other biochemical mechanisms must, therefore, 
be invoked to explain this aspect of sleep control. Likewise, the importance of 
circadian factors in the sleep-wake cycle is well recognized, particularly by 
individuals who have experienced shift work or jet-lag, and these factors must be 
accounted for.
Circadian and homeostatic aspects of sleep regulation are currently considered 
within the framework of the two process model (Daan et al., 1984). This model 
essentially postulates that there are two key parameters in the regulation of sleep: a 
homeostatic process (process S), which accumulates during wakefulness and 
dissipates during sleep; and a circadian process (process C), which is determined 
by endogenous pacemakers and is independent of prior sleep (Figure 2.4). First 
proposed in 1982, the two process model is still widely accepted and is able to 
account for a number of recognized phenomena such as jet-lag, the dependence of 
sleep duration on circadian phase, and recovery after sleep deprivation (Daan et 
al., 1984).
Process S -  the homeostatic process. The term ‘sleep homeostasis’ refers to the 
balance of sleep and wakefulness in an individual, and the tendency to counteract 
deviations from an individual’s ‘reference level’ of sleep (Borbely, 2005). In 
other words, it refers to those mechanisms controlling the amount of sleep an 
individual requires, as well as the tendency to become sleepier with prolonged 
wakefulness and to recoup sleep ‘lost’ through sleep deprivation.
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Figure 2. 4 The two process model o f sleep. SCN-dependent alerting promotes 
wakefulness and opposes sleep ‘load’, which increases throughout the wake period. 
When the alerting signal subsides, sleep results. From Shiraki K, Sagawa S, Yousef MK 
(Eds): Physiological basis o f occupational health: stressful environments. Amsterdam: 
SPB Academic publishing 1996, p253-265.
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The mechanisms involved in this process remain only partially understood, but 
much interest has focused on the role of somnogens. Somnogens are substances 
that are said to accumulate in the brain during wakefulness, promoting sleep, and 
disperse or break down during the subsequent sleep period. In a classic study 
undertaken in the early 20th century, it was found that injecting the CSF of sleep 
deprived dogs into the ventricles of non-sleep deprived animals led to rapid sleep 
onset, a finding that supported the validity of this concept (Legendre, 1913). Since 
that time, increasing numbers of potential somnogens have been identified, the 
most widely known and studied being adenosine.
Adenosine (AD), a purine molecule, is released in the brain in response to reduced 
adenosine triphosphate (ATP) levels. In such situations, which typically result 
from metabolic stressors such as seizures or ischaemia, AD inhibits neuronal 
activity and is neuroprotective (Portas et al., 1997). However, sleep deprivation or 
prolonged wakefulness can also increase AD levels in the basal forebrain and 
brainstem (Porkka-Heiskanen et al., 1997; Porkka-Heiskanen et al., 2000), with 
levels falling rapidly during recovery sleep (Arendt, 2004). Direct administration 
of AD in these regions, particularly the preoptic area, has been shown to promote 
sleep (Chamberlin et al., 2003; Thakkar et al., 2003), an effect that appears to be 
mediated via direct inhibition of wake-promoting regions and disinhibition of 
GABAergic neurons in the VLPO (Thakkar et al., 2003). Moreover caffeine, a 
methylxanthine Ai receptor antagonist, has well-known wake promoting effects; 
and blockade of Ai receptor synthesis (using an antisense oligonucleotide to the 
adenosine Ai receptor mRNA) slightly reduces spontaneous sleep, but strongly 
reduces rebound sleep following sleep deprivation (de Saint Hilaire-Kafi et al., 
1989; Kapas et al., 1993).
In terms of other possible somnogens, the gut peptides insulin, cholecystokinin, 
and bombesin (Hayaishi and Urade, 2002; Obal and Krueger, 2003), which are 
released after eating, have been shown to increase slow wave sleep and may be 
responsible for postprandial sleepiness. Cytokines including interleukin-lp, 
tumour necrosis factor (TNF) and prostaglandin D2 (Obal and Krueger, 2003), and 
hormones including growth hormone releasing hormone (GHRH), growth 
hormone and prolactin, appear to exert somnogenic effect. A number of other
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compounds such as oxidized glutathione and reactive oxygen species are also 
under investigation as potential somnogens (Moore, 1997).
Process C -  the circadian process. In addition to quantitative and homeostatic 
effects, the effects of circadian rhythm on sleep and wakefulness must also be 
explained. Circadian rhythms are a feature of almost all eukaryotic organisms 
(Johnson et al., 1988), and are generated by endogenous biological clocks. They 
comprise cycles of behaviour and physiology with a period of approximately 24 
hours; they occur in the absence of external stimuli but normally are synchronized 
to environmental day-night stimuli.
The circadian timing system has three main components: entrainment pathways, 
which allow circadian rhythm generators to be synchronized with external stimuli; 
the pacemaker, which generates cyclical output patterns; and effector systems, 
through which the cyclical firing patterns of the pacemakers are translated into 
physiological and behavioural patterns.
Light is the most important environmental stimulus responsible for entrainment 
(Zeitgeber). The entrainment effects of light are mediated through the 
retinohypothalamic tract (RHT), essential for this process but unrelated to other 
visual function (Turek, 1989), which projects directly from the retinal to the 
suprachiasmatic nucleus (SCN) in the anterior hypothalmus. Locomotor activity 
is also a zeitgeber (Czeisler et al., 1999), although has weaker effects than light. 
These stimuli ‘entrain’ the endogenous pacemaker, the SCN, to environmental 
stimuli which indicate day or night.
While zeitgebers produce the environmental entrainment of circadian rhythms, the 
SCN determines the individuals free-running circadian period (r), which in 
humans is reported to average 24.2 hours in the absence of light cues (Welsh et al.,
1995). The SCN is a population of neurons with intrinsic circadian oscillator 
properties (Shibata and Moore, 1988), which have extensive interconnections 
resulting in a distinct pacemaker function; its firing rate is high during the day but 
low at night (Moore and Danchenko, 2002). The rhythms themselves are 
generated on a molecular level within the SCN, a process which depends on the
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coexpression of specific clock genes, including the Period {Per I, Per 2, and Per 
3), Cryptochrome {CryI and Cry2), Clock and Bmalll. The protein products of 
these genes interact and oscillate over an approximately 24 hour cycle through a 
complex negative feedback loop (von Schantz and Archer, 2003). Polymorphisms 
in these genes may explain variability in sleep propensity and differences in 
morning or evening alertness between individuals (Moore, 1997).
The outputs of the SCN are not extensive; projections are restricted to the 
hypothalamus, basal forebrain and midline thalamus (Watts, 1991), although 
secondary projections exist from these regions to other effector regions in the 
anterior pituitary and brainstem, thereby mediating control over autonomic and 
metabolic functions as well as sleep architecture. The SCN also communicates 
with the pineal gland via a circuitous route, through which it modulates the release 
of melatonin (Arendt, 2004). Melatonin is effectively a ‘darkness hormone’, 
produced at night, and with the duration of secretion reflecting the length of night. 
Its function appears to be similar in all animals studied, acting as a time signal and 
organizing daily and annual rhythms; its release is low in daytime and increased at 
night in both nocturnal and diurnal creatures (von Schantz and Archer, 2003).
The 2 process model -  summary. According to the two process model of sleep 
regulation, sleep timing and structure is regulated by the interaction of 
homeostatic and circadian processes. This model predicts sleep timing and 
daytime vigilance, with sleepiness at any given time being a function of both the 
point in the circadian cycle and duration of prior wakefulness. The model has 
been validated computationally and has been shown to be sufficient to explain the 
variability in vigilance and sleepiness during normal wakefulness, as well as the 
effects of shift work, internal desynchronisation in the absence of time cues, and 
recovery from sleep deprivation (Daan et al., 1984).
Section 2.3. Electrophysiological changes in sleep
The neurochemical, circadian and homeostatic mechanisms discussed up to this 
point ultimately exert their influence on sleep and wakefulness through their 
effects on the intrinsic and synaptic excitability of cortical and thalamic neurons.
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These electrophysiogical changes are complex, and a full discussion of the subject 
is not feasible here. However, it is important to discuss the key 
electrophysiological correlates of NREM and REM sleep, as well as to briefly 
review the cellular basis of these features.
2.3a. Electrographic features of sleep
The background EEG patterns in wakefulness and sleep reflect the electrical 
activity at the cerebral cortex. Individual neuronal potentials are clearly too small 
to be detectable in scalp EEG, and the millions of action potentials (each lasting 
about a millisecond) firing almost simultaneously in the cortex simply cancel out. 
Rather, the EEG detects the rise and fall of summed postsynaptic inhibitory and 
excitatory potentials, which often occur in parallel in millions of neurons at the 
same time. Broadly speaking, the EEG patterns of NREM sleep reflect increasing 
synchronization of neuronal activity in the thalamus and cortex, wheras those of 
wakefulness and sleep reflect short scale synchronization of fast (20-50 Hz) 
rhythms over the cerebral cortex resulting in EEG ‘activation’ or ‘desynchronised’ 
patterns.
Features o f  N REM  sleep. The stages of NREM sleep are marked by characteristic 
EEG changes: attenuation of background rhythms with vertex sharp waves and 
increasing theta activity mark sleep onset in stage 1; in stage 2, sleep spindles and 
K-complexes are seen; in stage 3, increasing high amplitude delta activity (0.5 -  3 
Hz, anteriorly predominant and greater than 75pV) is seen, occupying 20-50% of 
the record, and spindle activity is still present during this stage; in stage 4, high 
amplitude delta activity occupies over 50% of the record, and sleep spindles are 
only rarely observed (Niedermeyer and Lopes da Silva, 2004).
Features o f  R E M  sleep. Electrographically, REM sleep has appearances similar to 
stage 1 sleep or wakefulness, with a mixed frequency, ‘activated’ or 
‘desynchronised’ appearance often containing significant theta activity. At times, 
sawtooth waves are seen over the frontocentral regions, usually in or around 
phasic REM (Niedermeyer and Lopes da Silva, 2004).
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2.3b. Cellular mechanisms of NREM sleep
Experimental studies in animals have shed some light on the neuronal substrates 
for these EEG changes. The features of NREM sleep seem to broadly arise from 
three forms of thalamocortical oscillation: spindle oscillations (7-14Hz), delta 
oscillations (l-4Hz) and slow oscillations (<lHz) (Steriade et al., 1985; Steriade et 
al., 1993). Broadly speaking, these NREM features are generated by 
hyperpolarisation of cortical and thalamic neurons, resulting in increased 
thalamocortical synchronization.
Spindle oscillations, which are seen as sleep spindles on scalp EEG from NREM 
stage 2, are seen at relatively low levels of hyperpolarisation and are generated by 
burst firing in the thalamic reticular nucleus (Steriade, 2004). These oscillations 
result through rhythmic and repetitive inhibitory bursts in the GABAergic neurons 
of the thalamic reticular nucleus, which produce rhythmic inhibitory postsynaptic 
potentials (IPSPs) in thalamocortical neurons. These bursts of inhibition are 
followed by sychronised postinhibitory rebound excitatory potentials, resulting in 
characteristic spindle oscillations (Timofeev et al., 1996). In addition to 
generating spindles, the inhibitory changes in the thalamus are also believed to be 
responsible for the cortical deafferentation that occurs in NREM sleep (Steriade et 
al., 1991).
Delta oscillations, responsible for the high amplitude delta of slow wave sleep, 
also result from inhibitory changes in the thalamic reticular nucleus and 
thalamocortical neurons. However, these are produced at a significantly greater 
degree of membrane hyperpolarisation than spindles, and hence the two 
oscillations are incompatible within a single cell (Steriade et al., 1993); this 
explains why spindle activity gradually disappears in slow wave sleep. The 
greater degree of thalamic inhibition at this stage also results in more profound 
thalamic deafferentation, and hence higher arousal thresholds than in stage 2 sleep.
Slow oscillations are somewhat different to delta and spindle oscillations in that 
they are generated in the cortex (Steriade, 2004). These oscillations, which have 
been observed in all major cell classes in the cerebral cortex, consist of slow (0.7-
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0.8Hz) hyperpolarisation and depolarisation occurring during both NREM and 
REM sleep. The main effect of these oscillations is to group and modulate the 
other patterns seen (e.g. limiting the duration of individual sleep spindles and K 
complexes). Overall, these three types of oscillation appear to interact during 
sleep, producing the characteristic scalp EEG patterns of the four stages of NREM 
sleep (Steriade, 2004).
2.3c. Cellular mechanisms of REM sleep and wakefulness
In contrast to NREM sleep, the EEG in wakefulness and REM sleep is 
characterised by low amplitude, mixed (but high) frequency activity. This pattern, 
reflecting activation of thalamocortical networks, is controlled by cholinergic 
inputs to the thalamus. In essence, these inputs have two major effects: they 
enhance thalamocortical excitability; and they inhibit the activity of the thalamic 
reticular nuclei, responsible for the generation of spindles and delta activity, the 
features of NREM sleep (Pare et al., 1988; Steriade et al., 1988).
The majority of thalamic inputs from the brainstem reticular formation act on 
association thalamic nuclei; the neurotransmitters involved are not known 
(although are probably largely glutamatergic). However, there are also major 
brainstem projections to the sensory thalamic nuclei; around 90% of these inputs 
are cholinergic, arising in the pedunculopontine (PPT) or laterodorsal tegmental 
(LDT) nuclei (Curro Dossi et al., 1991). It has been demonstrated that brainstem 
cholinergic activity projecting to these thalamic nuclei causes prolonged 
depolarization of thalamocortical neurons, with a corresponding increase in 
excitability; cholinergic antagonists in this region block this effect (Steriade and 
Deschenes, 1988). However, in the thalamic reticular nuclei, the opposite pattern 
is seen, with cholinergic stimulation producing prolonged hyperpolarisation and 
inhibiting spindle formation (Hu et al., 1989; Steriade et al., 1996; Steriade et al.,
1996). The increased thalamocortical excitability, combined with the inhibition of 
the reticular nuclei, results in the generation of fast rhythmic activity in 
intracortical, thalamocortical and intrathalamic networks (Woolf and Butcher, 
1986; Steriade, 2004); this produces the low amplitude ‘activated’ EEG pattern 
seen in wakefulness and REM sleep. It has been shown that this activated EEG
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pattern is, in fact, generated by highly synchronized 20-50Hz gamma activity, and 
so the term ‘desynchronised’ is best avoided in this context (Steriade et al., 1996; 
Steriade et al., 1996).
In addition to the thalamic effects, there is also a direct effect of the cholinergic 
system on cortical activation in wakefulness and REM sleep. As discussed, while 
most cholinergic thalamic inputs are to the sensory nuclei, the association nuclei 
(which have the wide cortical non-cholinergic projections) have inputs from other 
neurotransmitter systems; cortical activation these nuclei is therefore only 
indirectly influenced by the cholinergic system. However, direct activation of the 
cerebral cortex does occur, with cholinergic nuclei in the basal forebrain 
projecting diffusely and directly to the cortex. These basal forebrain nuclei have 
extensive connections with the LDT and PPT in the brainstem, and are largely 
driven by the activity of the brainstem nuclei (Steriade, 2004).
The profound muscle atonia that occurs during REM sleep is also generated via 
brainstem mechanisms. Clinically this is important as the cerebral motor system is 
activated during REM sleep; the muscle atonia prevents the physical ‘acting out’ 
of dreams during sleep (oneiric behaviours), and failure of this system results in 
the parasomnia REM sleep behaviour disorder (discussed later). In essence, the 
brainstem mechanisms which control REM and NREM sleep are also involved in 
the hypotonia observed. During wakefulness NOR and 5-HT, along with activity 
of subpopulations of the nucleus pontis oralis (NPO) under the influence of ACh, 
have an excitatory modulatory effect on pontomedullary motoneurons, thereby 
facilitating motor function (Chase and Babb, 1973). During NREM sleep, the 
reduced activity of these systems leads to a reduction in resting tone, observable 
through EMG monitoring on polysomnography. However, in REM sleep, there is 
complete dysfacilitation of motoneurons through these mechanisms which, as 
discussed previously, are silent at this time. In addition, cholinergic ‘REM on’ 
neurons, acting via subpopulations in the NPO, excite the inhibitory region of 
Magoun and Rhines, located in the ventral medulla (Magoun, 1946; Chase, 1976). 
From here, inhibitory intemeurons project to medullary motorneurons where they 
exert a potent inhibitory effect, causing hyperpolarisation of the neurons through 
glycine and GABA release (Kodama et al., 2003). This combination of
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dysfacilitation and active postsynaptic inhibition results in the muscle atonia of 
REM sleep.
SECTION 2.4. Sleep Function
The ultimate question with regards to sleep is one of function -  why does it 
happen? Sleep has been found to occur in all animals studied, and yet the reasons 
for its existence remain unclear. Many theories have been advanced, often based 
on the consequences sleep deprivation, with most authors proposing different 
functions for NREM and REM sleep. However, sleep deprivation studies, which 
have been used widely in both animals and humans to try to understand sleep 
function, have been unable to provide definitive answers. Total sleep deprivation 
in rats results in a characteristic pattern with dishevelled appearance, decline in 
body temperature, weight loss, skin lesions and death in about 14 days 
(Rechtschaffen et al., 1983). The cause of death has never been definitively 
established in such cases; certainly there is no evidence of organ failure, and the 
weight loss is less than that seen in starvation and would net seem sufficient to 
explain death. In humans, conversely, there is no evidence that sleep deprivation 
can be fatal. Cognitive, psychiatric and motivational effects are all observed, but 
interestingly homeostasis and organ function appear essentially unperturbed even 
by up to eleven days of total sleep deprivation (Bonnet, 2005). However, a ‘sleep 
debt’ is incurred, resulting in increased durations of slow wave sleep and, to a 
lesser extent, REM sleep during periods of recovery sleep (Dijk et al., 1990; 
Aeschbach et al., 1996).
2.4a. NREM sleep
There are many theories of NREM sleep function, but the most widely quoted fall 
broadly into three groups. Restorative theories view sleep as an opportunity for 
the brain and body to recover from the stresses and ‘wear and tear’ of wakefulness 
(Home, 1988). This concept is intuitively reasonable in view of the sense of 
replenishment felt after a good night’s sleep. However, there is little evidence that 
any organ in the body other than the brain undergoes increased repair during sleep; 
in fact, levels of amino acids in the blood (the major stimulus for tissue repair) are
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reduced during sleep as a result of the fasting state. Repair is facilitated by 
inactivity, but resting wakefulness appears equally or more effective than sleep for 
this, and there is no evidence that sleep deprivation slows wound healing 
(Mostaghimi et al., 2005). The release of growth hormone (GH) during NREM 
sleep has been cited as evidence for such theories, but GH probably has little to do 
with tissue repair per se, although its release may be a mechanism to protect tissue 
proteins against the effects of the sleep-induced fasting . The significant 
reductions in cerebral blood flow and metabolic rate observed during NREM sleep 
do, however, suggest that there may be some restorative function of NREM sleep 
in the brain (Maquet, 1995; Braun et al., 1997). Ecological theories propose that 
animals remain inactive and out of harm’s way during that part of the day-night 
cycle when they are least equipped to avoid predators and other dangers (during 
the night for animals that rely primarily on vision, and during the day for those in 
whom the olfactory sense is dominant (Webb, 1974). However, sleep would seem 
to be an overly complex physiologic process to evolve where wakeful inactivity 
would serve the same purpose. In addition, there is a negative correlation between 
sleep in general and predatory danger, with prey animals having less REM sleep 
than predators (Allison and Cicchetti, 1976; Berger and Phillips, 1995), making it 
unlikely to be a biological protection from predatory danger. The third major 
group of NREM sleep theories relates to energy conservation (Berger and Phillips,
1995), based on the similarities between sleep and hibernation (which is generally 
recognized as a mechanism for reducing energy expenditure during winter). 
However, recent work has suggested that sleep and hibernation are in fact quite 
distinct, with periodic arousal and sleep phases within a bout of hibernation 
suggesting that sleep is necessary even during the hibernating state and may thus 
serve some other purpose (Kilduff et al., 1993). In addition, the 10% reduction in 
metabolic rate which occurs during NREM sleep in humans seems insufficient, 
from an evolutionary perspective, to explain the essential nature of sleep.
2.4b. REM sleep
In contrast to theories of NREM sleep function, REM sleep is often purported to 
have a role in learning, memory and brain development (Horne, 1988; Stickgold, 
2005). Evidence favouring such a role includes ontogenic studies, indicating
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particularly high quantities of REM sleep in foetal and infantile development 
(Ioffe et al., 1980), and studies of learned perceptual skills which usually improve 
overnight but are disrupted by selective interruption of REM sleep (Kami et al., 
1994). However, such studies have numerous methodological problems, and most 
authors have concluded that a major role for REM sleep in memory consolidation 
is unproven and unlikely (Siegel, 2001; Vertes, 2004; Stickgold, 2005). The 
association of REM sleep with dreaming has been a major influence on the 
development of many theories of REM sleep; however, there is no widespread 
consensus on the physiological role of dreams or, indeed, whether they have any 
specific function at all (Home, 1988).
2.4c. Evolutionary Considerations
NREM and REM sleep patterns, essentially of the same nature as those seen in 
humans, are present in all birds and mammals, leading many researchers to the 
conclusion that these sleep states have evolved to serve some vital function. 
However, an alternative hypothesis has been proposed. In the theory of “advanced 
wakefulness” it is proposed that REM sleep, with associated loss of endothermic 
control, is analogous to the primitive resting state of our reptilian ancestors. 
Reptilian wakefulness, in terms of cerebral function, is said to be equivalent to 
mammalian sleep, and the “advanced” wakefulness of mammals is the most recent 
evolutionary development. In other words, according to this model both REM and 
NREM sleep states are essentially phylogenetic remnants; rather than these sleep 
states developing to serve a function, it is wakefulness has developed. The more 
primitive resting phases of sleep have been preserved, and taken on restorative or 
other functions, but are not themselves evolutionary additions (Nicolau et al.,
2000).
Conclusion
Sleep is an essential function, ubiquitous in the animal kingdom, but its precise 
role in life remains unclear. Despite this ongoing mystery, much progress has 
been made in understanding the mechanisms responsible for its regulation, 
although many areas of uncertainty remain. Furthermore, many of the insights
61
Chapter 2. Neurobiology o f Sleep
into these mechanisms are based on studies in experimental animals; not all 
findings from animal studies have been replicated in experiments in humans, and 
there are therefore some risks to directly extrapolating conclusions drawn from 
animal research to human sleep. With the development of new technologies, 
however, direct study of the human nervous system in sleep may increasingly 
become possible.
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CHAPTER 3. 
IMAGING SLEEP AND SEROTONIN -THE USE OF 
POSITRON EMISSION TOMOGRAPHY
Introduction
Positron Emission Tomography (PET) is a non-invasive imaging technique which 
is used to measure specific metabolic, physiological and molecular processes in 
vivo. In essence, the PET scanner works by detecting the rate of accumulation and 
the distribution of a tracer (a specific biologically active compound labeled with a 
positron emitting radioisotope) in a tissue under study. Many tracers have been 
developed with properties linking them to specific biologic functions such as 
glucose utilization, blood flow and receptor binding; as a result, PET has the 
unique capacity to measure any of these functions in vivo in a non-invasive 
fashion. While this technology may be used to image any region of the body, and 
can be used in both animal and human studies, this discussion will focus on 
cerebral PET in humans. In this chapter I will provide an overview of the 
principles of PET, before discussing principles of receptor binding studies and 
kinetic modeling. Finally, I will review the use of PET in the study of sleep and, 
more specifically, evaluate its capacity to examine a key component of sleep 
regulation, the serotonergic system.
Section 3.1. Principles of Positron Emission Tomography
3.1a. Basic concepts in PET scanning
The fundamental aim of cerebral PET scanning is to detect the rate of
accumulation and the distribution of a tracer, which is administered intravenously,
in the brain. Tracers are labeled with a positron emitting radioisotope {positron 
18 11emitter) such as F or C. Positron emitters are unstable, neutron-deficient 
isotopes which achieve stability through the conversion of a proton to a neutron. 
This conversion, or decay, results in the emission of a positron (a positive 
electron, i.e. antimatter) and a neutrino. The positron travels a short distance (up 
to 2 or 3mm) until it meets an electron; when this occurs, matter meets antimatter
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and an annihilation event occurs. This releases energy in the form of two photons 
(of equal energy) which leave the site of the annihilation at 180° to each other.
The PET scanner contains an array of scintillation detectors; when an annihilation 
occurs, photons are detected almost simultaneously on opposite detectors (a 
coincidence event). These coincidence events are registered and recorded by the 
PET scanner, and the 180° angle also enables tracing of a line o f response (LOR) 
of the photons.
Using this data, the source of the annihilation is accurately located and image 
reconstruction algorithms are used to generate a tomographic image. Attenuation 
correction of the image is an important component of this reconstruction process.
It allows for the attenuation by cerebral tissue of photons released in the 
annihilation, either through photoelectric absorption or scatter, factors of particular 
concern near the centre of the brain where up to 80% of photon pairs will be lost 
in this manner (Turkington, 2001). In addition, it should be noted that many 
photon pairs are lost in the image reconstruction process, as PET scanners are 
usually constructed with axial rings around the subject’s head. As a result, those 
photons that do not travel in the axial plane (plus or minus about 15 degrees) will 
not be detected.
Background noise in PET is due in a significant degree to two well recognized but 
unavoidable phenomena of the scanning process; scatter and randoms. Scatter 
describes the deflection of one or both photons from their original course 
following the annihilation event; these photons therefore register on the ‘wrong’ 
detectors, and the event is thus incorrectly assumed to have occurred on the line 
joining the two receptors. Randoms (random coincidences) occur through photons 
from two unconnected annihilation events arriving at detectors within the time 
window used to define a coincidence; as with scatter, an incorrect LOR is 
generated through such events. Corrections can be made for these phenomena but 
at the cost of increased background noise (Townsend, 2004).
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3.1b. PET Tracers
PET tracers are substances that follow (trace) a biologic process under study 
(Phelps, 1992). They comprise a pharmaceutical compound or other substrate 
which fulfils a number of criteria: it should behave in a predictable manner, 
identical or related to the biologic function being traced; it should be administered 
in very small quantities compared to the quantity of endogenous compound being 
traced, such that the tracer’s pharmacological properties exert minimal or no effect 
on the biological system (in general, the dose of tracer should be less than 1 % of 
the mass of endogenous compound); and any difference between the tracer and the 
natural compound should be negligible (Phelps, 1992). Tracers should have a 
high specific activity, in other words most of the compound should be 
radioactively labeled, with minimal ‘cold’ compound present.
The most widely used PET tracers are 18FDG and H2I50 . I8FDG is used to 
measure glucose utilization; it is transported into the brain through the blood brain 
barrier using the same carrier-mediated transport sites as glucose, and is then 
phosphorylated by hexokinase (as is glucose), when it becomes trapped and 
accumulates in the cells at a rate proportional to glucose utilisation. H2 150  is used 
to measure regional cerebral blood flow (rCBF). Substantial evidence indicates 
that excitatory neurotransmission is associated with local increases in rCBF, 
possibly mediated via nitric oxide release (Northington et al., 1992; Iadecola,
1993). These haemodynamic changes can be detected using H2I50 , and the 
technique has been widely used to find areas of brain ‘activation’ associated with 
various biological functions or neuropsycholgical tasks (Brooks, 1995; Andersson 
et al., 1998), although this technique has been largely supplanted by functional 
MRI.
Although 18FDG and H2I50  are well known and widely used, numerous other PET 
tracers have been developed which are sensitive to a number of more specific 
processes, such as cellular amino acid uptake (e.g. [MC] methionine) and 
ischaemic cerebral tissue (e.g. [I8F] MISO). Of particular interest in neurology is 
the use of radioligands which bind to specific neuroreceptors, such as 
dopaminergic (e.g. [n C] raclopride), cholinergic (e.g. A-85380), benzodiazepine
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(1 lC-flumazenil), and serotoninergic receptors (e.g. [n C] WAY-100635). These 
ligands are able to measure receptor densities and can often give significant 
insights into the roles of various neurotransmitter systems in pathological states. 
However, over the last decade, increasing evidence has accumulated to suggest 
that the binding of some radioligands (such as raclopride and diprenorphine) may 
be sensitive to concentrations of endogenous neurotransmitter. Tracers of this 
type are particularly interesting, as they have the capacity to provide insights into 
a range of physiological and pathological processes, including human sleep.
3.1c. Quantification of PET using kinetic modeling
In order to obtain information about changes in a particular biological process or 
function, a paired scan approach is often used. One scan is performed in a 
‘baseline’ state, and a second scan in the same individual performed in an 
‘activated’ state, in which scanning conditions other than the biological function 
of interest are kept identical. In receptor binding studies using ligands which are 
sensitive to endogenous neurotransmitter release, the distribution and magnitude 
of receptor binding between the two scans can provide important biological 
information regarding the neurotransmitter system under investigation.
While PET scans allow sequential measurements of radioligand distribution over 
time, the concentration and distribution of the ligand over the time course of a 
PET scan may be affected by a number of variables besides ligand-receptor 
binding. Factors such as blood flow, tracer clearance from plasma, specific 
activity and non-specific binding can vary between the baseline and activation 
scans, and may have a significant impact on the activity detected by the PET 
scanner (Ichise et al., 2001). In order to obtain biologically meaningful 
information, therefore, it is necessary to quantify the data in terms of a measurable 
parameter of interest. In practice this is achieved by the application of tracer 
kinetic models to the PET data. A full discussion of kinetic modeling is beyond 
the scope of this thesis, but here I will summarise some of the pertinent details 
relevant in receptor binding studies.
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(i) Parameters o f  interest. The aim of receptor binding studies is to measure the 
density of ‘available’ neuroreceptor sites. The most widely accepted measurement 
of this function is Binding Potential (BP) (Mintun et al., 1984), which represents 
the ratio BMax (the maximum concentration of receptor sites) divided by IQ (the 
equilibrium dissociation constant of the ligand). In order to estimate BP it is also 
necessary to measure the arterial input function, K /. Measurement of Kj usually 
requires arterial sampling of both the tracer and its radioactive metabolites during 
the scan, which is an invasive and technically complex process. However, the 
recent development of reference tissue models (discussed below), have removed 
the need for arterial sampling in many situations. These models cannot give 
absolute K| values, but are able to generate an estimate of the Ki ratio between the 
reference region and the tissue of interest. This ratio, termed Ro, is sufficient to 
generate BP values and also gives an estimate of relative blood flow between the 
reference tissue and the tissue of interest.
(ii) Compartmental models. Kinetic models used in PET quantification assume a 
‘compartmental’ system, based upon pharmacological principles, in which a 
‘compartment’ is a volume or space in which the tracer rapidly becomes uniformly 
distributed (Phelps, 1992). Compartments may have clear anatomical correlates 
(e.g. intravascular blood volume), but not necessarily (e.g. in brain unbound to 
receptor is a separate compartment to in brain bound to receptor). Several other 
assumptions are made in the generation of these models, including: (i) that 
radioligand in the system comes from a single source, arterial plasma, and that the 
tracer and plasma are well mixed; (ii) that the system under examination is in a 
physiological ‘steady state’ (iii) that radioligand can pass back and forth freely 
from arterial plasma to the free compartment; (iv) that first-order kinetics can 
describe the exchange of radioligand between compartments; and (v) that non- 
specifically bound radioactivity in the second compartment equilibrates rapidly 
with free tissue radioactivity (Ichise et al., 2001). Movement of tracer between 
these compartments is assumed to occur in a consistent and predictable fashion 
through first order kinetics, and is therefore governed by a number of rate 
constants. Using fundamental mathematical principles and Michaelis-Menton 
kinetics, first order differential equations are generated which can then be solved 
to enable measurements of the parameters of interest. In this discussion key
67
Chapter 3. Sleep, Serotonin and PET
underlying concepts are discussed in the main text, whereas more detailed 
mathematics is presented in the figures.
A summary of the simplest situation, the two compartment model (used for 
example with blood flow studies using H2I50 )  is shown in Figure 3.1. Essentially, 
the measurable parameters here are M j (the amount of tracer in the tissue of 
interest, which is measured by PET), and Ca (the arterial concentration of tracer). 
Sequential measurements of MT are made over time by the PET scanner (frames), 
from which a time-activity curve can be generated (Figure 3.1b).
Ca is measured (by arterial cannulation) for each of these M j measurements. 
Solving of the differential equations in terms of Mt and Ca enables measurement 
of Kj (Figure 3.1c), which corresponds to cerebral blood flow.
This basic model cannot be used for ligand studies, however, as the situation is 
more complex (Figure 3.2); ligand which has entered the brain may either bind to 
receptors or remain unbound (either free in tissue or nonspecifically bound to 
other, non-receptor, tissue). This binding must be taken into consideration in the 
kinetic modeling. Through basic pharmacological principles, the interaction of a 
free substrate (S) with a free receptor (R) to form the complex RS is described by
S + R *—*• RS
The association and dissociation constants (kon and koff) are such that, at 
equilibrium
kon[S][R] = k0ff[RS]
(where [square brackets] represent concentration). The affinity (Kd) of a ligand for 
a receptor is defined as k0ff/kon, and the total number of receptors is defined as 
Bmax, which is [R] + [RS]. So the above equation can be rewritten:
[RS] = Bmax [S]/([S ] + K d)
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Artery BBB Brain
Ki :
CA ■ Mj
: k*
Figure 3 1a Two compartment model as used for H2150 studies. CAand MT 
represent the concentration of tracer in the plasma (as measured by arterial 
sampling) and brain (as measured by PET) respectively. 1^  represents the 
influx rate constant (diffusion from blood to brain), and is equal to the rate of 
cerebral blood flow; k 2 is the efflux rate constant (diffusion from brain to blood). 
BBB is the blood brain barrier.
Influx rate = KiCa 
Efflux rate = k2 MT
Net rate of accumulation ( M t  );
Mr'(t) = KiCa(t) - k2 Mr(t)
The aim is to express Ki (equivalent 
to blood flow) in terms of the 
measurable variables MTand Ca.
This solves to:
e 1(21 Mr(t) = Ki/ e 1(21 Ca(t) dt
0
Figure 3.1c. Summary of mathematical 
equations used to measure blood flow 
(Ki).
Figure 3 .1 . Two compartment PET kinetic modeling as used for H2l5Q studies
Activity
Time
Figure 3.1b. Time-activity curve showing 
activity in brain detected by the PET scanner 
(Mr) and tracer in arterial blood (CA) on the y 
axis against time on the x axis
69
Chapter 3. Sleep, Serotonin and PET
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Ki : —
CA
---- 1 B --------- p
■ F B
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:  k2 
■
■
■
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.
Mt
Figure 3.2a. Model for receptor-ligand studies. Ki, k2 , CAand Mr are 
defined as in figure 3. F is free or non-specifically bound ligand in 
brain; B is receptor-bound ligand. M s the association constant (kon) 
and k< is the dissociation constant (korr)-
From Fig 3.2a:
B’ = k3F - k4B
F, = K1CA-(k2+ Kj)F + k4B
Where B’ and F’ are the net rates of accumulation of B and 
F respectively.
Thus at steady state, where B and F’ = 0: 
k3/ k4 = B/ F = Binding Potential (BP)
AND
MT = B + F = Ki/ k2 . [ky k4 + 1] CA 
So;
Mt/ Ca = Ki/ k2 . (1 + BP]
From this point, the equations can be differentiated and 
solved to give BP in terms of MT and CA (final equations not 
shown).
Figure 3.2b. Summary of mathematical equations used to measure 
binding potential (BP).
Figure 3.2. Modeling to determine binding potential (BP) in receptor-ligand studies
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However, in the PET setting, as [S] is a tracer and is hence very small compared to 
Bmax, this effectively becomes:
Bmax/ Kd = [RS]/ [S]
In other words, Bmax/ Kd is equal to the ratio of bound to free radioligand at 
equilibrium. This ratio is the Binding Potential (B.P.). By using the receptor- 
ligand model shown in Figure 3.2a, and rearranging the differential equations 
generated from this (Figure 3.2b), it is possible to express BP in terms of MT and 
C a .  and hence quantify BP in the scan (Figure 3.2b).
(iii) Reference tissue models and model simplification. As discussed previously, 
a major problem with kinetic modeling used in PET quantification is the need to 
measure the arterial input function. Such a measurement is essential, and usually 
requires arterial sampling of both the ligand and its radiolabeled metabolites, an 
invasive and complex process. However, ‘reference tissue’ models have been 
developed for use in ligand studies which allow the use of a reference tissue input 
function obtained from PET images, removing the need for arterial sampling.
Such models require a reference tissue in the brain, in which no specific ligand 
binding occurs (i.e. a tissue devoid of the receptors being studied). The modeling 
effectively uses this region as an indirect input function; in other words, 
differences in binding in this reference region (which by definition will be non­
specific, non-receptor related binding) with the binding in the tissue of interest are 
used to calculate BP values. It assumes that free and non-specifically bound tracer 
behave in the same manner in reference region and the tissue of interest.
The full reference tissue model (Cunningham et al., 1991) is summarised in Figure 
3.3. However, although this method generates robust BP measurements it gives 
large standard errors for other parameters (Hume et al., 1992). A simplified 
reference tissue model was subsequently developed by the same group based on a 
three compartment model, which effectively eliminated this problem 
(Lammertsma and Hume, 1996); this is summarised in figure 4
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BBB Artery BBB Brain
(tiuiM of interest)
Figure 3.3. Full reference tissue model for receptor-ligand studies. K1t k2, 
C a, M t, B, F, BBB are defined as in figure 4. M r is free or non-specifically 
bound ligand in reference tissue (by definition this region has no 
receptor-ligand binding); KA and KB are the influx and efflux rate 
constants for the reference tissue.
The aim of this model is to remove the need for direct 
measurement of the arterial input (CA) by using information 
from the reference region.
So:
M r ’= KaC a - KbM r
Where M r ’ is the net rate of accumulation of tracer in the 
reference tissue. Therefore:
C a = M r7 K a + K 0M b/ K a
So the arterial input function, CA, is expressed in terms of the 
accumulation of tracer in the reference region. This form of CA 
can be substituted into the equations for the standard receptor- 
ligand model (Figure 4), removing the requirement for direct 
arterial sampling.
Figure 3.3. Full reference tissue model for measurement o f binding potential 
(BP) in receptor-ligand studies withoutthe use o f arterial sampling.
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BBB Artery BBB Brain
(tissue oI Interest)
Figure 3.4a Simplified reference tissue model for receptor-ligand studies. K1f CA, MT, 
M r, Ka Kb are defined as in figure 5. Bound and unbound ligand in the tissue of interest 
are not distinguished; k2 is the efflux constant for all tracer in the tissue of interest.
Using this model, it becomes possible through substitution to solve the 
equations to establish the parameters of interest (including BP and Ki) in 
terms of M r and M T Overall, this model produces more robust parameter 
measurements than the full reference tissue model (REFS).
The solution can either be obtained through graphical methods in which BP 
is obtained from the slope of the linear portion of the (e.g. Logan plot, 
below);
Normalised intergrated plasma activity
or non-linear methods, such as the Lammertsma and Hume method which 
solves to:
Mt = Ki/Ka . Mr (t) + k2 [1 -  M 1+ B P )  / Ka] (e  k'2t(l T> M r 
Figure 3.4b. Linear and non-linear analysis of simplified reference tissue model
Figure 3. 4. Simplified reference tissue model for measurement o f binding potential 
(BP) in receptor-ligand studies without arterial sampling
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(iv) Graphical vs non-linear analysis methods. There are two broad approaches 
to parameter estimation based on kinetic models.
Graphical Methods. In graphical methods, the differential equations generated 
from the compartmental models are solved such that an estimation of the BP can 
be obtained by graphically fitting a straight line to experimental data, or by using 
linear regression analysis (Ichise et al., 2001). Because such graphs tend to be 
linear only as the system approaches equilibrium, early points are excluded by 
visual inspection for linearity, and the parameter of interest is then generated from 
the linear portion of the graph using linear regression procedures (often linear least 
squares). Examples of graphical methods include the Gjedde-Patlak plot for 
tracers with irreversible uptake (Patlak et al., 1983) and the Logan plot for tracers 
with reversible uptake (Logan, 2000). The Logan plot is useful in ligand studies 
as it is computationally efficient and can be used with a reference tissue input, 
removing the requirement for arterial sampling. However, it has been shown that 
there is some bias inherent in this model, (Slifstein and Laruelle, 2000), although 
techniques have been developed to minimize this problem (Varga and Szabo, 
2002).
Non-linear Methods. These methods differ from the graphical models through the 
use of non-linear regression techniques, which are mathematically more complex 
and computationally demanding than those used in the graphical methods. The 
reference tissue model initially described by Lammertsma and Hume using this 
approach was based on a four compartment model (Figure 3) and subsequently 
simplified to a three compartment model (Figure 4) (Lammertsma and Hume,
1996). Despite the computational demands of the simplified reference tissue 
model, it is robust and has now been validated for use with a number of 
radioligands (Gunn et al., 1997; Passchier et al., 2001).
In summary, kinetic modeling is an essential process which enables the 
quantitative estimation of parameters of interest (principally BP in receptor ligand 
studies) from PET data. These parameters can then be used to look for 
biologically significant differences between different scans.
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3.1 d. Using PET to measure neurotransmitter fluctuations in 
vivo
Over the last 10-15 years there has been significant interest in the measurement of 
endogenous neurotransmitter flux in vivo using PET with neuroreceptor ligands. 
While many ligands appear insensitive to levels of endogenous neurotransmitter, a 
number have been identified in whom such sensitivity clearly exists. To date, 
these have been predominantly D2 dopamine receptor ligands; the most widely 
studied is [ '1 C] raclopride. Initial studies demonstrated the sensitivity of [' !C] 
raclopride binding to endogenous dopamine through the use of pharmacological 
challenges with compounds known to stimulate dopamine release, typically using 
stimulants such as amphetamine or methylphenidate (Laruelle, 2000). Subsequent 
studies have gone on to implicate the dopaminergic system in a number of 
biological processes by demonstrating their association with altered n C-raclopride 
binding (Koepp et al., 1998; Laruelle and Huang, 2001).
The conventional explanation for this effect is the classical receptor occupancy 
model (Seeman et al., 1989). In this model it is proposed that ligands with an 
affinity for the receptor comparable to that of the endogenous neurotransmitter 
bind more ‘loosely’ to the receptor than those with a higher affinity. As a result, 
these receptors are vulnerable to displacement by increased concentration of 
endogenous neurotransmitter; their binding is increased in situations of low 
endogenous neurotransmitter release, but reduced in situations of increased 
neurotransmitter release (Figure 3.5). However, this model has been increasingly 
questioned, primarily because affinity is not always a reliable predictor of a 
ligand’s sensitivity to neurotransmitter flux (Laruelle, 2000; Laruelle and Huang,
2001).
A possible alternative mechanism of ligand sensitivity to endogenous 
neurotransmitter is through receptor internalization or ‘trafficking’ (Figure 3.6). It 
is well recognized that many receptors, including D2 dopamine receptors, are 
coupled to G-proteins and undergo internalization as a response to agonist 
stimulation (Dumartin et al., 1998; Martin-Negrier et al., 2000). Internalisation of 
receptors may differentially affect the binding of a radioligand on the basis of
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Figure 3. 5. The classic receptor occupancy model for ligand-neurotransmitter 
interactions in PET. The radioligand competes directly with endogenous 
neurotransmitter for receptor binding sites, thereby binding more extensively in 
situations o f reduced neurotransmitter release (Laruelle and Huang, 2001)
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Figure 3. 6. The receptor internalization (or ‘trafficking') model for 
ligand-neurotransmitter interactions in PET. In situations o f increased 
neuroreceptor internalization (as may occur with increased endogenous 
neurotransmitter release), neuroreceptors are internalized. In this state 
they are unavailable for ligand binding, resulting in reduced radioligand 
binding.
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properties other than affinity, such as lipophilicity. In theory, ligands with high 
lipophilicity (and which are therefore able to diffuse across cell membranes) 
should be unaffected by receptor internalization. In contrast, those with low 
lipophilicity (which are therefore unable to diffuse across cell membranes) will 
have their binding reduced in situations of high receptor internalization (Figure 
3.6). Unfortunately, studies indicate that lipophilicity, like affinity, is not 
necessarily a good predictor of a ligand’s vulnerability to competition from 
endogenous neurotransmitter (Laruelle and Huang, 2001). The situation is 
complex, and other factors are also likely to be involved in conferring this 
property; possibilities include a reduction in affinity of the radioligand for 
internalised receptors in a low sodium (intracellular) environment, or a 
conformational change of internalised receptors with occlusion of the binding site 
for the radioligand (Zimmer et al., 2004).
Section 3.2. The use of PET in sleep studies 
3.2a. General considerations.
A number of difficulties confront the researcher looking to investigate sleep using 
PET. Firstly, PET is a labour-intense and technically complex investigation; as a 
result, in the majority of centres it is only practical to perform PET scanning 
during the daytime. Furthermore, the scanning process requires subjects to sleep 
with their heads immobilized within the scanner, a process that can be 
uncomfortable. This reduces the chance of obtaining sleep during a scanning 
session; there is also the possibility that the sleep quality obtained in such a 
situation may by different to sleep in a more ‘normal’ setting. Some studies have 
used prior sleep deprivation to increase the likelihood of sleep during the scan. 
However, there is ample evidence from EEG-based studies that recovery sleep 
following sleep deprivation is qualitatively different to normal sleep (Cajochen et 
al., 1999; Finelli et al., 2001). Moreover, there is substantial evidence that 
neurochemical changes, particularly in the serotonergic system, result from sleep 
deprivation (Prevot et al., 1996; Gardner et al., 1997). These issues must be taken 
into consideration when planning any PET study of sleep.
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Most PET studies in sleep have examined either rCBF changes using H2150 , or 
patterns of glucose metabolism using l8FDG. H2I50  has some technical 
advantages which often make this the approach of choice in PET studies of human 
sleep. H2150  PET requires only brief acquisition times (around 4 minutes), and 
the tracer has a very short half-life (2.04 minutes). As a result, multiple scans can 
be performed in different sleep stages during a single sleep period in any given 
subject. In contrast, l8FDG studies require a long period of data acquisition (30 
minutes or more); this factor, combined with the longer half-life of l8FDG which 
allows only one scanning session in a night of sleep, makes this technique less 
attractive than H2I50 . Nevertheless, l8FDG PET has superior spatial resolution in 
comparison to H2I50  PET, an advantage that has been utilized in a number of 
sleep studies.
3.2b. H2150  Studies.
H2150  studies indicate that, in comparison to wakefulness, NREM sleep results in 
reduced regional cerebral blood flow (rCBF) in the following areas: central core 
structures (including brainstem, basal forebrain and thalamus); basal ganglia; 
cerebellum; and some cortical areas, primarily mesial temporal, frontal and 
parietal regions (Braun et al., 1997; Hofle et al., 1997; Maquet et al., 1997; 
Andersson et al., 1998). The reduction in rCBF is most marked and robust in the 
thalamus. More recent studies have correlated EEG delta power with magnitude 
of rCBF changes. These demonstrate a decline in rCBF with increasing delta 
power in similar regions to those identified in the dichotomous NREM sleep/ 
wake state studies, but with one important difference; correlations between delta 
power and rCBF are not seen in the thalamus and brainstem (Dang-Vu et al., 
2005). A study of rCBF on awakening from sleep demonstrated a very rapid 
increase in rCBF in thalamus and brainstem regions, but a more gradual and 
progressive increase in rCBF in anterior cortical regions through the first 15 
minutes of wakefulness (Balkin et al., 2002).
Taken together, it can be interpreted from these studies that the changes in rCBF 
(and, by inference, excitatory neurotransmission) seen in the brainstem and 
thalamus reflect state-dependent (i.e NREM sleep versus wakefulness) processes
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(Hofle et al., 1997; Dang-Vu et al., 2005). This is concordant with 
neurophysiological studies of sleep, which indicate fundamentally altered firing 
patterns in these regions in NREM sleep (see previous chapter for details). On the 
other hand, the gradual reduction in rCBF in cortical and other regions during 
NREM sleep indicates a progressive reduction in activity with increasing ‘depth’ 
of NREM sleep in these areas (Hofle et al., 1997; Dang-Vu et al., 2005). In 
combination, these findings support the concept that brainstem and thalamic 
regions are important in the determination of state (i.e. NREM sleep or 
wakefulness), whereas cortical function is not only a function of wakefulness or 
sleep per se, but also of depth of sleep and degree of alertness after waking.
REM sleep, in comparison with NREM sleep, is associated with reactivation of 
central core structures (including brainstem, thalamus, and basal forebrain) as well 
as the limbic system, and regions responsible for visual and auditory processing 
(both primary and association cortices); however, frontal and parietal association 
cortices remain deactivated as in NREM sleep (Maquet et al., 1996; Braun et al.,
1997). It has been suggested that this pattern of relative activation seen during 
REM sleep is consistent with the visually and emotionally rich content of dreams; 
likewise, relative deactivation of areas responsible for higher order processing 
may be related to their often bizarre and uncritically experienced nature (Braun et 
al., 1997).
3.2c. 18FDG studies.
These have been largely concordant with rCBF studies, although with some 
interesting additional findings. In NREM sleep, a global reduction in glucose 
metabolism is observed during NREM sleep, which returns to waking levels 
during REM sleep (Maquet et al., 1990). More specifically, reduction in glucose 
metabolism is observed in the thalamus and large areas of frontal, parietal, 
temporal and occipital cortex, primarily in regions of association cortex, with no 
change seen in limbic and primary sensorimotor areas (Maquet et al., 1992; 
Nofzinger et al., 2002). However, one study has also shown a clear increase in 
18FDG uptake in the hippocampus in NREM sleep compared to wakefulness,
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potentially supporting the concept that NREM sleep plays a role in memory 
(Nofzinger et al., 2002).
In REM sleep, global cerebral glucose metabolism resembles that seen in 
wakefulness (Buchsbaum et al., 1989; Maquet et al., 1990), but may in fact be 
increased in limbic and paralimbic regions (Nofzinger et al., 1997). These 
findings are comparable to those from rCBF studies, and appear to give a physical 
substrate to the rich emotional content widely described in dreams (Stickgold, 
2005).
Section 3.3: Serotonin and the CNS
While 18FDG and H2 lsO PET studies are useful for examining changes in 
metabolic rate and rCBF during sleep, they provide no information about the 
behaviour of specific neurotransmitter systems. The serotoninergic system, which 
appears to play and important role in sleep from animal studies, is a tantalizing 
target for ligand studies. Besides its role in sleep, this system has a putative role 
in many other neurological functions, such as cognition, affect, and locomotor 
activity (Jacobs, 1997), and also in psychiatric and neurodegenerative diseases 
such as anxiety, depression and schizophrenia (Andrade and Nicoll, 1987; 
Glennon, 1990; Saxena, 1995). However, while 1 ^-raclopride and other tracers 
sensitive to endogenous dopamine release have opened exciting new avenues for 
imaging dopamine neurotransmission (Koepp et al., 1998), finding comparable 
ligands for the serotonergic system has proved difficult. Before going on to 
discuss the current status of serotonergic imaging with PET, however, it is 
necessary to briefly consider the organisation of this system in the CNS.
3.3a. Anatomy and physiology.
The serotonergic system is composed of several neuronal groups, the somas of 
which are located in a medial saggital plane extending from the brain stem to the 
midbrain; these form the raphe nuclei (Figure 2.2). These neuronal groups send 
very widespread projections throughout the central nervous system. The caudal 
raphe nuclei (magnus, pallidus and obscurus) give rise to a prominent bulbospinal 
serotoninergic system. The rostral raphe nuclei project, via the medial forebrain
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bundle, to extensive forebrain regions including most of the cerebral cortex, 
hippocampus, basal ganglia and limbic regions; a single serotoninergic neuron 
may send divergent axon collaterals to a number of remote forebrain areas. 
Serotonin is synthesized from its precursor, tryptophan, within these serotonergic 
neurons where it is stored in vesicles until its release.
Release of serotonin is influenced principally by the rate of firing of the dorsal 
raphe nuclei (DRN), which occurs in a rhythmic, ‘pacemaker’-like fashion. This 
is regulated by a complex system comprising inputs from other neurotransmitter 
systems (principally stimulatory noradrenergic inputs from the locus coeruleus, 
and inhibitory influences from serotonergic somatodendritic 5HT iA autoreceptors). 
However, the amount of serotonin released from the axon terminals in response to 
action potentials at a given frequency is not constant, being heavily modified by 
the action of presynaptic autoreceptors and 5HT iB terminal autoreceptors (Adrien, 
1995; Gothert, 1997). Once release, free serotonin is cleared from the 
extracellular space by reuptake into the serotonergic neuron by a high-affinity 
transporter, or catabolised into 5-hydroxy-indolacetic acid (5-HIAA) by 
monoamine oxidase A (MAOA).
A number of endogenous or exogenous factors can also influence serotonin release 
in the CNS, and need to be considered when examining the serotonergic system.
In animal studies, serum tryptophan concentrations have been demonstrated to 
have a significantly influence serotonin release, with tryptophan infusions 
increasing CNS serotonin and tryptphan depletion having the opposite effect 
(Femstrom and Wurtman, 1971; Westerink and De Vries, 1991; Stancampiano et 
al., 1997). An intrinsic circadian effect on serotonin release has also been 
demonstrated independent of the sleep-wake cycle (Barassin et al., 2002; Malek et 
al., 2004). Abundant evidence from animal and human studies implicates 
serotonin in the regulation of mood and affect (Blier and de Montigny, 1999; 
Middlemiss et al., 2002), and antipsychotic and antidepressant appear to exert 
their effect at least in part through the serotonergic system (Stockmeier, 1997; 
Middlemiss et al., 2002). As might be anticipated from the involvement of 
serotonin in the sleep-wake cycle, stimulants drugs also appear to work through 
stimulation of serotonin (as well as dopamine) release. Best characterized in this
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Figure 3. 7. Schematic representation o f a serotonergic neuron located in the dorsal raphe 
nuclei. Serotonin (5-HT) is released into the extracellular space, where it may bind to a 
variety o f receptors, the most widespread of which are the post-synaptic 5-HTIA receptors. 
Presynaptic 5-HT)B receptors and somatodendritic 5-HT!A autoreceptors both negatively 
influence rates o f neuronal firing. Serotonin in cleared from the extracellular space, either 
by reuptake into the neuron via high-affinity serotonin transporters, or through catabolism 
into 5-hydoxy-indolacetic acid (5-HIAA) under the control o f the enzyme MAOA in glial 
cells.
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respect are methamphetamine and its derivatives; in animal microdialysis 
experiments, these drugs have been clearly demonstrated to result in substantial 
increases in serotonin and dopamine (Kuczenski and Segal, 1997; Segal and 
Kuczenski, 1997, 1999). In contrast, the stimulant methylphenidate appears to 
exert its effect solely through the dopaminergic system, with no appreciable effect 
on serotonergic neurotransmission (Kuczenski and Segal, 1997; Segal and 
Kuczenski, 1999).
3.3b. 5HT1A Receptors.
Although serotonergic neurons have a primitive architecture and simple firing 
patterns (Jacobs, 1997), the widespread projections and a highly complex receptor 
system of the serotonergic system enable it to influence a wide range of functions. 
To date, a total of 16 serotonin receptors are recognized (Hoyer et al., 1994); these 
comprise 7 major receptor types (5HTi to 5 HT7), with further subtypes (A-D) of 
5HTt and 5 HT2. All are G protein coupled receptors except for 5 HT3, a ligand- 
gated ion channel. Within the central nervous system, the most ubiquitous and 
functionally most important serotonin receptor is the 5HTiA receptor (Hoyer et al., 
1994). These receptors are found throughout the CNS, with highest densities in 
the hippocampus, limbic system, and raphe nuclei; however, they are not seen in 
the cerebellum, substantia nigra or striatum of the adult human brain (Burnet et al., 
1995; Hall et al., 1997). 5HT)A receptors are thought to be involved in a range of 
functions, but appear to have a particular role in the regulation of mood (Deakin, 
1991) and sleep (Gardner et al., 1997; Seifritz et al., 1997). They are inhibitory 
and have a dual pattern of distribution, being located both on serotonergic 
neurones (somatodendritic autoreceptors) and on the targets of serotonergic 
projections (post synaptic receptors or heteroreceptors). There is evidence to 
suggest that these two forms of 5HTiA receptor have somewhat different 
pharmacological profile (Millan et al., 1994); 5HT]A somatodendritic 
autoreceptors are desensitized by prolonged exposure to endogenous serotonin 
(Chaput et al., 1986; Le Poul et al., 1995), probably resulting from receptor 
internalisation (Riad et al., 2001), wheras 5HTiA heteroreceptors are not subject to 
such desensitisation. This difference in properties is believed to underpin the 
efficacy of antidepressant drugs (Blier and de Montigny, 1994).
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Section 3.4:5HT1A receptor radioligands
A number of 5HT iA receptor radioligands have been developed and investigated 
for PET imaging over the last two decades, although few have been successful 
enough in preclinical testing to reach the stage of human studies. Broadly 
speaking, these radioligands have been derivatives of either 8-OH-DPAT, a 
selective 5HT ia agonist, or W AY-100635, a selective 5HT)A antagonist.
3.4a. 8-OH-DPAT
8-OH-DPAT was the first 5HTiA ligand developed for imaging, being 
radioiodinated in 1988 for use in auroradiographic studies (Gozlan et al., 1988). 
However, it has not been developed for use in vivo; agonists such as 8-OH-DPAT 
bind only to those 5HT)A receptors which are G-protein-coupled, unlike 
antagonists which bind to both G-protein-coupled and uncoupled forms of the 
receptor. They therefore need a higher affinity than antagonists to reach an 
equivalent binding potential (ZW/^</)- As a result, the relatively low affinity of 8- 
OH-DPAT {Kd = 1.6nM) is probably insufficient to generate images in vivo, and 
has not been further investigated for this purpose (Passchier and van Waarde, 
2001). A number of derivatives of this compound have subsequently been 
developed with higher affinities but have not been adopted in human studies for a 
variety of technical reasons (Passchier and van Waarde, 2001).
3.4b. WAY-100635
The first potent radioligand for the delineation of the 5HTiA receptor in vivo was 
[n C] WAY-100635, an antagonist which binds potently and selectively to the 
5HT)A receptor (Forster et al., 1995; Khawaja, 1995). [n C] WAY-100635 has a 
high affinity for the receptor (inhibition constant [Ki]= 0.8nM (Zhuang et al.,
1994)); along with its derivative, DWAY, W AY-100635 has been used 
extensively in studies of 5HTiA receptor distribution and density (Pike et al.,
1996; Ito et al., 1999; Sargent et al., 2000; Parsey et al., 2006), and due to a high 
affinity produces images with a high signal-to-noise ratio and good contrast. 
However, there are several major drawbacks with this ligand in terms of its value 
in clinical and research studies. Firstly, ligands labeled with the radioisotope [n C]
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cannot be distributed from the cyclotron to remote hospitals due to its short half 
life (20 minutes); secondly, the radiosynthesis process for [n C] WAY-100635 is 
taxing (Houle et al., 2000); and thirdly, its binding appears to be insensitive to 
endogenous serotonin release (Maeda et al., 2001), so it has little or no value for 
imaging serotonin flux in vivo.
3.4c. MPPF
A derivative of WAY-100635, 4-2'-(methoxy-phenyl)-l-[2'-(A-2"-pyridinyl)-/?- 
fluorobenzamido]ethlpiperazine (abbreviated to MPPF) has been developed 
(Zhuang et al., 1994) which appears to overcome these drawbacks. MPPF is more 
simple to synthesise than [n C] W AY-100635 (Passchier and van Waarde, 2001), 
and is labeled with the positron emitter 18F (Shiue et al., 1997; Le Bars et al.,
1998) which has a longer half life (109.8 minutes) than [UC]. Moreover, MPPF 
has a lower affinity for 5HT]A receptors (A, = 3.3nM), close to that of endogenous 
serotonin (A,=4.7nM) (Zhuang et al., 1994); although this results in lower image 
contrast, it raises the possibility that MPPF may be sensitive to competition from 
endogenous serotonin.
Studies in animals confirm that [l8F] MPPF binds specifically and reversibly to 
5HT ia receptors (Shiue et al., 1997; Ginovart et al., 2000). Likewise, [18F] MPPF 
studies in healthy humans show uptake in close agreement with the known 
distribution of 5HT iA receptors in the human brain (Passchier et al., 2000, 2000), 
demonstrating the viability of this radioligand for 5HT iA receptor imaging. 
Moreover, the validity of the Logan analyses and the simplified reference tissue 
model (using the cerebellum as the reference tissue) for quantification [,8F] MPPF 
binding to 5HT iA receptors in the human brain have been confirmed (Passchier et 
al., 2001; Costes et al., 2002). As a result, neither metabolite correction nor 
arterial sampling are required for the evaluation of BP using [l8F] MPPF.
Considerable evidence from animal studies has accumulated to suggest that [l8F] 
MPPF binding to 5HTiA receptors in vivo is indeed sensitive to endogenous 
serotonin release. Most of this work has been performed using a p+-range- 
sensitive detector (Zimmer et al., 2002) in anaesthetized rats, combined with
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microdialysis. Initially, Zimmer et al. showed that endogenous serotonin release, 
mediated by fenfluramine administration, reduces [18F] MPPF binding in a dose- 
dependent manner (Zimmer et al., 2002). More recently they demonstrated that 
serotonin release evoked in a quasi-physiological manner, through electrical 
stimulation of the dorsal raphe nuclei, also results in reduced [18F] MPPF binding 
(Rbah et al., 2003). Furthermore, the same group subsequently showed that 
decreasing endogenous serotonin release by the administration of a tryptophan 
hydroxylase inibitor results in an increase in [l8F] MPPF binding (Zimmer et al.,
2003). As discussed earlier, the mechanism for this sensitivity is unclear; 
although the classical model of direct competition for available receptor binding 
sites may be relevant, it is likely to be an oversimplification of the situation. 
Recent animal data has suggested that internalization of receptors bound to 
endogenous or exogenous agonist will reduce [l8F] MPPF binding to 5HT iA 
autoreceptors in the raphe nuclei, although this effect is not seen on 
heteroreceptors in the hippocampus (Riad et al., 2004; Zimmer et al., 2004).
Interestingly, there remains some debate as to whether altered [18F] MPPF binding 
is truly detectable at physiological ranges of serotonin flux. Two studies, one in 
animals (de Haes et al., 2006) and one in humans (De Haes et al., 2002), have 
failed to demonstrate such changes. The latter study is, to date, the only human 
PET study which has attempted to demonstrate changes in [l8F] MPPF binding in 
the face of endogenous serotonin flux. This study has been criticisised, however, 
for using tryptophan infusions and tryptophan depletion in an attempt to 
manipulate CNS serotonin release; the timing and magnitude of CNS serotonergic 
changes is unpredictable with this methodology, making it impossible to draw 
firm conclusions regarding the value of [18F] MPPF PET. In the former (animal) 
study, however, supraphysiological increases in serotonin were induced using 
fenfluramine in conscious monkeys. These changes, measured using 
microdialysis, were not accompanied by changes in [18F] MPPF binding (de Haes 
et al., 2006). The authors of these two studies have suggested that the inconsistent 
results arise through a peculiarity of the 5HT iA receptor, which is able to exist in a 
‘high affinity’ and ‘low affinity’ state (Nenonene et al., 1994; Watson et al.,
2000). Antagonists (including [l8F] MPPF) will bind equally to receptors in the 
low and high affinity states, whereas agonists (including endogenous serotonin)
86
Chapter 3. Sleep, Serotonin and PET
will preferentially bind to receptors in the high affinity state (Nenonene et al.,
1994; Watson et al., 2000). [18F] MPPF binding will only alter in the presence of 
endogenous serotonin, therefore, if sufficient receptors are in the high affinity 
state. At present this remains a matter for conjecture, as this concept has not been 
tested. Moreover, while several studies have confirmed the value of [l8F] MPPF 
PET in measuring 5HTi A receptor density in humans (Passchier et al., 2000; 
Passchier et al., 2001; Merlet et al., 2004; Costes et al., 2005), more work is 
required to assess its potential to measure changes in serotonergic 
neurotransmission in vivo.
Conclusion
PET technology has a unique capacity to measure physiological processes in the 
living human brain in a noninvasive fashion. While studies to date have examined 
regional blood flow and metabolism in sleep, the development of new ligands and 
modeling techniques raises the possibility of imaging neurochemical changes 
during the sleep wake cycle. [I8F] MPPF, a tracer specific to the 5HT i a receptor, 
is one such ligand; while its usefulness in this setting is not yet fully proven, it 
may have the capacity to shed new light on changes in the human serotonergic 
system during sleep.
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CHAPTER 4 
EPILEPSY -  DEFINITIONS, CLASSIFICATION AND 
EPIDEMIOLOGY
Introduction
Before discussing frontal lobe epilepsy, a major focus of this thesis, it is necessary 
to review some important general concepts in epilepsy. This chapter comprises a 
review of the terminology, classification and epidemiology of epilepsy, including 
a discussion of the current limitations in these areas. Firstly, however, some key 
terms should be defined.
A seizure is the clinical manifestation of a paroxysmal disturbance of central 
nervous system function, associated with excessive neuronal discharge, that is 
synchronous and self-limited. As such, a seizure is an individual episode, and is 
distinct from epilepsy which is defined as a tendency to recurrent, unprovoked 
seizures. The current ILAE definition of epilepsy is the occurrence of at least two 
unprovoked seizures separated in time by at least twenty four hours. An epilepsy 
syndrome, on the other hand, is defined as ‘a cluster of signs and symptoms that 
customarily occur together’ (ILAE, 1985), and is usually made on the basis of 
clinical, neurophysiological and neuroimaging data.
Section 4.1. Classification Systems
Epilepsy is a heterogeneous disorder; seizure type, associated comorbidities, 
appropriate treatment and prognosis all vary widely between affected individuals. 
Accordingly there is a clear need, from both clinical and research perspectives, to 
subclassify this condition in a manner that will assist in patient evaluation, 
management and prognostication. Unfortunately, however, classification of 
seizures and epilepsy has proved both problematic and controversial, and remains 
a hotly debated topic.
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4.1a. Historical perspective
An attempt to classify epilepsy into subgroups was first attempted by Galen in the 
second century AD (Gastaut and Zifkin, 1985). Classification, however, really 
began in 19th Century France, where physicians at institutions such as the 
Salpetriere Hospital in Paris coined terms such as ‘grand mal’, ‘petit mal’ and 
‘status epilepticus’ ( ‘etat de mal’) (Temkin, 1994). These terms soon entered 
common usage and were used for many years, but no distinction was made 
between seizure types and epilepsy syndromes, and physicians used the terms in 
different ways. For example, the term ‘petit mal’ was meant, strictly speaking, to 
describe what in modem terminology are termed absence seizures; however, many 
physicians would use the term to describe any ‘small seizure’ including complex 
partial seizures.
4.1b. ILAE Classification systems
The first International Classification of the Epilepsies (ICE) was proposed by the 
ILAE in 1969 in an attempt to improve diagnostic consistency (Gastaut, 1969). 
This classification established a fundamental dichotomy in which epilepsies were 
either partial or generalised, a distinction that was made on the basis of clinical 
and electrographic features. Partial epilepsies were all considered to be 
symptomatic, wheras generalised epilepsies could be primary, secondary or 
undetermined. This system, while useful, was rather broad and contained a 
number of ambiguities.
In an attempt to improve upon this, the ILAE proposed a new classification 
system, the International Classification of the Epilepsies and Epileptic Syndromes 
(ICEES) (ILAE, 1981, 1985), which forms the basis of the current system. This 
required two levels of classification -  one for seizures, and the other for epilepsy 
syndrome. The aim was a more comprehensive and pluralistic approach to 
classification, with the key dichotomy between partial (or ‘localisation-related’) 
and generalised epilepsies remaining, and a further subdivision into idiopathic or 
symptomatic categories. Once categorised in this fashion, there was a final level 
of classification into discrete epileptic syndromes. The term ‘syndrome’ was 
preferred to ‘disease’, as it does not necessarily imply a common aetiology and
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prognosis within all subjects. Again, the syndrome diagnosis was made on the 
basis of clinical features (including seizure semiology, age at onset, and associated 
neuropsychological and neurological signs) in conjunction with findings from 
EEG and neuroimaging studies. Two additional categories were also included in 
this classification: epilepsies and syndromes undetermined whether focal or 
generalised; and special syndromes (which included febrile convulsions and 
isolated seizures).
The ICEES was revised in 1989 (ILAE, 1989), with some additions and 
clarifications, but with essentially the same structure. The main change made in 
this revision was to define ‘idiopathic’ more rigidly as referring to epilepsies with 
specific electroclinical characteristics and a probable genetic aetiology, and to 
introduce the term ‘cryptogenic’ for epilepsies which were likely to be 
symptomatic but in which no definite cause had been identified. This 
classification system remains in use today, and is displayed on Tables 4.1 and 4.2.
4.1c. Problems with the current classification system structure
The current classification system has been a considerable advance in the field of 
epileptology. It has provided clinicians and scientists alike with a common 
nomenclature, allowing clear and meaningful communication between both those 
involved in direct patient care and those involved in epilepsy research. However, 
there is a growing acceptance that the system is now outdated and change is 
required. There are several reasons for this viewpoint.
Descriptive nature. The current classification system is largely descriptive, with 
syndromes defined by particular electroclinical patterns but without necessarily 
having an underlying common pathology or prognosis. This was an intentional 
approach; at the time it was developed, not enough was known about aetiological 
and pathological processes in epilepsy to use these as the basis of a classification 
system. Since 1989, however, there have been considerable advances in scientific 
knowledge. For example, major advances in neuroimaging have revolutionised 
the understanding of epilepsy and provided the ability to diagnose abnormalities 
such as hippocampal sclerosis and malformations of cortical development in vivo.
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1 Partial (focal, local) seizures
1.1 Simple partial seizures (consciousness not impaired)
1.1.1 With motor signs
1.1.2 With somatosensory or special sensory symptoms
1.1.3 With autonomic symptoms or signs
1.1.4 With psychic symptoms
1.2 Complex partial seizures
1.2.1 Simple partial onset followed by impairment of 
consciousness
1.2.2 With impairment of consciousness at onset
1.3 Partial seizures evolving to secondarily generalised seizures 
(tonic-clonic, tonic or clonic)
1.3.1 Simple partial seizures evolving to generalised seizures
1.3.2 Complex partial seizures evolving to generalised seizures
1.3.3 Simple partial seizures evolving to complex partial seizures 
evolving to generalised seizures
2 Generalised seizures
2.1 Absence seizures
2.1.1 Typical absence seizures
2.1.2 Atypical absence seizures
2.2 Myoclonic seizures
2.3 Clonic seizures
2.4 Tonic seizures
2.5 Tonic-clonic seizures
2.6 Atonic (astatic) seizures
3 Unclassified epileptic seizures
Table 4 .1 . Summary o f the current ILAE classification o f epileptic seizures (ILAE, 1981)
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(focal) epilepsies
2. Generalised 
epilepsies
3. Undetermined 
epilepsies
4. Special Syndromes
1.1 Idiopathic 2.1 Idiopathic 3.1 With both generalised and 4.1 Situation related seizures
• Benign childhood epilepsy with • Benign neonatal familial focal seizures • Febrile convulsions
centrotemporal spikes convulsions • Neonatal seizures • Isolated seizures or
• Childhood epilepsy with • Benign neonatal • Severe myoclonic epilepsy isolated status epilepticus
occipital paroxysms convulsions in infancy • Seizures occurring only
• Primary reading epilepsy • Benign myoclonic epilepsy in • Epilepsy with continuous with acute metabolic or
infancy spike-waves during slow- toxic event
1.2 Symptomatic • Childhood absence epilepsy wave sleep • Reflex epilepsies
• Chronic progressive epilepsy • Juvenile absence epilepsy • Acquired epileptic aphasia
partialis corrtinua of childhood • Epilepsies with generalised • Other undetermined
• Syndromes characterised by 
seiures with specific modes of
tonic-clonic seizures on 
awakening
epilepsies
precipitation • Other idiopathic generalised 3.2 Without unequivocal focal
• Temporal lobe epilepsies
• Frontal lobe epilepsies
• Parietal lobe epilepsies
• Occipital lobe epilepsies
1.3 Cryptogenic
epilepsies
2.2 Cryptogenic or symptomatic
• West syndrome
• Lennox-Gastaut syndrome
• Epilepsy with myoclonic astatic 
epilepsy
• Epilepsy with myoclonic 
absences
or generalised features
(N
ON
Table 4. 2. Summary o f the current ILAE classification o f epilepsies and epileptic syndromes (ILAE, 1989).
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Such abnormalities often have important implications in terms of pathophysiology 
and prognosis, but are not incorporated into the framework of the current 
classification.
Similar problems arise with respect to the genetics of epilepsy. While the term 
‘idiopathic’ is used in the classification system to imply a genetic basis to an 
epilepsy syndrome, the utility of the system in distinguishing genetic conditions is 
limited. For example, in the condition of Generalised Epilepsy with Febrile 
Seizures Plus (GEFS+), different family members with the same inherited 
mutation of the sodium channel a  subunit gene (SCN1A) receptor may develop 
different seizure types (Scheffer and Berkovic, 1997; Wallace et al., 2001). Under 
the current classification, each will be diagnosed with a different syndrome, 
despite carrying the same fundamental biological abnormality, the genetic 
mutation. Conversely, in other conditions such as Autosomal Dominant Nocturnal 
Frontal Lobe Epilepsy (ADNFLE), indistinguishable phenotypes can arise from 
mutations in different genes (McLellan et al., 2003). In view of such advances in 
neuroimaging, genetics and other areas, a new classification system which 
incorporates diagnostic entities with common pathophysiologic and anatomic 
features, as opposed to the current syndromic approach, would be desirable.
Practical application. A further problem with the current classification structure 
is that some individuals with epilepsy are difficult to classify within it. They may 
have overlapping features of more than one syndrome (Reutens and Berkovic, 
1995) or clinical features that do not clearly fit any category or syndrome. In 
some situations the question may be raised as to whether these cases represent new 
syndromes. As no clear definition exists as to what constitutes a syndrome, this 
somewhat arbitrary decision is based on a consensus of expert opinion, a process 
with limited scientific validity. This problem is exacerbated by the fundamental 
dichotomy between focal and generalised epilepsy syndromes in the current 
system. It has become increasingly apparent that there may be overlap in this 
area; focal seizures may be seen in some generalised epilepsies (Taylor et al.,
2004) and generalised spike-wave discharges may be seen in some focal epilepsies 
(Beydoun et al., 1992). Although the concept of focal and generalised seizures
93
Chapter 4. Epilepsy: Classification & Epidemiology
and epilepsies is a useful one, it is important to recognise that it is not applicable 
in all situations and attempting to do so may be misleading and counterproductive.
M ixing o f  semiological and electrographic data. The structure of International 
Classification of Epileptic Seizures has been criticised on the grounds that seizures 
are classified on the basis of ictal and interictal EEG findings in addition to 
clinical semiology. Luders and colleagues have stressed the fact that often clinical 
semiology and EEG findings are not strictly concordant, and that seizure 
classification should therefore be undertaken on a purely semiological basis. They 
make the point that the ictal semiology is analogous to a neurological sign in other 
disorders (e.g. tremor in Parkinson Disease), and that this information should be 
analysed separately to other data such as neuroimaging, clinical history and EEG 
findings. All information should then be integrated to define the epileptic 
syndrome precisely (Luders et al., 1998, 1999).
4.1 d. What is the purpose of the classification system?
A more fundamental question in the debate over the classification of epilepsy is 
whether a classification system based on syndromic diagnoses is really the most 
useful approach. A key question here is what is meant by classification, and what 
purpose it is designed to fulfil. This was originally characterised in the writings of 
Hughlings Jackson (Jackson, 1932) in which he compared the classification of a 
botanist, based on scientific and taxonomic principles, with that of a gardener, 
which has a practical, utilitarian basis. Addressing the scientific aspect, Berg has 
compared classification in epilepsy with the biological classification of life. She 
has made the point that in biology classification is a highly developed discipline 
with clear underlying principles and rules (Wolf, 2003). This is in marked 
contrast to the classification of epilepsy in which there are no rules, guidelines or 
standards to establish what constitutes a syndrome, and until such criteria exist, 
the concept of an ‘epilepsy syndrome’ will remain a nebulous one from the 
scientific perspective.
Criticisms of the classification system have also been made from the practical, 
‘gardeners’, point of view. Soon after its publication, several studies assessed the
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utility of the system in clinical practice, judging this by the percentage of patients 
in a sample who could be classified. The majority of these studies reported very 
high proportions of adequately classified patients (>95%) (Loiseau et al., 1991), 
leading to the conclusion that the system was clinically practical and useful. 
However, the majority of diagnoses in such series tend to be in the broad, non­
specific categories such as ‘cryptogenic localisation related’ and ‘undetermined’, 
rather than in the more specific syndromes. In the UK National General Practice 
Study of Epilepsy (Manford et al., 1992), approximately two thirds of all patients 
fell into these broad, non-specific categories. Moreover, one study from the 
Cleveland clinic (Kellinghaus et al., 2004) reported that even in this tertiary 
setting only 4% of adults and 21% of children had specific syndromic diagnoses, 
with the remainder in unspecified categories. It has, therefore, been argued by 
more than one author (Manford et al., 1992; Everitt and Sander, 1999),that the 
reported accuracy of the classification scheme is artificial. Most patients, 
particularly outside of specialised centres, will be categorised in one of the non­
specific groups which provide very little information pertaining to aetiology, 
treatment or prognosis. The classification is therefore of limited value in the 
majority of individuals with epilepsy.
4.1 e. Development of a new classification system
While most epileptologists agree that the present classification system is 
imperfect, there is no such agreement on how to replace it. Broadly speaking, 
there are two fundamental problems to overcome.
The first issue remains, as in Hughlings Jackson’s time, developing a system that 
is scientifically meaningful but also practical enough to be used in routine 
neurological practice. A truly useful classification system will need to be 
applicable in a huge variety of research situations in addition to its function in 
clinical practice. It must be practical enough to be used by clinicians in the 
everyday diagnosis and management of patients with epilepsy, from the most 
straightforward cases to those patients with intractable epilepsy requiring epilepsy 
surgery. For research it should be precise enough to be relevant in scientific
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studies of the genetic basis and pathophysiology of various forms of epilepsy, and 
yet simple enough to be applicable in large scale epidemiological population 
studies (in which many patients will not have had specialist neurological, let alone 
tertiary epileptological, input). The new classification system should, therefore, 
be capable of incorporating the enormous recent advances in the scientific 
understanding of epilepsy, but not be reliant on these to have clinical utility.
The second major problem arises from the need to approach epilepsy classification 
in a manner that is acceptable to the international epileptology community (Engel,
2001). A classification system will clearly have an impact upon the way epilepsy 
is conceptualised by researchers and clinicians. Unsurprisingly, many experts 
have differing opinions on such a conceptualisation, often influenced by their 
personal experience, knowledge base and research. Finding a solution that is 
acceptable to all, or at least the majority, of this community is a significant 
challenge in the development of a new classification.
As a result of these problems, work on the classification of epileptic seizures and 
epilepsy is still ongoing. In 2001, the ILAE Task Force on Classification and 
Terminology published a proposed diagnostic scheme for people with seizures and 
epilepsy (Engel, 2001). This was an attempt to revise the 1989 classification with 
purely descriptive ictal phenomenology, and while not a classification in itself, 
was proposed as a framework for the new classification scheme. The basis of this 
framework is a five-axis approach with Axis 1 being a description of ictal 
semiology, using a standardised glossary of terms. Axis 2 is the epileptic seizure 
type, representing diagnostic entities with aetiologic, therapeutic and prognostic 
implications. Axis 3 is the epilepsy syndrome, to be applied when possible. Axis 
4 then specifies aetiology when known, and Axis 5 is a designation of the degree 
of impairment arising from the epilepsy. While this framework has been accepted 
in principle by the ILAE membership, there remains lively debate as to its 
usefulness (Wolf, 2003).
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Section 4.2. Epidemiology of Epilepsy
Epidemiology is the study of the frequency, distribution and behaviour of a 
disease in populations. Numerous epidemiological studies of epilepsy have been 
conducted which have provided considerable information regarding its occurrence 
and natural history. The interpretation of much of the available data has, however, 
been limited by problems largely related to study methodology, and further well- 
conducted studies are still required.
4.2a. Incidence and prevalence
The incidence of a condition is defined as its rate of occurrence in a population, 
and is usually expressed in terms of cases per 100 000 of the population per year. 
The overall incidence of epilepsy in developed countries is in the region of 50 per 
100 000 per year (Kotsopoulos et al., 2002). Within these countries, however, 
there are significant socioeconomic influences, with an increased incidence 
observed in lower socioeconomic groups (Heaney et al., 2002). In addition, 
studies over the last three decades indicate that the incidence of epilepsy is 
decreasing in children but increasing in the elderly (Everitt and Sander, 1998). It 
has been suggested that improved prenatal and antenatal care are responsible for 
the reductions in childhood , wheras the increase in the elderly is attributable to 
greater survival rates in individuals with stroke and cerebrovascular disease.
Fewer incidence studies exist from developing countries, but available data 
suggests that in such areas the incidence of epilepsy is at least double that 
observed in developed countries (Lavados et al., 1992; Placencia et al., 1992); this 
finding may be related, at least in part, to endemic infections such as malaria and 
cysticercosis in some of these regions (Preux and Druet-Cabanac, 2005).
Prevalence is defined as the proportion of a defined population affected with a 
condition at a point in time, and is usually expressed as the number of cases per 
1000 population. Studies from around the world indicate prevalence rates of 4-10 
per 1000 (Sander, 2003), with studies in developing countries reporting prevalence 
at the higher end of the spectrum; the highest rates appear to be in the rural regions 
of developing countries. When lifetime prevalence (as opposed to prevalence of
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active epilepsy) is considered, rates are much higher. Up to 5% of the population 
will experience at least one non-febrile seizure in their lifetime, a consistent 
finding in both developed and developing nations (Sander and Shorvon, 1996).
4.2b. Prognosis
Prognostic studies have addressed both the potential for remission and the 
mortality in epilepsy. An estimated 70% of individuals with epilepsy will enter 
remission at some point in their condition (Sander and Shorvon, 1996), with the 
dominant predictor of remission being the number of seizures in the early months 
after presentation (MacDonald et al., 2000). Seizure type does not seem to 
influence prognosis, but there is insufficient data from available studies to make 
any definitive statement about the importance of aetiology or epilepsy syndrome 
as factors. Mortality studies have shown that, despite the generally good 
prognosis for seizure control, individuals with epilepsy are at increased risk of 
death compared to those without. The overall standardised mortality ratio in 
epilepsy has been estimated at 2.5 -  3 (Cockerell et al., 1997; Shackleton et al., 
1999; Shackleton et al., 2002), but this figure is higher in individuals with 
refractory symptomatic epilepsy and intellectual disability. Suicide (Nilsson et al., 
2002) and Sudden Unexplained Death in Epilepsy (SUDEP) (Pedley and Hauser, 
2002) as well as trauma, status epilepticus and pneumonia (Sander, 2003) have all 
been identified as significant causes of death in epilepsy.
4.2c. Methodological problems
It is crucial that sound study methodology is employed if epidemiological studies 
are to provide valid and meaningful information. Unfortunately, however, in 
many studies of the epidemiology of epilepsy this has not been the case. 
Suboptimal methodologies have resulted in a number of inconsistencies between 
some studies, and some questionable findings (Kotsopoulos et al., 2002). The 
methodological issues fall into a number of areas.
A fundamental problem has resulted from the fact that different investigators, 
particularly in older studies, have used different definitions of epilepsy and
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different classification models. This clearly makes comparison of the findings in 
different studies difficult or impossible. To address this issue, in 1997 the ILAE 
published guidelines for epidemiologic studies (Toczek et al., 1997) and these 
have been supplemented by recommendations arising through major meta­
analyses (Kotsopoulos et al., 2002). The guidelines consist of a list of definitions 
for seizures, seizure types, aetiological factors and indices of measurement that 
should be adopted for use in such studies.
A second issue is that of study design. Ideally studies should be prospective in 
design, with attention paid to methods of case ascertainment, as such methods will 
impact strongly on the accuracy of the results. For example, if data is collected 
exclusively from specialist neurological centres it is likely to be accurate and 
complete from a diagnostic point of view; this sample, however, will be biased by 
referral patterns and will therefore be unlikely to reflect the patterns of epilepsy in 
the population as a whole. On the other hand, community-based studies, such as 
the UK General Practice Study of Epilepsy (Cockerell et al., 1997) and the 
Rochester Epidemiology Project (Zarrelli et al., 1999) will give a more accurate 
reflection of epilepsy in the population, but diagnostic accuracy in such studies 
may be lower. Also, even in these studies, there may be individuals who have 
seizures but are either unaware of them or simply do not report them, resulting in 
inaccuracies in the findings.
A further, and related, problem is that of diagnostic accuracy. A definitive 
diagnosis of epilepsy is not always straightforward to make, being based almost 
entirely on the clinical history. As such it is strongly reliant on both the quality of 
the available seizure descriptions and the proficiency and experience of the 
clinician (Sander, 2003). This problem will be compounded in studies attempting 
to address specific syndromes in which additional factors, such as access to 
diagnostic technology and specialist services, will also be relevant. As outlined 
above, there may often be some trade-off in studies between diagnostic accuracy 
and optimal case ascertainment - obtaining both within a study may be difficult to 
achieve.
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4.2d. Outstanding issues:
There remain epidemiological aspects of epilepsy which have not been well 
studied to date. A major inadequacy is the lack of good quality incidence and 
mortality studies in developing countries (Toczek et al., 1997); of those studies 
which have been performed, many are methodologically suboptimal being either 
cross-sectional or retrospective in design (Preux and Druet-Cabanac, 2005). Large 
scale prospective studies are still needed to help understand differences in epilepsy 
in these regions compared to the developed world.
Another major shortcoming, and one that applies to all regions of the world, is the 
paucity of data regarding individual epilepsy syndromes. While broad aetiological 
classifications have been used in some studies in developed countries (Manford et 
al., 1992), there exist relatively few well designed, prospective studies which have 
attempted to accurately and comprehensively classify patients. As a result, little is 
known about the incidence and prevalence of individual epilepsy syndromes in the 
general population. Other specific issues, such as SUDEP and the impact of drug 
treatment on prognosis, also require further epidemiological study (Toczek et al., 
1997; Sander, 2003).
Conclusion
The epilepsies are a complex group of disorders with variable presentations, 
prognoses and comorbidities. The study of these conditions requires clear, 
commonly applicable definitions and classification systems, and a sound 
understanding of their epidemiology.
The 1989 ILAE classification system for seizures and epilepsy represented a major 
advance in epileptology. It has provided clinicians and researchers alike with a 
common nomenclature for use in the heterogeneous group of conditions which fall 
under the umbrella term “epilepsy”. The challenge now, however, is to replace it 
with a system that incorporates the recent advances in scientific knowledge. 
Achieving such a system, which has both clinical utility and scientific validity, is 
by no means straightforward. Despite the enormous progress in scientific
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knowledge that has been made since the time of Hughlings Jackson, the modem 
challenge in classification remains to find a system that is valid and appropriate 
for both “gardeners” and “botanists”.
From an epidemiological perspective, while much has been learned about the 
occurrence and distribution epidemiological studies, considerable challenges 
remain. Long-term, population-based, prospective studies with attention to 
syndromic diagnosis are still required in developed countries, but this need is even 
greater in the developing world. Such studies will be major undertakings but, if 
well conducted, may contribute substantially to our understanding of the 
epilepsies.
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CHAPTER 5 
SLEEP AND EPILEPSY
Introduction
Sleep and epilepsy are intimately related. While sleep and sleep deprivation are 
undeniably important factors in the precipitation of seizures, particularly in certain 
epilepsy syndromes, there are also important effects in the opposite direction; 
epilepsy may disrupt sleep, either directly through seizures and epileptiform 
activity, or indirectly through medication related effects. Here I shall review the 
important interactions between the physiological state and the pathological 
condition, firstly reviewing the effects of sleep on epilepsy and subsequently the 
effects of epilepsy on sleep.
Section 5.1: The effects of sleep on epilepsy
The first major study of sleep and epilepsy was performed on Gowers in the late 
19th century. In a study of institutionalized patients, he noted that in 21% of 
patients, seizures occurred only at night, in 42% they occurred only during the 
day, and in the remaining 37% they occurred randomly either during the day or at 
night (Gowers, 1885). Subsequent work into the influence of sleep on epilepsy has 
identified a complex picture, and identified a number of relationships.
One of the earliest recognized concepts was that of the ‘pure sleep epilepsy’. This 
term is used in those patients in whom seizures are limited exclusively to sleep; it 
is a relatively uncommon, being seen in about 6% of epilepsy patients admitted to 
a neurology department in one study (Young et al., 1985). Pure sleep epilepsies 
do not belong to any single epilepsy syndrome, but in general appear to respond 
well to treatment with antiepileptic drugs (Yaqub et al., 1997). In other cases, 
seizures are seen predominantly but not exclusively in sleep, and these constitute a 
further 4% of individuals with epilepsy; in other words, seizures occur 
predominantly or exclusively in sleep in around 10% of epilepsy patients (Young 
et al., 1985).
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A separate relationship, first identified by Janz, is that of the ‘awakening epilepsy’ 
(Janz, 1962). In these cases, individuals show a tendency to have seizures occur 
around awakening, usually within the first hour or two after arousal. Such a 
pattern is commonly seen in some idiopathic generalized epilepsy syndromes.
Finally, a relatively common but non-specific relationship between epilepsy and 
sleep is a modification of the electroclinical manifestations of the epilepsy 
depending upon the sleep-wake cycle. EEG abnormalities, seizure types and 
seizure frequencies may all be influenced by the sleep-wake state in variety of 
ways.
While there are many unexplained aspects in these relationships, overall they 
appear to depend largely upon two factors: firstly, the epilepsy syndrome; and 
secondly, the stage of sleep. In addition, sleep deprivation can influence both the 
electrographic features of the interictal state, and the precipitation of seizures.
5.1a. Epilepsy syndrome.
There are a number of syndromes in the ILAE classification in which clear 
relationships of seizures to sleep have been observed, and these are listed in Table 
5.1.
Idiopathic Generalised Epilepsies (IGE). Broadly speaking, the seizures of 
idiopathic generalized epilepsy occur during wakefulness, and are commonly 
‘awakening epilepsies’ as described by Janz (Janz, 1962; Herman, 2002). In 
particular, the syndromes of Juvenile Myoclonic Epilepsy and Epilepsy with 
Generalised Tonic Clonic Seizures on Awakening are classical awakening 
epilepsies. Seizures in these syndromes also occur more commonly following 
nights of sleep deprivation, for reasons that are not well understood. On EEG, 
generalized epileptiform discharges tend to be most frequent during NREM sleep 
and least frequent in REM (Niedermeyer, 1965; Lieb et al., 1980; Sammaritano et 
al., 1991; Niedermeyer, 1996). The spike-wave discharges are most prominent in 
stage 2 sleep, where they are often seen in conjunction with K complexes. 
According to Niedermyer, these K complexes tend to have an abnormal
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Idiopathic Focal 
Syndromes
Idiopathic
Generalised
Syndromes
Symptomatic 
Focal Syndromes
Symptomatic
Generalised
Syndromes
Syndromes 
unclear whether 
focal or 
generalised
Benign childhood 
epilepsy with centro- 
temporal spikes
Juvenile Myoclonic 
Epilepsy
Frontal Lobe Epilepsy Lennox Gastaut 
Syndrome (tonic 
seizures)
Epilepsy with 
Continuous spike-wave 
during slow wave sleep
Benign childhood 
epilepsy with occipital 
paroxysms
Autosomal Dominant 
Nocturnal Frontal 
Lobe Epilepsy 
(ADNFLE)
Epilepsy with 
Generalised Tonic 
Clonic Seizures on 
Awakening
Nocturnal Frontal Lobe 
Epilepsy
Temporal Lobe 
Epilepsy 
(including Nocturnal 
Temporal Lobe 
Epilepsy)
West Syndrome 
(infantile spasms)
Landau-Kleffner
syndrome
Table 5.1 Epilepsy syndromes with a clearly recognised relationship with sleep
Chapter 5. Sleep and Epilepsy
morphology with a frontal predominance, and he has proposed that this pattern 
represents ‘dyshormia’, or disordered arousal (Niedermeyer, 1996). A small 
subgroup of up to 10% of individuals with IGE may present as pure sleep 
epilepsies, with generalized tonic-clonic seizures restricted to sleep. In these 
individuals EEG abnormalities are often only seen during sleep (Young et al.,
1985; Chokroverty, 1998).
Symptomatic Generalised Epilepsies (SGE). In contrast to IGE, the seizures of 
symptomatic generalised epilepsy occur in both wakefulness and sleep. However, 
the electroclinical manifestations may be significantly influenced by the sleep- 
wake state. In West syndrome, the characteristic high amplitude ‘hypsarrhythmic’ 
interictal EEG pattern is seen most prominently in early NREM sleep 
(Niedermeyer and Lopes da Silva, 2004). The infantile spasms of this condition 
also show some relationship to sleep, being seen predominantly on awakening or 
during drowsiness before sleep onset, although they are uncommon during sleep 
itself. (Kellaway et al., 1979). In contrast, the tonic seizures of Lennox Gastaut 
Syndrome, occur much more frequently during NREM sleep than wakefulness. 
They may be very subtle or clinically silent during sleep but are often very 
frequent, being associated with characteristic paroxysmal fast activity; such sleep- 
related tonic seizures are seen in over 90% of patients with (Gastaut, 1974). In 
addition to the influence of sleep on seizures in Lennox-Gastaut syndrome, there is 
facilitation and modulation of the interictal slow spike-wave pattern during sleep 
(Baldy-Moulinier et al., 1988).
Idiopathic Focal Epilepsies. Seizures in the idiopathic focal epilepsy syndromes 
of childhood have a tendency to occur during sleep. Benign childhood epilepsy 
with centrotemporal spikes is associated with partial or secondarily generalized 
seizures, which occur exclusively from sleep in 70-80% of cases (Eeg-Olofsson,
2002). On EEG, the interictal epileptiform discharges of this condition are often 
infrequent or absent during wakefulness, but are markedly activated during 
drowsiness and light NREM sleep (Niedermeyer and Lopes da Silva, 2004). In 
benign childhood epilepsy with occipital paroxysms (particularly of the 
Panayiotopoulos syndrome subtype), partial seizures, sometimes with secondary 
generalization, may also occur during sleep. Likewise, the interictal occipital
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sharp waves are accentuated by NREM sleep (Loiseau, 2001). Autosomal 
Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), while not a benign focal 
epilepsy of childhood, is another example of an idiopathic focal epilepsy with 
predominantly nocturnal seizures; this syndrome will be discussed in detail later in 
a later chapter of this thesis.
Symptomatic and Cryptogenic Focal Epilepsies. The so-called pure sleep 
epilepsies are more commonly focal than generalized. Around 80% of such cases 
are associated with a focal epilepsy syndrome (Yaqub et al., 1997), most 
commonly temporal or frontal lobe epilepsy; syndromes of nocturnal frontal lobe 
epilepsy, discussed in detail later (Provini et al., 1999), and nocturnal temporal 
lobe epilepsy (Bemasconi et al., 1998) have been well described. Frontal lobe 
seizures occur more commonly during sleep than temporal lobe seizures, although 
the latter are much more likely to secondarily generalize in sleep (Bazil and 
Walczak, 1997; Crespel et al., 1998; Herman et al., 2001). Interestingly, 
idiopathic or lesion-negative focal epilepsies appear more likely to remain strictly 
nocturnal than those with an associated lesion (D'Alessandro et al., 1983).
In focal epilepsies, deep (stage 3 and 4) NREM seems to be most effective in 
facilitating epileptiform discharges (Sammaritano et al., 1991; Malow et al.,
1998). As well as being more frequent during NREM sleep, there is often 
extension of the field of the discharges (Sammaritano et al., 1991). In contrast, 
discharges in REM sleep have a more restricted field; some authors have asserted 
that the field in REM sleep is the most reliable interictal indicator of the 
epileptogenic zone (Sammaritano et al., 1991; Sammaritano, 1998).
Epilepsies undetermined as to partial or generalized. Epilepsy with continuous 
spike-waves during slow-wave sleep (CSWS) and Landau-Kleffner syndrome are 
two related syndromes which are undetermined as to whether they are partial or 
generalized under the current ILAE classification (ILAE, 1989). Both disorders 
are characterized by almost continuous subclinical spike wave activity on EEG 
during sleep, accompanied by neuropsychological deterioration, and represent 
age-related epileptic encephalopathies. In CSWS, this activity is associated with 
predominantly nocturnal focal motor seizures, although absences may also be seen
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in wakefulness in some patients (Tassinari et al., 2000); the neuropsychological 
impairment may be global or selective for cognitive or expressive functions, and 
motor deficits such as ataxia, dystonia or hemiparesis may occur (Tassinari et al., 
2000). Landau-Kleffner syndrome is characterized by a specific 
neuropsychological deficit, verbal auditory agnosia, which is sometimes seen in 
conjunction with other types of aphasia (Soprano et al., 1994). Seizures are not 
invariably seen, and the EEG findings are very similar to those of CSWS; the 
commonalities between these two disorders has led some authors to suggest that 
they are in fact different subclasses of a single condition (Tassinari et al., 2002; 
Smith and Hoeppner, 2003).
5.1 b. Sleep Stage. While epilepsy syndrome is a key factor in the 
relationship between sleep and epilepsy, the other major aspect is sleep stage. In 
general, NREM sleep appears to facilitate both seizure onset and seizure spread, 
wheras REM sleep appears to suppress seizures. Essentially, NREM sleep is 
characterized by increasing cerebral hypersynchrony; in slow wave sleep, virtually 
every cell in the brain is discharging synchronously (Steriade et al., 1993). This 
state facilitates both the appearance of interictal epileptiform discharges and the 
onset of seizures, wheras very low rates of seizure onset (0-5%) have been 
reported during REM sleep (Herman et al., 2001; Minecan et al., 2002). Focal 
seizures (particularly those arising in the temporal lobe) secondarily generalize 
much more frequently during sleep compared to wakefulness (Bazil and Walczak, 
1997), presumably reflecting this increased synchronization.
Interictal epileptiform discharges become increasingly frequent with increasing 
depth of NREM sleep, being most often seen in stage 3 and 4 slow wave sleep 
(Sammaritano et al., 1991; Malow et al., 1998). In contrast, while most sleep- 
related seizures also occur in NREM sleep, they are clearly most common in stage 
2 sleep (61-68%), with lower rates (9-14%) in stages 3 and 4 (Herman et al., 2001; 
Minecan et al., 2002). The propensity to seizure occurrence in NREM sleep is 
apparently not solely a reflection of increased neuronal synchrony - if this were 
the case stage 3 and 4 sleep should have the highest rate of seizures. K- 
complexes, sleep transients seen during stage 2 sleep, have been clearly associated
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with electroclinical epileptic phenomena (Halasz, 1981; Niedermeyer E., 2004). It 
has been demonstrated that the appearance of these phenomena is related to a 
pattern of periodic arousal instability within NREM sleep, termed the ‘cyclic 
alternating pattern’ or CAP (Terzano et al., 1985). Essentially CAP is identified 
by repetitive stereotyped EEG patterns (including vertex waves and K-complexes) 
lasting <60 sec and separated by time-equivalent intervals of background activity 
with relatively few sleep transients. As such, the CAP cycle is composed of two 
phases, each of up to one minute in duration: phase A, which is characterized by 
relative arousal and the appearance of sleep transients; and phase B, which is a 
period of reduced arousal. These phases, which are said to reflect arousal 
instability, alternate during periods of ‘CAP sleep’(Terzano et al., 1991; Manni et 
al., 2005); they occur most prominently around periods of transition between sleep 
stages. CAP sleep alternates with longer periods of non-CAP sleep in which there 
is relative NREM stability. A number of studies have demonstrated that nocturnal 
seizures, particularly those occurring in clusters, occur predominantly during 
phase A CAP, and this feature may explain why seizures in sleep have been found 
to occur most commonly at times of sleep stage transition (Sammaritano, 1995). 
Such a relationship between CAP and seizures has also been established 
specifically in nocturnal frontal lobe epilepsy (NFLE), a not unexpected finding in 
view of the clusters of sleep-related seizures seen in this condition (Zucconi et al., 
2000).
5.1c. Sleep deprivation. Sleep deprivation is well recognized as a 
precipitant for seizures and epileptiform discharges, a feature first reported by 
Gibbs and Gibbs (Gibbs and Gibbs, 1947). While the mechanisms responsible for 
its efficacy remain debatable, it is used clinically as a standard procedure for EEG 
activation.
In terms of interictal discharges, sleep deprivation may induce NREM sleep 
which, as discussed above, facilitates the appearance and propagation of these 
phenomena. However, sleep deprivation may have EEG activating effects 
independent of the propensity to induce drowsiness and sleep, through increasing 
neuronal excitability (Ellingson et al., 1984). Some authors have emphasized
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differing benefits of sleep deprivation depending on the epilepsy syndrome. In 
idiopathic generalized epilepsy, the short fluctuations in level of awareness 
induced by maintaining wakefulness during the recording may be particularly 
useful for facilitating discharges; in focal epilepsy, on the other hand, the deeper 
stages of NREM sleep which may be reached if the patient is allowed to sleep 
following sleep deprivation may be more useful (Niedermeyer and Lopes da Silva,
2004).
While most studies in this area have examined the effect of sleep deprivation on 
EEG abnormalities, sleep deprivation also appears to precipitate seizures. 
Observational studies, many of which have looked at seizure in military personnel, 
consistently implicate sleep deprivation in the onset of isolated seizures, although 
stress and alcohol or drug consumption are also important in such cases (Bennett, 
1963; Gunderson et al., 1973; Friis and Lund, 1974). Other studies have also 
identified sleep deprivation as a trigger for seizures in epilepsy patients (Rajna and 
Veres, 1993; Frucht et al., 2000), although interestingly it does not seem to 
influence the rate of seizure occurrence in patients admitted for video EEG 
monitoring (Malow et al., 2002). This finding may be a group effect, reflecting 
the intractable nature of the such patients, but it may imply that sleep deprivation 
alone (without other stressors of day to day life) is a less potent precipitant of 
seizures than when it is combined with other factors such as stress, drugs or 
alcohol.
Section 5.2: The effects of epilepsy on sleep
While sleep has a significant influence on epilepsy, a reciprocal effect is also seen, 
with epilepsy and antiepileptic drugs also affecting sleep in individuals with 
epilepsy.
5.2a. Seizures and sleep
There is considerable evidence that seizures interfere with normal sleep 
architecture. This phenomenon is thought to be largely responsible for the
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insomnia and daytime somnolence which follows both diurnal and nocturnal 
seizures, and may last for well beyond the post-ictal period per se.
A number of studies have looked at the effects of nocturnal focal or generalized 
seizures on sleep architecture in both adults and children, with broadly similar 
results. The most consistent finding is a reduction in REM sleep of up to 50% on 
nights with seizures, along with increased REM latency (Baldy-Moulinier, 1982; 
Besset, 1982; Touchon et al., 1991). In addition, reduced sleep efficiency and 
total sleep time, increased sleep fragmentations with recurrent arousals, and a 
reduction in slow wave sleep have been observed on these nights. These 
disturbances are likely to be the cause of the subjective and objective sleepiness 
observed on the day following a nocturnal seizure (Bazil and Walczak, 1997). In 
frontal lobe epilepsy, disruption of sleep architecture may be a particular issue due 
to the large number of seizures which often occur per night (Provini et al., 1999); 
treatment of seizures in these patients may result in significant improvements in a 
number of sleep parameters including REM sleep duration, slow wave sleep 
duration and sleep efficiency (Tachibana et al., 1996). In addition to the effects of 
nocturnal seizures, diurnal seizures have also been shown to affect sleep 
architecture on the night following the seizure, resulting in reductions in both 
REM sleep and NREM sleep (Bazil et al., 2000; Vaughn and D'Cruz, 2004).
These findings suggest that the functional disturbances of sleep caused by seizures 
may extend beyond the immediate postictal period.
It appears likely that these effects on sleep architecture result from a temporary 
disruption of the brainstem neurotransmitter systems modulating sleep state (see 
previous chapter), with REM sleep being the most susceptible state (Bazil, 2002). 
There is considerable evidence that discharges of generalized seizures and 
propagation of partial seizures involve brainstem structures (Walker, 1956; Wada, 
1960), and it is possible that this involvement results in the sleep dysfunction 
observed.
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5.2b. The interictal state and sleep
While the effect of seizures themselves on sleep is unequivocal, the effect of the 
interictal epileptic state is less clear. Some studies have identified changes in 
sleep architecture in seizure-free patients with epilepsy (Touchon et al., 1991; 
Sammaritano, 1996; Maganti et al., 2005). One such study found that untreated 
patients with IGE or focal epilepsy had reduced sleep efficiency, reduced SWS 
and increased stage shifts compared to controls; these abnormalities improved 
after treatment with antiepileptic drugs (Touchon et al., 1991). Some 
abnormalities in sleep architecture, such as reduced REM latency, have also been 
associated with daytime behavioral changes in seizure-free children (Maganti et 
al., 2005). It is possible that interictal discharges influence sleep architecture 
through increased arousals and increased stage shifts (Peled and Lavie, 1986), but 
other authors have found interictal discharges to be only rarely associated with 
arousals (Malow et al., 1998). While a number of abnormalities have been 
identified in the interictal state, studies in this area are often difficult to interpret. 
This is particularly true when sleep architecture in epilepsy is compared with that 
of normal controls, as these studies are frequently confounded by the presence of 
antiepileptic drugs (AEDs) which have effects of their own on sleep architecture 
(Sammaritano and Sherwin, 2000).
Section 5.3: Sleep and antiepileptic drugs
In addition to the effects of seizures and the interictal state, independent effects of 
antiepileptic drugs on sleep have been observed. Although the anticonvulsant 
effects of many of these drugs is incompletely understood, the majority appear to 
exert their clinical effects through influences on sodium or calcium channels, or by 
modulating GABA or glutamate neurotransmission (Sammaritano, 2002); these 
effects appear to influence sleep processes in many cases. The effects on sleep of 
the ‘classical’ antiepileptic drugs (AEDs) such as carbamezapine, valproate and 
phenytoin have been most widely studied, but data is also available into the effects 
of some newer drugs such as lamictal and gabapentin.
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As with all studies in this area, a number of confounding factors are present in 
many AED studies in sleep -  in patients with epilepsy it is often difficult to be 
sure what effects are due to the drug itself and which reflect improved or altered 
epileptic control. Studies in normal controls, on the other hand, are often small in 
size and only examine short-term effects of the drugs. However, through a 
combination of study designs, patterns of sleep alteration associated with many 
AEDs have become apparent. For example, carbamazepine appears to consolidate 
sleep, reducing awakenings and arousals, while increasing SWS and reducing 
REM (Yang et al., 1989; Gann et al., 1994; Gigli et al., 1997; Sammaritano and 
Sherwin, 2000). Phenytoin, on the other hand, may disrupt sleep causing 
increased arousals and reducing REM; it may also increase slow wave sleep in 
short-term use, although these effects become less prominent with chronic use 
(Roder-Wanner et al., 1987; Declerck and Wauquier, 1991). Valproate has 
predominantly sleep stabilizing properties, although some patients on this drug 
may have an increased frequency of arousals (Findji, 1982; Dadmehr et al., 1987).
The newer AEDs in general have fewer negative effects on sleep and some have 
positive effects. For example, gabapentin reduces awakenings during sleep and 
increases both REM and slow wave sleep (Rao et al., 1988; Placidi et al., 2000; 
Placidi et al., 2000); lamotrigine appears to stabilize sleep, increasing REM while 
reducing stage shifts and total SWS, without effects on daytime sleepiness (Placidi 
et al., 2000); and levetiracetam has been found to have little if any effects on sleep 
architecture (Bazil et al., 2005). The role of these effects on the side effect profile 
and efficacy of these drugs is, however, unclear.
Conclusion
Sleep and epilepsy are intimately related, with mutual and reciprocal interactions. 
While sleep or sleep deprivation may result in deteriorating seizure control, 
seizures, as well as the interictal state and AED therapy, may have profound 
effects on sleep. An appreciation of these interactions is essential when 
considering specific sleep-related epilepsy syndromes such as nocturnal frontal 
lobe epilepsy.
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CHAPTER 6 
FRONTAL LOBE EPILEPSY 
Functional Anatomy of the Frontal Lobes
Introduction
The major focus of this thesis is the relationship between frontal lobe epilepsy 
(FLE), sleep and benign sleep disorders. To effectively study FLE, an 
appreciation of the structural and functional anatomy of the frontal lobes is 
required. These structures are large, accounting for 30-50% of brain mass and 
volume, and are involved in numerous neurological and neuropsychological 
processes. Many of these concern higher level cognitive functioning, and some 
authors have argued that it is the frontal lobes which define us as human (Stuss 
and Levine, 2002). This chapter addresses the gross anatomy and localisation of 
function within these complex structures.
Section 6.1. Gross anatomy.
The frontal lobe is the largest in the human brain. It occupies the entire area 
anterior to the central sulcus and superior to the lateral sulcus on the lateral 
surface. Medially it envelopes the anterior part of the corpus callosum and is 
bounded posteriorly by an imaginary line drawn between the central sulcus and 
the corpus callosum. The inferior surface of the frontal lobe lies on the orbital 
plate of the frontal bone.
The convexity of the frontal lobe is divided into four gyri: the precentral gyrus, the 
superior frontal gyrus, the middle frontal gyrus and the inferior frontal gyrus 
(Figure 6.1). The precentral gyrus lies anterior to the central sulcus on the 
convexity of the frontal lobe; on the medial aspect it is contiguous with the 
paracentral lobule. The remainder of the the lateral surface of the fontal lobe is 
divided into the superior, middle and inferior frontal gyri, which are oriented 
parallel to each other and approximately perpendicular to the precentral gyrus.
The superior frontal gyrus runs above the superior frontal sulcus, and continues 
onto the medial aspect of the frontal lobe as far as the cingulate sulcus.
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Figure 6. 1. Medial and lateral aspects o f the left cerebral hemisphere, showing the 
major sulci and gyri (Williams and Warwick, 1980).
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The middle frontal gyrus lies between the superior and inferior frontal sulci. The 
inferior frontal gyrus lies below the inferior frontal sulcus, and is visibly divided 
into three parts: (i) the orbital part, which is most anterior and is continuous with 
the orbital (inferior) surface of the frontal lobe; (ii) the opercular part, which is 
most posterior and constitutes part of the frontal operculum; and (iii) the triangular 
part, which lies between the other two.
The cingulate gyrus lies on the medial aspect of the frontal lobe, between the 
corpus callosum and the cingulate sulcus; the anterior part of this gyrus is 
structurally part of the frontal lobe; functionally it is usually considered as part of 
the limbic system.
The inferior aspect of the frontal lobe consists of a variable group of gyri known 
collectively as orbitofrontal cortex. The only consistent gyrus in this region is the 
gyrus rectus, which is the most medial gyrus on the orbitofrontal cortex and is 
separated from the other gyri by the olfactory sulcus.
Section 6.2. Functional Anatomy
Notwithstanding the gross anatomy of the frontal lobe, regional divisions within 
this lobe are largely defined in terms of traditional cytoarchitectonics and cortical 
function. While some regions (such as the primary motor cortex) have relatively 
tight anatomical boundaries, others (including the SMA) are relatively poorly 
defined anatomically. In functional terms, the various regions in the frontal lobes 
are largely concerned with motor activity, judgement and foresight, and mood and 
affect.
6.2a. Primary Motor Area
The primary motor area (Ml)  is located in the precentral gyrus; it corresponds to 
Brodmann’s area 4 and is characterized by Betz cells (Figure 6.2). The main 
sources of input to this are the premotor cortex, primary sensory cortex, and the 
ventral lateral thalamic nucleus (which receives major afferent inputs from the 
cerebellum). The main efferent pathways from M 1 are the corticospinal and
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Figure 6. 2. Important functional neuroanatomy o f the frontal lobes (Williams and 
Warwick, 1980). Panels A and B show Brodmann 's area 4 (corresponding to primary 
motor cortex), 6 and 8 (which correspond to premotor and supplementary motor cortex), 
and 44 and 45 (corresponding to the motor speech area o f Broca. Panel C shows the 
frontal eye field (FEF), corresponding to parts o f Brodmann’s areas 6, 8 and 9. Panel D 
shows the motor homunculus with somatotopic representation in the primary motor cortex 
(Penfield and Rasmussen, 1950).
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corticobulbar tracts, which comprise the pyramidal system. About 30% of 
pyramidal tract fibres originate in this region. Electrical stimulation of M 1 elicits 
contraction of muscles on the opposite side of the body. The classical stimulation 
studies of Penfield (Penfield, 1954) demonstrated a consistent and reproducible 
cortical representation of the body in the primary motor cortex; this homunculus is 
shown in Figure 6.2. The size of the area of cortex assigned to a particular region 
of the body is loosely proportional to the level of motor dexterity required for 
normal functioning of that region (e.g. large areas for mouth and hand, small areas 
for trunk and shoulder).
Destructive lesions of primary motor cortex result in paresis of voluntary 
movements for the corresponding area of the body. Recovery of function may 
occur, possibly related to functional cortical reorgansation (Ward, 2004). Residual 
deficits tend to be most prominent in the distal parts of the limbs and particularly 
affect skilled movements.
6.2b. Premotor Area
The premotor area (PMA) constitutes that part of Brodmann’s area 6 located on 
the lateral convexity of the hemisphere, and may also invove part of area 8 (Figure 
6.2). It has a different cytoarchitectonic appearance to M l, with a heterotopic 
agranular composition. It is widely connected with other cortical regions, but also 
receives inputs from the anterior division of the ventral lateral nucleus of the 
thalamus, which itself receives inputs from the striatum.
The PMA contributes to the pyramidal tracts directly, and also influences the 
primary motor cortex. It is involved in generating motor programs for actions, 
particularly those which are guided by sensory inputs such as visual and tactile 
stimuli (Roland and Zilles, 1996). While the primary motor cortex is responsible 
for the execution of movements, the premotor area directs the primary motor 
cortex in its execution. Unlike the primary motor cortex, the PMA is involved in 
both ipsilateral and contralateral distal movements (Roland et al., 1980).
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6.2c. Supplementary Motor Area
The Supplementary Motor Area (SMA) has been widely studied, with much of the 
initial work being performed by Penfield and his co-workers (Penfield and Welch, 
1951). It is not strictly defined anatomically, but corresponds broadly to that part 
of Brodmann’s area 6 that lies on the medial aspect of the hemisphere, and has the 
same cytoarchitecture as the premotor cortex. It has major inputs from the basal 
ganglia via the thalamus, particularly the anterior division of the ventral lateral 
nucleus and the dorsomedial nucleus. Efferent connections are with the putamen, 
thalamus, pontine nuclei and spinal cord; there are also widespread reciprocal 
connections with many cortical regions including M 1, and dense callosal 
connections with the opposite hemisphere (Buser et al., 1992).
Functional imaging studies (Roland et al., 1980) indicate that the SMA is involved 
in planning and preparation of movement, with similar functions to the PMA; like 
the PMA, unilateral distal movements result in bilateral activation of this area in 
functional imaging studies (Roland et al., 1980). However, the SMA appears to be 
particularly important in planning and initiating well-learned complex motor 
sequences which do not require sensory information for their execution, wheras 
the PMA is more important in movements which are based on sensory input 
(Roland and Zilles, 1996). Electrical stimulation of SMA results in a conscious 
‘urge to move’ followed at higher currents by actual movements (Fried et al.,
1991). These movements usually consist of the adoption of proximal, segmental 
postures which may be unilateral (usually contralateral) or bilateral (Penfield and 
Welch, 1951). A somatotopic organization of the SMA exists, with the face 
represented rostrally and the lower limb caudally (Penfield and Welch, 1951; Mitz 
and Wise, 1987; Fried et al., 1991).
6.2d. Frontal Eye Field
The frontal eye field (FEF) is located on the dorsal convexity of the fontal lobe. It 
lies anteriorly to the premotor cortex, in the lower part of Brodmann’s area 8, 
principally at the intersection of the precentral and superior frontal sulci. The FEF 
may also involve part of Brodmann’s areas 6 and 9 (Figure 6.2). This area is 
responsible for the preparation and triggering of voluntary conjugate saccadic eye
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movements. It is also involved in pursuit eye movements, in conjunction with the 
parietal eye field, but is less involved with reflexive saccades triggered by a 
suddenly appearing peripheral target (Pierrot-Deseilligny et al., 2004).
Electrical stimulation of this area causes conjugate deviation to the opposite side 
(Blanke and Seeck, 2003). Destructive lesions in this area cause conjugate 
deviation towards the side of the lesion.
6.2e. Broca’s (motor) language area
The language system is complex and a full discussion of its components and 
organization are beyond the scope of this review. In brief, however, the motor 
language area occupies the opercular and triangular region of the inferior frontal 
gyrus, corresponding to Brodmann’s areas 44 and 45, on the dominant hemisphere 
(usually the left). It functions in conjunction with Wernicke’s (sensory) language 
area, which is located in the superior temporal gyrus; the two regions are 
connected by the arcuate fasciculus. Destruction of any part of the language 
system results in aphasia; classically destruction of the motor language area results 
in a non-fluent, expressive aphasia with relatively preserved comprehension.
6.2f. Anterior Cingulate Cortex
The anterior cingulate cortex forms a large region around the rostrum of the 
corpus callosum. It comprises Brodmann’s area 24, and functionally also involves 
areas 25 and 32 (Devinsky et al., 1995), and is characterized cytoarchitectonically 
by prominent layer V neurons. It has afferent connections with the anterior, 
dorsomedial, midline and intralaminar thalamic nuclei; efferent projections are 
widespread, including the primary motor cortex and striatum. It has prominent 
reciprocal connections with other parts of the limbic system (particularly the 
parahippocampal gyrus) through a major association fasciculus, the cingulum.
Functionally, the anterior cingulate cortex is involved with the regulation of 
autonomic and endocrine functions, as well as being implicated in the control of 
affect, particularly conditioned emotional learning and vocalizations associated
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with expressing internal states. As such, it appears to play a key role in social 
interactions (Devinsky et al., 1995). Cortical stimulation studies in this region 
result in autonomic, visceromotor and affective sensations, along with simple or 
more complex movement patterns; the latter may result from a degree of 
functional overlap with the SMA (So, 1998). Anterior cingulate lesions result in 
affective and motor neglect, clinically presenting with apathy, akinetic mutism, or 
disturbed social behaviour (Devinsky et al., 1995; So, 1998).
6.2g. Prefrontal Cortex
The large region of cortex in the frontal lobes which is not directly associated with 
motor activity is known as the prefrontal cortex. This region is essentially 
association cortex, playing an essential role in higher-order cognitive functions, 
and is highly developed in humans. It is characterized cytoarchitectonically by 
granular cortex and corresponds to Brodmann’s areas 9, 10, 11 and 12. These 
areas have variations in cytoarchitecture, but it is not possible to ascribe specific 
functions to any given area (Ramnani and Owen, 2004). Likewise, how exactly 
the prefrontal cortex achieves its cognitive functions is not understood (Wood and 
Grafman, 2003). It has wide and extensive connections throughout the brain, both 
cortically and subcortically. The most prominent subcortical connections with the 
prefrontal cortex are from the mediodorsal thalamus, which appears to send 
afferents and receive efferents with all areas of prefrontal cortex (Fuster, 1997). 
There are also reciprocal connections with the hypothalamus, the mesencephalon 
and the limbic system. The limbic connections are largely through the uncinate 
fasciculus, a well defined bundle of nerve fibres between the orbitofrontal cortex 
and the temporal pole.
Cortically, there are widespread reciprocal connections between areas within the 
prefrontal cortex and the frontal lobes of both hemispheres. The left and right 
frontal lobes are connected primarily via the corpus callosum. There are also 
extensive connections with parietal, occipital and temporal cortex resulting in 
direct and indirect connections with those areas responsible for somatosensory, 
visual and auditory processing and memory. These connections are particularly 
prominent with other areas of association cortex, and their fibres constitute a
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number of identifiable white matter tracts. These include the superior and inferior 
longitudinal fasciculi, and the superior and inferior occipitofrontal fasciculi.
The extensive connectivity of the prefrontal cortex appears to facilitate the access 
of sensory, spatial, motivational and affective data (both current and remembered) 
and to use these data in executive and cognitive functioning. Damage to the 
prefrontal cortex produces a number of neuropsychological deficits attributable to 
disruption of this system (Fuster, 1997; Stuss and Levine, 2002; Godefroy, 2003); 
these are interrelated and overlap considerably within individual subjects.
(i) Deficits o f  attention and perception. These take a variety of forms including 
distractibility, poor concentration and lowering of general awareness. 
Neuropsychological assessment of attentional functions may reveal deficits in an 
individual’s ability to switch attention between different tasks, their ability to 
attend to selective stimuli while ignoring others, and their ability to sustain 
attention to a given task.
(ii) Memory deficits. Prefrontal cortical function plays an important role in both 
the retrieval of memory, and the placing of memories in spatial and temporal 
contexts. Memory disorders, including confabulation and retrograde amnesia, are 
common sequelae of prefrontal dysfunction.
(iii) Impairment o f  language. Problems with with impaired activation and 
formulation of speech and language, may occur with prefrontal cortical 
dysfunction. These “paralinguistic” disorders reflect truncated spontaneous 
language, and problems with formulation of sentences and more complex 
narratives (such as stories).
(iv) Dysfunctional planning and execution. This may take a variety of forms. 
Individuals may have problems initiating responses and actions, or, conversely, 
may be unable to suppress inappropriate responses. They may have difficulties 
with tasks which require problem-solving or the recognition of rules. Finally, the 
ability to plan or develop strategies is often impaired. As a result of these
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problems, individuals may continue to perform old routines without difficulty, but 
are often unable to plan and initiate new goal-directed patterns of behaviour.
(v) Dysfunctional motility. This may take the form of either reduced spontaneous 
movement (more prevalent with dorsolateral lesions) or excessive and aimless 
mobilisation (more often seen with orbitofrontal lesions).
(vi) Disordered emotional and social behaviour. Ventral and polar frontal cortex 
appears to be vital in these aspects of human personality. Impairment of these 
regions most commonly manifests with apathy and blunting of emotional 
response, although occasionally a euphoric or hypomanic state may be seen. The 
individual often loses basic social decision-making skills, apparently unable to 
regulate their behaviour according to internal goals and restraints.
These neuropsychological deficits occur to varying degrees in individuals with 
prefrontal cortex dysfunction. Clinically, they result in a recognizable but 
heterogeneous entity termed “frontal lobe syndrome” or “dysexecutive syndrome”. 
Features including abulic affect, confabulation, perseveration or stereotyped 
behaviour, distractibility and disinhibition are key components of this clinical 
syndrome. Disturbances of emotional, sexual and social behaviour may also be 
features; when present these are often striking and socially disabling.
Conclusion.
The frontal lobe is the largest lobe in the human brain, and is involved in a variety 
of functions including motor control, language, emotion and higher cognitive 
processes. In view of its large size, functional complexity and extensive 
connectivity, a wide variety of seizure types originating in the frontal lobe might 
be expected. This is indeed the case, and these will be discussed in the following 
chapter.
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CHAPTER 7 
FRONTAL LOBE EPILEPSY 
Electroclinical features of Frontal Lobe Seizures
Introduction
Frontal lobe epilepsy (FLE) is the second most common focal epilepsy in large 
surgical series (Manford, 1996), accounting for about 20% of cases. In contrast to 
temporal lobe epilepsy, the most common focal epilepsy, seizures arising in the 
frontal lobes can present with a wide variety of clinical and electrographic features 
(Williamson and Jobst, 2000). This variability has resulted in a somewhat 
confusing literature on the subject, which I have addressed here by dividing the 
chapter into five sections. In the first section, general features of frontal lobe 
epilepsy are reviewed. In the second, the current ILAE subclassification of FLE is 
discussed, and in the third section a more practical and frequently used 
classification is described. The fourth section is a review of possible physiological 
mechanisms responsible for the nature of frontal lobe automatisms, and the final 
section comprises a discussion of the electrographic features of FLE.
Section 7.1. Frontal lobe seizure semiology: general 
features
The recognition of seizure semiology referable to frontal lobe involvement dates 
from the observations of Penfield and his intracranial stimulation studies of the 
motor cortex and supplementary motor area (Penfield, 1954). Since then, 
however, the wide range of seizure types and ictal manifestations referable to the 
frontal lobes has become increasingly apparent - this is in contrast to seizures of 
temporal lobe origin which, in general, are broadly similar from patient to patient. 
The great variability seen in frontal lobe seizures, due at least in part to the 
functional complexity and extensive connectivity of this region, makes it difficult 
to describe a ‘typical’ event. As such, attempts have been made to subdivide 
frontal lobe seizures on anatomical or semiological grounds, and these will be
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discussed later in this chapter. Before considering these, however, the general 
features of frontal lobe seizures are reviewed.
7.1a. Aura
Auras are relatively common in frontal lobe seizures, although in reported case 
series of frontal lobe epilepsy the frequency has ranged widely from 11 % to 69% 
(Rasmussen, 1983; Williamson et al., 1985; Salanova et al., 1994; Chauvel, 1995; 
Jobst et al., 2000; Kotagal et al., 2003). The most common aura is somatosensory, 
usually a non-specific cephalic sensation but also commonly a feeling in the trunk, 
limbs, chest or throat (Rasmussen, 1983; Chauvel, 1995; Salanova et al., 1995; 
Scheffer et al., 1995; Jobst et al., 2000). Autonomic auras, consisting of hot 
flushes, feelings of difficulty breathing, palpitations or a need to urinate are 
relatively common, as are emotional auras characterized by feelings of fear or 
terror (Broglin, 1992; Jobst et al., 2000). Visual auras have been occasionally 
reported (Williamson et al., 1985; Broglin, 1992; Chauvel, 1995), usually 
consisting of a non-specific and non-lateralising manifestation such as blurring of 
vision. Although psychointellectual complaints including the phenomena of 
“forced thinking”, originally described following stimulation of the medial-orbital 
frontal region (Penfield, 1954), are said to be highly suggestive of frontal lobe 
origin, they are rarely reported (Broglin, 1992). In general, auras in FLE are 
relatively non-specific and rarely have clear lateralizing or localizing value 
(Williamson and Spencer, 1986; Williamson and Jobst, 2000).
7.1b. Vocalisation
Vocalisation is common in FLE, being reported in between 50% and 80% of 
cases (Williamson et al., 1985; Waterman et al., 1987; Salanova et al., 1995; Jobst 
et al., 2000). It ranges from simple (moaning, screaming or grunting) to complex 
(syllables, incomprehensible words or palilalic speech). Speech arrest is well 
described, particularly in dominant hemisphere seizures involving the 
supplementary motor area or dorsolateral convexity (Morris et al., 1988; Broglin, 
1992; Quesney et al., 1992; Salanova et al., 1995).
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7.1c. Motor Activity
The majority of seizures of frontal lobe origin, unlike temporal lobe seizures, have 
prominent motor manifestations (Waterman et al., 1987; Jobst et al., 2000; 
Williamson and Jobst, 2000). These may take a number of forms, including tonic 
posturing, focal clonic activity and agitated gestural and semipurposful 
automatisms (Waterman et al., 1987; Broglin, 1992; Williamson, 1992; Chauvel, 
1995; Salanova et al., 1995; Williamson and Jobst, 2000).
Automatisms. As with vocalisation, motor automatisms range from the simple 
(such as crossing and uncrossing of the legs or rubbing hands) to the complex and 
sometimes ambulatory (with running, screaming of obscenities, and complex 
agitated movements)(Waterman et al., 1987; Williamson and Jobst, 2000). 
Characteristically, automatisms are bilateral and often have a prominent axial 
component (Waterman et al., 1987). They are often accompanied by changes in 
facial expression which may be blank staring, but more commonly are fearful; 
occasionally smiling and laughter are observed (Chauvel, 1995). Sexual 
automatisms, including pelvic thrusting and genital manipulation may be seen 
(Spencer et al., 1983). The automatisms, while highly varied between subjects, 
are usually stereotyped within a given subject, although sometimes more complex 
automatisms may adapt to incorporate environmental stimuli (Broglin, 1992).
Postural Manifestations. In some frontal lobe seizures, tonic posturing is the 
dominant clinical manifestation, and these will be described in more detail below. 
However, a degree of tonic posturing is common in many frontal lobe seizures, 
presumably due to involvement of the SMA and PM A (Wieser, 1992).
7.1 d. Rapid and frequent secondary generalization.
It is often stated that secondary generalization is both rapid and common in fontal 
lobe epilepsy (Rasmussen, 1983; Williamson, 1992). Video EEG studies have 
supported the assertion that secondary generalization, when present, tends to occur 
more rapidly in frontal lobe epilepsy than in temporal lobe epilepsy (Kotagal et al., 
2003). However, some authors have questioned the concept that secondary 
generalization is particularly common in frontal lobe epilepsy, as it has been an
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infrequent finding in some case series (Chauvel, 1995; Jobst et al., 2000; Kotagal 
et al., 2003).
7.1 e. Brief duration.
Unless secondary generalization occurs, frontal lobe seizures are characteristically 
brief, usually under 1 minute in duration (Williamson et al., 1985; Kotagal et al., 
2003).
7.1 f. Clustering.
Frontal lobe seizures often occur in clusters or flurries (Waterman et al., 1987; 
Jobst et al., 2000; Williamson and Jobst, 2000). Patients may have multiple 
seizures in a period of hours or days; it is not uncommon for a patient to report 
over thirty seizures in a single day or night (Jobst et al., 2000). Periods of days or 
weeks with frequent seizures may alternate with longer periods with few or no 
seizures.
7.1 g. Nocturnal predominance.
Many individuals with frontal lobe epilepsy have predominantly nocturnal 
seizures. The proportion of patients who show this predominance varies between 
studies, but has been reported in about 35% to 60% of subjects (Crespel et al., 
2000; Jobst et al., 2000; Williamson and Jobst, 2000). Some individuals have 
seizures exclusively or almost exclusively during sleep; this condition is known as 
nocturnal frontal lobe epilepsy, or NFLE (Meierkord et al., 1992; Provini et al.,
1999).
7.1 h. Status epilepticus.
Status epilepticus appears to be relatively common in frontal lobe epilepsy 
(Williamson et al., 1985). Convulsive, complex partial, or focal motor status 
epilepticus have all been widely reported (Williamson, 1992).
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Section 7.2.The I LAE subclassification of frontal lobe 
seizures
7.2a. Current subclassification and its limitations
In the most recent International League Against Epilepsy classification system 
(ILAE, 1989), frontal lobe epilepsy is divided into six anatomically and clinically 
distinct subtypes, the clinical features of which are summarised in Table 1. The 
utility of this subclassification has, however, been questioned (Manford, 1996).
As discussed in Chapter 2, the ILAE sytem classifies seizures on electroclinical 
grounds, with a combination of seizure semiology and electrographic features 
being used to determine the epilepsy syndrome. Ultimately, the value of such a 
system depends upon the reliability of the stated clinical and electrographic 
features in localizing the site of seizure onset. However, the extensive anatomical 
connections within the frontal lobes (and between the frontal lobes and other 
cortical and subcortical regions), results in extremely rapid seizure propagation, 
within milliseconds; in addition, many areas in the frontal lobes are clinically 
‘silent’. As a result, the clinical features observed in frontal lobe seizures often 
arise through the involvement of regions distant from the site of origin. Seizures 
rarely remain restricted to one subregion of the frontal lobe (Chauvel, 1992; 
Manford, 1996), and this produces considerable overlap between seizure types 
seen from different regions. In many cases it is impossible to locate the true site of 
seizure origin (Williamson, 1992).
7.2b. Methodological considerations
Examination of the methodology used to develop the subclassification reveals the 
reasons for its limitations. The system was drawn up in the pre-MRI era, and is 
based on data of two types. The first is ‘pure cultures’ of patients with frontal lobe 
epilepsy, in whom seizure localization has been confirmed by post-surgical 
remission (Rasmussen, 1983; Quesney et al., 1992; Smith et al., 2004), in 
conjunction with data from intracranial and scalp EEG. In other words, the 
classification is based on a group of patients who have been fully assessed for 
surgery, have undergone a surgical resection of a region of the frontal lobe, and 
have been rendered seizure free by their procedure. While this methodology
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Anatomical region Principal clinical manifestations
Supplementary Motor Area Postural, simple focal tonic seizures with 
vocalization, speech arrest and fencing, or 
complex focal with urinary incontinence. 
Ictal EEG shows flattening, rhythmic 
polyspikes, and secondary generalization.
Cingulate Complex focal seizures, with sexual 
automatisms, vegetative signs, affective 
changes and urinary incontinence.
Depth electrode exploration is mandatory 
for detection of the seizure focus.
Anterior (polar) frontal region Loss of contact, adversive and subsequent 
contraversive movements of head and 
eyes, axial clonic jerks and falls, and 
autonomic signs. Frequent evolution to 
GTCS.
Orbitofrontal Complex focal with automatisms, olfactory 
hallucinations, autonomic signs and 
urination. The EEG shows flattening, 
rhythmic polyspikes and secondary 
generalization. Nasoethmoidal and orbital 
electrodes may be helpful.
Dorsolateral Simple focal tonic with versive movements 
and aphasia, or complex focal with 
automatisms. The EEG focus is usually 
detected by scalp EEG.
Motor cortex Mainly simple partial seizures with 
Jacksonian march; the exact symptoms 
depend on the side and topography of the 
area involved.
Table 7. 1 The ILAE subclassification o f frontal lobe seizures
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represents the gold standard for localization of the epileptic focus, there are 
relatively small numbers of such patients reported in the literature. Frontal lobe 
epilepsy is highly variable in its clinical presentation, and validity of extrapolating 
the findings from small, selected samples of individuals to the broader patient 
population is questionable. This is particularly true when so little data is 
published describing the electroclinical features in the 60-80% of individuals 
undergoing frontal lobe epilepsy surgery who showed little or no improvement 
(Rasmussen, 1991).
The second type of data is that arising from patients with frontal lobe epilepsy 
who have undergone monitoring with scalp or implanted intracranial electrodes 
(Tharp, 1972; Waterman et al., 1987; Morris et al., 1988; Munari, 1992). 
Unfortunately, this technique is fraught with difficulties in frontal lobe epilepsy 
(Williamson, 1992). This is mainly due to two factors: firstly, the very large 
surface area of the frontal lobes, which makes complete coverage of the region 
with electrodes or even subdural grids impossible; and secondly the extremely 
rapid spread of seizures in the frontal lobes, such that electrical onset may appear 
almost instantaneously in several brain regions (Veilleux et al., 1992; Williamson, 
1992). As a result, intracranial EEG monitoring of frontal lobe epilepsy is prone 
to sampling error, in which the area of seizure onset is not directly sampled by the 
implanted electrodes. Sampling error may result in negative findings, in which 
widespread ictal rhythms with no clear localization are obtained; it may also result 
in ‘false positive’ findings, in which an area of seizure propagation is sampled but 
the true area of ictal onset is not. This gives an appearance of seizures onset from 
the site of propagation and is therefore falsely localising. For example, a patient 
may have seizures characterized by asymmetric tonic posturing, which in fact are 
originating from a clinically silent region of prefrontal cortex but rapidly 
propagating to the SMA. If the relevant area of prefrontal cortex is not sampled 
but the SMA is, false localization to the SMA may occur.
Since the current classification system was developed, it has become apparent that 
the ILAE subclassification is indeed overly proscriptive. Rapid advances in 
neuroimaging have enormously improved the ability of clinicians to localize 
epileptogenic lesions in vivo, and the widespread availability of video EEG
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monitoring has enabled the study of large numbers of patients with frontal lobe 
epilepsy. These advances have highlighted the great variability of this condition 
and the inconsistent relationship of seizure semiology to the site of ictal onset 
(Manford, 1996).
Section 7.3. Practical categorisation of frontal lobe seizures
Although the ILAE classification has not yet been revised, it is practically more 
useful to categorize frontal lobe seizures on the basis of seizure semiology. The 
three main types of seizure described are the supplementary motor area (SMA) 
seizure, the focal motor clonic seizure, and the frontal lobe complex partial seizure 
(FLCPS) (Salanova et al., 1995; Williamson and Jobst, 2000). Further subtypes 
have been described, and these will be also be discussed briefly. These seizure 
types are descriptive and do not imply a specific site of seizure origin.
7.3a. SMA seizures
The effects of electrical stimulation of the Supplementary Motor Area (SMA) in 
humans were first described by Penfield and his co-workers, who demonstrated 
that stimulation of this region elicited complex postures (the ‘fencing posture’) 
and speech disturbance (Penfield and Welch, 1951; Penfield, 1954). SMA 
seizures were subsequently described by Ajmone-Marsan and Ralston (Ajmone- 
Marsan, 1957), who termed the characteristic asymmetric tonic posturing the 
‘M2e posture’.
Since that time, particularly in the 1980s and 1990s, extensive studies of SMA 
seizures have been undertaken using video monitoring and scalp or implanted 
intracranial electrodes (Morris et al., 1988; Veilleux et al., 1992; So, 1998). 
Typically, an SMA seizure will start with the sudden, often explosive, adoption of 
an asymmetric tonic posture. There is deviation of the head and eyes 
contralaterally to the EEG focus, accompanied by abduction and external rotation 
of the contralateral arm at the shoulder with elbow flexion such that the patient 
appears to be looking at his upraised hand. The tonic posturing may involve one 
or more limbs, and all four limbs may be affected (Morris et al., 1988); if the
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ipsilateral arm is involved it is often flexed (Williamson, 1992). In addition to this 
characteristic posture, a number of other features may be present. It may be 
preceded by a somatosensory aura, either a pulling, heavy sensation, or 
occasionally numbness and tingling (Salanova et al., 1995; Williamson and Jobst, 
2000). Arrest of speech is common, but in some patients speech is unaffected and 
the patient may utter coherent words. More commonly, inarticulate groaning or 
grunting is heard. Consciousness is characteristically retained during the seizure. 
The seizures are usually frequent, occurring in clusters, and arising primarily from 
sleep (Waterman et al., 1987).
It should be noted that although involvement of the SMA is assumed in seizures of 
this type, they are by no means pathognemonic of seizure onset in this region. 
Onset may be elsewhere within or even outside the frontal lobes but present in this 
fashion due to the extensive connectivity of the region.
7.3b. Focal clonic motor seizures
Although SMA seizures were described half a century ago, focal clonic motor 
seizures have been recognised since antiquity (Temkin, 1994). They were first 
carefully studied by Bravais and Herpin in the 19th Century (Loiseau, 1992), but it 
is John Hughlings Jackson’s influential clinical and theoretical studies later in that 
century that are most widely associated with this seizure type (Jackson, 1958). As 
a result of his insights, supported by Penfield’s identification of the human motor 
homunculus in the precentral gyrus (Penfield, 1954), focal clonic seizures have 
become almost synonymous with primary motor cortex onset. However, as with 
other seizure types, it is now recognized such seizures may originate elsewhere in 
the brain, with the clinical manifestations reflecting propagation to eloquent 
cortex.
Two broad subtypes of focal clonic motor seizure are recognized: the Jacksonian 
March and epilepsy partialis continua.
Jacksonian M arch . The primary manifestation of this seizure type is clonic 
jerking of one side of the body, contralateral to the site of seizure origin. Onset
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may be in any muscle group, but is most common in those areas which have larger 
cortical representations on the motor homunculus of the primary motor cortex. 
Therefore, if starting in the face, it will often begin in the mouth, as this has a 
large cortical representation; likewise, in the upper limb it will usually start in the 
hand, often the thumb or index finger, and in the lower limb it will begin in the 
foot, often in the great toe (Jackson, 1958). Clinically the seizure may spread at a 
variable rate, and as noted in Jackson’s original writings “The point of great 
interest is the march of the spasm. Fits beginning in the foot have a different 
march from those beginning in the hand, although in each the same muscles are 
ultimately convulsed. When a fit begins in the hand, it goes up the arm and down 
the leg. Now patients who have fits beginning in the foot tell me the spasm goes 
up the leg and down the arm” (Jackson, 1958). This sequence reflects the 
progressive spread of the seizure through motor cortex. In addition to the clonic 
jerking, unilateral tonic posturing of the affected limbs is very common during 
these seizures, with abduction, elevation or flexion of either limb often observed 
(Chauvel, 1992). Head and eye version may be seen, but is not common, and may 
be either contralateral to the seizure focus or ipsilateral, apparently reflecting 
propagation of the seizure to the opposite hemisphere (Chauvel, 1992). 
Consciousness is preserved. Clinically, the seizures may remain restricted to this 
pattern, or may spread. Sensory symptoms, such as tingling or numbness, are 
common and indicate involvement of the primary sensory cortex located in the 
post central gyrus (Bancaud, 1992; Chauvel, 1992); bilateral asymmetric tonic 
posturing (presumably due to the involvement of SMA) may be seen (Chauvel, 
1992; Salanova et al., 1995) often immediately prior to secondary generalization 
(Lehman et al., 1994).
Although focal clonic motor activity is a reliable lateralizing sign, indicating 
seizure onset in the contralateral hemisphere (Salanova et al., 1995; Jobst et al., 
2000), its localizing value is limited. As with SMA seizures, extensive 
connectivity in the region results in rapid seizure propagation; while therefore 
implies involvement of the primary motor cortex in the seizure, it does not 
necessarily follow that it is the site of seizure origin. Even when focal clonic 
activity is the only clinical manifestation, true seizure onset may be located in a
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clinically ‘silent’ area elsewhere within, or even outside, the frontal lobes 
(Williamson and Jobst, 2000).
Epilepsia Partialis Continua (EPC). This represents a specific form of focal 
motor seizure, characterized by continuous focal myoclonus which was first 
described by Kojewnikow (Kojewnikow, 1895). It has been defined as 
“spontaneous regular or irregular clonic twitching of cerebral cortical origin, 
sometimes aggravated by action or sensory stimuli, confined to one part of the 
body, and continuing for a period of hours, days or weeks” (Obeso, 1985). EPC 
differs from Jacksonian seizures in three major ways: firstly, it does not have a 
general tendency to spread or ‘march’ (although Jacksonian seizures may evolve 
from EPC); secondly, it does not stop after the usual time course of focal motor 
seizures; and finally it is highly refractory to treatment with antiepileptic drugs 
(Bien et al., 2005). The exact nature and origin of EPC was the subject of 
considerable debate for many years, but data from implanted depth electrodes in 
patients being considered for surgery have now confirmed that EPC represents a 
form of focal motor status epilepticus (Wieser, 1977; Chauvel, 1992). It is most 
commonly associated with an underlying structural lesion such as stroke, tumour 
or arteriovenous malformation (Cockerell et al., 1996). Rasmussen’s encephalitis, 
a rare immune-mediated brain disorder that causes unilateral hemispheric atrophy, 
is classically associated with EPC and is the most common cause of this condition 
in children (Cockerell et al., 1996; Bien et al., 2005).
7.3c Frontal Lobe Complex Partial Seizures
Frontal lobe seizures with unusual behavioural manifestations were described in 
the 1970s and earlier (Geier et al., 1976; Geier et al., 1977), but since the 
widespread availablility of video EEG technology Frontal Lobe Complex Partial 
Seizures (FLCPS) have been extensively studied and the key features more 
clearly defined (Williamson et al., 1985; Waterman et al., 1987; Wieser, 1992; 
Chauvel, 1995). As discussed previously, they may begin with an aura, most 
commonly a somatosensory sensation but with affective or autonomic features 
also often reported. The seizures are then characterized by the explosive onset of 
prominent motor automatisms, which usually have an agitated appearance. The
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activities seen include prominent bimanual and bipedal movements, such as 
cycling or kicking movements of the legs, hand clapping and leg slapping. Axial 
movements, such as rocking, thrashing, running (often in an apparently agitated or 
distressed manner), sitting up and head nodding are common. In some patients 
automatisms have a semipurposeful quality (Chauvel, 1995), and sexual 
automatisms, including pelvic thrusting and genital manipulation, are sometimes 
observed (Spencer et al., 1983). Vocalization is common, and often consists of 
unintelligible screaming or moaning. In some individuals palilalic speech or the 
screaming of obscenities is seen; others breath deeply or eccentrically but without 
actual vocalization (Waterman et al., 1987; Chauvel, 1995).
FLCPS tend to be brief and frequent, and occur in clusters with a nocturnal 
preponderance (Waterman et al., 1987; Crespel et al., 2000; Williamson and Jobst,
2000). Their onset is usually explosive, and offset is abrupt, often with no 
apparent post-ictal state. During the episode, consciousness may be entirely or 
partially retained. The subject often describes being aware of his surroundings 
during the event but without control over his actions and unable to respond 
(Williamson et al., 1985; Waterman et al., 1987; Williamson, 1995).
7.3d. Other types of frontal lobe seizure
Seizures resembling temporal lobe seizures. Frontal lobe seizures may present 
with features very similar to those seen in temporal lobe epilepsy, with arrest of 
activity, unresponsiveness and oroalimentary automatisms; they may also be 
associated with electroencephalographic features of temporal lobe epilepsy 
(Williamson and Jobst, 2000). In some such cases the site of origin has been 
localized to the orbitofrontal region (Munari, 1992; Smith et al., 2004).
Intracranial studies have suggested that the orbitofrontal area itself results in very 
few clinical manifestations, and that the seizure semiology in these cases is a 
result of rapid propagation to adjacent areas (Munari, 1992). In some cases this 
will be the temporal lobe, but spread to other regions in the frontal lobes may also 
occur, resulting in more dramatic presentations (Tharp, 1972; Bancaud, 1992; 
Munari, 1992).
134
Chapter 7. Seizures in Frontal Lobe Epilepsy
Frontal Lobe ‘Absences’. Seizures clinically resembling absences have been 
reported in patients with frontal lobe epilepsy; these patients may also have 
generalized tonic-clonic seizures, giving a clinical picture similar to idiopathic 
generalized epilepsy (Bancaud, 1992). Occasionally these are associated with 3Hz 
spike wave patterns, giving an appearance similar to true absence seizures, 
although the spike-wave activity is usually more irregular and at a slower 
frequency than idiopathic generalized epilepsy (Bancaud, 1992; Chauvel, 1995). 
In other cases a more disorganized, diffuse EEG has been described (Williamson 
and Jobst, 2000).
Section 7.4. Interpretation of automatisms in FLE
The main types of frontal lobe seizure described (SMA seizure, focal clonic motor 
seizure, and frontal lobe complex partial seizure, FLCPS) appear to have 
fundamentally different mechanisms. The ‘Jacksonian march’ is clearly referable 
to a cortical structure, the motor homunculus of the precentral gyrus; similarly, the 
asymmetric tonic posturing of SMA seizures appears to have a clear relationship 
to a region of frontal cortex, as demonstrated by the electrical stimulation studies 
of Penfield (Penfield and Welch, 1951). However, the bizarre and dramatic 
automatisms of FLCPS are more difficult to explain. Such automatisms have not 
been elicited by way of direct cortical stimulation, and it is conceptually difficult 
to link the range of dramatic, emotional and sometimes violent behaviours to a 
specific region of frontal lobe cortex (Tinuper et al., 2005).
Some authors have speculated that these automatisms reflect innate behavioural 
patterns which are released from inhibition by the focal seizure (Tassinari et al., 
2005). These authors hypothesise that such behaviours, being fundamental and 
phylogenetically primitive survival behaviours, are encoded in subcortical neural 
networks known as central pattern generators (CPGs), and are released from 
higher inhibition by the seizure. CPGs are well recognized in basic neuroscience. 
They comprise neural networks in the spinal cord, brainstem and other subcortical 
regions, which are responsible for basic innate behaviours such as locomotion 
(Grillner and Wallen, 1985). At the present time, study of CPGs has been largely
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restricted to mechanisms for walking and swimming in simple lizards and 
amphibians. However, similar patterns are thought to exist in all animals, and it is 
widely believed that they are also responsible for more complex behaviours such 
as emotional expression and feeding (Grillner, 2003; Kiehn, 2006). The negative 
emotional facial expressions, vocalization, and ambulatory automatisms prominent 
in FLCPS have been interpreted by some authors as a release from inhibition of 
fundamental survival behaviours encoded in subcortical CPGs (Tassinari et al., 
2003; Bartolomei et al., 2005; Tassinari et al., 2005); indeed, these authors 
speculate that other automatisms, such as chewing and lip smacking in temporal 
lobe epilepsy, may reflect similar phenomena (Meletti et al., 2004).
Section 7.5. Electroencephalographic findings 
7.5a. Interictal EEG
The interictal scalp EEG in frontal lobe epilepsy can be difficult to interpret. In 
temporal lobe epilepsy, interictal and ictal discharges have a relatively high 
localizing and lateralizing value (Blume et al., 2001; Foldvary et al., 2001). This 
is not the case in frontal lobe epilepsy, particularly when the epileptic focus lies on 
the medial aspect of the frontal lobes (Williamson, 1995; Vadlamudi et al., 2004). 
In a significant proportion of these cases no interictal epileptiform discharges are 
seen. The EEG may be entirely unremarkable, or may show only non-specific 
abnormalities such as bilateral or midline theta slowing (Morris et al., 1988).
When interictal epileptiform discharges are present, they are often of limited 
lateralizing or localizing value, being located only in the midline or diffusely over 
both frontal regions. (Williamson et al., 1985; Waterman et al., 1987; Morris et al., 
1988; Bautista, 1998). Occasionally a ‘secondary bilateral synchrony’ pattern is 
seen. This was first described in patients with parasaggital lesions (Tukel, 1952) 
and consists of bilateral spike and wave discharges. While there may be 
similarities with the generalized spike-wave pattern seen in idiopathic generalized 
epilepsy, the activity is usually more irregular and of a lower frequency. This 
finding has been reported frequently since the initial observation (Williamson,
1992), and has also been associated with seizures of cingulate origin (Mazars, 
1970).
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Focal and lateralizing EEG discharges are more frequently seen if the epileptic 
focus lies on the dorsolateral convexity than the medial structures (Bautista, 1998; 
Vadlamudi et al., 2004), but even in these cases they tend to be regional than 
highly focal (Quesney, 1992). The findings depend, at least in part, on the nature 
and extent of the epileptic focus. A spectrum of interictal patterns, ranging from a 
normal interictal EEG to continuous focal or regional spiking, has been reported in 
these patients (Niedermeyer and Lopes de Silva, 2004).
7.5b Ictal EEG
In general, the ictal EEG patterns of frontal lobe seizures are broadly similar to 
those of other neocortical epilepsies (Niedermeyer and Lopes de Silva, 2004). As 
with interictal EEG, the problem is one of sampling; the medial and inferior 
aspects of the frontal lobes are not directly accessible using scalp EEG monitoring. 
While in some patients, generally those with a seizure focus on the dorsolateral 
convexity, ictal scalp EEG may be informative (Williamson and Spencer, 1986), 
more often the patterns seen are unhelpful. Many frontal lobe seizures, 
particularly those arising from medial frontal foci, are associated with little or no 
change in the EEG, and subtle changes may be obscured by muscle and movement 
artifact from prominent motor activity (Williamson, 1992; Salanova et al., 1995; 
Bautista, 1998). Other seizures are associated with non-specific electrographic 
changes such as attenuation of background rhythms or diffuse postictal slowing, 
without clear ictal rhythms (Morris et al., 1988). As a result, many subjects with 
frontal lobe epilepsy may be incorrectly diagnosed with pseudoseizures or other 
non-epileptic events (Morris et al., 1988; Kanner, 1990).
When ictal rhythms are present on the scalp EEG, the must be interpreted with 
caution as they may be misleading. Rapid propagation from mesial foci to the 
dorsolateral convexity can give a misleading impression of the site of seizure 
origin (Veilleux et al., 1992). In other cases frontal lobe seizures, particularly 
those arising in the orbitofrontal region, can be associated with interictal and ictal 
scalp EEG changes suggestive of a temporal focus (Williamson and Spencer, 
1986).
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7.5c. Intracranial EEG.
As stated previously, although clinical seizure patterns have been associated with 
involvement of SMA and primary motor cortex, there is ample evidence that such 
seizures may originate elsewhere within or even outside the frontal lobes and 
rapidly propagate to these regions (Williamson, 1992; Salanova et al., 1995; 
Manford, 1996; Jobst et al., 2000). Aspects of semiology such as tonic posturing 
or clonic jerking may be useful in lateralizing ictal onset (Bleasel et al., 1997; 
Werhahn et al., 2000), but are of limited value in accurate localization. Likewise, 
scalp EEG is often of limited value for the reasons discussed in this section. 
Monitoring with intracranial electrodes is usually mandatory when surgery is 
considered in such cases but, due to the limited area of brain tissue that may be 
sampled by this technique, is susceptible to the problems with sampling error. 
Careful analysis of all data, including clinical history, ictal semiology, scalp EEG 
and imaging findings must be performed when planning the implantation strategy 
in such patients.
Summary
Although seizures of frontal lobe origin may present with a wide variety of clinical 
manifestations, a number of common features such as prominent motor activity, 
clustering and nocturnal predominance have been identified. Attempts to attribute 
various clinical features of these seizures to specific regions within the frontal 
lobes have, however, been largely unsuccessful. While some features appear to be 
associated with involvement of specific cortical regions (such as asymmetric tonic 
posturing with SMA involvement), the large area of clinically ‘silent’ cortex in the 
frontal lobes, coupled with the extensive connectivity in this region, makes 
accurate localization of seizure onset on clinical grounds almost impossible.
Seizures are best considered as either focal motor seizures, SMA seizures or 
complex partial seizures. These seizure types, while implying involvement of 
certain areas within the frontal lobes, are semiological categories and do not 
provide implicit information as to the site of seizure origin.
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The inaccessibility of large areas of the frontal lobes to scalp EEG makes 
electrographic localization of seizure onset problematic, even with intracranial 
monitoring, and many frontal lobe seizures are associated with a normal EEG or 
only non-specific changes. When attempting to identify the site of seizure onset it 
is of paramount importance that all available data, including clinical history, 
seizure semiology, electrographic changes and imaging findings are utilized.
Even when this occurs, in many cases of frontal lobe epilepsy accurate localization 
is not possible.
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CHAPTER 8 
FRONTAL LOBE EPILEPSY 
Nocturnal Paroxysmal Dystonia and Nocturnal 
Frontal Lobe Epilepsy
Introduction
It has been recognized for some time that frontal lobe seizures have a predilection 
to occur during sleep. However, as a result of the unusual seizure manifestations 
and the frequently unhelpful EEG findings, an appreciation of the full range of 
FLE presentations was slow to emerge. In particular, frontal lobe seizures 
restricted to sleep caused, and continue to cause, considerable diagnostic 
difficulty. In this chapter, the recognition of nocturnal frontal lobe epilepsy 
(NFLE) as a distinct clinical entity is discussed, and the clinical features of this 
condition are described.
Section 8.1. Development of concepts 
8.1a. Nocturnal Paroxysmal Dystonia
In 1981, five patients with frequent sleep-related events were reported by Lugaresi 
and Cirignotta (Lugaresi and Cirignotta, 1981). These individuals had frequent 
steroptyped events, occurring almost every night, characterized by tonic and 
dystonic posturing and coarse, violent movements. The episodes all arose from 
stage 2 sleep, were not associated with epileptiform abnormalities on EEG, and 
were responsive to carbamazepine. Lugaresi and Cirignotta named this condition 
hypnogenic paroxysmal dystonia, and suggested three possible underlying 
mechanisms. They suggested that the movements could be a form of sleep terror 
(i.e. a benign parasomnia), a form of paroxysmal dystonia triggered by arousal 
from sleep (i.e. a movement disorder), or a form of epilepsy arising from deep or 
mesial structures.
Over the next decade, further reports of this condition appeared in the literature 
(Godbout et al., 1985; Lugaresi et al., 1986; Lehkuniec et al., 1988; Maccario and
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Lustman, 1990). Whilst evidence for an epileptic basis was seen in some cases, in 
others the association with the subsequent development of Huntingdon’s disease 
(Lugaresi et al., 1986) concurrent reflex dystonia (Lehkuniec et al., 1988) 
suggested that the NPD was in fact a movement disorder . It was hypothesized, 
therefore, that the condition was heterogeneous, and included paroxysmal 
disorders with different underlying aetiologies. In general, brief attacks (which 
tended to be more responsive to anticonvulsants) were held to be epileptic in 
origin, wheras the rarer longer attacks (many of which did not respond to 
anticonvulsants) were thought to represent extrapyramidal disturbances (Tinuper, 
2002). The condition became widely known as nocturnal paroxysmal dystonia 
(NPD).
At this time, reports were also emerging of patients with multiple, very brief, 
arousals from NREM sleep. These arousals caused significant sleep fragmentation 
and daytime somnolence, and in some cases appeared to have an epileptic basis 
(Peled and Lavie, 1986; Montagna et al., 1990). In addition, the phenomenon of 
episodic nocturnal wanderings was described (Pedley and Guilleminault, 1977; 
Maselli et al., 1988) characterized by episodes of vocalization, complex and 
sometimes violent automatisms, and ambulation.
8.1b. Nocturnal Frontal Lobe Epilepsy
The nature of these episodes, particularly NPD, was widely debated (Lee et al., 
1985; Berger et al., 1987), but as more work was performed on the semiology of 
frontal lobe epilepsy, the similarities between NPD and frontal lobe seizures 
became apparent. Both conditions presented with prominent tonic and dystonic 
features or bizarre automatisms, were often associated with preservation of 
consciousness, and frequently had no associated ictal EEG changes (Rasmussen, 
1983; Spencer et al., 1983; Williamson et al., 1985; Waterman et al., 1987; Morris 
et al., 1988). The tendency of frontal lobe seizures to occur in sleep was also 
recognized. These striking similarities, combined with the presence of definite 
epileptiform discharges in a number of NPD patients, resulted in the appreciation 
that most (if not all) NPD cases were epileptic in origin (Tinuper et al., 1990;
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Meierkord et al., 1992), and the term ‘nocturnal frontal lobe epilepsy’ (NFLE) was 
coined.
8.1c. Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
It was noticed by some clinicians that a number of individuals with NFLE had a 
family history of similar sleep related events. In 1994, Scheffer et al described a 
group of families from Australia, Canada and the UK in whom NFLE was 
inherited in an autosomal dominant fashion, thus describing autosomal dominant 
nocturnal frontal lobe epilepsy (ADNFLE) (Scheffer et al., 1994). A genetic 
mutation was subsequently identified in a nicotinic acetylcholine subunit gene in 
one of these family (Steinlein et al., 1995), making ADNFLE the first form of 
human epilepsy for which the fundamental genetic basis had been established . 
ADNFLE will be considered in detail in Chapter 9.
Section 8.2. Semiological considerations 
8.2a. Seizure types in NFLE
Once an epileptic basis to NFLE had been identified, the Bologna group undertook 
painstaking studies of the semiologic spectrum of this condition. They grouped 
the seizures of NFLE into three major types, based on their semiology and 
duration: paroxysmal arousals, lasting 20 seconds or less; paroxysmal nocturnal 
dystonia, lasting up to 2 minutes; and epileptic nocturnal wanderings, lasting up to 
3 minutes (Montagna, 1992). Patients rarely had only a single type of attack; the 
brief paroxysmal arousals were conceptualized as fragments of larger seizures 
(Provini et al., 1999), and all events were considered to be manifestations of the 
same underlying epileptic process.
Paroxysmal arousals consist of abrupt arousal from sleep with vocalization and 
highly stereotyped motor activity, often consisting of head movements, frightened 
expressions, and dystonic posturing of the limbs (Provini et al., 2000). They occur 
repetitively and very frequently throughout the night, often with a periodic 
repetition (Provini et al., 1999) and are often under-reported. Some individuals
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are completely unaware of them and present with excessive daytime somnolence 
(Peled and Lavie, 1986).
Nocturnal paroxysmal dystonia seizures begin as a paroxysmal arousal, but are 
subsequently associated with more complex movements including bipedal 
automatisms, rhythmic twisting movements of the trunk and pelvis, vocalization 
and tonic or dystonic posturing (Provini et al., 2000).
Episodic nocturnal wanderings usually begin as a paroxysmal arousal, 
progressing through the nocturnal paroxysmal dystonia stage, followed by 
jumping from the bed and ambulation (usually in an agitated fashion), screaming 
or other vocalisation, and sometimes semipurposeful automatisms which may be 
violent (Maselli et al., 1988; Plazzi et al., 1995). Such episodes are infrequent, 
with paroxysmal arousals and nocturnal paroxysmal dystonia making up the 
majority of events in any given individual (Provini et al., 2000).
8.2b. Clinical and electrographic features of NFLE
The definitive study of the clinical features of NFLE was published by the same 
group at the end of the last century (Provini et al., 1999). They reviewed video 
EEG and PSG monitoring of one hundred patients with NFLE, examining a total 
of 660 seizures. A number of key findings arose from this study.
Patients had a mean age of onset of 14 years, but with a very wide range (1 to 64 
years). They reported a mean of 20 seizures per month, with one to twenty 
occurring per night. Most had no identifiable triggers for their seizures. From the 
history, one third of patients had occasional daytime seizures, and 28% had 
occasional secondarily generalized tonic clonic seizures. Interestingly, a large 
number had a personal or family history of events which, from the clinical 
description, were consistent with typical parasomnias such as sleep walking and 
sleep terrors. While some patients complained of sleep disturbance, over 70% 
were unaware of their events and the problem was reported by relatives. 
Neurological examination was normal in 92%, and neuroradiologic al examination 
(with CT or MRI) was normal in 86%.
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In terms of ictal semiology, by far the most common seizure type was the 
paroxysmal arousal, constituting 75% of the recorded seizures; paroxysmal 
nocturnal dystonia constituted a further 23%, with epileptic nocturnal wanderings 
making up only 2% of recorded seizures. Most patients had at least two of these 
seizure types identifiable on monitoring, and autonomic features such as 
tachycardia and irregular respiration were prominent.
Electrographically, almost all the events occurred during NREM sleep, with about 
70% occurring in stage 1 or 2. Interictal EEG was normal in the majority of 
patients, with only 33% showing clear-cut epileptiform discharges in wakefulness 
and 45% in sleep. Ictal EEG showed no epileptiform activity in 44%, and in the 
majority of the remainder focal attenuation or rhythmic theta or delta was the 
prominent rhythm; only 8% showed spike and wave activity, and another 8% 
showed focal fast activity.
Conclusion
NFLE is a relatively uncommon and recently recognized form of epilepsy. Major 
semiological studies of this condition have led to a wider appreciation of its most 
important clinical features, although accurate diagnosis can still be difficult in 
clinical practice. While NFLE is not a common disorder, major scientific 
advances have resulted from its identification (and in particular the familial form 
ADNFLE) which are likely to have implications for other forms of epilepsy. 
Further understanding of this condition, both in terms of the clinical features and 
the genetic basis, is still necessary.
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CHAPTER 9 
FRONTAL LOBE EPILEPSY 
Pathology and Clinical Genetics
Introduction.
The range of pathologic substrates associated with frontal lobe epilepsy (FLE) 
must be considered in any discussion of this condition. Partial epilepsies tend to 
be associated with a variety of underlying pathologies, and FLE is no exception. 
However, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), a 
form of FLE with an established genetic basis, deserves particular consideration. 
The discovery of this disorder, and the genetic mutations which cause it, has 
transformed our appreciation of the role played by genetic factors in epilepsy.
In the first section of this chapter the pathological basis of FLE is reviewed, along 
with neuroimaging correlates. The second secection is a discussion of the clinical 
and molecular genetics of ADNFLE.
Section 9.1. Pathology and neuroimaging in FLE: general 
9.1a. Pathological basis of FLE
With the exception of ADNFLE, an idiopathic partial epilepsy, FLE is usually 
classified as a symptomatic or cryptogenic partial epilepsy. Accordingly, it has a 
similar range of underlying pathologies to other symptomatic partial epilepsies. 
These include congenital abnormalities (such as malformations of cortical 
development, vascular malformations and developmental tumours), and acquired 
insults (including neoplasms, CNS infections, vascular insults, head injury and 
perinatal injury) (Foldvary, 2001).
Most work addressing the pathological basis of FLE has examined post-surgical 
data. Several FLE series of this nature have been presented, with broadly similar 
findings. The most widely cited is from the Montreal Neurological Institute, and 
comprises pathological data from 40 ‘pure’ frontal lobe epilepsy patients
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(Rasmussen, 1983); this series was subsequently extended to 187 cases 
(Robitaille et al., 1992). Tumours and vascular malformations were excluded 
from these series, in which the most common underlying pathology was 
meningocerebral cicatrix (essentially scarring involving the meninges and 
cerebral cortex), which accounted for 50% and 33% of cases respectively in the 
two series). Other common pathological findings were gliosis (33% in both 
series) and cortical dysgenesis (7.5% and 15.5%). The cause of the acquired 
lesions observed in these series was not discussed in detail, although trauma in 
general was said to account for 50% of cases and birth trauma was the ‘presumed’ 
aetiology in 7.5%.
In an earlier large series of surgically treated FLE reported by the same group, a 
comparable range of aetiologies was identified (Rasmussen, 1963): Head injury 
(31%), tumour (25%) and birth trauma (10%) constituted the majority of cases, 
with the remainder attributed to gliosis (secondary to abcess, haematoma etc.;
6%), encephalitis (5%), gunshot (4%) and other known pathology (8%). No 
pathology was identified in 11% of cases in this series. Another major series of 
100 surgically treated cases of FLE from Paris identified neonatal anoxia, head 
trauma and encephalitis as the most common pathological lesions; only 7% had an 
underlying tumour and in 37% the cause was unknown after surgery (Talairach et 
al., 1992).
While these surgical series provide important insights into the pathological basis 
of FLE, their applicability to FLE in general is unclear. There are several reasons 
for this. Firstly, these series included a significant number of veterans from the 
Second World War. While frontal lobe injury is a recognised risk factor for the 
development of post-traumatic epilepsy (Frey, 2003), it is probably less prevalent 
in comtemporary society than in these series. Secondly, improvements in 
neuroimaging over the last decade or so have resulted in increased detection of 
focal cortical dysplasia and other malformations of cortical development in 
refractory focal epilepsies, including FLE (Taylor et al., 1971; Chung et al., 2005; 
Kakita et al., 2005). These abnormalities are almost certainly responsible for more 
than 7-15% of FLE as reported in the Montreal series. More recent, although 
smaller, neurosurgical series of frontal lobe epilepsy report malformations of
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cortical development in between 26% and 76% of cases (Kim et al., 2002; 
Schramm et al., 2002); furthermore, cortical dysplasia may be the responsible 
lesion in a significant proportion of ‘lesion-negative’ cases (Palmini et al., 2004), 
many of whom are not considered for surgery. Thirdly, in these series the 
ascertainment of cases may have been biased towards those individuals with 
secondarily generalized seizures. As discussed in Chapter 7, the spectrum of 
frontal lobe seizures was not fully appreciated at the time these series were 
compiled; many patients with FLE without generalized tonic-clonic seizures may 
have been misdiagnosed with pseudoseizures or parasomnias and not considered 
for surgical treatment. Finally, these series take no account of genetic factors in 
FLE. Until the relatively recent descriptions of familial frontal and temporal lobe 
epilepsy syndromes, partial epilepsies persisting into adulthood were assumed to 
be symptomatic in nature. However, it is increasingly apparent that genetic 
mutations can be responsible for a number of focal epilepsies, including frontal 
lobe epilepsy. While at present a clear genetic basis to frontal lobe epilepsy is 
only apparent in a small minority of patients, it is possible that the influence of 
genetic factors in non-familial FLE is greater than is currently appreciated.
9.1b. Structural imaging in FLE
Magnetic resonance imaging (MRI) is well established as the most sensitive and 
specific neuroimaging technique in all partial epilepsies, including frontal lobe 
epilepsy (Bergen, 1989; Cascino, 1991; Kuzniecky et al., 1993). Its effectiveness 
has been established in the detection of a range of epileptogenic pathologies: 
malformations of cortical development, post-traumatic gliosis, infection-related 
changes, and tumours (the most common underlying pathologies from surgical 
series in FLE) may be detected with high diagnostic yields (Bergen et al., 1989; 
Palmini et al., 1991; Cascino et al., 1992; Kuzniecky et al., 1993). In particular, 
the importance of focal cortical dysplasia (FCD) in intractable focal epilepsy has 
only become apparent since the advent of MRI; this pathology is rarely visible 
using older imaging modalities such as CT. Type 2, or ‘Taylor type’, dysplasia 
(with dysplastic neurons and /or balloon cells) is usually, although not invariably, 
visible on MRI. Cortical thickening (Chan et al., 1998), blurring of the grey/white 
interface (Chan et al., 1998; Lee et al., 1998), and increased signal on T2 or
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FLAIR sequences (Bronen et al., 1997; Lee et al., 1998) are the typical MRI 
findings. In contrast, Type 1 FCD (defined as dysplastic cortex without 
dysmorphic or balloon cells) is not always detectable, although clarification of 
diagnostic yields of MRI is still unclear in this setting (Palmini et al., 2004).
The ability to detect and delineate epileptogenic lesions is of both practical and 
academic importance. Epilepsy surgery in FLE has a substantially greater success 
rate in patients with preoperatively recognized lesions, with an excellent outcome 
obtained in 72% of individuals with a concordant lesion versus 41% in those with 
no detectable MRI abnormality (Mosewich, 2000). The overall diagnostic yield of 
MRI from presurgical series in FLE is quoted at 45 - 60% (Swartz, 1989; Cascino, 
1992; Mosewich, 2000); the most recent series have recorded highest yields, 
presumably a result of technical MRI improvements and increased familiarity with 
subtle abnormalities.
9.1c. Functional imaging in FLE
Although structural neuroimaging using MRI is the principle technique employed
18in the evaluation of patients with partial epilepsy, the usefulness of F-FDG PET 
and ictal single-photon emission computed tomography (SPECT) has also been 
established, particularly in the presurgical setting.
Positron Emission Tomography (PET). As discussed in Chapter 3, PET is based 
upon computerized reconstruction of images based on the distribution of 
radioactive tracers in the brain. A wide number of radioactive tracers have been 
developed for use in PET, allowing measurement of glucose metabolism, blood 
flow or receptor density for specific neurotransmitters. The bulk of experience in 
epilepsy is with l8F-FDG PET, which measures glucose metabolism. 
Characteristically, reduced metabolic activity is observed around the epileptic 
focus (Kuhl et al., 1980; Engel et al., 1982; Lee et al., 1994), and over 70% of 
patients with partial epilepsy show a localised area of decreased cerebral glucose 
metabolism on l8F-FDG PET. This is usually regional or lobar (Sadzot, 2004); in 
widespread or multilobar cases, the most hypometabolic lobe is usually the lobe of 
seizure onset (Sadzot et al., 1992). False localizations have occasionally been
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reported in extratemporal epilepsies, but false lateralization is exceptional (Sadzot 
et al., 1992; Sperling et al., 1995). The sensitivity of 18F-FDG PET is influenced 
by the location of the seizure focus. In general terms, the sensitivity is greater in 
temporal than extratemporal epilepsies; Spencer et al. reported a sensitivity of 
84% in TLE compared to only 33% in extratemporal epilepsy (Spencer, 1994). 
More recently, in a study specifically addressing 18F-FDG PET findings in FLE, 
hypometabolic lesions were identified in 55% of patients (Kim et al., 2002).
While PET abnormalities are frequently identified in individuals with a structural 
lesion on MRI, unfortunately sensitivity is considerably lower in individuals with 
normal MRI (Ryvlin et al., 1991). In frontal lobe epilepsy, the sensitivity of 18F- 
FDG PET has been quoted as 73% in individuals with structural lesions on MRI 
and only 36% of those with a normal MRI (Kim et al., 2002). Despite this lower 
yield, in clinical practice 18F-FDG PET is most likely to provide useful diagnostic 
information in the patients in whom the MRI is normal or non-specific; a 
definitive MRI lesion, when present, is almost invariably more informative than 
PET data. In general, the use of 18F-FDG PET is limited to localization of the 
epileptic focus, and there is little capacity to distinguish between different 
pathologies. However, in neuronal migration disorders, displacement of grey 
matter activity to a white matter region may occasionally be observed (Lee et al.,
1994). This pattern is seen infrequently but when present is highly specific 
(Sadzot, 2004).
Other PET ligands have been used in epilepsy patients to examine the distribution 
of various receptors in the interictal state. Most widely used is n C-flumazenil 
(n C-FMZ), a selective antagonist of GABAa receptors (Savic et al., 1988). 
Evidence is accumulating that n C-FMZ may be a useful technique for the 
identification of epileptogenic abnormalities, including patients with 
extratemporal epilepsies and normal MRI (Richardson et al., 1998; Juhasz et al., 
2001; Hammers et al., 2002). Other ligands, including n C-diprenorphine for 
opioid receptors and 18F-FCWAY and l8F-MPPF for serotonergic 5HT ia 
receptors, have been used in epilepsy research studies, but their usefulness in FLE 
has not been examined to date.
149
Chapter 9. Pathology and Genetics o f NFLE
Single Photon Emission Computed Tomography (SPECT). SPECT studies 
involve the administration of blood flow tracers during a seizure. A number of 
tracers exist for this purpose, including " mTc-HMPAO and " mTc-ECD. These 
compounds are lipophilic, and therefore cross the blood-brain barrier; they are 
then metabolised to hydrophilic compounds that become trapped within cells. 
Cerebral uptake is complete within 2 minutes of injection, and images of relative 
blood flow during the seizure can be obtained for up to 3 hours after the 
administration of the tracer. The sensitivity of ictal SPECT for seizure 
localization is very high in temporal lobe epilepsy (95%), and is also high in 
extratemporal epilepsies (90%); the sensitivity of the test falls significantly if the 
injection is given postictally (Newton et al., 1992). The usefulness of ictal SPECT 
has been established specifically in FLE, in which it has a sensitivity of 91% 
(Harvey et al., 1993). However, while SPECT can be effective at localizing 
seizure onset, it does not provide information on the pathological substrate of the 
seizure.
9.1 d. Pathology and neuroimaging in NFLE
Although seizures in NFLE occur exclusively or almost exclusively during sleep, 
their semiological features are indistinguishable from those of frontal lobe 
epilepsy in general. However, the underlying pathological processes involved 
may be distinct. Personal antecedents such as birth anoxia, febrile convulsions 
and head injury are less common in NFLE, being reported in 13% of subjects; 
likewise, abnormalities were seen on cranial imaging with CT or MRI in only 14% 
(Provini et al., 1999). These findings are unlike those in most partial epilepsies, 
and are much lower than the 45-60% found in frontal lobe epilepsy as a whole 
(Swartz, 1989; Cascino, 1992; Mosewich, 2000). Moreover, Autosomal 
Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) comprises up to 25% of 
cases of NFLE. Taken together, these findings suggest that a ‘functional’ (as 
opposed to a ‘structural’) mechanism may be responsible in many, although not 
all, cases of NFLE (Provini et al., 1999). In the small group of patients in whom 
pathological lesions are identified on MRI, the lesions are broadly consistent with 
the findings of other FLE series, with arteriovenous malformations, cerebral
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ischaemic lesions, focal cortical dysplasia and frontal gliosis being reported 
(Provini et al., 1999).
In terms of functional imaging, there are no specific reports of PET finding in 
NFLE, other than in two patients with ADNFLE (see later). Ictal SPECT has been 
reported in two cases of sporadic NFLE, both of which demonstrated anterior 
cingulate hyperperfusion (Schindler et al., 2001; Vetrugno et al., 2005).
Section 9.2: Autosomal Dominant Nocturnal Frontal Lobe 
Epilepsy
9.2a. ADNFLE - background
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) was first 
described in 1994 in families from Australia, Canada and the United Kingdom 
(Scheffer et al., 1994), but has since been described in ethnically diverse 
populations from around the world, including Italy, Japan, Korea and Norway 
(Oldani et al., 1998; Nakken et al., 1999; Ito et al., 2000; Cho et al., 2003). When 
a mutation was discovered in the nicotinic acetylcholine receptor a4 subunit gene 
in one of these families (Steinlein et al., 1995), ADNFLE became the first human 
epilepsy in which the fundamental genetic defect had been identified. 
Subsequently, further mutations in nicotinic acetylcholine receptor a4 and 02 
subunit genes have been identified in families around the world (Hirose et al., 
1999; De Fusco et al., 2000; Ito et al., 2000; Phillips et al., 2001). These 
discoveries, along with ion channel mutations in other familial epilepsy 
syndromes, have led to major changes in the understanding of epilepsy. In 
particular they led to the concept of epilepsies, including partial epilepsies, as 
channelopathies.
9.2b. ADNFLE - clinical features
The clinical features of FLE and NFLE have been considered in detail already in 
Chapters 7 and 8. However, ADNFLE has been studied in some detail as an
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independent entity. Seizures usually begin in childhood, with a mean age of onset 
of around 11 years (Scheffer et al., 1995; Oldani et al., 1998). Although about 
85% of cases begin before age 20 (Scheffer et al., 1995), seizure onset has been 
reported from 1 to 52 years of age (Scheffer et al., 1995; Oldani et al., 1998). In 
the great majority of cases, affected individuals are of normal intellect and have a 
normal neurological examination (Scheffer et al., 1995; Oldani et al., 1998), 
although two familes with mental retardation in association with ADNFLE have 
been described. In one of these families, mental retardation and ADNFLE were 
inherited in a bilineal fashion, raising the possibility that the connection was 
coincidental (Khatami et al., 1998). In the other, however, coexisting ADNFLE 
and mental retardation were reported in association with the CHRNA4 Ser252Leu 
mutation in a Korean kindred (Cho et al., 2003). Such a pattern is not found in 
other reported kindreds, although interestingly some affected members of an 
unrelated Japanese family with ADNFLE and the CHRNA4 Ser252Leu mutation 
were reported to have mental retardation (Hirose et al., 1999).
Seizures in ADNFLE occur almost exclusively from sleep, although up to one 
third of patients may have infrequent daytime seizures, particularly in periods of 
poor seizure control (Scheffer et al., 1995; Oldani et al., 1998); about one half of 
subjects may also have rare secondarily generalized tonic-clonic seizures. The 
majority of patients experience seizures just as they are dozing off to sleep, but 
seizures may also occur soon before wakening or, less commonly, throughout the 
night (Scheffer et al., 1995). Patients are often woken by a relatively non-specific 
aura, often a shiver or feeling in the limbs ; such an aura is more common in 
ADNFLE (Scheffer et al., 1995) than sporadic NFLE (Provini et al., 1999). The 
seizure often begins with vocalization, which may be a grunt, moan, or a single 
word (Scheffer et al., 1995). Prominent motor features are usually seen, including 
tonic or dystonic posturing, sometimes with superimposed clonic jerking; sitting 
up or jumping up; bipedal and bimanual automatisms; and sometimes violent 
behaviour (Scheffer et al., 1995; Oldani et al., 1998). Consciousness is often 
preserved, and individuals usually experience fear or panic during the seizure; 
some individuals have prominent vocalization during this period (Oldani et al., 
1998). The seizures are typically stereotyped and brief, often one minute or less in 
duration, and occur in clusters. During clusters, patients usually have six or seven
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attacks per night, but in some cases between 20 and 70 attacks per night have been 
recorded (Scheffer et al., 1995).
Within families there is wide variation in the severity of the disorder (Oldani et al.,
1998) and within the manifestations of the seizures themselves (Hayman et al., 
1997). In individual subjects, the disorder tends to be at its most severe in 
childhood and adolescence. Seizures usually become milder and less frequent in 
adulthood, although rarely completely disappear (Scheffer et al., 1995; Oldani et 
al., 1998). They are usually responsive to treatment with antiepileptic drugs, with 
carbamazepine being particularly effective (Scheffer et al., 1995; Oldani et al., 
1998; Thomas et al., 1998; Picard et al., 1999; Gambardella et al., 2000); 
acetazolamide has also been reported as effective in resistant cases (Varadkar et 
al., 2003). In a single patient with a known a4 nicotinic acetylcholine receptor 
subunit, nicotine (administered via patch) was found to result in a significant 
reduction in seizure frequency (Willoughby et al., 2003); however, nicotine has 
not been used in larger trials in ADNFLE.
9.2c. EEG and neuroimaging in ADNFLE
Interictal awake EEG is usually normal inADNFLE; during sleep, interictal 
epileptiform abnormalities may be seen in up to 50% of cases, but even when 
present these are often sparse (Scheffer et al., 1995; Oldani et al., 1998; Picard et 
al., 2000). Non-specific abnormalities such as frontal theta and delta slowing may 
be seen in some patients.
Seizures arise from NREM sleep, usually stage 2 but less frequently also from 
stage 3 or 4. The ictal EEG is often obscured by muscle and motion artifact.
When ictal electrographic patterns are discemable they are usually poorly 
localized, although typically have a frontal predominance. Ictal patterns may 
comprise rhythmic sharp waves or repetitive 8-11 Hz spikes; recruiting rhythms 
are rarely seen. More often, however, diffuse flattening or rhythmic frontal theta 
or delta rhythms are recorded (Scheffer et al., 1995; Hayman et al., 1997; Oldani 
et al., 1998; Provini et al., 1999). In about 25% of cases, both interictal and ictal 
EEG will be normal (Oldani et al., 1998).
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MRI studies are normal in ADNFLE (Scheffer et al., 1995; Oldani et al., 1998; 
Picard et al., 2000). Interictal PET studies in two unrelated patients showed 
hypometabolism in the left fronto-polar region in one and the right mid-frontal 
parasaggital region in the other; in both subjects these regions were hyperperfused 
on ictal SPECT (Hayman et al., 1997).
9.2d. Clinical Genetics
ADNFLE is inherited in Mendelian autosomal dominant fashion with incomplete 
(70-80%) penetrance (Steinlein et al., 1995; Steinlein et al., 1997; Oldani et al., 
1998; Hirose et al., 1999; De Fusco et al., 2000; Picard et al., 2000). In those 
families published in the literature, penetrance is quoted from 100% to as low as 
29% (Leniger et al., 2003).
However, the family history may be elusive; even once NFLE has been diagnosed 
in an individual, ADNFLE may only be recognized if a very careful family history 
is taken. As there is marked variability in severity within families, other family 
members may have had milder sleep-related events for which they did not seek 
medical attention; even in more severe cases, the unusual nature of the seizures 
may have resulted in misdiagnoses (often as parasomnias or pseudoseizures) in 
family members (Scheffer et al., 1994). A further complication is the increased 
rates of benign arousal parasomnias (such as sleep terrors, sleepwalking and 
confusional arousals) reported in ADNFLE families by some authors (Oldani et 
al., 1996; Provini et al., 1999). It is important both from the perspective of patient 
management and for molecular genetic studies that such conditions are 
distinguished accurately.
9.2e. Molecular Genetics -  the a4(32 nAChR
Linkage analysis has led to the identification of two definite genetic loci for 
ADNFLE, which map to chromosome 20ql3.2 (ADNFLE Type 1, OMIM 
#600513), and 1 p21 (ADNFLE Type 3, OMIM #605375). Underlying genetic 
mutations have been identified for both of these loci, all of which are in genes 
coding for subunits of the neuronal nicotinic a4|32 acetylcholine receptor. There
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are, however, many families with unknown linkage; a possible third locus has 
been identified at 15q24 (ADNFLE Type 2, OMIM #603204), but no associated 
mutation has been identified here.
In ADNFLE Type 1, four mutations have been identified in the gene coding for 
the neuronal nicotinic acetylcholine receptor a4 subunit (CHRNA4): three 
missense mutations, Ser248Phe, Ser252Leu, and Thr265Ile (Steinlein et al., 1995; 
Hirose et al., 1999; Leniger et al., 2003); and one insertion, 776ins3 (Steinlein et 
al., 1997). In ADNFLE Type 3, two missense mutations (Val287Leu and 
Val287Met) have been identified in CHRNB2, the gene coding for the neuronal 
nicotinic acetylcholine receptor 02 subunit (De Fusco et al., 2000; Phillips et al.,
2001). Recently, an additional CHRNB2 mutation (Ile312Met) has been 
described, occurring de novo in a twin pair with ADNFLE (Bertrand et al., 2005). 
These recognized mutations in ADNFLE have been identified in families from a 
variety of ethnic backgrounds, including European, Middle Eastern, Japanese and 
Korean (Steinlein et al., 1995; Ito et al., 2000; Phillips et al., 2000; Cho et al., 
2003).
These findings have led to the concept of ADNFLE as a disorder of the neuronal 
nicotinic a402 acetylcholine receptor (nAChR). The nAChRs are important 
ligand-gated ion channels which are distributed widely throughout the central 
nervous system, although the function of these receptors is not fully understood. 
There is good evidence that they are involved in presynaptic modulation of 
neurotransmitter release in a number of systems, enhancing the release of 
norepinephrine, dopamine, GABA, serotonin and acetylcholine (Role and Berg, 
1996). In addition there may be direct nicotinic synaptic neurotransmission in the 
CNS (although there is relatively little evidence of this), and the nAChR is 
believed to play a role in the regulation of gene expression and neuronal 
pathfinding during development(Role and Berg, 1996). Functional nAChRs are 
heteropentameric structures, comprising various combinations of a and 0 subunits, 
with the a402 subtype (two a subunits and three 0) being the predominant form 
expressed in the human brain. Each nAChR subunit consists of an N-terminal 
extracellular domain involved in ligand binding, four hydrophobic transmembrane 
domains and a cytoplasmic loop between domains 3 and 4. The second
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transmembrane domain, M2, forms the ion channel pore which appears to be 
critical; all identified mutations in ADNFLE except one (Leniger et al., 2003) are 
located in this region.
The clinical features of ADNFLE in families with different mutations appear to be 
indistinguishable; a direct comparison of families with the CHRNA4 Ser248Phe 
and CHRNB2 Val287Met mutations did not identify any clinical differences 
between them (McLellan et al., 2003). One exception to this phenomenon, 
however, appears to be a possible association between the ser2521eu mutation, 
which has been reported in three families, and increased rates of mental 
retardation and unresponsiveness to antiepileptic medication (Hirose et al., 1999; 
Phillips et al., 2000; Cho et al., 2003). Furthermore, the newly identified 
CHRNB2 Ile312Met mutation appears to be associated with distinct memory 
deficits; however, this mutation has only been identified in two individuals to date 
and larger pedigrees await identification to confirm a causal relationship (Bertrand 
et al., 2005).
ADNFLE, therefore, displays both phenotypic and genetic heterogeneity. The 
term ‘phenotypic heterogeneity’ refers to the phenomenon of a single genetic 
mutation producing a phenotype of widely differing severity; this variability may 
be seen within a given family (Scheffer et al., 1995). Genetic heterogeneity, on 
the other hand describes different mutations causing a similar phenotype, and 
takes two forms; allelic heterogeneity, referring to different mutations at the same 
locus, and locus heterogeneity, referring to mutations at different loci. Both forms 
of genetic heterogeneity are seen in ADNFLE. In fact, the situation may be even 
more complex: the fact that the known nAChR mutations have not been identified 
in so many of the established cases of ADNFLE raises the possibility of an 
alternative mechanism, unrelated to the nAChR genes, in some individuals 
(Combi et al., 2004).
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9.2f. Functional consequences of a4(32 nAChR mutations in 
ADNFLE
Although seven mutations in a4(32 nAChR subunit genes have been identified to 
date, the mechanism by which these cause ADNFLE is not entirely clear. A 
number of in vitro studies have been performed in an attempt to clarify the 
functional consequences of the recognised mutations on receptor function and help 
explain the pathogenesis of this condition. Most such studies have expressed 
mutant a4p2 receptors in Xenopus oocytes and compared various physiological 
parameters of these receptors with non-mutant receptors. Early studies 
demonstrated a number of physiological effects of the receptor mutations, 
including increased receptor desensitization, reduced mean ACh-evoked current 
amplitude, and reduced calcium permeability (Kuryatov et al., 1997; Steinlein et 
al., 1997; Bertrand et al., 1998). As these properties implied a loss of nAChR 
function, it was initially hypothesised that ADNFLE results from a reduced 
modulatory effect of ACh on other neurotransmitter systems (Weiland et al.,
2000).
However, these initial studies were criticised on the grounds that the receptor 
populations examined in the experiments differed from those in ADNFLE patients 
in two important respects: firstly, the cDNA used was obtained by genetic 
engineering and may therefore have been different in some way to that seen in 
patients; and secondly, the Xenopus oocytes studied contained only mutant 
receptor subunits. As ADNFLE is an autosomal dominant condition, and patients 
are heterozygotes for the CHRNA4 or CHRNB2 genes, both normal and mutant 
subunits should be expressed in the Xenopus oocytes being studied (Bertrand et 
al., 2002). When heterozygous receptors were generated and studied in 
subsequent experiments, the properties observed were quite different to those seen 
in the homozygous forms. Bertrand et al. studied four ADNFLE mutations 
(a4Ser248Phe, a4776ins3, a4Ser252Leu, and p2 Val287Leu) expressed in a 
heterozygous fashion. Interestingly, many of the abnormalities seen in the 
homozygous condition disappeared; features such as receptor desensitisation and 
ACh-evoked current amplitude were indistinguishable in mutant and control 
receptors. All four mutations produced one common trait, however, which was an
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increase in receptor ACh sensitivity. This finding was important for two reasons: 
firstly it provided a common mechanism for all mutations involved in ADNFLE, 
which would be expected from the clinically indistinguishable phenotypes 
produced by the different mutations; and secondly, it led to a new hypothesis in 
which ADNFLE is produced by a gain of a4$2 nAChR function, rather than a loss 
of function as previously believed (Bertrand et al., 2002).
This hypothesis was supported by further work (on the same mutations plus the 
p2Val287Met mutation) which demonstrated reduced Ca2+ - induced increases in 
the ACh response in all five ADNFLE mutations; in other words, the mutations 
reduced the Ca2+ dependence of a4f2  nAChR activity (Rodrigues-Pinguet et al., 
2003). As Ca2+ dependence may prevent presynaptic a4p2 nAChR from 
overstimulating glutamate release at excitatory synapses, the authors suggested 
that the reduction in the Ca2+ sensitivity (producing a gain of a4p2 nAChR 
function) may result in increased a4p2 -  stimulated glutamate release and hence to 
seizures.
Finally, circumstantial evidence for a gain of a4p2 nAChR function in ADNFLE 
comes from the clinical and experimental responses to carbamazepine. 
Carbamazepine has been reported as one of the most effective antiepileptic drugs 
in the treatment of ADNFLE in clinical practice (Scheffer et al., 1995). Moreover, 
it has been found to act as a non-competitive inhibitor at the a4p2 nAChR, with 
the a4Ser248Phe and a4776ins3 mutant receptors showing a greater sensitivity to 
this inhibitory effect (Picard et al., 1999). Interestingly, in the hetrozygous 
receptors studied by Bertrand et al, it was found that all mutations showed 
increased sensitivity to blockade by carbamazepine compared to controls except 
for the a4Ser252Leu; this is the mutation which has clinically been associated 
with a clinical ADNFLE phenotype that is more resistant to pharmacotherapy and 
a poor response to carbamazepine (Hirose et al., 1999; Cho et al., 2003). These 
findings would support a gain of function of the a4p2 nAChR resulting in 
the ADNFLE phenotype.
Interestingly, a possible link between this proposed gain of function and the 
nocturnal seizures of NFLE has been proposed on the basis of an [18F] -F-A-
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85380 PET study. Binding of [i8F] -F-A-85380, a high affinity a4p2 nAChR 
agonist, was examined in 8 subjects with ADNFLE and a confirmed mutation in 
either CHRNA4 or CHRNB2. Compared to a normal comparison group, the 
ADNFLE group demonstrated increased [18F] -F-A-85380 binding in the 
mesencephalon, cerebellum and pons, with reduced binding in the right prefrontal 
cortex. The authors hypothesise that the increased receptor density observed in 
brainstem and mesencephalic structures observed may result in hyperfunction of 
cholinergic pathways involved in sleep and arousal. As a result, physiological 
thalamocortical oscillations in sleep such as spindles (which, like the seizures of 
ADNFLE, are common in stage 2 NREM sleep) may develop into pathological 
thalmocortical oscillations, resulting in seizures (Picard et al., 2006). Although at 
present this hypothesis is based on a small patient sample, it is interesting and 
warrants further consideration.
9.2g. Molecular genetics -  possible non-a4(32 mechanisms
Despite the considerable evidence for involvement of the a4p2 nAChR in 
ADNFLE, only a minority of patients with the condition carry one of the 
identified mutations. Screening studies in sporadic NFLE and ADNFLE patients 
have had a very low pick up rate for these mutations (Tenchini et al., 1999; Duga 
et al., 2002; Combi et al., 2004); from the available literature it has been estimated 
that they account for less than 10% of all cases of ADNFLE (Combi et al., 2004). 
Recently, two studies have suggested that alternative molecular mechanisms, 
unrelated to a4p2 dysfunction, may be responsible for ADNFLE in some families.
Combi et al. reported two polymorphisms in the promoter region of the 
corticotrophin releasing hormone (CRH). One of these was found to cosegregate 
with ADNFLE in three familes, but is a recognised polymorphism occurring in 
approximately 3% of normal controls. The other was not found in any controls, 
suggesting that it is a mutation, but was found in only a single subject with 
ADNFLE. In vitro studies demonstrated that both these polymorphisms had 
functional consequences, with the former causing an increase in CRH expression 
but the latter producing a decrease (Combi et al., 2005). Thus while overall these 
findings suggest a possible role for the CRH gene in ADNFLE, they fall short of
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providing conclusive evidence; further work is needed to clarify the nature of any 
association.
More recently, however, more convincing evidence for involvement of the a2 
nAChR subunit was presented. Aridon et al. described a large family with 
ADNFLE in whom a homozygous missense mutation, I279N, was identified in the 
neuronal nicotinic acetylcholine a2 subunit gene (CHRNA2). This mutation 
localizes to the first transmembrane domain (M 1) of the a2 nAChR subunit, which 
is not a direct component the receptor’s ion-gating structure, but may alter the 
relative movements of other parts of the receptor during the gating process. 
Functional studies indicated that the CHRNA2 mutation results in a marked 
increase in receptor sensitivity to acetylcholine (Aridon, 2006).
9.2h. Familial Partial Epilepsy with Variable Foci (FPEVF)
Finally, a further genetic syndrome often associated with NFLE should be 
considered at this point. Familial Partial Epilepsy with Variable Foci (FPEVF) 
frequently presents with nocturnal seizures of suspected or proven frontal lobe 
origin (Scheffer et al., 1998; Berkovic et al., 2004); the condition may be confused 
with ADNFLE, as the family history reveals other affected individuals with 
epilepsy inherited in an autosomal dominant fashion. However, in contrast to 
ADNFLE, in FPEVF not all affected family members have nocturnal tonic or 
hyperkinetic frontal lobe seizures. Seizure patterns and EEG localisation 
indicating frontal, temporal centroparietal and occipital lobe epilepsy have all been 
recognised in family members in FPEVF, although affected individuals have a 
constant seizure type throughout their lives (Scheffer et al., 1998). In those 
individuals with an NFLE phenotype, the clinical pattern in FPEVF is often 
somewhat different to that seen in ADNFLE. In FPEVF, frontal lobe seizures 
occur both from wakefulness and sleep, secondarily generalise more frequently, 
and often occur singly in a night rather than in the clusters seen in ADNFLE 
(Berkovic et al., 2004).
To date, several families with this condition have been described (Scheffer et al., 
1998; Xiong et al., 1999; Picard et al., 2000; Callenbach et al., 2003). As with
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other idiopathic focal epilepsies, all affected members have normal cerebral 
imaging on MRI. One Australian family was reported to have prominent interictal 
epileptiform discharges on EEG (Scheffer et al., 1998); in other families, interictal 
discharges are seen only infrequently (Xiong et al., 1999; Callenbach et al., 2003).
Linkage studies in the Australian family suggested localisation of the gene to 
chromosome 2q, wheras there has been strong evidence from other families from 
Spain, Canada and the Netherlands of linkage to Chromosome 22ql2. It seems 
likely that at least two clinical forms of FPEVF exist with different genetic 
substrates, although the number of case reports in the literature to date is relatively 
low.
Conclusions.
Frontal lobe epilepsy has a wide range of pathological correlates. Gliosis 
secondary to trauma or infection, cortical dysplasia and tumours are all seen 
commonly, with corresponding features on neuroimaging. Interestingly, however, 
in both sporadic and familial NFLE, pathological lesions are found in only a small 
number of cases. This finding suggests that other mechanisms may be important 
in NFLE, a fact borne out by the recognition of the syndromes of ADNFLE and 
FPEVF which are clearly genetic in origin. The identification of mutations in 
genes coding for subunits of the a4(32 nAChR in ADNFLE has led to significant 
changes in the understanding of epilepsies and introduced the concept of 
epilepsies as channelopathies.
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CHAPTER 10 
FRONTAL LOBE EPILEPSY 
Aspects of differential diagnosis
Introduction
The diagnosis of frontal lobe epilepsy (FLE) can be difficult. The wide range and 
often bizarre nature of presenting features, combined with frequently normal or 
non-specific interictal and ictal EEG findings, can easily result in misdiagnosis. 
During wakefulness, the most troublesome distinction is with psychogenic non­
epileptic seizures (PNES), also known as pseudoseizures. It is now increasingly 
recognized that some individuals previously diagnosed with non-epileptic events 
in fact have frontal lobe seizures. The situation is even more problematic when 
frontal lobe seizures are restricted to sleep; many non-epileptic sleep disorders are 
also characterized by paroxysmal motor activity, and differentiating these 
conditions from NFLE may not be straightforward (Scheffer et al., 1994; Zucconi 
and Ferini-Strambi, 2000). In general, the most common source of diagnostic 
confusion is with the NREM arousal parasomnias such as sleep terrors and 
somnambulism. However, the spectrum of motor disorders of sleep is wide, and a 
diagnostic uncertainty may arise in a number of situations depending on the 
referral base of the clinician involved.
This chapter is divided into three sections. Section 1 is a discussion of PNES, the 
main differential diagnosis of FLE during wakefulness; Section 2 comprises a 
review of non-epileptic motor sleep disorders, as classified by the International 
Classification of Sleep Disorders (ASDA, 2000); and in Section 3 the important 
clinical features enabling discrimination between NFLE and other sleep disorders, 
particularly the NREM parasomnias, are considered.
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Section 10.1. Differential Diagnosis Of Frontal Lobe 
Seizures In Wakefulness: PNES
The most important differential diagnosis of diurnal frontal lobe seizures is 
psychogenic non-epileptic seizures (PNES). These have been recognized for 
centuries and were well studied by Charcot and Gowers in the 19th century 
(Charcot, 1877; Gowers, 1964). However, since the spectrum of behaviours 
associated with FLE has been more widely recognized, it has become apparent 
that these conditions are easily confused, particularly by clinicians with limited 
direct experience of FLE (Williamson, 1995). This issue has significant practical 
implications. Failure to recognize epilepsy will result in patients being denied 
appropriate investigation and management; if, on the other hand, PNES are not 
recognized (particularly in prolonged events mimicking status epilepticus) the 
patient may be subjected to inappropriate, expensive, and potentially harmful 
treatment (Wilner and Bream, 1993; Tuxhom and Fischbach, 2002).
10.1a. Definition and pathology of PNES
Psychogenic non-epileptic seizures (PNES) are defined as psycogenically 
determined clinical events that resemble epileptic attacks but are not associated 
with neurophysiological dysfunction (Ozkara, 1993; Andriola and Ettinger, 1999). 
A small minority of these cases are factitious in origin, with conscious fabrication 
of symptoms to maintain a sick role (as in Munchausen’s syndrome) or to obtain 
some other recognizable benefit (Krumholz, 1999). However, in the great 
majority cases, PNES are considered to be a somatoform disorder, thus requiring a 
psychiatric approach to treatment (Krumholz, 1999).
A detailed discussion of the psychopathology of PNES and somatoform disorders 
is beyond the scope of this review, but the condition is heterogeneous in origin. A 
number of mechanisms appear to be involved, including dissociation reactions to 
abuse or trauma (Bowman, 1996; Devinsky, 1996; Akyuz et al., 2004), underlying 
personality disorders (Vanderzant, 1986; Bowman, 1996) and posttraumatic stress
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disorder (Bowman, 1996). In addition, other psychiatric co-morbidities such as 
depression and anxiety are common in patients with PNES (Bowman, 1999).
10.1b. Clinical Features of PNES -  the history.
PNES may present in a variety of ways, with generalized convulsive features, 
altered consciousness or focal features. Gulick et al (1982) divided PNES into 
four major groups based on the predominant clinical phenomena: those 
characterized by bilateral motor activity; those with unilateral motor activity; 
those showing multiple phenomena; and those characterized by decreased 
responsiveness alone. As a result, they can superficially resemble any of the 
major seizure types including generalized tonic clonic seizures, complex partial 
seizures of temporal and frontal lobe origin, and absence seizures (Gulick, 1982; 
Boon and Williamson, 1993). While it is often very difficult to make a definitive 
diagnosis of PNES from the clinical history alone, some features may raise the 
suspicion of this diagnosis. These include a long-standing history of non­
stereotyped attacks unresponsive to anticonvulsant medications (Boon and 
Williamson, 1993), prolonged duration of episodes (Krumholz, 1999), 
precipitation by emotional situations (Trimble, 1986), and unusual behaviours 
such as ictal weeping (Walczak, 1996). The social history may be as important as 
the medical data in these individuals (Boon and Williamson, 1993).
10.1c. Clinical features of PNES - Video EEG monitoring
Often video EEG monitoring (VEM) is the only way to accurately characterize 
PNES. If events are occurring frequently enough, this may be possible in the 
outpatient setting (Watemberg et al., 2005). PNES can often be provoked by 
emotional stimuli or suggestion (Cohen, 1982; Walczak, 1994; Zalsman et al.,
2002), a feature recognized by Charcot in the nineteenth century (Massey, 1986), 
and some authors advocate the routine provocation of PNES for diagnostic 
purposes. For example, administration of intravenous saline, while suggesting this 
will induce a seizure, may be sufficient to precipitate an event (Slater et al., 1995). 
Although such techniques generally involve misleading the patient, making their
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use in routine clinical practice ethically questionable, some authors have argued 
that it is possible to undertake such testing honestly and ethically (Devinsky,
1996).
More commonly, however, admission for formal video EEG monitoring is 
required. The reported PNES events recorded on video-EEG monitoring fall into 
to major categories: convulsive events, broadly resembling generalized tonic- 
clonic seizures; and events broadly resembling complex partial seizures.
PNES resembling generalized tonic-clonic seizures. The most widely studied 
group of PNES is characterized by generalized convulsive movements (Gulick, 
1982; Gates, 1985). However, the nature of these events is almost invariably 
different to generalized tonic clonic seizures (GTCS), and they will not usually be 
confused by an experienced observer.
True GTCS follow a characteristic and well-described pattern (Rodin, 1981) with 
loss of consciousness, brief flexion of the upper limbs and often a cry, followed by 
jaw clenching and cessation of respiration associated with tonic limb extension in 
which the upper limbs are usually kept alongside the body. This tonic phase is 
followed after about 35 seconds by clonic ‘in phase’ jerking of the limbs, usually 
symmetrical in nature, which also usually lasts around 35 seconds and ends with a 
deep inspiration and subsequent stertorous breathing. Post-ictally there is initially 
stupor, followed by confusion within minutes. Often the patient will then fall 
asleep. These seizures may be associated with tongue biting (usually on the lateral 
aspect) and excessive salivation, and urinary (although very rarely bowel) 
incontinence may occur.
In contrast, PNES usually comprise thrashing, trembling, writhing, ‘out of phase’ 
limb movements and pelvic thrusting; these features are very rare in GTCS 
(Gulick, 1982; Gates, 1985; Leiss, 1992). Movements often also appear to have a 
semipurposeful quality, and consciousness is often retained (Krumholz, 1999).
The characteristic GTCS sequence is not seen; events often have a ‘waxing and 
waning’ quality, with recurrent periods of motor activity interspersed with quiet
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unresponsiveness (Gulick et al, 1982). They generally last significantly longer 
than GTCS (Gates, 1985) and post ictal recovery is often rapid (Krumholz, 1999).
PNES resembling complex partial seizures. Although the distinction with GTCS 
is usually relatively straightforward if events are recorded on VEM, it can be more 
difficult to distinguish these behaviours from complex partial seizures, particularly 
those of frontal lobe origin. Many of the bizarre features of frontal lobe complex 
partial seizures, discussed in Chapter 7, are also seen in pseudoseizures. Features 
common to both conditions include pelvic thrusting, retained awareness, 
vocalization and sexual automatisms (Saygi, 1991; Geyer et al., 2000). Typically, 
neither type is associated with significant post-ictal confusion (Saygi, 1991), and 
although frontal lobe seizures are usually more stereotyped in nature, PNES may 
be highly stereotyped within subjects too (Gulick et al. 1982). Forced eye closure, 
trembling, slow evolution, a waxing and waning quality and prolonged duration 
are also more suggestive of PNES than frontal lobe epilepsy (Andriola and 
Ettinger, 1999; Krumholz, 1999). In a direct comparison of frontal lobe epilepsy 
and NPES, Saygi et al. found that younger age of seizure onset, the presence of 
MRI abnormalities, short ictal duration, seizures with a prone posture and 
nocturnal occurrence were useful indicators of FLE rather than PNES.
It should be noted that a significant number of PNES are characterized by reduced 
responsiveness with few or absent motor features; in some reported series this is 
the most common event type (Leiss, 1992). The majority of such events are 
associated with a non-specific ‘aura’ (Gulick, 1982; Leiss, 1992), which is usually 
followed by unresponsiveness. Such events can be very difficult to distinguish 
from temporal lobe epilepsy (or occasionally absence seizures) on the grounds of 
seizure semiology.
EEG findings. In events characterised by prominent motor manifestations, the 
EEG will be normal or be obscured by muscle or movement artifact (Krumholz,
1999). This is not necessarily useful in distinguishing episodes from frontal lobe 
seizures, which may also be associated with normal or non-specific EEG changes 
in up to 50% of cases (Zucconi and Ferini-Strambi, 2000). Likewise, if the patient 
is reporting subjective sensations without observed behavioural change, a normal
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EEG is also unhelpful as simple partial epileptic seizures (with retained 
awareness) may be associated with normal scalp EEG (Devinsky, 1988).
However, in the presence of clinically altered awareness, preservation of normal 
awake background rhythms is not consistent with epileptic events and is typical of 
PNES (Leiss, 1992). Testing of awareness during events is therefore important in 
this setting.
10.1d. Epidemiology
PNES are common. They are reported to account for 5 to 20% of patients with 
intractable epilepsy (Desai, 1979; King, 1982), and 10 to 40% of admissions for 
video EEG monitoring (Meierkord et al., 1991; Krumholz, 1999). They may 
occur in any age group, from childhood to old age, although most commonly 
present between the ages of 15 and 35 years (Krumholz, 1983). As with other 
somatoform disorders they occur more commonly in females, with women 
constituting 70 to 80% of cases in most reports (Meierkord et al., 1991; Walzack,
1995).
10.1e. Psychological and psychiatric considerations
In addition to psychopathology per se, a number of predisposing factors for PNES 
have been described. The most widely reported is a history of sexual abuse, with 
studies reporting such a history in between 25 and 67% of patients with PNES 
(Alper, 1993; Bowman, 1996). Physical abuse and other trauma is also widely 
reported (Harden, 1997; Fleisher et al., 2002), and head trauma, often mild, may 
precipitate these events in some individuals (Barry, 1998). In addition, a co­
occurrence of PNES has been widely reported in both children and adults with 
epilepsy (Ramani, 1980). The exact incidence is unclear, with between 10% and 
40% of individuals with PNES also having established epilepsy (Lesser, 1996; 
Krumholz, 1999). Often in this situation, the epileptic seizures are well controlled 
and the PNES are the troublesome events (Devinsky, 1996). PNES may provide 
such individuals with means of gaining attention or maintaining the sick role, or 
may arise in the presence of a concomitant personality disorder or impaired coping 
mechanisms (Krumholz, 1999).
167
Chapter 10. Differential Diagnosis
Some authors have reported a ‘typical’ patient profile with PNES. This is a 
female, usually with low intelligence and a personality disorder, and often with 
other psychiatric diagnoses including depression, anxiety and suicide attempts 
(Boon and Williamson, 1993). While some of these observations may be valid, 
some individuals with epilepsy may also exhibit many of these traits. Several 
authors have cautioned against using psychological profiles to distinguish between 
NPES and epilepsy, while bearing in mind that psychiatric assessment can provide 
important diagnostic information (Boon and Williamson, 1993)
10.1f. Prognosis
The outcome of PNES is dependent upon a number of factors. In general, children 
and adolescents have a better outcome than adults; one major study reported 
approximately 50% seizure freedom immediately after diagnosis and almost 80% 
at two years (Wyllie, 1991). Studies in adult populations indicate 20 to 50% of 
patients are seizure free at 1 year, with a similar figure at 5 years (Krumholz,
1983; Bowman, 1999). Clinical features including personality disorder, recurrent 
major depression, and denial of stressors and psychosocial problems have been 
associated with a poor prognosis (Kanner et al., 1999), as have a prolonged 
duration of PNES, persistent somatization, and unfavourable family dynamics 
(Bowman, 1999). The diversity of underlying psychiatric disorders presenting 
with pseudoseizures means that tailored treatment approaches are required for 
individual patients, and as such the value of individual strategies has not been 
widely assessed. Most authors agree, however, that both psychiatric treatment and 
supportive neurological input is necessary in the management of PNES 
(Aboukasm, 1998; Bowman, 1999; Kanner et al., 1999).
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Section 10.2. Non-Epileptic Motor Disorders Of 
Sleep
Non-epileptic motor disorders of sleep are common and take a wide variety of 
forms. Using the International Classification of Sleep Disorders (ICSD), 
developed by the American Sleep Association (ASDA, 2005), they can be broadly 
grouped into parasomnias, sleep related movement disorders, and ‘others’. When 
considering the differential diagnosis of NFLE, it is important to consider the full 
range of these conditions, which are summarized on Table 1 and discussed in the 
following section.
10.2.1. Parasomnias
This group of sleep disorders is most frequently confused with NFLE.
Parasomnias are defined in the International Classification of Sleep Disorders 
(ICSD-2) as ‘unpleasant or undesirable behavioural or experiential phenomena 
that occur predominantly or exclusively during the sleep period’ (ASDA, 2005). 
They are subdivided on the basis of the phenomenology into three subgroups: 
disorders of arousal (from NREM sleep), parasomnias usually associated with 
REM sleep, and others (Table 1.)
NREM Arousal Disorders.
Definition and clinical features
Arousal disorders characteristically occur during deep non-REM sleep (slow wave 
sleep) and are attributed to impaired arousal mechanisms. They are the most 
frequently encountered parasomnias, usually beginning in childhood and resolving 
in adolescence, and are the most important group from the perspective of 
diagnostic confusion with epilepsy. The arousal disorders are characterised by 
paroxysmal motor behaviours without conscious awareness, and have a broad 
spectrum of clinical manifestations. In clinical practice, they are subdivided into 
three main forms: confusional arousals, which are associated with little motor or 
autonomic involvement; somnambulism (sleepwalking), which is associated with
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I. Parasomnias
a. NREM Arousal disorders
i. Confusional arousals
ii. Sleepwalking
iii. Sleep terrors
b. Parasom nias usually associated with REM sleep
i. REM sleep behaviour disorder
ii. Parasom nia overlap disorder
iii. Sleep paralysis
c. Other parasom nias
i. Catathrenia (nocturnal groaning)
II. Sleep-related movement disorders
a. Periodic limb movements of sleep
b. Sleep bruxism
c. Nocturnal leg cramps
d. Rhythmic movement disorder (jactacio capitis noctuma)
III. Other (non-parasomnia, non-movement disorder) 
paroxysmal nocturnal events
a. Sleep starts
b. Somniloquy
c. Benign sleep myoclonus of infancy
d. Nocturnal psychogenic non-epileptic seizures (PNES, pseudoseizures)
e. Nocturnal panic attacks
f. Sleep-related breathing disorders
g. G astroesophageal reflux
h. Newly recognized conditions
i. Excessive fragmentary myoclonus
ii. Propriospinal myoclonus at sleep onset
iii. Rhythmic feet movements while falling asleep
iv. Alternating leg muscle activation during sleep and arousals
Table 10 .1 . The major Paroxysmal Motor Disorders o f Sleep, categorized according to the 
International Classification o f Sleep Disorders (ASDA, 2005.)
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motor activity but little autonomic involvement; and sleep terrors (pavor 
nocturnus), in which prominent autonomic involvement is observed accompanied 
by a variable degree of motor activity. Although these groupings are used in 
practice, based on the predominant clinical features observed, common underlying 
mechanisms are believed to be responsible. Similar electroclinical features are 
seen in each group, and affected individuals may display features of more than one 
subtype.
Confusional arousals are characterized by sudden arousal with disorientation and 
confusion, sometimes associated with some semipurposeful behaviours. 
Vocalisation, and sometimes coherent speech, is common, and the patient may 
appear upset. Some individuals may become aggressive or agitated, particularly if 
attempts are made to console or waken them. The events may be brief, lasting 
only one or two minutes, but may continue for ten minutes or more (sometimes 
considerably longer) during which time the patient is very difficult or impossible 
to awaken (Aldrich, 1999; Sheldon, 2000).
During somnambulism, the most common manifestation of the arousal disorders, 
affected individuals display simple or complex motor behaviours during sleep, 
typically associated with getting out of bed and walking. Patients will often walk 
out of the bedroom, sometimes leaving the home, and may conduct purposeful or 
semipurposeful tasks such as moving objects, talking (although often 
nonsensically), dressing, eating and drinking (Aldrich, 1999), and even driving 
(Schenck and Mahowald, 1995). Some individuals will appear frantic and 
agitated; sexual and violent behaviours have occasionally been reported 
(Rosenfeld and Elhajjar, 1998), and sleepwalking has been used successfully as a 
defence against a charge of murder (Broughton et al., 1994). The episodes may 
last from a few minutes to over 30 minutes, and usually end with the patient 
returning to bed and to sleep; some sleepwalkers will respond to a command to 
return to bed. One widely reported variant of somnambulism (although nofyet 
listed as a specific disorder in the ICSD) is sleep related eating disorder (SRED), 
in which individuals leave the bed to eat during sleep. It often occurs in 
individuals with no other history of parasomnias, predominantly affects women
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with onset around 25 years of age, and may be triggered by a number of factors 
including stress, dieting or psychotropic drug use (Schenck et al., 1991).
Sleep terrors are the most dramatic arousal disorders, characterized by prominent 
autonomic and affective features. The individual will suddenly arouse from deep 
sleep, usually with a ‘blood-curdling’ scream, and appear pale and terrified. There 
is often agitated behaviour and sometimes the individual will attempt to leave the 
room; extreme agitation may result in injuries from jumping out of windows or 
down stairs. Autonomic features, including tachycardia and diaphoresis, are 
prominent. Individuals are usually inconsolable and difficult to wake and the 
event may last from a matter of minutes to 10 minutes or longer.
Although the arousal disorders are subdivided in this manner, in reality there is 
considerable overlap between the groups. In general, individuals have no 
recollection of the events, although some will report vague recollections of 
terrifying situations (Aldrich, 1999). A number of precipitating factors are 
recognized, including febrile illness, sleep deprivation or a chaotic sleep schedule, 
and emotional stress (Sheldon, 2000), although interestingly they appear to decline 
during pregnancy (Hedman et al., 2002).
Epidemiology
Arousal disorders are common disorders of childhood, occurring in an estimated 
15-20% of preadolescent children (Laberge et al., 2000; Agargun et al., 2004).
The prevalence of sleep terrors has been estimated at 1% - 6.5% (DiMario and 
Emery, 1987),with somnambulism affecting up to 15% of individuals at some time 
during childhood or adolescence (Jacobson, 1969). Sleep terrors tend to begin at 
around 18 months of age, with a peak prevalence at 5-7 years of age (DiMario and 
Emery, 1987); confusional arousals also occur in very young children, usually 
under 5 years of age (Leo, 2003). Sleepwalking usually occurs a little later in 
childhood (Zaiwalla, 2005). Arousal disorders infrequently persist into adulthood; 
while the prevalence of sleepwalking is estimated at 15% in childhood, it is only 
1% to 4% in adulthood (Cirignotta, 1983; Hublin et al., 1997).
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Pathophysiology
The arousal disorders are so named because they are believed to arise through 
incomplete or impaired arousal from deep NREM sleep (Broughton, 1968); there 
is therefore a dissociation between the behavioural state, with waking behaviours 
observed, and the EEG which often shows sleep patterns. A recent SPECT study 
performed during an episode of somnambulism supported this concept, showing 
increased cerebral blood flow in some regions (mainly the posterior cingulate 
cortex and cerebellum), but reduced blood flow consistent with deactivation in 
large areas of frontal and parietal association cortex (Bassetti et al., 2000). Due to 
their high prevalence in otherwise normal children they are usually considered to 
represent altered physiological processes rather than true pathology.
Although analyses of sleep macrostructure show no significant differences 
between adult somnambulistic patients and controls (Schenck et al., 1998; 
Gaudreau et al., 2000), there is evidence of microstructural abnormalities and 
abnormal arousal in individuals with parasomnias. These individuals have 
fragmented sleep, with more frequent arousal and awakenings from slow wave 
sleep compared to controls (Espa et al., 2000; Gaudreau et al., 2000). EEG studies 
with spectral analysis indicate that, while the slow wave power is lower overall 
during the early periods of deep NREM sleep (Gaudreau et al., 2000) the intensity 
of slow wave sleep immediately prior to a parasomnia is unusually increased 
(Espa et al., 2000). Cyclic alternating pattern (CAP) rate, a measure of NREM 
instability, is also increased in individuals with parasomnias (Zucconi et al., 1995). 
Arousal disorders are, therefore, conceptualized as an inability to maintain 
consolidated slow wave sleep (Joncas et al., 2002), possibly due to coexistent 
disorders causing frequent arousal in slow wave sleep (Espa et al., 2002). This 
hypothesis is supported by the increasing evidence that adult somnambulism is 
significantly associated with obstructive sleep apnoea (Pressman et al., 1995; Espa 
et al., 2002). Treatment with CPAP has been shown to be effective in controlling 
both sleep apnoea and the parasomnias in these individuals (Guilleminault et al., 
2005), and there is also evidence that such mechanisms may be relevant in 
children (Guilleminault et al., 2003).
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While the frequency of arousals is important, however, it is not the only relevant 
factor in the development of these conditions; individuals with obstructive sleep 
apnoea, for example, have very frequent arousals but do the majority do not 
sleepwalk. It is possible that abnormally deep slow wave sleep at the time of the 
arousal makes full awakening difficult, resulting in a disordered arousal leading to 
a parasomnia (Espa et al., 2000). This hypothesis is supported by the fact that 
prior sleep deprivation increases the frequency of somnambulistic episodes in 
sleepwalkers (Joncas et al., 2002). While this unusual intensity of sleep is not well 
understood it may, in some cases, result from drug administration. Sleepwalking is 
associated with a number of drugs which are known to influence NREM sleep, 
including lithium, zolpidem (alone and in combination with serotonin specific re­
uptake inhibitors) and olanzapine (Landry et al., 1999; Kolivakis et al., 2001; 
Lange, 2005). These drugs appear to increase the intensity of slow wave sleep, 
and thereby raising the possibility of a disordered arousal and a parasomnia.
The high prevalence of arousal disorders in childhood may result from incomplete 
maturation of chronobiological mechanisms. These mechanisms, which govern 
slow wave sleep and arousal, are responsible for normal sleep cycling. Minor 
changes in routine may result in desynchronisation of normal rhythms in children, 
resulting in internal arousal stimuli coming at the ‘wrong time’ causing incomplete 
arousal from very deep sleep. As development continues, these mechanisms 
mature, synchronisation occurs and the symptoms resolve unless an alternative 
pathology such as sleep apnoea exists (Sheldon, 2000). Some authors have 
proposed that the serotonergic system is the key substrate in this process. 
Activation of this system is known to be partially responsible for arousal, as well 
as having a role in motor activity (Jacobs and Fomal, 1999); in addition, the 
serotonergic system is normally activated by hypercapnia (Richerson et al., 2001). 
It is proposed that in individuals who sleepwalk there is abnormal excitability of 
the serotonergic system which, when activated independently of other 
neurotransmitters involved in arousal, results in motor behaviours but incomplete 
arousal. It is proposed that hypercapnia during obstructive sleep apnoea triggers 
this system in susceptible individuals, resulting in a parasomnia (Juszczak and 
Swiergiel, 2005).
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Finally, the mechanisms by which ‘awake’ behaviour occurs in an ‘asleep’ brain 
in these disorders are unclear. Some authors have speculated that the central 
pattern generators proposed to underpin epileptic automatisms (see Chapter 7, 
page 136) are also activated in parasomnias (Mahowald, 2002; Tassinari et al., 
2005). Ambulation and apparent fear are the main behavioural features of these 
disorders. The hypothesis that they are subcortically encoded survival patterns, 
and that they are somehow released from inhibition during sleep during 
parasomnias, is plausible. However, at present, no detailed semiological or 
physiological data exists to support or oppose such a premise. If similar 
mechanisms are responsible for parasomnias and NFLE one would expect very 
similar, possibly indistinguishable, semiological features, but sufficiently detailed 
studies of parasomnias have not been reported to assess this.
Psychiatric disturbance and the arousal disorders
Until recently, it was widely assumed that arousal parasomnias, particularly if 
associated with violence, were the result of significant psychiatric pathology or 
unresolved psychological stress (Schenck and Mahowald, 2000). This belief can 
be traced back centuries, with the disturbed wanderings of Lady Macbeth 
providing the prototypical example; the fact that stress often appears to precipitate 
these attacks probably strengthened this belief. Some early studies showed 
increased rates of psychopathology in adults with arousal disorders, apparently 
supporting this view (Fisher et al., 1974; Kales et al., 1980; Schenck et al., 1989; 
Llorente et al., 1992). However, the findings of more recent studies have largely 
refuted this belief, indicating that psychopathology and parasomnias are not 
associated by their onset, clinical course, or treatment (Schenck et al., 1989; 
Guilleminault et al., 1995; Moldofsky et al., 1995; Schenck and Mahowald, 2000). 
Other authors have identified psychological stress as just one of a number of 
contributory factors in the development of these disorders (Moldofsky et al.,
1995).
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Parasomnias associated with REM sleep 
REM Sleep Behaviour Disorder (RBD)
Clinical features and associated pathology. This disorder is characterized by a 
loss of atonia during REM sleep resulting in the acting out of dream content 
(termed oneiric behaviours). The condition was first described by Jouvet in a 
feline model (Jouvet, 1965). In these studies, REM sleep without atonia and 
behaviours resembling ‘oneirism’ were noted following bilateral lesions of pontine 
regions surrounding the locus coeruleus. REM Sleep Behaviour Disorder (RBD) 
in humans, however, was not described until 1986 (Schenck, 1986). As in the 
animal model, impairment or loss of the usual muscle atonia of REM sleep results 
potential harmful dream-enacting behaviours. During REM sleep, patients will 
display complex dramatic, agitated and often violent behaviours such as speaking, 
screaming, punching and kicking, jumping out of bed and running (Schenck and 
Mahowald, 2002). These may result in injury to the patient or their bedpartner 
(Olsen, 2002). Patients are not in contact with the environment during these 
episodes but can usually be wakened, when they will often (but not invariably) 
report vivid dream mentation (Fantini et al., 2005); they also often report more 
vivid and intense dreams coincident with the onset of RBD (Schenck and 
Mahowald, 2002). If left alone, patients will usually return to sleep and remain 
oblivious to their sleep behaviour. Episodes may last from a few minutes to half 
an hour, and while some patients will have episodes several times per night, in 
others they will be much less frequent. Events occur preferentially in the second 
half of sleep, when the greatest proportion of REM sleep occurs (Schenck, 1986). 
Clonazepam is usually effective in preventing or controlling the episodes 
(Schenck and Mahowald, 2002).
RBD may present clinically as either an acute or chronic condition. Acute RBD 
may be precipitated by certain drugs, particularly tricyclic or SSRI antidepressants 
(Schenck, 1992), or by the withdrawal of alcohol, benzodiazepines or barbiturates 
(Silber, 1996); in this situation the condition usually develops abruptly and is 
usually short-lived. Precipitation by acute psychological stress has also been 
occasionally reported (Hefez, 1987; Sugita, 1991).
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A strong association between chronic RBD and degenerative neurological 
conditions has been reported, with Parkinson’s disease (PD) and Multiple System 
Atrophy (MSA) by far the most common, although other parkinsonian syndromes, 
narcolepsy, dementia, cerebrovascular disease, multiple sclerosis and Machado- 
Joseph disease have also been causally associated in some cases (Schenck, 1993; 
Sforza et al., 1997; Olsen, 2002; Schenck and Mahowald, 2002; Friedman et al.,
2003). Such an association is seen in about 60% of RBD patients (Olsen, 2002) 
and the sleep disorder may precede the waking manifestations of the underlying 
condition by several years (Schenck, 1996; Plazzi, 2004). When no neurological 
lesion or disorder is identified the term ‘idiopathic RBD’ is used. However, even 
among this group there is now increasing evidence that RBD is an early 
manifestation of a more pervasive neurodegenerative process, rather than a simple 
parasomnia per se (Fantini et al., 2005). There are a small number of reports of 
RBD in children, often in association with brainstem pathology or narcolepsy, but 
also occasionally without known central nervous system pathology (Sheldon and 
Jacobsen, 1998).
RBD variants. Some variants of RBD warrant specific mention. Parasomnia 
overlap disorder consists of overlapping NREM and REM motor parasomnias, 
predominantly sleepwalking, sleep terrors and RBD (Schenck et al., 1997). The 
mean age of onset in this group is younger than in typical RBD, at 15 years (range 
1 to 66 years), but with a strong male predominance. In some patients the disorder 
is idiopathic; but in about one third of individuals it is associated with neurological 
disorders (such as narcolepsy, multiple sclerosis or brain tumour) or ethanol/ drug 
abuse or withdrawal. Another variant, Narcolepsy-RBD, has been described in 
which the two conditions develop in tandem (Schenck and Mahowald, 1992; 
Mayer, 1993). Treatment of cataplexy with tricyclic antidepressants in 
narcolepsy may induce or worsen RBD (Schenck and Mahowald, 1992). Status 
Dissociatus is the most extreme form of RBD, in which there is complete 
breakdown of normal state-determining boundaries (Mahowald, 1991). Patients 
will appear to be either awake or asleep, but their sleep is very atypical, both 
behaviourally (with twitching, vivid dreams and vocalizations) and 
polysomnographically, with loss of the normal REM and REM features. Sleep 
instead consists of an admixture of features of wakefulness, NREM and REM
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sleep. This condition has been associated with alcohol withdrawal, 
olivopontocerebellar degeneration and brainstem lesions, and similar features are 
seen in familial fatal insomnia. (Schenck and Mahowald, 2002; Provini et al.,
2004).
Pathophysiology. The underlying pathogenesis of RBD remains unclear, but it 
appears to arise through a failure of the mechanisms generating skeletal muscle 
atonia during REM sleep. A number of neural substrates participate in this 
process, any of which could potentially play a role in RBD. The most important 
site, however, appears to be the pons. Animal studies have demonstrated co­
localisation of REM-atonia and locomotor systems in the pons (Lai, 1990), and a 
number of case reports support the association of pontine pathology and RBD 
(Barros-Ferreira, 1975; Plazzi, 1997). There is some evidence that the 
pedunculopontine and retrorubral nuclei may be implicated (Lai, 1990; Schenck, 
1993), and the strong association with parkinsonism suggests that the 
dopaminergic system may be involved. The latter supposition has been supported 
by functional imaging studies in idiopathic RBD; striatal dopamine transporter 
binding is reduced in these individuals when compared to control subjects, 
although is significantly greater than in subjects with Parkinson’s disease 
(Eisensehr, 2000).
Epidemiology. Chronic RBD mainly affects individuals over age 50 years 
(Schenck and Mahowald, 2002), with men affected in over 80% of large reported 
series (Schenck, 1993; Olsen, 2002). However, to date no major epidemiological 
studies have been undertaken to assess the incidence and prevalence of RBD in 
either the general population or within specific clinical populations (such as those 
with Parkinson’s disease).
Recurrent Isolated Sleep Paralysis
Sleep paralysis is characterized by the absence of voluntary motor activity at the 
beginning or end of a sleep period. Patients are aware of their environment but 
feel completely paralysed, and may experience vivid hallucinations. The attacks 
are presumed to be a manifestation of REM sleep intrusion into wakefulness.
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They usually last for only a few minutes and typically subside spontaneously, 
although may be aborted if the individual is touched (Sheldon, 2000). Sleep 
paralysis may occur in otherwise normal individuals, particularly after a period of 
sleep disruption or a change in sleep schedule (Takeuchi, 1992), but is also an 
extremely common feature of narcolepsy (Overeem et al., 2001). In the latter 
situation, other features such as excessive daytime sleepiness and cataplexy are 
also present. Unless narcolepsy is suspected, further investigation and treatment 
are not usually required.
Catathrenia
Catathrenia, or nocturnal groaning, is a recently described parasomnia consisting 
of recurrent moans and groans (Vetrugno et al., 2001). Each vocalisation lasts for 
2 to 20 seconds each, and the groans often occur in clusters over a period of up to 
an hour. They may occur in both NREM sleep (predominantly stage 2) and REM, 
and are not associated with significant motor activity or sleep-disordered 
breathing. Patients are entirely unaware of the events, and bedpartners or parents 
usually initiate the medical consultation in this condition.
10.2.2 Sleep-related Movement Disorders
Periodic limb movements during sleep (PLMS)
Clinical Features. Periodic limb movements during sleep (PLMS) are 
characterised by repetitive and stereotyped movements of the legs, predominantly 
during NREM sleep. The typical movement is extension of the great toe and 
dorsiflexion of the ankle, often associated with flexion of the knee and hip; 
occasionally the upper limbs may be involved. They may be unilateral or 
bilateral, and occur quasi-periodically at intervals of about 20 to 40 seconds 
(Coleman, 1982); conventionally they are scored on polysomnography only if they 
are part of a series of four or more movements lasting 0.5 to 5 seconds with an 
intermovement interval of 4 to 90 seconds (ASDA, 2005). It is classified under 
the ICSD as a dyssomnia (a disorder causing either excessive sleepiness or 
insomnia), but there is considerable overlap between PLMS and restless legs
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syndrome (RLS), a quasi physiological phenomenon present in up to 30% of those 
over 50 years of age (Bixler, 1982).
Pathophysiology. The pathophysiology of RLS and PLMS is not well established. 
There is evidence of a significant genetic contribution, with a family history being 
reported in around 50% of cases overall (Walters et al., 1996; Winkelmann et al., 
2000) and autosomal dominant inheritance patterns in some families ; linkage to 
loci on chromosome 9p, 12q and 14q has been reported in the literature (Bonati et 
al., 2003; Chen et al., 2004; Ferini-Strambi et al., 2004; Winkelmann et al., 2005). 
There remains some debate as to the neural substrates for the condition, with some 
evidence favouring a peripheral basis but other evidence pointing towards spinal 
cord or brainstem origin. The dopaminergic system appears to be involved, with 
L-dopa and dopamine agonists improving the symptoms and constituting the 
mainstay of pharmacotherapy in these conditions (Stiasny et al., 2001; Hening et 
al., 2004), but supporting evidence from neuroimaging studies is relatively scanty. 
Brain iron deficiency is a potentially important, although currently unproven, 
mechanism in RLS and PLMS. Reduced ferritin and increased transferrin levels 
have been identified in the CSF of patients with RLS, even though serum levels 
may be normal (Earley et al., 2000; Mizuno et al., 2005); an MRI study has 
indicated reduced iron concentrations in the substantia nigra and putamen (Allen 
et al., 2001); and a recent large epidemiological study demonstrated significantly 
reduced soluble transferrin receptor concentrations (a marker of incipient iron 
deficiency) in this group of patients (Hogl et al., 2005). Furthermore, treatment 
with supplemental iron may resolve or improve the symptoms of RLS and PLMS 
(Nordlander, 1953; Kryger et al., 2002; Earley et al., 2004, 2005). Interestingly, 
iron plays several important roles in dopaminergic neurotransmission. It is a 
critical cofactor in dopamine synthesis, but also influences dopamine transporter, 
Di and D2 receptor density and function; these are reduced in iron deficiency states 
(Youdim et al., 1980; Erikson et al., 2000; Erikson et al., 2001).
From a diagnostic perspective, however, while RLS and PLMS may cause 
significant sleep fragmentation with subsequent excessive daytime sleepiness, the 
nature of the movements rarely, if ever, results in diagnostic confusion with 
epilepsy.
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Epidemiology. The prevalence of RLS has been estimated at 5.5% in the general 
population, with PLMS affecting around 4% (Ohayon and Roth, 2002).
However, the prevalence of both conditions rises with age (Tan et al., 2001; 
Ulfberg et al., 2001) with one study reporting rates of RLS 3% in individuals 
under 30 years, 10% in those aged 30-79, and 19% in people over 80 years of age 
(Phillips et al., 2000). PLMS affects 80-90% of individuals with RLS 
(Montplaisir et al., 1997). Some studies have indicated higher rates of RLS in 
women (Rothdach et al., 2000; Ulfberg et al., 2001), although others have not 
confirmed this observation (Lavigne and Montplaisir, 1994; Phillips et al., 2000).
Sleep Bruxism
Bruxism, or teeth grinding, consists of grinding or clenching movements of the 
jaws during sleep which is noisy and can cause significant dental wear or 
temporomandibular joint pain. It is most common in children, but often persists 
into adulthood (Rugh, 1988), particularly in intellectually disabled individuals. 
The cause of bruxism is unknown, although in some individuals it may be 
precipitated or aggravated by drugs including SSRI antidepressants and levodopa 
(Magee, 1970; Ellison and Stanziani, 1993). Patients are usually unaware of the 
grinding, which occurs in NREM sleep (particularly stage 2), and often seek help 
due to complaints from a bed partner or because of dental problems. Treatment is 
required in individuals who have sustained significant dental damage, with splints 
often being the most useful treatment (Dylina, 2001). While bruxism rarely 
mimics epilepsy, it may be confused with faciomandibular myoclonus, which is 
characterized by frequent nocturnal myoclonic jerks of the masseter and 
orbicularis oris muscles of subcortical origin. The relationship between these 
disorders is unclear; indeed it is possible that several forms of sleep bruxism exist, 
resulting from more than one underlying mechanism, with faciomandicular 
myoclonus representing one subtype (Vetrugno et al., 2002).
Nocturnal leg cramps
This condition consists of painful, involuntary contractions of the leg muscles, 
arising suddenly during sleep or the transition from wakefulness to sleep. The
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posterior quadrant of the leg and foot are most commonly affected, with the 
muscles palpably contracted and the feet and toes being held in extreme plantar 
flexion (Montagna, 2004). The cramps usually affect one side at a time, last from 
seconds to minutes, and resolve spontaneously or by forced dorsiflexion. They 
occur in all age groups, particularly the elderly and pregnant women. In some 
cases they may be related to electrolyte disturbances or other systemic illnesses 
(Abdulla, 1999), but often the cause is unknown (Montagna, 2000).
Rhythmic movement disorder (jactacio capitis nocturna)
This condition consists of stereotyped repetitive movements of the head and neck 
that occur at sleep onset and stage 1 sleep or during short arousals in light sleep 
(particularly stage 2, (Dyken, 1992). Head rolling from side to side is the most 
common movement, but headbanging may also occur; in some cases this may be 
violent enough to cause bruising or callus formation (Montagna, 2004). In some 
individuals, limbs or the whole body may be involved in the rhythmic movements; 
in some children body rocking (with the child on his or her knees) is the prominent 
movement. The behaviours last between a few seconds and 30 minutes, and are 
associated with varying degrees of awareness; some patients acknowledge a 
pleasurable aspect to them, whereas others are entirely unaware (Zaiwalla, 2005)
The condition is extremely common in very young children, particularly males. It 
occurs in up to 60% of infants at 9 months of age , but usually resolves early in 
childhood, with prevalence dropping to 5% by 5 years (Klackenberg, 1971); rarely 
it may persist into late childhood or adulthood, particularly in autistic or 
intellectually disabled individuals (Chisholm, 1996). It should not be confused 
with epilepsy, although the rarity of the condition in adulthood may occasionally 
lead to misdiagnosis in this age group.
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10.2.3 Other (non-parasomnia, non-movement disorder) 
paroxysmal nocturnal events
Although the parasomnias discussed above are the main conditions which need to 
be distinguished from NFLE, a number of other motor conditions also warrant 
consideration in the differential diagnosis. These are classified under a number of 
headings in the ICSD-2, including sleep-related breathing disorders, isolated 
syndromes, normal variants and unresolved issues. For the sake of clarity they 
will be considered together in this review.
Sleep starts
Sleep starts, also known as hypnic jerks, are an extremely common phenomenon 
and are essentially physiological in nature. They consist of brief myoclonic jerks, 
usually affecting the whole body, at the transition of wakefulness to sleep. They 
are often associated with sensory phenomena, most commonly a sensation of 
falling. Caffeine, stress and excessive exercise may increase the frequency of 
jerks in some individuals. They rarely require investigation or treatment, although 
if very severe can cause sleep-onset insomnia, a condition known as excessive 
fragmentary hypnic myoclonus (Broughton, 1985; Vetrugno et al., 2002) which is 
listed as a proposed sleep disorder in the ICSD classification (ASDA, 2005). The 
physiological basis of these events is not well understood; while some authorities 
have suggested that they result from volleys of activity in the pyramidal tracts 
(Broughton, 1985), others have proposed that the principal disturbance is of 
sensory processing, with the motor activity a secondary phenomenon (Nielsen and 
Zadra, 2005).
Somniloquy
Sleep talking, or somniloquy, usually occurs during light NREM sleep or during 
arousals from deeper sleep, but occasionally arises during REM sleep (Aldrich,
1999). It is very common, particularly in children; one review of 600 sleep studies 
reported sleep talking in 13% of the studies (Rechtschaffen, 1962). It usually 
consists of single words or short sentences, usually with minimal affective content,
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and is sometimes associated with body movement. Somniloquy may occur from 
any stage of sleep; while its cause is unknown, there appears to be a familial 
predisposition which it shares with other parasomnias such as somnambulism 
(Abe, 1984). It is sometimes associated with arousal disorders, obstructive sleep 
apnoea or REM behaviour disorder; however, unless the history is suggestive of 
one of these conditions, investigation and treatment is unnecessary.
Benign sleep myoclonus of infancy
This condition appears within the first month of life, and is characterised by 
clusters of brief, repetitive, synchronous, multifocal or generalised jerks of the 
limbs during NREM sleep (Coulter and Allen, 1982). Usually the upper limbs are 
affected, but occasionally the lower limbs are also involved. Neurological 
examination is normal, and the jerks usually resolve by two to four months of age. 
Transient immaturity of the serotonergic system has been proposed as a possible 
mechanism for this condition (Resnick et al., 1986).
Nocturnal psychogenic non-epileptic seizures (PNES)
In general events from sleep are unlikely to represent PNES, which arise from 
wakefulness. However, there is increasing evidence that PNES may be relatively 
common in apparent sleep ( ‘pseudosleep’) in which from a behavioural 
perspective the patient appears asleep, but on EEG shows signs of wakefulness 
such as eye blinks and a posterior dominant rhythm. Studies have indicated that 
between 12 and 58% of patients with PNES have events arising from apparent 
sleep (Thacker, 1993; Benbadis et al., 1996; Duncan et al., 2004). A history of 
sleep related events does not, therefore, preclude the diagnosis of PNES.
However, PNES restricted exclusively to pseudosleep is very rare, with most 
affected individuals having events in both wakefulness and apparent sleep 
(Duncan et al., 2004).
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Nocturnal panic attacks
Nocturnal panic attacks consist of recurrent awakening with a feeling of 
impending doom, often with tachycardia, sweating and choking; the symptoms are 
similar to panic attacks occurring during wakefulness (Craske and Barlow, 1989) 
They are relatively common amongst patients with panic disorder, with 44-71% 
reporting at least one such episode (Roy-Byme, 1988; Mellman and Uhde, 1989). 
Patients nearly always experience daytime panic attacks as well, although a small 
subgroup have symptoms predominantly at night (Craske and Tsao, 2005). Most 
patients report nocturnal panic attacks to occur 1-3 hours after sleep onset, and 
they rarely occur more than once per night (Craske and Barlow, 1989). The 
episodes usually last 2-8 minutes, return to sleep is difficult, and vivid recall of the 
events is typical (Craske and Tsao, 2005). They are not generally associated with 
significant motor behaviours, with fear and autonomic features such as 
tachycardia, tachypnoea and diaphoresis predominating (Hauri et al., 1989; 
Mellman and Uhde, 1989). The underlying pathology is uncertain; while 
psychological factors are likely to be important, some authors have reported 
evidence of underlying disturbances of autonomic regulation in such patients 
(Sloan et al., 1999).
Sleep-related breathing disorders
As discussed above, there is increasing evidence that obstructive sleep apnoea 
may trigger arousal parasomnias (Guilleminault et al., 2003; Guilleminault et al.,
2005). In addition, children with this condition may suddenly awaken and scream 
or cry following obstructive events (Carroll, 1995).
Gastroesophageal reflux
Sleep-related gastroesophageal reflux may result in recurrent awakenings from 
sleep, and usually presents with recurrent arousals with crying, vomiting, or 
epigastric pain (Wise, 2002). There is an association between reflux and 
respiratory problems, which may be the presenting feature (Sheikh, 1999).
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Hypnic hallucinations
Although not strictly a motor disorder of sleep, hypnic hallucinations may 
occasionally cause diagnostic uncertainty. These hallucinations (termed 
‘hypnagogic’ when occurring around sleep onset and ‘hypnopompic’ when around 
awakening) are associated with sleep-wake transition, and usually occur with 
partial awareness of the environment. They are common in the normal population, 
with up to 37% of the population reporting such events regularly (Ohayon et al.,
1996). The most commonly reported hallucination is a sensation of falling, which 
occurs in 25% of people, and may be accompanied by a hypnic jerk. However, 
hypnic hallucinations are also frequently reported in narcolepsy, when they may 
be complex and vivid; intense visual or tactile elements are commonly reported, 
and the hallucinations are often terrifying for the patient (Bassetti, 2000).
Newly recognised conditions
A number of recently described conditions, categorized as ‘isolated syndromes, 
apparently normal variants, and unresolved issues’ in the ICSD-2, involve 
paroxysmal motor activity in sleep, generally at sleep onset. These conditions 
include arhythmic feet movements while falling asleep (Broughton, 1988), 
alternating leg muscle activation during sleep and arousals (Chervin et al., 2003), 
excessive fragmentary myoclonus (Broughton, 1985), propriospinal myoclonus at 
sleep onset (Vetrugno et al., 2001). These conditions consist of myoclonic jerks 
or excessive movements around the time of sleep onset, but as yet are not widely 
recognized and do not appear to be commonly confused with seizures.
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Section 10.3: Differentiating Non-Epileptic Events in 
Sleep from Epilepsy
As discussed in Section 10.2, a wide range of conditions are characterized by 
paroxysmal motor activity during sleep. In reality, however, most do not cause 
diagnostic confusion with epilepsy. For example, the prolonged nature of 
conditions like bruxism and the characteristic description of periodic limb 
movements in sleep (PLMS) have little in common with the paroxysmal events 
which characterize nocturnal seizures. The predominant sources of confusion are 
episodes characterized by sudden arousal with motor activity and often dramatic 
or bizarre behaviours. The main disorders which present in this fashion are the 
NREM arousal parasomnias, REM sleep behaviour disorder, and nocturnal panic 
attacks.
10.3.1 Features of the clinical history 
NREM Arousal Disorders vs NFLE
The NREM arousal disorders such as night terrors and somnambulism (Provini et 
al., 1999; Zucconi and Ferini-Strambi, 2000) cause the greatest diagnostic 
confusion with NFLE; distinguishing these conditions can be a major challenge 
for even the most experienced sleep physician or epileptologist. NREM arousal 
disorders are common in childhood, not uncommonly persist into adulthood, and 
often do not follow ‘classical’ patterns (Vaughn, 2002); it has been well 
recognized that some individuals diagnosed with parasomnias for years in fact had 
NFLE (Scheffer et al., 1994; Lombroso, 2000). Some authors have examined the 
differences between these conditions, and the clinical and electrographic features 
which may be useful in discriminating between them. These will be reviewed 
below. It should be noted, however, that papers with a complete and detailed 
description of arousal disorder episodes are scanty (Zucconi and Ferini-Strambi,
2000). Most descriptions of arousal disorders in the literature are not based on 
video EEG or PSG findings. In the few papers in which video monitoring has 
recorded events, usually only minor episodes with a limited resemblance to the 
patient’s full blown attacks are seen, and only limited behavioural descriptions are
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Parasomnias
(NREM arousal disorders)
NFLE
Age at onset Usually < 10 years Variable; usually childhood or adolescence
Positive family history 60-90% up to 40%
Attacks per night (mean) 1 or 2 3 or more
Episode frequency/ month <1 to 4 20-40
Clinical course (over years) Tends to disappear by adolescence Often stable with increasing age
Disease duration (mean) Approx 7 years Approx 20 years
Episode duration Seconds to 30 minutes Seconds to 3 minutes (often less than 2 minutes)
Semiology of movements Variable complexity; not highly stereotyped (on 
video)
Highly stereotyped on video monitoring, often 
vigorous movements.
Trigger factors Sleep deprivation, febrile illness, alcohol, stress Often none identified
Associated conditions Obstructive sleep apnoea Often none identified
Ictal EEG Slow waves, no epileptiform features Often normal, or obscured by movement. Frankly 
epileptiform ictal rhythms in <10%
Time of episodes during sleep First third of night but usually after 90 minutes of 
sleep
Any time, but may occur in first 30 - 60 minutes
Sleep stage when events occur NREM stage 3 or 4 Usually stage 2 NREM, 
occasionally stage 3 or 4
oooo
Table 10. 2. Comparison o f clinical and video EEG/PSG features o f parasomnias versus NFLE (adapted from Provini et al. 1999 and 
Zucconi and Ferini-Strambi, 2000).
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given. As such, many of the features attributed to NREM arousal parasomnias are 
based largely on clinical impressions. In addition there is the definite possibility, 
particularly in older studies performed before nocturnal frontal lobe epilepsy was 
well recognized, that some descriptions of parasomnias may have in fact referred 
to patients with NFLE (Scheffer et al., 1994). The features said to b important 
discriminators between NFLE and NREM parasomnias are discussed below and 
summarized in Table 10.2.
(i) Age o f  onset and persistence into adulthood. Both NFLE and arousal disorders 
usually first appear in the paediatric population. Overall, parasomnias tend to 
appear at a somewhat earlier age than frontal lobe seizures, with onset often in 
early childhood. Prevalence of night terrors peaks at 5-7 years of age (Kales et al., 
1980; Zucconi and Ferini-Strambi, 2000); somnambulism usually presents a little 
later, with a peak prevalence at age 10 (Montagna, 2000). In contrast, in the 
largest series of NFLE patients reported, the mean age of onset was 14 years 
(Provini et al., 1999). However, in both groups the range is wide. Sleepwalking 
has been reported to begin after age 14 years in up to 10 % of cases (Hublin et al.,
1997), and in one study of 13 patients with troublesome arousal disorders recorded 
on PSG, the mean age of onset was 13.5 years (Zucconi et al., 1995). In the NFLE 
series quoted above, age of onset ranged from 1 year to 64 years. Thus, while 
onset in later childhood or adolescence is more typical of NFLE than parasomnias, 
the great variability in the presentation of both conditions limits the discriminatory 
value of this parameter.
A number of authors have also described the persistence of events into adulthood 
as a possible indicator of an epileptic aetiology (Provini et al., 1999; Zucconi and 
Ferini-Strambi, 2000). The mean lifetime duration of somnambulism is only 7 
years (Sours, 1963), with the majority of sleepwalkers remitting before 18 years of 
age (Cirignotta, 1983), whereas the mean lifetime duration of NFLE was 20 years 
in Provini et al’s study. However, arousal disorders in adults are not uncommon, 
being seen in up to 4% of the population (Hublin et al., 1997). Although the exact 
prevalence of NFLE is unknown, it is considerably smaller than this. While 
persistence into adulthood may be a typical characteristic of NFLE, the high
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prevalence of arousal disorders in the community means that the majority of 
individuals with sleep related events persisting into adulthood are likely to have 
parasomnias. Moreover, this feature is of little value for the clinician when it 
comes to making a diagnosis in a child or adolescent.
(ii) Frequency and clustering o f  events. The arousal disorders characteristically 
occur quite infrequently, typically 1-3 times per month on average (DiMario and 
Emery, 1987; Zucconi and Ferini-Strambi, 2000), but there are few large scale 
studies in this area. It is recognized, however, that they can occur on a nightly 
basis (Guilleminault et al., 2003), and unusually may occur more than once per 
night (Provini et al., 1999). On the other hand, frontal lobe seizures very 
commonly occur in clusters, with many events occurring on a single night. On 
average, individuals will experience 3 to 8 events in one night, usually in the space 
of a few hours (Provini et al., 1999; Berkovic, 2002)\, but some patients report 20 
or more seizures per night. Overall, in Provini’s series the mean number of 
reported seizures per month was 20, significantly more than is usually seen in 
arousal disorders (Sours, 1963; Montagna, 2000).
(iii) Timing o f  events. Disorders of arousal arise from deep NREM sleep (stage 3 
or 4, slow wave sleep) (Montagna, 2000; Niedermeyer and Lopes da Silva, 2004). 
As a result, these episodes are not usually seen until the patient has been asleep for 
some time, typically 90 minutes to 2 hours after sleep onset. They most 
commonly occur within the first third of the sleep period, during the longest 
consolidated period of slow wave sleep (Zucconi and Ferini-Strambi, 2000). In 
contrast, seizures in NFLE usually arise from stage 2 NREM sleep (Crespel et al., 
1998; Provini et al., 1999). This is bom out by historical accounts, in which 
seizures are reported to occur at any time but most commonly within 30 minutes 
of sleep onset (Berkovic, 2002).
(iv) Behaviours during events. The behaviours reported in NREM arousal 
disorders and NFLE are discussed in detail elsewhere in this review. The motor 
patterns observed during these events, such as wandering, semipurposeful
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automatisms and motor agitation, may be seen in both conditions, and there are 
few if any specific features which discriminate between the conditions (Zucconi 
and Ferini-Strambi, 2000). However, the prominent stiffening and dystonic 
posturing often seen in NFLE is unusual in the arousal disorders (Provini et al., 
1999).
(v) Duration o f  events. Parasomnias are usually described as relatively prolonged 
events, usually over 5 minutes in duration (Provini et al., 1999; Zucconi and 
Ferini-Strambi, 2000), although they may be briefer than this (Zaiwalla, 2005). 
Whilst individual episodes may be reported which last for less than 1 minute, the 
individual’s typical attacks often persist for much longer, occasionally up to 30 
minutes (Aldrich, 1999). In contrast, the events seen in NFLE are brief. Provini 
et al recorded 660 nocturnal frontal lobe seizures in 100 patients; the vast majority 
of events lasted for less than 2 minutes and the longest recorded seizure was 3 
minutes in duration (Provini et al., 1999). As previously discussed, frontal lobe 
seizures have been subdivided into paroxysmal arousals, paroxysmal nocturnal 
dystonia and epileptic nocturnal wandering (Montagna, 1992). Only epileptic 
nocturnal wanderings have been reported to last over 2 minutes and this seizure 
type is relatively uncommon, constituting less than 3% of events in NFLE (Provini 
et al., 1999).
(vi) Stereotypy. NREM arousal disorders may be broadly stereotyped within an 
individual, but there is usually some variability in the behaviours observed in 
individual events. In contrast, seizure of NFLE are highly stereotyped, with 
smaller events representing fragments of larger seizures (see Chapter 8, page 142).
(vii) Recall. Subjects are unaware of their surroundings during parasomnias; in 
most instances they will return to restful sleep after the event without waking, and 
will have no recollection of the event the following day (Aldrich, 1999; Montagna, 
2000; Zaiwalla, 2005). Some individuals, however, report vague, poorly formed 
memories of frightening dreams (Schenck and Mahowald, 1995) or a partial 
recollection of the episode intermingled with dream mentation (Aldrich, 1999).
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On these occasions, the subject usually does not remember the onset of the event, 
but may have a hazy and dream-like recollection of the moments shortly before 
full waking. In contrast, awareness may be retained during frontal lobe seizures. 
Many individuals, particularly those with autosomal dominant nocturnal frontal 
lobe epilepsy (ADNFLE), are woken from sleep with a characteristic aura, most 
commonly a sensation of dyspnoea or choking (Scheffer et al., 1995). Individuals 
with NFLE often have a clear recollection of at least some of their events and can 
often give clear descriptions.
(viii) Vocalisation. Vocalisation is common in both NFLE and parasomnias. 
Shouting, screaming and incoherent speech may occur in either condition, and 
therefore these features are not helpful in discriminating between them. Coherent 
speech, however, is a more useful feature. Coherent speech in NFLE is usually a 
feature of the retained awareness and speech content is recalled by the patient 
(Williamson, 1995). In parasomnias, speech is conducted while the patient is 
unaware and the patient will usually have no recall of any conversation the 
following day (Sheldon, 2004). Some subjects may wake during the events and 
have some recall of end of their conversation the following day, and others may 
have a dreamy partial recollection of a conversation, but clear and complete recall 
of speech is very uncommon in a parasomnia.
Overall, the most consistently identified clinical features for discriminating 
between NFLE and parasomnias are: frequency of events, timing of events during 
sleep, and the duration of individual events (Provini et al., 1999; Zucconi and 
Ferini-Strambi, 2000). A number of other features said to be useful may in fact 
have less practical value. For example, a positive family history is common in 
parasomnias but may also be seen in ADNFLE (Scheffer et al., 1995); and the 
triggering of events by disrupted sleep or stress is said to be very common in 
parasomnias, but may also contribute to the provocation of seizures (Zucconi and 
Ferini-Strambi, 2000). Overall, despite some suggestive features, the 
differentiation of these disorders on the basis of the history alone can be difficult. 
All authors stress the importance of recording episodes by way of video EEG/PSG
192
Chapter 10. Differential Diagnosis
to confirm the diagnosis (Roberts, 1998; Provini et al., 1999; Zucconi and Ferini- 
Strambi, 2000). This raises logistical problems in individuals with irregular or 
infrequent events, and in regions where this service is not readily available.
RBD vs NFLE
While REM sleep behaviour disorder may have some superficial similarities to 
NFLE, its clinical course is usually quite different.
a)Age o f  onset. The most important difference between NFLE and RBD from a 
diagnostic point of view is its tendency to develop in older individuals; the mean 
age of onset is 52-62 years (Schenck, 1993; Sforza et al., 1997; Olsen, 2002), and 
it is uncommon in children (Sheldon and Jacobsen, 1998). This is clearly in 
contrast to both nocturnal frontal lobe epilepsy and NREM arousal disorders 
which usually appear in the paediatric age group (Aldrich, 1999; Provini et al., 
1999).
b) Association with neurological diseases. The strong association of RBD with 
neurodegenerative disorders (particularly Parkinson’s disease and Multiple System 
Atrophy), as well as other neurological conditions such as narcolepsy, is in 
marked contrast to individuals with NFLE who almost always have normal 
neurological examination and neuroimaging (Provini et al., 1999).
c) Altered dream patterns, dream enactment and sleep-related injury. Almost 
90% of individuals with RBD complain of intense, vivid, and often violent 
dreams, which are qualitatively different to their premorbid dreams. A similar 
number have ‘oneieric’, or dream enactment, behaviours with swearing, punching, 
kicking, jumping out of bed and running. These often result in injury to the 
patient or bed partner, which is often the presenting complaint in RBD (Schenck 
and Mahowald, 2002). In contrast, dream quality does not change with the onset 
of NFLE. While seizures may involve behaviours such as vocalization, running 
and jumping, they are not associated with dreaming; they are either not 
remembered at all, or occur with genuine recollection of the event. Injury may
193
Chapter 10. Differential Diagnosis
occur during nocturnal frontal lobe seizures, but is not widely reported, and is 
rarely the presenting complaint (Schenck et al., 1989).
d) Duration o f  event and rousability. The events of RBD are of variable duration, 
but individuals are generally rousable, being woken by their bedpartner, collision 
or injury. In contrast, the events of NFLE are in the main very brief, but cannot be 
terminated by external stimuli.
e) Stereotypy. As discussed previously, the seizures of NFLE are highly 
stereotyped, but this is not the case in RBD. In the latter case, behaviours of the 
patient reflect the dream content, which usually varies from night to night. 
Furthermore, multiple non stereotyped minor behaviours often occur throughout 
sleep, such as twitches, groans, sleep talking and gross limb jerks (Schenck, 1986; 
Schenck and Mahowald, 2002), often preceding the development of overt RBD.
Nocturnal panic attacks vs NFLE
Although nocturnal panic attacks share a number of clinical features with 
nocturnal frontal lobe epilepsy they should rarely be a source of significant 
diagnostic confusion. From the perspective of diagnosis, the most important 
feature of nocturnal panic is the coexistence of panic disorder and daytime panic 
attacks (Craske and Tsao, 2005). Nocturnal panic attacks in these individuals are 
not significantly different to daytime panic attacks, being characterised by fear and 
autonomic features such as tachycardia and sweating (Craske and Barlow, 1989); 
they will usually be recognised as panic attacks by the patient who is fully aware 
throughout (Craske and Tsao, 2005). They are predominantly affective 
phenomena without significant motor activity , are relatively prolonged, lasting 2- 
8 minutes on average, and rarely occur more than once in a night (Craske and 
Barlow, 1989; Craske and Tsao, 2005).
However, the presence of retained awareness and subjective feelings of choking 
and breathlessness may present some diagnostic difficulty in the rare individual 
with exclusively nocturnal events, particularly if they are of brief duration.
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10.3.2 Features of video EEG/PSG monitoring
In cases of diagnostic doubt, video EEG or video EEG-PSG monitoring may be 
the only way of accurately distinguishing NFLE from other paroxysmal motor 
disorders of sleep.
Video EEG findings in NFLE
The video EEG findings in NFLE have been well described (Provini et al., 1999) 
and are reviewed in detail in Chapters 7 and 8. By far the most common seizure 
type is the paroxysmal arousal, constituting 75% of the recorded seizures; 
paroxysmal nocturnal dystonia constitute a further 23%, and epileptic nocturnal 
wanderings make up only 2% of recorded seizures. Most patients have at least 
two of these seizure types identifiable on monitoring, and autonomic features such 
as tachycardia and irregular respiration are often prominent. Although individuals 
with NFLE may have events of varying duration and complexity, brief attacks 
tend to represent fragments of the larger seizures (Provini et al., 1999). The onset 
patterns of these events is usually strikingly stereotyped (Provini et al., 1999), a 
finding that can be clearly seen by the use of split-screen video EEG-PSG 
(Tinuper et al., 2004; Valenti et al., 2006). Stereotypy may not be invariably the 
case, however; a recent intracranial electrode study indicated that in some patients 
with NFLE, the semiology of brief epileptic paroxysmal arousals may be different 
in individual events (Nobili et al., 2005).
Electrographically, events occur almost invariably during NREM sleep, with about 
70% occurring in stage 1 or 2. Interictal EEG is usually normal, with clear-cut 
epileptiform discharges present in only 33% of individuals in wakefulness and 
45% in sleep. Ictal EEG shows no epileptiform activity in almost 50%; in the 
majority of those which do show abnormalities, focal attenuation or rhythmic theta 
or delta is the prominent rhythm; only around 10% will show spike and wave 
activity, and another 10% show focal fast activity.
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Video EEG in Arousal disorders
Video EEG and video PSG recording of these disorders is often not possible due 
to their infrequent or unpredictable occurrence, and there are relatively few well 
documented series in the literature (Zucconi and Ferini-Strambi, 2000). Often 
during a monitoring period the events recorded are minor compared to the usual 
episodes, or they do not occur at all. As a result there are very few clear 
descriptions of semiology from video monitoring in the literature; most reported 
events are characterised by little more than the patient sitting up, looking around 
and vocalizing (Kavey et al., 1990; Espa et al., 2002). Most patients do not leave 
the bed in the laboratory; often they are restricted by the EEG electrodes and lie 
back down to sleep (Kavey et al., 1990).
Electrographically, events usually occur in the first part of the night, arising from 
slow wave NREM sleep (i.e. stage III or IV (Gastaut, 1965; Kavey et al., 1990; 
Pressman et al., 1995; Espa et al., 2002). Classically, a combination of alpha, 
delta and theta frequencies is seen, without evidence of clear wakefulness 
(Jacobson, 1965). Sometimes a non-reactive posterior alpha pattern is seen 
(described by Gastaut and Broughton as substage la3), which gives a picture of 
mixed awake and asleep rhythms (Gastaut, 1965). In individuals with sleep 
terrors there may be rapid desynchronisation or low voltage waking patterns, often 
combined with increased heart rate, tachypnoea, and increased muscle tone.
During somnambulism, light sleep patterns (stage 1) are often seen. Importantly, 
epileptiform activity is not present during these episodes (Niedermeyer and Lopes 
da Silva, 2004).
Video EEG/PSG in RBD
The diagnosis of RBD is usually confirmed using video-polysomnographic 
monitoring. According to the International Classification of Sleep Disorders 
(ASDA, 2005) one of the following findings during REM sleep confirms RBD: 
either excessive augmentation of chin EMG tone; or excessive chin or limb phasic 
twitching (irrespective of the chin EMG activity), with jerking or complex 
behaviours and without epileptic activity. Normal sleep architecture is preserved
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(Schenck, 1993; Olsen, 2002). Frank events may be recorded during REM sleep 
on video EEG or PSG monitoring, with violent limb movements such as flailing, 
punching or kicking; simple or complex behaviours (such as waving, pointing, 
searching or reaching) corresponding to dream activity; and prominent 
vocalization including laughing, talking moaning and chanting (Schenck, 1986). 
The timing of events in the sleep cycle (REM sleep vs stage 2 NREM for 
seizures), in conjunction with the nature of the observed behaviours and the 
observation of preserved EMG tone during REM sleep, should result in a 
relatively straightforward diagnosis in most cases. Epileptiform activity is not 
seen during these events.
Video EEG/ PSG in nocturnal panic attacks
On nights without panic attacks, patients with nocturnal panic show PSG and EEG 
parameters which are similar to those of control subjects, although they may have 
slightly longer sleep latencies and increased movement during sleep (Hauri et al., 
1989; Landry et al., 2002). Panic attacks usually arise from stage 2 or 3 NREM 
sleep, often around the time of sleep stage transition (Lesser et al., 1985; Hauri et 
al., 1989). Subjects have only single events in any monitored night, often have a 
prolonged sleep latency after the attack (up to 2 hours), and have vivid recall of 
the event the following day (Hauri et al., 1989). In some individuals, some 
observable features of the events, such as tachycardia and movement, appear 
during sleep, but in others these features were only seen after waking.
Conclusion
There are many non-epileptic disorders characterized by motor activity in sleep. 
From a practical perspective, it should usually be possible for the clinician to 
accurately identify these on the basis of the clinical history,. However, NFLE may 
present in a very similar fashion to some of these, particularly the NREM arousal 
parasomnias; it may be difficult or impossible for even very experienced 
epileptologists and sleep physicians to make a definite diagnosis. Interical EEG, 
PSG and cerebral imaging may be useful in some individuals, but these 
investigations are frequently non-contributory. In such cases the recording of
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episodes using video EEG- PSG may be required to make a definite diagnosis, 
although this may be difficult to achieve. Moreover, in many sleep disorders, 
most notably the NREM arousal parasomnias, comprehensive video EEG/PSG 
studies are still lacking. As the EEG may be non-contributory in both NFLE and 
parasom nias,, diagnostic doubt may remain even after the recording of events.
From a biological perspective, the understanding of sleep disorders is still in its 
infancy. The current understanding of underlying mechanisms is usually based 
upon data from small case series or single cases, and is often highly speculative. 
Moreover, in many cases the conditions themselves may represent extremes of 
normal physiology. For example, periodic limb movements in sleep and arousal 
parasomnias are seen so frequently in the general population that they cannot be 
considered as pathological in their own right; such conditions only become a 
‘disorder’ when they result in distress, injury or harm to the individual or others. 
Detailed further study in this area is therefore warranted, not only to understand 
these conditions per se, but also to provide insights into the process of sleep itself.
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CHAPTER 11 
Serotonergic Neurotransmission in Human Sleep: 
Evidence from an 18F-MPPF Study
Introduction
The neurochemical changes which underpin human sleep may play a key role in 
the precipitation of seizures in some epilepsy syndromes. Serotonin, interacting 
with other neurotransmitters such as acetylcholine and noradrenalin, appears to 
promote wakefulness and suppress REM sleep. The serotonergic system is 
phylogenetically ancient, and is found in all mammalian species. The majority of 
serotonergic cell bodies are located in the raphe nuclei, which lie around the 
midline of the brainstem, but these have widespread projections throughout the 
brain. Previous animal studies have suggested that the system is a fundamental 
component in the neurochemical regulation of sleep. Activity demonstrated with 
single unit recordings from serotonergic neurons in the dorsal raphe nucleus 
(McGinty and Harper, 1976; Trulson and Jacobs, 1979; Cespuglio et al., 1981) is 
tightly linked to the stage of sleep. The neurons are active in wakefulness, 
becoming progressively less active during non-REM sleep, and are essentially 
quiescent during REM sleep. Microdialysis studies in cats and rats (Portas and 
McCarley, 1994; Portas et al., 1998; Park et al., 1999; Strecker et al., 1999) have 
demonstrated changes in serotonin concentration which parallel the changes in 
neuronal firing rates (see Chapter 2 page 45-6 for further details).
Most available information about changes in serotonergic neurotransmission 
through the sleep-wake cycle has been obtained in experimental animals. There 
are dangers in extrapolating this to humans given our knowledge of interspecies 
differences. For example, serotonin exerts dramatic modulatory effects on 
circadian rhythms in hamsters but not mice (Antle et al., 2003), and lesions of the 
dorsal raphe nucleus have been shown to reduce sleep in cats (Jouvet, 1972) but 
not in rats (Bouhuys and Van Den Hoofdakker, 1977). The only human data on 
serotonin release during the sleep-wake cycle to my knowledge is a single case 
report showing that the serotonin concentration in the CSF from the lateral
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ventricles was greatest in wakefulness and lowest in REM sleep (Zeitzer et al., 
2002).
Aim and Hypothesis 
Aim
In light of the paucity of human data, the aim of this study was to evaluate 
endogenous serotonin release in wakefulness and sleep in human subjects using 
the 5HT ia PET ligand [,8F]MPPF.
Hypothesis
i o
[ F]MPPF binding is greater in sleep than in wakefulness, reflecting a reduction 
in endogenous serotonin release during sleep.
Methods
This study comprised two sections, a human study (Part 1) and an animal study 
(Part 2).
Part I: Effect of sleep on [18F]MPPF binding: Human study
Subjects. One of the problems faced by functional neuroimaging studies of human 
sleep is the lack of predictability with which spontaneous sleep occurs. Patients 
with narcolepsy were studied here as a way of circumventing this problem. 
Fourteen subjects with a diagnosis of narcolepsy (12 females, 2 males; median 
age: 55 years; age range: 26-67 years) were studied. The clinical features of the 
subjects are described in Table 11.1. The following inclusion criteria were 
applied: age over 18 years; diagnosis of narcolepsy made by a consultant 
neurologist following appropriate investigation; treatment with either 
methylphenidate alone or no medication. Subjects were excluded from the study 
if they had taken neuroleptic, antidepressant or stimulant medication other than 
methylphenidate within 1 month of enrolment; if there was a history of other 
neurological or psychiatric illness; or if the subject was pregnant. Subjects 
underwent a medical interview prior to enrollment in the study. In view of the
201
Chapter 1 l . lfiF-MPPF PET in sleep and wakefulness
potential effects of mood and serum tryptophan on endogenous serotonin release, 
all subjects completed the Beck Depression Inventory (BDI) and the Beck Anxiety 
Inventory (BAI) on the day of each PET scan. They were supplied with 
standardized meals for 24 hours prior to each scan (no caffeinated drinks were 
permitted during this period), and serum tryptophan levels were measured 30 
minutes prior to each scan. All subjects gave their written informed consent to the 
study protocol, which was approved by the medical ethics committee of the Austin 
Hospital.
Radiochemistry. Tracer synthesis was performed by Rachel Mulligan and Henri 
Tochon-Danguy in the Deprtment of Nuclear Medicine, Austin Hospital, 
Melbourne. [I8F]MPPF was obtained by nucleophilic substitution of the aromatic 
nitro group using previously described methods (Le Bars et al., 1998). The purity 
of [,8F]MPPF was greater than 99% on each synthesis, and specific activity ranged 
from 873-3300 mCi/pmol.
i o
PET. Each patient underwent two [ FjMPPF scans (total injected dose 4mCi), 
one whilst taking their usual doses of methylphenidate (during which the subject 
was required to stay awake), and one after the subject had omitted 
methylphenidate on the day of the scan (during which the subject was allowed to 
fall asleep in the scanner prior to tracer injection). Each scan was carried out with 
polysomnographic monitoring (EEG, EOG and EMG) to monitor sleep state 
during the acquisition period. The PET scans were performed between 2 and 3 pm 
in every case, with the two scans being performed 1 week apart. Dynamic PET 
scans comprising 26 frames were acquired over 60 minutes using an ECAT 
positron tomograph (951/31R, CTI Siemens, Knoxville, TN, USA). The scanner 
was operated in 3D mode. Head movement was minimized using a moulded 
head-rest and head restraint. The data were reconstructed using the Kinahan and 
Rogers 3D reprojection algorithm (Kinahan, 1989) with a Hanning filter. 
Attenuation correction was performed using data from a 10 minute transmission 
scan with gallium-68 /germanium -68 sources. The final image comprised 
128x128x31 slices where the pixel size was 2.34mm and the slice thickness was 
3.37mm.
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Sex Age (years) Methylphenidate
dose
(mg/day)
%ageoftime spent in 
sleep
Wake Sleep 
scan scan
Classification Mean [ loF]MPPF BP 
(Whoie Brain)
Wake Sleep 
scan scan
M 51 30 0 84 Good Sleeper 0.223 0.241
F 54 45 3 93 Good Sleeper 0.1% 0.240
F 62 30 0 87 Good Sleeper 0.188 0.212
F 59 90 0 85 Good Sleeper 0.237 0.283
F 27 40 0 93 Good Sleeper 0.318 0.349
F 26 Nil 0 84 Good Sleeper 0.238 0.278
F 35 Nil 0 89 Good Sleeper 0.272 0.276
F 66 30 0 19 Poor Sleeper 0.228 0.234
F 56 50 0 34 Poor Sleeper 0.212 0.199
F 29 50 0 21 Poor Sleeper 0.191 0.194
M 52 10 8 26 Poor Sleeper 0.235 0.264
M 66 70 0 29 Poor Sleeper 0.265 0.265
F 58 70 0 52 Poor Sleeper 0.224 0.212
F 67 40 0 30 Poor Sleeper 0.284 0.281
Table 11. 1. Summary o f clinical and treatment information for subjects in the study, with 
details o f sleep duration in ‘wake' and ‘sleep' scans
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MRl. MRI acquisition consisted of a high resolution three-dimensional T1 - 
weighted image comprising 120 contiguous slices of 1mm thickness and 1mm x 
1mm pixel dimensions, with the anatomical volume covering the whole brain.
MRI scans were acquired on a 1.5T Signa Echospeed Superconducting Imaging 
System (General Electric Medical Systems, Milwaukee, WI). The three 
dimensional spoiled gradient recalled echo acquisition comprised TR 10.5 
milliseconds, TE 2.2 milliseconds, TI 350 milliseconds, flip angle 20 degrees,
FOV 25cm, matrix 256 x 256, NEX 1.
Data analysis
Kinetic Analysis. A parametric image, obtained by estimating the binding 
potential (BP) and Ki ratio (Ro) for each voxel, was generated for each PET 
dataset using a simplified reference tissue model (Lammertsma and Hume, 1996) 
validated for MPPF studies (Passchier et al., 2001). This model derives BP from 
the ratio of the volumes of distribution of the ligand in the region of interest 
relative to the cerebellum, which has been shown to be devoid of 5HT!A specific 
binding (Burnet et al., 1995; Hall et al., 1997). No arterial sampling was 
performed, and Ki was not directly measured. The cerebellar region of interest 
was manually drawn on MRI images using interactive mouse driven software. 
These MRI images had previously been registered to an image comprising the sum 
of all frames from the dynamic PET acquisition. Linear registration was 
performed using AIR (Woods et al., 1992) yielding a 9 parameter transformation 
matrix for translation, rotation and scaling along each of the principal axes.
Whole brain BP and K] ratio (Ro) values. Mean whole brain BP values were 
obtained after transformation of the images to a common stereotaxic coordinate 
space. This allowed the application of a common whole brain mask for each pair 
of sleep and waking scans. The mask was created using a standard template which 
included the whole brain apart from the reference region. Because the field of 
view of the positron emission tomograph used in this study did not incorporate the 
entire cerebrum, to correct for subtle differences in patient position between scans, 
only voxels imaged in both the sleep and wake states were included in the mask.
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Regions o f Interest. In sleep and waking scans, mean values for BP and R0 were 
calculated for ROIs drawn on the same MRI images that were used for the 
cerebellar ROI. Because of their potential importance in the regulation of the 
sleep-wake cycle or because of the high content of 5HT1A receptors, the 
following regions were selected: anterior cingulate gyrus, mesial temporal region 
(hippocampus and amygdala), and temporal cortex (temporal pole, 
parahippocampal gyrus and temporal neocortex). Regions of interest 
incorporating the raphe nuclei were not examined because of the difficulty in 
accurate anatomical delineation on MRI scans and the potential errors in 
parameter estimates relating to partial volume effect and the small size of the 
nuclei.
Polysomnographic Analysis. Duration of sleep during the scanning period was 
encoded from the polysomnographic data which were reviewed and staged 
according to the classification system of Rechschaffen and Kales (Rechtschaffen, 
1968). Scoring was undertaken by the author prior to PET data analysis, and 
therefore blind to the PET results. The polysomnographic data were used to 
divide the subjects into (i.) ‘good sleepers’, who slept > 75% of total scan time 
and (ii.) ‘poor sleepers’, who slept < 75% of total scan time.
Statistical Analysis.
Change in BP in sleep wake cycle. The paired Student’s t-test was used to 
compare mean BP in the whole brain and in individual ROIs in sleep and wake 
scans for the entire group. This analysis was then performed separately for the 
‘Good Sleepers’ group and the ‘Poor Sleepers’ group.
Second, the change in BP between wake and sleep scans (ABP) was calculated 
using the following formula:
A _ B P sleep  scan -  BPwake scan
ABP= lOOx--------------------------
BPwake scan
The unpaired t-test was then used to compare mean ABP in the population of 
‘Good Sleepers’ vs ‘Poor Sleepers’.
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Change in KI ratio (Ro) in sleep wake cycle. To assess whether BP changes were 
associated with changes in tracer delivery as reflected by R o , the analyses above 
were repeated for the Ro and for A R 0 :
. ^  Roslecpscan -  RowakescanAR> = lOOx------------------------
Rowake scan
Influence o f other variables. To assess whether affective state (BDI and BAI 
scores), serum tryptophan values, A Ro and methylphenidate dose were related to 
ABP, these additional variables were included in a multivariate stepwise 
regression analysis.
Part II: Effect of methylphenidate on [18F]MPPF binding (p- 
microprobe study)
To assess the possible impact of treatment with methylphenidate, changes in 
[18F]MPPF binding were examined following administration of methylphenidate 
in rats using an intracerebral p-sensitive detector (the p-microprobe; Zimmer et 
al., 2002). Previous studies have shown this technique to be reliable in detecting 
changes in [l8F]MPPF binding correlated with changes in endogenous serotonin 
release (Zimmer et al., 2002; Rbah et al., 2003; Zimmer et al., 2003; Riad et al., 
2004). The author designed and assisted in the experiments which were conducted 
under the direction of Didier Le Bars and Luc Zimmer at CERMEP Biomedical 
Cyclotron, Lyon France.
Radiochemistry. Radiosynthesis was undertaken by Didier le Bars at CERMEP, 
Biomedical Cyclotron, Lyon, France. The radiochemical purity of [18F]MPPF 
was greater than 95% on each synthesis, and specific activity ranged from 74 x 103 
MBq/pmol to 148 x 103 MBq/pmol (2-4 Ci/pmol).
Animals. 5 adult male Sprague Dawley rats (250±50g body weight; Charier River, 
L’Arbresle, France) were housed at a constant temperature and with ad libitum
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access to food and water. All procedures involving animals and their care abided 
by the regulations of the European Economic Commission (86/09/EEC) and were 
approved by the Animal Care Committee at the Claude Bernard University. As 
described in detail previously (Zimmer et al., 2002), after anesthesia with urethane 
(1.7gm/kg, i.p.), each rat was positioned in a stereotaxic frame on a 
thermostatically controlled heating blanket (37±1 C), and a catheter was inserted 
into the tail vein to allow subsequent injection of the radiotracer. Two (3- 
microprobes were then implanted under stereotaxic control; one in the cerebellum 
and one in the hippocampus. The sensitive end of the probe consisted of a plastic 
scintillating fiber that was 1mm in length and 1mm in diameter. The sensitivity of 
the probes, measured in vitro is close to 0.55 measured counts per kilobecquerel 
per milliliter. According to previous Monte Carlo simulations, the probe detection 
volume is defined as a 1.3 mm radius sphere centered on the probe end 
corresponding to 90% of the recorded signal.
Methylphenidate treatment and [18F]MPPF binding kinetics. [I8F]MPPF
injections were performed 2 hours after implantation of the probes. For each 
18acquisition, 2mCi [ F]MPPF was injected over a 45 second period. The course of 
radioactivity was studied for 180 minutes in the hippocampus and cerebellum, 
using a 10 second time integration acquisition. At 20 minutes after [l8F]MPPF 
administration, each rat received an injection of methylphenidate at 15mg/kg, a 
dose at which clear behavioral effects have been observed in rats, and which is 
significantly larger than that used therapeutically in humans. After protocol 
acquisition, the anaesthetized rats were killed and their brains quickly removed 
and frozen at -80°C. Coronal sections were cut and probe placements were atlas 
matched.
Data analysis. The raw data were expressed as mean number of disintegrations 
(Zimmer et al., 2002) per 10 seconds, averaged at 1 minute intervals and corrected 
for radioactive decay. Analysis was conducted comparing means obtained from 
previously acquired control data with methylphenidate-treated rats.
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Results
Part 1: Human Study
Of the 14 subjects studied, 7 slept for greater than 75% of the study ( ‘Good 
Sleepers’) and 7 slept for less than 75% of the scan time (‘Poor Sleepers’).
Change in BP in sleep wake-cycle. The values for mean BP change in whole brain 
and each ROI are presented in Table 11.2. Mean BP in whole brain and all ROIs 
was significantly greater in sleep than in wakefulness for the group as a whole. 
This difference was more pronounced in ‘Good Sleepers’; mean parametric 
images in wakefulness and sleep from the population of ‘Good Sleepers’ are 
shown in Figure 11.1. In contrast, no significant difference was seen between 
sleep and wake scans in the ‘Poor Sleepers’ group. ABP was significantly greater 
in ‘Good Sleepers’ than in ‘Poor Sleepers’ in the whole brain and in all ROIs 
except the mesial temporal region (Figure 11.1).
Change in Ki ratio (Ro) in the sleep wake-cycle. No significant change in Ro was 
seen in the whole brain either in the group as a whole or the ‘Good Sleepers’. 
However a small but statistically significant increase in Ro during sleep was seen 
in some regions of interest. In the group as a whole, the mean increase in Ro was 
0.04 in the cingulate ROI and 0.03 in the mesial temporal ROI (p<0.05 for both). 
This finding was also seen when only the ‘Good Sleepers’ were examined 
(increase in Roin cingulate: 0.08, p<0.01; in mesial temporal ROIs: 0.04, p<0.01). 
In this group there was also an increase in Ro in the temporal neocortex of 0.03 
(p<0.05). A Ro was not significantly different in ‘Good Sleepers’ compared to 
‘Poor Sleepers’ in the whole brain (p = 0.3) or in any ROI. There was no 
correlation between A Ro and ABP (r = 0.27, p = 0.4).
Influence o f other variables besides sleep. Measures of mood and serum 
tryptophan concentration were found to be similar in the sleep and wake scans.
The median BDI score for the wake scan was 4 (range 0-16), and for the sleep 
scan was 3 (range 0-12). The median BAl score for the wake scan was 5 (range 0-
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Brain Region Mean increase in [ISF]MPPF BP in sleep scan compared to wake scan (±SD)
All subjects ‘Good Sleepers’ ‘Poor Sleepers’
(n=14) (n=7) (n=7)
Whole Brain 0.016 (± 0.02)* 0.030 (± 0.01)** 0.001 (±0.01)
Cingulate Gyrus 0.045 (±0.06)* 0.092 (±0.04)** 0.000 (±0.05)
Mesial Temporal 0.092 (± 0.14)* 0.160 (± 0.14)** 0.024 (±0.09)
Temporal Cortex 0.034 (±0.04)* 0.056 (+/- 0.04)** 0.011 (±0.03)
Table 11.2. Mean difference in BP in sleep and wake scans in whole brain and individual ROIs; values 
are given for the whole group, and the groups o f ‘good sleepers ’ and 'poor sleepers '. The differences in 
BP have been analyzed using paired t tests and are statistically significant in all regions in the ‘All 
subjects ’ group and to a larger extent in the ‘Good sleepers ’ group. In contrast, no significant difference 
between BP in the sleep and wake scans is seen in the ‘Poor sleepers’ group.
* significant at p<0.05 
** significant at p<0.01
60  
50  
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Figure 11. 1 A comparison o f mean ABP in ‘Good sleepers' and ‘Poor 
sleepers’, showing significantly larger ABP values in ‘Good sleepers’. Error 
bars are o f the standard error o f the mean.
p = 0 .0 2 *  p = 0 1 0
p = 0 .0 4 7 *p = 0 .0 0 5 *
■ Good Sleepers 
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15) and for the sleep scan was 4.5 (range 0-13). Mean serum tryptophan levels 
were 60 (± 16) pM for the wake scan, and 57 (± 15)pM for the sleep scan. 
Stepwise regression showed no significant correlation between ABP and serum 
tryptophan levels, change in BAI and BDI scores, methylphenidate dose or ARo in 
the whole brain.
Part II: Rat p-microprobe study
Administration of high dose methylphenidate induced no displacement of 
[ l8F]MPPF in 5 rats. Time-activity curves from the p-microprobe are shown in 
Figure 11.2; it can be seen that the time-activity curves of the methylphenidate 
treated rats and the control rats showed no difference in [l8F]MPPF binding 
following the methylphenidate bolus.
JT
m
o_
CL
MPH 15mg/kg 
18F-MPPF I
Hippocampus - MPH
Hippocampus - Control
Cerebellum (MPH and 
Control)
— i— i— i— i— i— i— i— i— i— i— i— i— i— i— i— i—
0 10 20 30 40 50 60 70 80
Time (minutes)
Figure 11. 2. Time- activity curves measured by fi-microprobes located in the hippocampus 
and cerebellum o f rats following an intravenous injection of2mCi /  I8F/MPPF. Time- 
activity curves from control rats and rats treated at 20 min with methylphenidate (MPH) are 
shown and are indistinguishable, demonstrating that methylphenidate injection has no effect 
on [ I8FJMPPF binding. Error bars are o f the standard error o f the mean.
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Awake Asleep
Figure 11. 3. Parametric images o f mean representative ,SF-MPPF Binding Potential (BP) 
in the group o f  'Good sleepers ’ in wakefulness and sleep, spatially normalized to common 
stereotaxic coordinates. A widespread increase in BP is present in the sleep image, seen 
here in the mesial temporal and temporal cortical regions.
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Discussion
18This study has demonstrated an increase in [ F ]MPPF binding in sleep, 
indicating increased 5HTiA receptor availability in sleep compared to 
wakefulness. To my knowledge, this is the first time such changes have been 
demonstrated in humans.
Relationship to endogenous serotonin release.
[I8F]MPPF is a selective 5HTiA receptor antagonist (Thielen and Frazer, 1995). It
has an affinity for the 5HTi A receptor (A', =3.3nM) comparable to that of serotonin
(K, = 4.7nM) (Zhuang et al., 1994), and a number of studies in anaesthetized rats 
18have indicated that [ F]MPPF binding is sensitive to endogenous serotonin 
release (Zimmer et al., 2002; Rbah et al., 2003). These changes in [ lxF]MPPF 
binding may simply reflect competitive inhibition of ligand binding by 
endogenous serotonin, although observations of the effect of endogenous ligand 
on dopamine D1 receptor binding have given rise to an alternative explanation 
based on receptor trafficking (Laruelle, 2000). In this model, the release of 
endogenous ligand results in receptor internalization and reduced radioligand 
binding (see Chapter 3. page 77-78 for further details).
This study is the first to examine changes in [18F]MPPF binding with 
physiological changes in endogenous serotonin, in contrast to previous animal 
studies in which the pharmacological challenges used may have produced 
supraphysiological fluctuations. However, a previous attempt to influence 
serotonin release in humans using tryptophan depletion and supplementation did 
not alter [18F]MPPF binding in humans (De Haes et al., 2002). It is likely that 
larger changes in serotonin release occur in sleep as observed in the present study 
than are achieved by manipulation of blood tryptophan concentration. The 
reduction in central serotonin concentration following tryptophan depletion is 
approximately 309f and occurs after 8-12 hours (Carpenter, 1998). Tryptophan 
infusions produce only minor and transient increases in central serotonin release 
(Ternaux, 1976; Hoebel, 1989).
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Recently the same group was also unable to demonstrate changes in [l8F] MPPF 
binding in conscious monkeys, despite inducing supraphysiological increases in 
serotonin using fenfluramine (de Haes et al., 2006). The authors concluded that 
this result was due to the capacity of the 5HTiAto exist in either a ‘high affinity’ 
or ‘low affinity’ state (Nenonene et al., 1994; Watson et al., 2000). As antagonists 
(including [18F] MPPF) will bind equally to receptors in the low and high affinity 
states, whereas agonists (including endogenous serotonin) will preferentially bind 
to receptors in the high affinity state (Nenonene et al., 1994; Watson et al., 2000), 
[ l8F] MPPF binding will only be altered by endogenous serotonin if sufficient 
receptors are in the high affinity state. It was suggested that changes in [1XF] 
MPPF binding are observed in anaesthetized rats, but not conscious monkeys, 
because a greater proportion of 5H T|A receptors are in the high affinity state 
during anaesthesia than in wakefulness (de Haes et al., 2006). This concept is 
speculative, but may be relevant to the current findings. It is conceivable that the 
altered [18F] MPPF binding observed in this study is not solely a reflection of 
endogenous serotonin release, but is also influenced by changes in the affinity 
state of 5HT)A receptors. The current findings indicate that serotonin receptor 
availability changes through the sleep-wake cycle, but whether this is synonymous 
with serotonin release alone is yet to be fully clarified.
The involvement of serotonin in myriad neuropsychological functions such as 
cognition and emotion (Meneses, 1999), as well as neuropsychiatric conditions 
such as depression, schizophrenia and dementia (Sumiyoshi et al., 1996; Celada et 
al., 2004), has led to considerable interest in studying endogenous serotonin 
release. The wide range of applications would parallel the use of competitive 
displacement of [n C] raclopride (Koepp et al., 1998) to measure dopamine fluxes 
induced by behavioral and pharmacological manipulations in vivo. Although 
established 5HT!A ligands, such as WAY 100635, have not been shown to be 
sensitive to endogenous serotonin release (Maeda et al., 2001), [l8F] MPPF may 
prove to be a useful ligand for this purpose.
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Methodological considerations.
Factors other than conscious state which may have affected the results of this 
study included the omission of methylphenidate prior to the sleep scan. However, 
this is unlikely to have been a significant effect. Firstly, there is evidence that 
methylphenidate blocks presynaptic dopamine uptake (Schenk, 2002), but has 
negligible effect on serotonergic neurotransmission (Kuczenski and Segal, 1997; 
Segal and Kuczenski, 1999). Secondly, no correlation between dose of 
methylphenidate and magnitude of change in [l8F]MPPF binding was observed in 
the current study; some of the largest changes in binding potential were seen in 
untreated subjects. Finally, the data from the P-microprobe study in which 
methylphenidate was administered at high doses (substantially higher than 
therapeutic doses in humans), demonstrated no change in [l8F]MPPF binding in 
methylphenidate-treated rats compared to controls (Figure 3). These data strongly 
suggest that the changes in [18F]MPPF binding observed the current study were 
not influenced by methylphenidate. Other factors, including mood, circadian 
effects and dietary tryptophan, were carefully controlled for.
The Ki ratio term (Ro)in the simplified reference tissue model used reflects 
relative tracer delivery between the tissue of interest and the cerebellar reference 
region (Lammertsma and Hume. 1996). There was no significant correlation 
between A Ro and ABP making it unlikely that changes in BP were an artifact of 
altered tracer delivery. There was a small but statistically significant increase in Ro 
in sleep compared to wakefulness in the cingulate, mesial temporal and temporal 
cortex regions of interest. This finding is consistent with previous studies of 
cerebral blood flow demonstrating greater reductions in blood flow in the 
cerebellum than in cortical regions during sleep (Sakai et al., 1980; Braun et al., 
1997; Hofle et al., 1997). The magnitude of the cerebral blood flow changes 
observed previously cannot account for the large changes in BP observed in this 
study.
Subjects with narcolepsy-cataplexy were studied to increase the likelihood of 
sleep during the scans. This raises issues as to the generalisability of the findings 
to normal sleep. Narcolepsy is a neurological condition characterized by chronic
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sleepiness and intrusions into wakefulness of REM sleep phenomena including 
hallucinations, cataplexy and sleep paralysis. Polysomnographic measures of 
sleep in this condition are qualitatively similar to normal sleep although REM 
latency is reduced (Broughton and Mamelak, 1980; Montplaisir and Godbout, 
1986). There is now compelling evidence that narcolepsy results from the loss of 
hypocretin-producing neurons in the dorsolateral hypothalamus (Nishino et al., 
2000; Mignot et al., 2003) and that fundamental changes in the serotonergic 
system are not directly responsible (see Chapter 2 page 49 for details). Secondary 
changes may lead to reductions in serotonergic inhibiton of REM-on neurons early 
in sleep (Brown et al., 2002; Liu et al., 2002). However, it seems likely that 
similar patterns of serotonin release occur in normal sleep, although this requires 
empirical confirmation. While functional neuroimaging studies of sleep in normal 
subjects have been accomplished with the aid of preceding sleep deprivation, these 
are more difficult to perform. Moreover, there is considerable evidence to suggest 
that sleep deprivation may have influences on serotonergic neurotransmission 
(Prevot et al., 1996; Gardner et al., 1997), although such influences have not been 
studied in humans and are not fully understood. In the absence of a practically 
achievable ideal methodology, the study of subjects with narcolepsy-cataplexy 
provides a workable means of obtaining sleep during the experimental procedure.
Serotonin and sleep.
A detailed understanding of the neurochemical changes in human sleep is essential 
for a full understanding the role of sleep in health and disease, and to develop 
effective treatments for sleep disorders. Serotonin has long been thought to play a 
key role in sleep on the basis of findings in animals (Jouvet, 1972). However, in 
light of the substantial interspecies variations that have been demonstrated in 
serotonergic function (Cragg et al., 1997; Antle et al., 2003), the extrapolation of 
such findings to human sleep may be misleading. In our study we have provided 
substantial evidence that serotonin receptor availability is increased in the human 
brain during sleep, a finding consistent with existing animal data. We also found 
that changes in binding during the sleep-wake cycle were widespread throughout 
the brain. While the raphe nuclei have widespread efferent connections, different 
target regions in the central nervous system are innervated by anatomically distinct
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subpopulations of raphe neurons; these may be differentially activated in some 
behavioral states (Fomal 1996). Our findings, however, suggest that this does not 
occur during sleep when a global change in serotonin receptor availability is 
observed.
Conclusion
In conclusion, this study demonstrated widespread changes in [18F]MPPF binding 
consistent with increased serotonin receptor availability during sleep in the brains 
of subjects with narcolepsy. These findings confirm a role for serotonin in the 
modulation of human sleep. Moreover they suggest that [18F]MPPF PET may 
provide a valuable tool for the further investigation of serotonergic 
neurotransmission.
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CHAPTER 12 
SLEEP DISORDER OR SEIZURE? 
DIAGNOSING BUMPS IN THE NIGHT
Introduction
The diagnosis of abnormal paroxysmal motor events in sleep presents a particular 
challenge for the clinician. On the one hand, they may be parasomnias, benign 
non-epileptic sleep disorders defined as ‘unpleasant or undesirable behavioural or 
experiential phenomena that occur predominantly or exclusively during the sleep 
period’ (ASDA, 2005). On the other hand, they may be epileptic seizures, 
requiring investigation and treatment. In many cases, distinguishing seizures and 
parasomnias by means of the clinical history is relatively straightforward 
(Mahowald and Ettinger, 1990). However, frontal lobe epilepsy can be difficult to 
accurately diagnose. Seizures in frontal lobe epilepsy have a predilection for sleep 
and, in many patients, are entirely restricted to sleep. Nocturnal Frontal Lobe 
Epilepsy (NFLE) occurs sporadically or as an inherited form with an established 
genetic basis (Autosomal Dominant Nocturnal Frontal Lobe Epilepsy, ADNFLE) 
(Scheffer et al., 1995). Mutations in the genes encoding the a4 and p2 subunits of 
the neuronal nicotinic acetylcholine receptor (CHRNA4 and CHRNB2), and more 
recently in the gene coding for the a2 subunit, have been associated with 
ADNFLE (Steinlein et al., 1995; De Fusco et al., 2000; Phillips et al., 2001), 
although such mutations are only identified in a minority of families with this 
condition (Combi et al., 2004). Seizures in NFLE may have bizarre clinical 
features, with vocalisation, complex automatisms and ambulation; investigation 
with electroencephalography and magnetic resonance imaging often shows no 
abnormality (Provini et al., 1999). These characteristics result in frequent 
misdiagnosis, with the events often being labelled as pseudoseizures or 
parasomnias, and some cases previously being designated as ‘paroxysmal 
nocturnal dystonia’ (Scheffer et al., 1994). Such misdiagnoses are clearly to the 
detriment of the patient, who may be denied appropriate treatment.
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Conversely, some parasomnias are violent or dramatic, and may be confused with 
NFLE. While typical parasomnias are usually recognized as benign events, some 
individuals, in whom events are severe or frequent, come to medical attention.
Such subjects present a diagnostic dilemma, and are sometimes incorrectly 
diagnosed with, and treated for, epilepsy. Parasomnias may also cause difficulties 
in the research setting, particularly in genetic studies of ADNFLE. Diagnostic 
accuracy is essential in genetic research, as linkage and molecular genetic studies 
rely upon precise phenotyping. Parasomnias, potential phenocopies of NFLE, are 
common, occurring in up to 15% of the general population (see chapter 10, page 
171 for further discussion), and they may therefore appear in large ADNFLE 
kindreds. Incorrect inclusion of phenocopies, or exclusion of actual cases due to 
misdiagnosis, may result in the failure of linkage or the generation of spurious 
results.
A number of historical features have been described which may distinguish NFLE 
from parasomnias (Provini et al., 1999; Zucconi and Ferini-Strambi, 2000), but the 
value of these features has not been systematically assessed or directly compared 
between the conditions. Moreover, although rigorous scientific studies of NFLE 
have been undertaken, most clinical descriptions of parasomnias are based on 
smallsamples or clinical anecdote. As a result, most authorities recommend video- 
EEG or video EEG-polysomnography (Zucconi and Ferini-Strambi, 2000) for the 
diagnosis of paroxysmal nocturnal events. These investigations involve 
monitoring the patient in sleep through neurophysiological, video, and sometimes 
cardio-respiratory modalities, and recording their nocturnal events. They are 
expensive and inconvenient investigations requiring admission to hospital, and are 
only practical if the nocturnal events are happening on a frequent, preferably 
nightly, basis. In those patients with less frequent events it will often not be 
possible to capture an event during a monitoring period, in which case the 
investigation will not usually clarify the diagnosis. From a practical perspective, 
access to video-EEG and polysomnography monitoring services varies widely in 
different regions, and for many patients these investigations are not readily 
available. In genetic studies, affected individuals (either with ADNFLE or 
parasomnias) may no longer be experiencing events, as both conditions often 
remit in adulthood. In such situations, phenotyping relies entirely on the history.
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In many cases, therefore, the effective standard for diagnosis is the expert clinical 
interview. However, at present the reliability of the history in discriminating 
between NFLE and parasomnias is unclear. Many individual components (such as 
screaming, standing, and complex behaviours) have been reported in both 
conditions (see Chapter 7, pages 133-4 and Chapter 10, pages 185-90, for 
additional discussion) and the relative discriminatory value of such features is 
unclear. There is, therefore, a need to address this issue, and provide an evidence- 
based diagnostic approach for situations in which video-EEG and 
polysomnography are impractical or unhelpful.
Aims and Hypotheses 
Aims:-
To assess the usefulness of historical features in distinguishing nocturnal frontal 
lobe epilepsy from parasomnias, by:
(i) the development and validation of a clinical scale, the Frontal Lobe Epilepsy 
and Parasomnias (FLEP) Scale, based on reported differences between nocturnal 
frontal lobe seizures and parasomnias.
(ii) a direct statistical comparison of historical features in a population of 
individuals with established diagnoses of parasomnias or NFLE.
Hypotheses:
(i) The FLEP scale is a reliable instrument for distinguishing NFLE from 
parasomnias when compared with the clinical current ‘gold standard’ diagnostic 
evaluation (i.e. expert interview and, when necessary, recording of events using 
video EEG monitoring)
(ii) Clear differences are identifiable in the historical features of NFLE and 
parasomnias on statistical analysis
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Methods
Scale Development
The FLEP scale (Figure 12.1) was developed, following review of the literature, 
by an expert panel. This panel comprised Professor Samuel Berkovic 
(neurologist/ epileptologist), Professor Ingrid Scheffer (paediatric neurologist/ 
epileptologist), Dr Murray Johns (sleep physician), Dr Carla Marini (neurologist) 
and the author. The scale consists of a series of specific questions based on the 
clinical features of NFLE and parasomnias. Particular consideration was given to 
the NREM arousal parasomnias such as sleep walking and night terrors, as these 
conditions are most commonly confused with NFLE (Provini et al., 1999; Zucconi 
and Ferini-Strambi, 2000), but the scale was designed to be broadly applicable. 
Questions were designed to address those features which, according to the medical 
literature and in the experience of the clinicians involved, are useful in 
discriminating between the conditions (see Chapter 10, pages 185-190 for detailed 
literature review). A choice of possible responses was assigned to each question, 
each with a score. Responses favouring epilepsy (such as events of brief duration, 
occurring multiple times per night) scored positively, and those favouring 
parasomnias (such as coherent speech without recall) scored negatively. Those 
features considered to be particularly strong indicators of either condition were 
given greater weighting, based on the findings of a pilot study of 18 case histories; 
these 18 cases were not recruited into the formal validation study. The study was 
designed such that the total score, calculated by summing the individual scores on 
completion of the scale, should predict the correct diagnosis - an overall positive 
score should indicate epilepsy, and a zero or negative score should indicate 
parasomnias.
In addition to the clinical scale, a semistructured interview questionnaire was 
designed to form the basis of the telephone interview (see Appendix A for details). 
This included all the clinical features alluded to in the FLEP scale, but also 
included other features which could potentially be observed at different 
frequencies in parasomnias and NFLE.
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Clinical Feature Response Score
Aqe at o n s e t -
At what age did the patient have their first clinical Under 55 years of age 0
event? 55 years or older -1
Duration:-
W hat is the duration of a  typical event? Less than 2 minutes +1
2-10 minutes 0
Longer than 10 minutes -2
Clusterinq:-
What is the typical number of events to occur in a O ne or two events only 0
single night? 3 to 5 events +1
More than 5 events +2
Tlminq:-
At what time of night do the events most commonly Within 30 minutes of sleep onset +1
occur? Other times (including if no d e a r  pattern identified) 0
Semiololgy:-
Are the events associated with a definite aura? Yes +2
No 0
Does the patient ever wander outside the bedroom Yes -2
during the events? No (or uncertain) 0
Does the patient perform complex, directed Yes -2
behaviours (eg picking up objects, dressing) during No (or uncertain) 0
events?
Is there a clear history of prominent dystonic Yes +1
posturing, tonic limb extension or cramping during No (or uncertain) 0
events?
Stereotvov:-
Are the events highly stereotyped or variable in Highly stereotyped +1
nature? Som e variability/ uncertain 0
Highly variable -1
Recall
Does the patient recall the events? Yes, lucid recall +1
No, or vague recollection only 0
V ocalisation:-
Does the patient speak during the events and, if so, is No 0
there subsequent recollection of this speech? Yes, sounds only or single words 0
Yes, coherent speech with incomplete or no recall -2
Yes, coherent speech with recall +2
Total Score
Figure 12. 1. The Frontal Lobe Epilepsy and Parasomnias (FLEP) scale.
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Scale Validation and Statistical Analysis
Inclusion and exclusion criteria. The study population comprised patients who 
had been referred to a sleep physician or neurologist with a history of nocturnal 
events of uncertain cause. Individuals with NFLE were eligible for the study if 
they had a history consistent with NFLE and at least one of the following: video- 
EEG monitoring with clinical or electrographic evidence of nocturnal frontal lobe 
seizures; or a genetic mutation consistent with Autosomal Dominant Nocturnal 
Frontal Lobe Epilepsy (ADNFLE). In families with ADNFLE, no more than two 
family members from the same kindred were recruited. Patients with parasomnias 
were recruited in two subgroups. The first group consisted of subjects who were 
referred to a sleep clinic for diagnosis of their nocturnal events, but in whom a 
definite diagnosis of ‘typical’ parasomnia was made by the specialist on the basis 
of the history and without recourse to video EEG monitoring. This specialist, Dr 
Margot Davey, was an independent sleep paediatrician with extensive experience 
in the diagnosis and management of parasomnias, and was not involved in the 
scale validation process. The second group comprised cases in which there was 
diagnostic uncertainty on the basis of the history alone and in which the diagnosis 
was established by video EEG or video polysomnography (PSG) monitoring. 
These cases were designated ‘atypical’ parasomnias.
Recruitment. Patients with nocturnal events were recruited from four centres in 
Melbourne, Australia (Austin Health, Royal Children’s Hospital, Monash Medical 
Centre and Epworth Hospital). Subjects with NFLE and ‘atypical’ parasomnias 
(confirmed by video EEG/PSG monitoring) were recruited retrospectively from a 
review of existing medical databases and records covering a 10 year period. All 
patients with confirmed diagnoses who could still be contacted were approached 
regarding participation as well as all new cases identified during admission for 
investigation over a two year period. Subjects with ‘typical’ parasomnias were 
recruited as a consecutive case series presenting to a paediatric sleep clinic over a 
two year period. All subjects gave their written informed consent to the study 
protocol, which was approved by the medical ethics committees of the Austin, 
Royal Children’s, Monash and Epworth Hospitals.
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Scale administration. Semi-structured interviews (Appendix A) were conducted 
twice for each subject by different researchers on separate occasions. The two 
interviews were at least four weeks apart. One interviewer was a research 
assistant experienced in taking epilepsy histories, but without medical training. 
The other was the author, a medical practitioner with experience of the diagnosis 
and treatment of sleep disorders and epilepsy. The researchers were blinded to the 
patients’ identities and diagnoses, as well as to each other’s interviews. During 
the interviews, clinical information was obtained from the patient and a witness 
(usually a partner, relative or parent). Participants were reminded at recruitment 
and at the start of each interview not to discuss the nature of any investigations, 
treatment or the diagnosis they had received.
Statistical Analysis -  validation study. For the statistical analysis, the FLEP scale 
was treated as a diagnostic test for NFLE, with a total score of +1 or greater 
indicating a diagnosis of epilepsy, and a score of zero or less indicating 
parasomnias. Sensitivity, specificity and positive and negative predictive values 
were calculated, with 95% confidence intervals. Inter-rater agreement for the 
diagnosis was assessed using Cohen’s Kappa (Cohen, 1960).
Statistical Analysis -  all historical features. In addition to the validation study of 
the FLEP scale, the discriminatory value of each individual historical feature 
identified in the semistructured interview (as recorded by the author) was 
examined between NFLE and NREM arousal parasomnias. Fisher’s exact test 
was applied for categorical variables, and the Mann-Whitney U test was used for 
continuous variables. All statistical tests were performed using SPSS 14.0 
software. As recommended by several authorities (Rothman, 1986; Pemeger, 
1998), no statistical adjustments were made for multiple comparisons, but the 
dataset is presented in its entirety with the results of all comparisons displayed.
To identify the most important individual clinical features in predicting a 
diagnosis of NFLE or parasomnias, multivariate analysis using binary logistic 
regression (forward stepwise selection method) was also performed using 
Statistical Package for Social Sciences (SPSS) 14.0 software.
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Results
Subjects
The study was undertaken between the 1st June 2003 and 1st June 2005. 84 
subjects who met the entry criteria for the study were identified. Twenty-two 
subjects were not contactable or declined to participate in the study, leaving a total 
of 31 participants (15 males) with NFLE, 11 (8 males) with ‘atypical’ parasomnias 
and 20 (12 males) with ‘typical’ parasomnias. All patients with ‘atypical’ 
parasomnias and NFLE had undergone diagnostic video EEG monitoring. The 
specific diagnoses for the participants were: 8 ADNFLE, 23 sporadic NFLE, 29 
NREM arousal disorders (confusional arousals, sleepwalking or sleep terrors) and 
2 REM sleep behaviour disorder (RBD). In the NFLE group, the median age of 
subjects in the study was 18 years (range 1 2 - 7 7  years), and the median age of 
symptom onset was 7 years (range 6 months -  27 years); in the NREM arousal 
parasomnia group the median age of subjects was 9.5 years (range 2 - 5 3  years), 
and the median age of symptom onset was 4 years (range 6 months -  16 years); 
and in the RBD group the median age in the study was 69.1 years (range 62 -  77 
years) with a median age at onset of 64.0 years (range 55 -  73 years).
Validation Study (FLEP scale)
There was almost perfect inter-rater agreement in diagnosis based on the FLEP 
scale, with a Kappa statistic of 0.97.
The median FLEP score for the NFLE group was +5 (range +1 to +11). The 
median score for the complete parasomnia group was -4 (range -12 to +3); for the 
‘typical’ parasomnias it was -4 (range -9 to -1) and for the ‘atypical’ parasomnias - 
4 (range -12 to +3). The distribution of scores according to diagnosis is given in 
Figure 12.2.
For interviewer 1 (non-medically trained), sensitivity was 1.00 (95% Cl 0.86 -
1.00), specificity was 0.90 (95% Cl 0.73 - 0.97), positive predictive value was 
0.91 (95% Cl 0.75 - 0.97), and negative predictive value was 1.00 (95% Cl 0.85 -
1.00). For interviewer 2 (medically trained), sensitivity was 1.00 (95% Cl 0.86 -
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FLEP Score
F&rasomnias vs NFLE
Diagnosis
□  Parasomnia 
■  NFLE
Bars showcouts
-10 .00  -5.00 0 .0 0  5 .00  10.00
FLEP Score
Figure 12. 2. Frequencies o f FLEP scores generated by the non-medically trained 
interviewer, colour coded according to actual diagnosis. Of the 62 patients 
interviewed, a total o f 3 were incorrectly diagnosed using the scale; these were all 
parasomnias who generated low positive scores. The graph generated by the medically 
trained interviewer is very similar, but with only 2 misdiagnoses.
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1.00), specificity was 0.93 (95% Cl 0.79 - 0.98), positive predictive value was 
0.94 (95% Cl 0.78 - 0.98) and negative predictive value was 1.00 (95% Cl 0.85 -
1.00).
Statistical Analysis
The relative frequencies of the individual historical features recorded in the NFLE 
and NREM arousal parasomnia groups are summarised in Tables 12.1 and 12.2, 
and ordered according to statistical significance. Categorical variables, with the 
results of Fisher’s exact test, are displayed on Table 12.1. Continuous variables, 
evaluated using the Mann Whitney U test, are displayed in Table 12.2.
From this data, the features reported significantly more often in NFLE compared 
to parasomnias were aura, stiffening or abnormal postures, lucid recollection of 
events, events in the first 30 minutes of the sleep period, tongue biting or 
incontinence, fatigue the following day, stereotypy and clustering of events. 
However, all these features (with the exception of tongue biting and lucid recall of 
events) were also seen in some individuals with parasomnias.
The features reported significantly more frequently in parasomnias were coherent 
speech, wandering outside the bedroom, complex directed behaviours and timing 
of events in the first third of sleep (but after the first 30 minutes). Again, however, 
all these features were seen in a proportion of individuals in NFLE; none occurred 
exclusively in parasomnias.
Several features were frequently reported in both conditions. In particular, clear 
trigger factors (usually stress, sleep deprivation or intercurrent illness), shouting or 
screaming, and a family history of nocturnal events were commonly described in 
both. A vague recollection of episodes was less common but reported at similar 
frequencies in both disorders.
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Historical feature
%age of 
parasomnias 
(28 cases)
%age of NFLE 
(31 cases)
Aura
Stiffening/ abnormal postures
Lucid recall of episodes
Events in first 30 minutes of sleep
Fatigued next day
Tongue biting
Stereotypy
Clustering
Incontinence
4%
18%
0%
7%
32%
0%
57%
21%
4%
45%
77%
52%
55%
81%
35%
90%
58%
29%
P
value
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.006
0.007
0.013
Anytime/ no pattern 11% 26% 0.11
Triggers to events (stress/ illness etc) 61% 81% 0.15
Recall of coherent speech 4% 16% 0.20
Psychiatric or behavioural problems 11% 16% 0.71
Developmental delay 7% 11% 1.00
Vague recollection of episodes 25% 19% 0.76
Family history of nocturnal events 57% 42% 0.30
Shouting/ screaming 75% 58% 0.27
Coherent speech 71% 26% 0.001
Complex directed behaviours 45% 7% 0.001
Wandering outside the bedroom 75 26 <0.001
Events in first 1/3 of night (not first 30
minutes) 82% 19% <0.001
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Table 12. 1. Categorical variables recorded from the semistructured interview o f 
subjects with parasomnias or NFLE, and ranked according to the statistical 
significance o f the difference between the groups. Statistical comparison is made 
using Fisher's exact test. Shaded variables are those which reach statistical 
significance (threshold p < 0.05).
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Mean for Mean for t p
Historical feature parasom nias  NFLE statistic value
____________________________________ (28 cases)  (31 cases)__________________
Max number of events per 'attack night' 2.5 15 5.2 <0.001
Typical number of events per 'event night' 1.25 6 4.7 <0.001
Maximum duration witnessed (minutes) 14.6 1.7 -5.3 <0.001
Typical duration witnessed (minutes) 7.5 0.9 -4.9 <0.001
Age at onset (years) 4.9 8.1 2.48 0.02
Typical number of 'attack nights' per 
month 11.8 16.5 1.83 0.08
Table 12. 2. Continous variables recorded from the semistructured interview o f subjects with 
parasomnias or NFLE, and ranked according to the statistical significance o f the difference 
between the groups. Statistical comparison is made using the Mann-Whitney U test. Shaded 
variables are those which reach statistical significance (threshold p < 0.05).
Clinical Feature B
Wald x 
value
P
value
odds
ratio
Odds ratio 95% Cl
Lower Upper
First 1/3 of sleep (not first 30 
minutes) -3.92 10.3 0.001 0.02 0.006 0.201
Aura 3.36 7.6 0.006 27.5 2.6 291.5
Wandering outside the bedroom -3.13 6.8 0.009 0.04 0.004 0.464
Table 12. 3. Results o f the multivariate analysis, showing the significant variables identified 
through stepwise logistic regression ranked according to the statistical significance. The table 
shows the logistic regression coefficient (B), odds ratio and Wald yf value for each o f the 
predictor variables.
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Table 12.3 shows the logistic regression coefficient, Wald test and odds ratio for 
the significant variables included in the model generated by the stepwise logistic 
regression analysis. The presence of an aura was the most significant positive 
indicator of epilepsy; wandering outside the bedroom and a typical onset in the 
first third of the sleep period (but after the first half hour) were significant 
predictors of parasomnias. Other variables, although significant in the univariate 
analysis, did not reach statistical significance in the multivariate analysis.
The odds ratios from the logistic regression analysis indicate that the odds of a 
history of aura are 27.5 times greater in the NFLE group than parasomnias, the 
odds of a history of wandering outside the bedroom are 25 times greater in 
parasomnias than epilepsy, and the odds of a typical onset in the first third of sleep 
(but after the first 30 minutes) in parasomnias are 50 times those in NFLE. 
However, the confidence intervals for these values are very wide (Table 12.3).
A test of the model arising from the stepwise logistic regression analysis, using the 
three statistically significant variables (aura, wandering out of the bedroom and 
onset in the first third of sleep), was statistically significant at (p<0.001) when 
compared to one with intercept only. With this data, the model has an overall 
diagnostic success rate of 93% (NFLE is diagnosed with a sensitivity of .90 [95% 
Cl 0.73-0.97] and a specificity of 0.96 [95% Cl 0.79-0.99]).
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Discussion 
Principal findings
Paroxysmal events in sleep can pose a significant diagnostic challenge in both 
clinical practice and genetic research. While a number of conditions are 
associated with motor activity in sleep, particular confusion can arise when trying 
to differentiate between NREM arousal parasomnias and NFLE. This confusion 
arises through the similarities in the clinical presentation of these conditions, and 
the fact that in both conditions investigation with MRI and interictal EEG is often 
normal (Zucconi et al., 1997; Provini et al., 1999). While potential differences in 
the historical features of these conditions have previously been reported (Provini 
et al., 1999; Zucconi and Ferini-Strambi, 2000), their usefulness has not 
previously been systematically examined. Although the studies of NFLE which 
led to the identification of these features are thorough, the comparisons themselves 
are largely anecdotal, and contain limited direct study of parasomnias. Reported 
differences are usually couched in terms of ‘red flags’; in other words, as features 
which should raise the clinical suspicion of epilepsy as a prelude to video EEG 
monitoring. This investigation is currently considered essential to confirm a 
diagnosis of NFLE or troublesome parasomnias. (Provini et al., 1999; Zucconi and 
Ferini-Strambi, 2000). In this study, however, by examining a sample of 
individuals referred to tertiary centres with nocturnal events, we have confirmed 
clear differences in the presenting features of these conditions. More significantly, 
we have also shown that historical features are usually sufficient to reliably make 
a diagnosis of NFLE or parasomnias without confirmatory video EEG monitoring, 
even in atypical cases. If a careful history is taken, and weighted appropriately, 
the correct diagnosis will be reached in almost 95% of cases.
The FLEP scale has been shown to be a valid and reliable instrument for 
facilitating the diagnostic process and may, therefore, be a useful tool particularly 
for clinicians with limited direct experience with nocturnal frontal lobe epilepsy. 
The sensitivity of 1 and specificity of 0.9 is good for a test of this kind, and a 
Cohen’s Kappa of 0.97 indicates almost perfect inter-rater reliability. While both
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individuals conducting the interviews had some experience in taking epilepsy 
histories, the fact that the scores of the physician and the research assistant (who is 
not medically trained) were very similar suggests that specialist epileptological or 
sleep training is not required to reliably use the scale.
The examination of individual clinical features was largely concordant with 
existing reported differences, with a couple of notable exceptions. Stereotypy, 
which is widely cited as strongly suggestive of NFLE (Provini et al., 1999; 
Zucconi and Ferini-Strambi, 2000), was reported in over half the parasomnia 
group suggesting that this feature is not very useful from a diagnostic perspective. 
Trigger factors (such as fatigue or stress) have previously been reported as more 
common in parasomnias than NFLE (Provini et al., 1999), this was not bom out in 
our findings. Other previously reported features, however (such as increased 
frequency, brief duration, presence of aura and clustering in NFLE, and onset in 
the first third of sleep and complex directed behaviour in parasomnias), were 
reported at different rates in the NFLE and parasomnias.
It is remarkable, however, that very few features were reported exclusively in one 
condition. Tongue biting was never reported in parasomnias, but was also not 
particularly common in NFLE (although 35% of the NFLE reported tongue biting 
on at least one occasion, it was usually an infrequent manifestation of their 
seizures). Lucid recall in at least a proportion of events was a relatively common 
feature in the NFLE group, and was never reported in parasomnias (although 
vague recall was common in both groups). Apart from these two features, 
however, all the others were reported by subjects in both groups, albeit at different 
frequencies. This finding underlines the diagnostic difficulty facing clinicians in 
this situation -  no individual clinical feature can be claimed to be a truly reliable 
indicator of either condition.
The result of the logistic regression analysis indicates that three features have the 
greatest predictive value in this situation. The single most important 
discriminatory variable favouring a diagnosis of epilepsy is aura, which was
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present in almost half the NFLE series; occurrence in the first third of sleep (but 
not in the first half hour), and wandering out of the bedroom during some or all 
events, were both strongly predictive of parasomnias. The odds ratio for each of 
the three significant variables in the logistic regression analysis was very large, 
and possibly greater than might be expected. However, the very wide confidence 
intervals indicate that precision of these values is quite low. These confidence 
intervals are likely to be primarily a result of the sample size, which is relatively 
small for a multivariate analysis of this type, but there is also some collinearity 
between the variables examined. Thus while it can be stated with confidence that 
aura, wandering out of the bedroom, and occurrence in the first third of the sleep 
period (but after the first 30 minutes) are significant predictor variables in the 
diagnosis of NFLE or parasomnias, the precise magnitude of their predictive value 
is less clear. Other features, such as lucid recall of events and stiffening or 
posturing during episodes, while highly significant in the univariate analysis, did 
not significantly contribute to the accuracy of the multivariate model.
Overall, our data indicates that when the features of the history are taken in 
combination and weighted appropriately, a correct diagnosis will usually be made. 
This is useful, as it enables greater diagnostic confidence in situations when video 
EEG monitoring is unhelpful or not feasible.
Methodological Considerations
The main weakness of the study is the retrospective nature of recruitment for the 
monitored group of patients. These factors reflect the fact that nocturnal frontal 
lobe epilepsy is not common, and parasomnias, although reported in around 15% 
of the pediatric population (Agargun et al., 2004), are usually mild and do not 
require tertiary referral for diagnosis and management. In the group of severely 
affected patients, recording events during video EEG monitoring may still be 
difficult or impossible due to the unpredictable nature of the attacks. In view of 
the relatively small numbers of patients with confirmed video monitoring findings 
per year, it was not practical to administer the FLEP scale prospectively (i.e. 
before the diagnosis was confirmed by video monitoring).
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A further potential criticism relates to the absence of confirmatory video EEG 
monitoring in the consecutive series of ‘typical’ parasomnias. The NREM arousal 
parasomnias (which cause most diagnostic confusion with respect to NFLE) are 
benign, quasiphysiological disorders which are notoriously difficult to capture on 
video EEG monitoring. Their occurrence is markedly influenced by sleeping 
environment, a finding that has been described in previous studies (Gastaut, 1965; 
Jacobson et al., 1965; Joncas et al., 2002), and often emerges in individual case 
histories. Thus, although from a scientific perspective such supportive data would 
be desirable, in reality obtaining it is impractical. If a secure diagnosis of 
parasomnias has been made by an expert on the basis of the history it is rarely 
justified, clinically or economically, to admit a child for prolonged monitoring, 
particularly as the investigation will often be fruitless.
It could, then, be argued that only the ‘atypical’ parasomnia group with 
confirmatory video EEG monitoring should have been included in the study, in 
order to make the diagnostic criteria as robust as possible. However, to have used 
such a methodology would have potentially distorted the findings; only patients 
with unusual and frequent parasomnias, in which there had been a very high 
suspicion of epilepsy, would have been included. While it was clearly vital to 
include such cases, as they are the most difficult to diagnose, it was also important 
to address the full clinical spectrum of parasomnias. We therefore included 
subjects in the ‘typical’ parasomnia group without video EEG data, but in the 
‘atypical’ group (in whom the diagnosis was regarded as uncertain), video EEG 
monitoring confirmation of the diagnosis was mandatory. It is worth reiterating at 
this point that all subjects in the NFLE group (in addition to the ‘atypical’ 
parasomnia group) had been fully investigated, with confirmatory video EEG 
monitoring in all cases.
Use of the scale
Using the clinical features we have identified in the FLEP scale, an accurate 
assessment of the likelihood of epilepsy may be made at the initial consultation, 
even when the clinician has limited experience with these conditions. Appropriate
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reassurance and management strategies may be given to those individuals with 
parasomnias, avoiding the need for specialist referrals and unnecessary anxiety 
and expense. Likewise, prompt investigation and management will be possible in 
those individuals with epilepsy. In ADNFLE genetic linkage studies, the scale 
may be used as a guide to the inclusion or exclusion of uncertain cases in whom 
video EEG monitoring is not possible.
From a practical perspective, there was a small degree of overlap in the FLEP 
scores for the two groups. We would conclude that, on the basis of this study, any 
patient with a score of zero or less is very unlikely to have epilepsy, and any score 
of greater than +3 is very likely to have epilepsy. In those with a score of + 1 to 
+3, there is a relatively high chance of epilepsy, but further investigation would be 
desirable in these individuals; however, in our sample such subjects made up less 
than 20% of the total group.
While the reality of this difficult clinical problem is that some patients will always 
need confirmatory video EEG monitoring, an increased understanding of 
important discriminators in the history may reduce this need, as well as increasing 
diagnostic confidence in situations when the recording of events is not possible.
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CHAPTER 13
THE NREM AROUSAL PARASOMNIAS: ANALYSIS 
OF ELECTROCLINIC AL FEATURES AND 
COMPARISON WITH NOCTURNAL FRONTAL LOBE
EPILEPSY
Introduction.
Parasomnias are divided on the basis of phenomenology into three subgroups: 
disorders of arousal from NREM sleep, parasomnias usually associated with REM 
sleep, and others (ASDA, 2005). The NREM arousal disorders are characterised 
by paroxysmal behaviours without conscious awareness, usually arising from 
stage 3 or 4 NREM sleep, and have a broad spectrum of clinical manifestations.
In practice they are subdivided into three main forms, although common 
underlying mechanisms are believed to be responsible. Confusional arousals are 
associated with little motor or autonomic involvement; somnambulism 
(sleepwalking), is associated with motor activity but little autonomic involvement; 
and sleep terrors (pavor nocturnus), involve prominent autonomic involvement 
accompanied by a variable degree of motor activity (Mahowald, 2002; ASDA, 
2005). While the diagnosis of these conditions is often straightforward, some 
individuals present with frequent, severe or unusual episodes which raise the 
suspicion of epilepsy. Of particular concern is nocturnal frontal lobe epilepsy 
(NFLE), which also presents with varied and sometimes bizarre motor, vocal and 
behavioural manifestations from sleep (Montagna, 1992; Provini et al., 1999; 
Provini et al., 2000). As demonstrated in Chapter 12, distinguishing between 
parasomnias and NFLE on historical grounds is often possible but can sometimes 
be difficult. Challenging cases usually require the recording of events with video 
EEG monitoring; however, the situation is complicated by the fact that interictal 
and ictal EEG are frequently unremarkable or non-diagnostic in both parasomnias 
and NFLE (Provini et al., 1999; Zucconi and Ferini-Strambi, 2000), and the 
diagnosis is therefore often based primarily on ictal characteristics of the events as 
recorded on video. The semiology of frontal lobe seizures, and those occurring in 
NFLE in particular, have been established over the last 20 years (Williamson et 
al., 1985; Waterman et al., 1987; Salanova et al., 1995; Provini et al., 1999).
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However, the ictal semiology of the NREM arousal parasomnias has not been 
studied in detail. Initial neurophysiological studies of the parasomnias contained 
general descriptions of event types, but were conducted in the pre video EEG 
monitoring era, and also predated the recognition of NFLE (Gastaut, 1965; 
Jacobson et al., 1965; Broughton, 1968). Subsequent reports of parasomnias 
contain very limited semiological information (Kavey et al., 1990; Zucconi and 
Ferini-Strambi, 2000), and few centres report direct experience of them. 
Therefore, although the broad behavioural characteristics of parasomnias are 
widely accepted, surprisingly little is known regarding the details of their ictal 
manifestations.
As a result of the paucity of information regarding parasomnias, distinguishing 
them from NFLE on video EEG monitoring may be difficult. In practice it is 
often a ‘negative’ process, based upon the absence of clear features of epilepsy, 
rather than on the identification of ‘positive’ features of parasomnias. Diagnostic 
uncertainty may remain even after events have been recorded. Moreover, 
although EEG findings in parasomnias are usually unhelpful, in some cases they 
may be misleading. Incidental interictal epileptiform discharges such as 
centrotemporal spikes, and normal arousal patterns such as rhythmic frontal 
rhythmic theta and delta activity may lead the clinician into towards an erroneous 
diagnosis of epilepsy.
In order to improve diagnostic certainty, more detailed descriptions of 
parasomnias are required. In this study a video EEG monitoring series of NREM 
arousal parasomnias was compiled to address this issue and provide an evidence- 
based approach to diagnosis.
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Aims
The aims of this study were firstly to accurately describe the semiological and 
electrographic features of NREM arousal parasomnias; and secondly, to directly 
compare these features with those of NFLE.
Hypotheses
(i) Parasomnias have distinct, identifiable, semiological features and behaviour 
patterns.
(ii) Parasomnias and NFLE have different clinical presentations, identifiable 
through statistical analysis of elemental clinical features.
Methods.
Subjects
Parasomnia cases were recruited from three epilepsy monitoring centres (National 
Hospital for Neurology and Neurosurgery, Queen Square, London; Austin 
Hospital, Melbourne, Australia; and the Royal Children’s Hospital, Melbourne, 
Australia); NFLE cases were from the Austin Hospital, Melbourne. In both 
groups the diagnosis was made on the basis of historical, imaging and EEG 
findings. Detailed histories were obtained through a review of clinical records and 
direct interviews with the subject and witnesses. All subjects interviewed for the 
purposes of the study gave full informed consent. In all cases, individuals had 
been admitted for diagnostic video EEG monitoring for troublesome nocturnal 
events of uncertain aetiology, and at least one sleep-related event containing some 
or all the components of a habitual attack, with full video and EEG data, had been 
recorded.
In view of the potential problems in accurate diagnosis of NREM parasomnias, 
which have no ‘gold standard’ diagnostic test, rigorous inclusion and exclusion 
criteria were applied to both the parasomnia group and the NFLE comparison 
group. Subjects with parasomnias were included only if (i) the history was 
consistent with a diagnosis of parasomnias according to the FLEP scale (see
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Chapter 12), and (ii) there was consensus agreement regarding the diagnosis by all 
clinicians involved in the patient’s management (neurophysiologists and 
neurologists with experience in sleep disorders and epilepsy), following review of 
the history and all investigations. Subjects were excluded if any diagnostic 
uncertainty remained despite the recording of events, or if there was any clinical 
evidence of epilepsy, specifically (i) any history of paroxysmal events suggestive 
of seizures (other than the nocturnal events under investigation), (ii) epileptiform 
abnormalities on interical or ictal EEG, or (iii) potentially epileptogenic lesions on 
neuroimaging. It is recognised that these criteria excluded parasomnia patients 
with known epilepsy.
A comparison group of ‘pure’ NFLE subjects was acquired for parallel analysis of 
semiological and EEG features. Subjects were included in this NFLE comparison 
group only if they fulfilled the following criteria: (i) the history was compatible 
with a diagnosis of nocturnal frontal lobe epilepsy according to the FLEP scale;
(ii) there was consensus agreement regarding the diagnosis by the clinicians 
involved in the patient’s management (neurophysiologists and neurologists with 
experience in sleep disorders and epilepsy), following review of the history and all 
investigations; (iii) at least one of the following biological correlates was present: 
a potentially epileptogenic frontal lobe lesion on neuroimaging (14% of cases); an 
established diagnosis of autosomal dominant nocturnal frontal lobe epilepsy 
(ADNFLE) with a proven genetic mutation (14% of cases); a recruiting ictal 
rhythm (comprising rhythmic fast, sharp or spike wave activity) on EEG during 
the episodes (38% of cases); or an ictal SPECT scan demonstrating prominent 
focal frontal hyperperfusion (43% of cases). NFLE (as opposed to frontal lobe 
epilepsy per se) was only diagnosed if at least 90% of the subject’s seizures arose 
from sleep on the basis of both historical and video EEG monitoring findings. 
Subjects were excluded if they had either habitual convulsive or diurnal seizures, 
as such presentations do not cause diagnostic confusion with parasomnias.
Video EEG monitoring
In all parasomnia and NFLE subjects, simultaneous video and EEG data were 
acquired during the subject’s nocturnal events. Video data were captured using
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either digital or analogue video cameras; digital or paper EEG was recorded using 
a minimum of 21 electrodes placed according to the International 10-20 system, 
with simultaneous single channel ECG. In some patients, data from additional 
EEG channels, chin EMG and EOG were also recorded.
Ictal EEG findings were categorised as: no change; artefact; partial arousal to 
lighter sleep; arousal to awake pattern EEG; dissociative pattern (posterior 
dominant rhythm plus sleep patterns such as theta or delta activity, sleep spindles 
or vertex sharp waves seen simultaneously); rhythmic slow activity (non­
epileptiform); ictal recruiting rhythm; epileptiform ictal discharges (comprising 
rhythmic sharp or spike wave activity); and other. These ictal EEG categories 
were not mutually exclusive (i.e. one event could show more than one pattern).
The video EEG monitoring data for each event were reviewed and detailed 
descriptions recorded. The presence or absence of 68 elemental clinical features 
was recorded, using a similar approach to that used previously in the analysis of 
seizure semiology (Manford, 1996; Kotagal et al., 2003). The features included in 
the analysis were initially generated following analysis of the literature and 
through clinical experience of the authors, and modified following a pilot study of 
9 subjects. These were grouped into the following categories: respiratory; 
autonomic; simple motor (head, upper limbs, lower limbs, trunk); complex motor 
(facial, upper limbs, lower limbs); vocal; and others.
The video EEG monitoring recordings were each reviewed and analysed by two 
observers (the author with Dr Simon Harvey or Dr Matthew Walker). The 
reviewers were not blinded to the diagnosis, as the study was not designed as a test 
of diagnostic accuracy. Rather, parasomnias were examined in batch, followed by 
the NFLE group, to facilitate the reviewers’ recognition of common features 
including behaviours not usually assessed in seizure analysis. As some subjects in 
the NFLE group had large numbers of events recorded, with the potential to distort 
a quantitative analysis, a maximum of three seizures per subject were analysed in 
this group. In patients with more than three recorded seizures, data from the first 
three clearly recorded seizures only were included in the study.
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In addition to the video and EEG features, the number of events in total and the 
maximum number of events per night were recorded for each subject. For each 
event, the duration of the episode, as well as the duration of any arousal 
behaviours preceding the major motor behaviour, was recorded. In view of the 
fact that parasomnias are often said to be ameliorated by sleeping in unfamiliar 
environments (Jacobson et al., 1965; Joncas et al., 2002), the proportion of 
individuals in each group in whom events occurred on the first night of monitoring 
was documented.
Statistical Analysis
Elemental clinical features. For the elemental clinical features, data for a binary 
outcome (parasomnias or NFLE) were analysed using logistic regression. For 
each subject, the number of events was the denominator and the number of events 
showing the feature of interest was the numerator. This ensured statistical 
independence between the observations analysed, effectively generating a single 
observation for each subject irrespective of the number of events recorded. The 
explanatory variable fitted by this analysis was diagnosis (i.e. NFLE or 
parasomnia); the test of significance gave a p-value for the strength of the 
association between the feature and diagnosis, and the odds ratio indicated the 
direction of the association.
For some variables, one group did not display a particular feature in any events. 
Logistic regression fails for these variables, since it relies on large sample 
approximations in which the estimated odds ratios are neither zero nor infinity. In 
such cases, the association between the group and the feature of interest was 
analysed by recording whether a subject showed the feature of interest in any 
event, and then using Fisher’s exact test to compare between NFLE and 
parasomnias. As for logistic regression, this approach assesses the strength of 
association at the “subject” level, not the “event” level, preserving statistical 
independence between the observations.
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For the continuous variables (e.g. time to major motor behaviour, duration of 
event etc), median values were obtained for each subject. The means were 
compared between NFLE and parasomnia groups using the Mann-Whitney U test.
As recommended by several authorities (Rothman, 1986; Pemeger, 1998), no 
statistical adjustments were made for multiple comparisons in these analyses, but 
the dataset is presented in its entirety with the results of all comparisons displayed.
Cluster analysis and decision tree. To identify the natural grouping of NFLE 
seizures and parasomnias according to their elemental clinical features, and to 
examine the degree of overlap between them, statistical cluster analysis was 
performed on the 120 events from the video EEG/ polysomnography data, based 
on the presence or absence of the elemental features (Table 1). The analysis was 
performed on Statistical Package for Social Sciences (SPSS) software using 
Ward’s method with Euclidean squared distance measurements; this is a 
hierarchical cluster technique which has previously been adopted in studies of 
seizure semiology (Manford, 1996). Internal validation was undertaken using a k- 
means cluster analysis, an alternative, non-hierarchical cluster analysis technique.
Using the individual elemental clinical features identified from the video 
recordings of each event, a model for classification was generated using the 
exhaustive CHAID decision tree algorithm (Biggs, 1991) performed with the 
Statistical Package for Social Sciences (SPSS) Answer Tree 3.0 software.
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Results
Video EEG monitoring data from 120 nocturnal events in 44 patients were 
studied. The study group comprised 57 NREM parasomnias from 23 subjects (14 
males) and the comparison group comprised 63 NFLE seizures from 21 subjects 
(13 males). The median age of onset for parasomnias was 8.5 years (range 1.5 - 
39 years) and for NFLE was 7.0 years (range 0.5 - 34 years). Median age at the 
time of video monitoring was 12 years (range 4 - 6 9  years) for the NREM 
parasomnia group and 21 years for the NFLE groups (range 3 - 38 years). Fifteen 
of the 23 parasomnia cases and 10 of the 21 NFLE subjects were children (under 
18 years).
Individuals in the parasomnia group had a median of two events in total during the 
monitoring period, compared to 8 for NFLE subjects (p<0.001); the median 
duration of monitoring was 3.5 nights. 42% of parasomnia subjects had events on 
the first night of monitoring compared to 76% of NFLE subjects (p=0.03).
The median maximum number of events recorded per night was 2 (range 1-5) in 
the parasomnia group and 7 (range 1-10) in the NFLE group (p<0.001). Median 
event duration was significantly longer in the parasomnia group (60 seconds, 
range 11 seconds - 14 minutes) than the NFLE group (37 seconds, range 9 - 1 2 5  
seconds; p<0.001). 27% of parasomnias lasted over two minutes; 44% lasted less 
than a minute. In NFLE, the historical accounts of individuals’ seizures were very 
similar to recorded events in terms of both attack duration and component 
features. This contrasted with parasomnias, in which monitored events were often 
shorter and less elaborate than those described in the history.
Both parasomnias and seizures arose exclusively from NREM sleep. Seizures 
tended to be from lighter stages (9% stage 1, 79% stage 2 and 13% stage 3) in 
comparison to parasomnias (all from stage 3 or 4). Definitive ictal thythms were 
seen in 38% of NFLE subjects, although this figure may be artificially high due to 
our incusion criteria (see Methods). In 52% of individuals with parasomnias, 
light sleep patterns (vertex waves, sleep spindles and theta activity) were seen at 
some point during events; in a subgroup of these (27% of cases) evidence of state
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dissociation was seen at some point, with posterior dominant alpha rhythm 
suggestive of resting wakefulness in posterior electrodes but anterior theta activity, 
sometimes with vertex waves or spindles, consistent with light sleep (Figure 13.1). 
These findings were not seen in NFLE seizures.
Other findings showed considerable overlap between NFLE and parasomnias, and 
did not significantly favour one condition or the other. Muscle and movement 
artefact were prominent in both, in some cases obscuring cerebral rhythms; 
rhythmic non-epileptiform theta or delta activity over the anterior quadrants was 
commonly observed in both conditions (61% parasomnias, 52% NFLE; p=0.36); 
diffuse attenuation in EEG amplitude, a manifestation of seizure onset or state 
change, was also seen frequently in both groups (43%NFLE, 39% parasomnias; 
p=0.64).
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F ig u re  13. 1 EEG (transverse m ontage) during a prolonged parasomnia, showing a dissociation  
pattern; a clear alpha rhythm is seen in posterior channels consistent with the subject s posterior  
dominant rhythm, with anterior and midline theta activity and vertex sharp waves consistent with 
light NREM sleep .Tim escale is 1 page  = 10 seconds.
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1. Statistical analysis
Elemental clinical features. The frequencies of individual elemental clinical 
features in parasomnias and NFLE are summarised in Table 13.1, along with 
comparative statistics. The features that most strongly favoured a diagnosis of 
parasomnias were crying or sobbing, a waxing and waning quality, modification 
of the event by individuals in attendance, coherent speech in sentences, and 
normal arousal behaviours such as face and nose rubbing, scratching and rolling 
over in bed. In contrast, bicycling movements, thrashing, grunting, grimacing and 
dystonic posturing, all common in NFLE, were very infrequent in parasomnias.
Cluster analysis and decision tree. Ward’s cluster analysis generated two major 
groups of event from the 120 individual episodes examined. These groups were 
identified through visual inspection of the dendrogram output of the analysis, and 
through graphical examination of the cluster coefficient against cluster number; 
while the gradient of this plot increased gradually with decreasing cluster 
numbers, it increased substantially when the number of clusters fell from two to 
one, suggesting the correct number of natural clusters was two. Internal validation 
using k-means analysis was subsequently performed for two clusters; there was 
97% concordance in the clustering of cases using these two techniques. The two 
major clusters identified corresponded to an NFLE group and a parasomnia group. 
Overall, 91% of events were correctly classified using Ward’s method, (90% using 
the k-means cluster technique). Using the Ward method, within the NFLE cluster 
98% of events were true NFLE seizures (96% using k-means analysis); within the 
parasomnia cluster, 85% were true parasomnias (84% using k-means analysis).
The diagnostic classification tree, based on the video features of events only, is 
shown in Figure 13.2. In our dataset this algorithm correctly classified 113 of 120 
(94%) nocturnal events. The model therefore has a 6% misclassification risk (SE= 
0 .02).
As the elemental clinical features alone do not adequately portray the semiology 
of parasomnias, a detailed description is provided below, comprising details of 
event onset, evolution, and offset, followed by a summary of the fundamental
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Clinical Feature %age of %age of Wald x2 odds p
NFLE parasomnia B statistic ratio value* 
------------------------------------------------------------------------------------ S m lS --------- events_______________________________________
scratching 2% 23% 2.9 7.6 18 <0.001
crying or sobbing 2% 21% 2.8 7.0 16 <0.001
waxing and waning quality 0% 39% n/a n/a n/a <0.001
‘settling* behaviours after episode (adjusting position etc) 32% 85% 2.6 30 13 <0.001
event modified by people in the room (ended/ exacerbated) 4% 35% 2.4 13 11 <0.001
verbal interaction with individuals in attendance 4% 35% 2.1 13 8.0 <0.001
rubbing (nose or face) 25% 70% 1.9 22 6.9 <0.001
coherent speech (sentences of more than 2 words) 5% 32% 1.9 11 6.8 <0.001
periods of motionless staring 22% 60% 1.6 16 5 2 <0.001
rolling over in bed 11% 39% 1.6 11 5.0 <0.001
pleading behaviours and speech 2% 18% 2.6 5.8 13 0.001
mumbling/ incoherent speech or single words 7% 30% 1.8 9.6 6.2 0.001
manipulation of objects or clothing 16% 42% 1.4 9.5 3.9 0.001
coughing 2% 16% 2.5 5.2 12 0.003
myoclonic jerks 2% 12% 2.2 4.0 8.7 0.01
moaning or groaning 8% 25% 1.3 2.4 3.8 0.01
clear external environmental trigger (e.g.noise) 6% 21% 1.3 5.0 3.9 0.01
physical interaction with people 11% 30% 1.2 6.1 3.4 0.01
looking around 49% 72% 1.0 6.3 2.7 0.01
rubbing body or limbs (not face) 6% 21% 1.4 5.0 3.9 0.02
yawning 0% 19% n/a n/a n/a 0.02
physical interaction with objects 11% 30% 0.83 4.5 2.3 0.03
kneeling 3% 12% 1.5 3.1 4.2 0.05
chewing 6% 18% 1.1 3.4 3.1 0.05
sitting up 46% 65% 0.61 3.0 1.9 0.08
axial flexion (any) 63% 77% 0.67 2.6 2.0 0.1
shouting 6% 14% 0.88 1.9 2.4 0 2
tremor or trembling/ shivering 3% 9% 1.1 1.6 2.9 0.2
sighing 0% 9% n/a n/a n/a 0.2
pelvic thrusting movements 5% 10% 0.86 1.4 2.4 0.2
clonic jerking 12% 0% n/a n/a n/a 0.2
complex and directed behaviours 19% 28% 0.51 1.4 1.7 0.2
stiffening (not dystonic -  includes stretching) 51% 40% -0.42 1.2 0.7 0.3
trunk hyperextension 7% 3% -0.83 0.90 2.3 0.3
wiggling/ wriggling, lower limb 44% 51% -0.3 0.66 0.7 0.4
wiggling/ wriggling, upper limb 65% 57% 0.26 0.49 1.3 0.5
foot stamping 2% 4% 0.81 0.44 2.3 0.5
holding/ hugging (people or objects) 20% 15% -0.33 0.46 0.7 0.5
head elevation 75% 79% -0.24 0.31 1.3 0.5
screaming 10% 12% -0.28 0.23 1.3 0.6
sad/ unhappy expression 20% 18% -0.20 0.19 0.81 0.7
fearful expression 43% 46% -0.11 0.09 1.1 0.8
searching behaviours 19% 21% -1.3 0.07 1.1 0.8
walking 3% 2% -0.61 0.24 0.51 0.6
standing 10% 5% -0.64 0.76 0.49 0.4
head nodding 5% 2% -1 0.80 0.40 0.4
agitated quality to event 67% 56% -0.44 1.4 0.61 0.2
swallowing 0% 7% n/a n/a n/a 0.2
punching or hitting 10% 4% -1.1 1.6 0.40 0.2
head shaking 13% 5% -0.96 1.9 0.41 0.2
highly repetitive behaviours within an event 44% 26% -0.81 4.2 0.50 0.04
apnoea/ stopped breathing 29% 0% n/a n/a n/a 0.02
marked asymmetry 27% 0% n/a n/a n/a 0.02
writhing or choreoathetoid movements 29% 0% n/a n/a n/a 0.02
eyes open during episode 97% 84% -1.7 4.7 0.2 0.01
head version 22% 0% n/a n/a n/a 0.004
no change from onset position 46% 19% -1.2 9.2 0.30 0.002
axial twisting movements 36% 11% -1.6 9.9 0.20 0.001
dystonic stiffening/ posturing 49% 0% n/a n/a n/a <0.001
kicking 29% 5% -2.0 9.1 0.14 <0.001
hyperventilation 52% 12% -2.1 18 0.13 <0.001
rocking movements 33% 5% -2.2 11 0.11 <0,001
grimacing 33% 4% -2.6 12 0.07 <0.001
sudden, clear offset 76% 16% -2.8 37 0.06 <0.001
hyperkinetic thrashing 27% 2% -3.0 8.3 0.05 <0.001
grunting respirations 52% 0% n/a n/a n/a <0.001
apparent full wakefulness after event 88% 26% -3.1 38 0.04 <0.001
■flsling movement------------------------------------------------------- . , m  , , ....  2ft..... ...........13.. _____ <3,00.1 „
Table 13. 1. Frequencies o f elemental semiological features recorded in parasomnias and NFLE.
The table is ordered according to the strength of association of each feature to diagnosis. Raw 
percentages of events in each group showing the feature are given. The statistical significance of 
these values, according to binary logistic regression or Fisher’s exact test, accounts for the number 
of events in each subject as described in the methods section. The logistic regression coefficient (B), 
Wald statistic, odds ratio and uncorrected p  values are given for those elemental features analysed 
using logistic regression. For those assessed using Fisher’s exact test, p  values only are given. Light 
shading represents p values o f0.05 -  0.001; dark shading represents p  values o f < 0.001.
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behavioural patterns observed. Although the features of parasomnias are 
contrasted with the NFLE comparison group, the clinical features of the NFLE 
group are not discussed in detail as this condition has been thoroughly described 
elsewhere (Williamson, 1995; Provini et al., 1999); our findings were consistent 
with previously published reports.
2. Temporal aspects of parasomnias
(i) Event onset.
Parasomnia onsets usually comprised (79% of events) ‘normal’ arousal, with 
stirring, opening the eyes, head elevation and looking around or staring. This 
lasted from one or two seconds to several minutes, and in 65% of cases was 
followed by more dramatic manifestations. Less commonly (21 %), there was 
explosive motor behaviour with apparent fear or agitation at onset. This typically 
comprised sitting forward with a frightened expression, often with agitated 
searching behaviours (the typical ‘sleep terror’ pattern). Usually this onset was 
associated with distressed and coherent, but simple, speech (“help me”, “what’s 
happening”, “mum” etc).
Regardless of the type of onset, tachycardia was almost universal; there tended to 
be a greater increase in heart rate in the ‘sleep terror’ onset, with often a doubling 
of heart rate, and the degree of tachycardia was greatest in young children. Onset 
was triggered by a clear external stimulus such as a noise or an internal stimulus 
such as a cough or snore in a considerable proportion of parasomnias (39% in total 
-  see video 13.1 and 13.2).
Comparison with NFLE. A brief arousal, indistinguishable from that seen in 
parasomnias, also preceded the major behaviours in 49% of NFLE seizures 
(p=0.10; see video 13.3); this was of comparable median duration in the two 
conditions (approximately 7 seconds). An abrupt onset with no preceding arousal 
was seen in 51 % of NFLE seizures (video 13.4), although fearful behaviour was 
not invariably a feature of these events. As with parasomnias, NFLE seizures
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were universally associated with tachycardia. However, obvious triggers such as 
noise were seen in only 8% of seizures.
(ii) Progression
There was often evidence of increasing interaction during the episode (video 
13.5). At onset, typically minimal physical interaction was seen, and speech was 
absent or limited to brief simple phrases. As the event progressed, however, 
hugging or holding of people nearby, semipurposeful behaviours, and more 
complex interactive speech were increasingly seen. Moreover, over one third of 
parasomnias appeared to be modified (either exacerbated or terminated) by the 
actions of other persons who were present. Secondly, a waxing and waning 
pattern of motor activity and emotional distress was observed in 39% of events 
(video 13.5).
Comparison with NFLE. Environmental interaction was less prominent in NFLE. 
While present in 11% of seizures, it was usually simple (repeatedly grabbing at 
bed sides or occasionally a person in attendance), and did not increase through the 
event.
Coherent speech was unusual in NFLE, and tended to be frenetic and agitated 
without a discemable interactive quality (Table 13.1; video 13.4). Likewise, a 
waxing and waning pattern was not seen in NFLE seizures which tended to be 
monophasic.
(iii) Event offset.
Parasomnias terminated with either full arousal to normal wakefulness (26%) or to 
light NREM sleep (74%). A clear and distinct offset was uncommon (16% of 
events). Subjects showingf NREM sleep at offset usually progressed rapidly back 
to deep slow wave sleep. In parasomnias terminating in wakefulness, the precise 
point at which full ‘normal’ consciousness was reached was difficult to determine 
(video 13.5), and for those events without full wakefulness a ‘tapering o ff  of 
motor behaviour was seen with gradual settling back to sleep. A few parasomnias 
(9%) ended with the patient waking fully, leaving the bed and urinating. Although
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not seen in most events, this behaviour may reflect autonomic activation, or 
implicate a full bladder in the initial arousal stimulus. Incontinence was not 
observed.
Comparison with NFLE. The offset pattern in NFLE was strikingly different to 
that of parasomnias, with 88% of seizures ending in full wakefulness. All seizures 
with florid automatisms ended in wakefulness; the only events that did not were 
those characterised by brief dystonic posturing only. Likewise, a distinct offset 
was usually seen in NFLE seizures (76%). A brief postictal period was sometimes 
seen, and when present the behaviours observed were qualitatively very similar to 
those in parasomnias (video 13.6). No seizures ended with the subject waking and 
urinating, and no incontinence was seen.
3. Fundamental behaviour patterns in parasomnias
A relatively narrow repertoire of behaviours was seen during parasomnias, and 
many events were very similar in onset and progression. Overall, three 
fundamental patterns of behaviour were seen, and most individual events (79%) 
comprised a composite arrangement of more than one of these.
The first pattern resembled normal arousal behaviours. These were seen at some 
point in almost all events (92%). They typically occurred around onset or towards 
the end of the episode, but in some events were the only feature. The basic 
arousal behaviours were eye opening, head elevation, looking around and staring 
(video 13.7). However, more elaborate behaviours were also seen; in particular, 
prominent and often vigorous rubbing of the nose or face, yawning, rolling over in 
bed and scratching of the head or body often became prominent as the event 
progressed, sometimes associated with moaning and incoherent speech or 
mumbled single words. Also, in some cases myoclonic jerks and trembling or 
shivering were seen. Normal hypnic jerks appeared to precipitate some 
parasomnias; in other events tremor and shivering were seen intermittently during 
the event (videos 13.8 and 13.2). These were rare in NFLE.
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The second pattern comprised non-agitated motor behaviour and was seen at some 
point in 12% of events. Sitting forward, manipulation of objects in the immediate 
vicinity, and searching behaviours (looking over the side of the bed, under pillows 
etc) was seen. Facial expression was impassive, although sometimes individuals 
looked perplexed. More directed behaviours such as pointing at things (real or 
imagined), hand licking, looking under bedclothes, and picking up and 
manipulating EEG equipment or objects around the bed (taking tissues from a box, 
opening water bottles etc) were also observed (videos 13.1 and 13.9). Usually 
these directed behaviours were brief in duration, lasting for 10-15 seconds. 
Although standing and walking on the bed were occasionally observed during this 
phase (video 13.10), no frank somnambulism was seen as subjects were restrained 
by EEG equipment or individuals in the room. Speech, sometimes mumbled and 
unintelligible, but more typically coherent, was also common. A clear interactive 
component to speech and behaviour was frequently observed during this pattern 
(44% of events).
The third pattern comprised distressed emotional behaviour (51% of events). This 
typically comprised fearful, agitated behaviours and facial expressions. Sitting or 
standing, screaming, frantic looking around, recoiling or evasive behaviours from 
a perceived or imagined threat, and negative or fearful speech ( ‘they’re going to 
kill me”, “I’m going to die”) were prominent (videos 13.11 and 13.12). During 
this pattern, attempts to console or restrain the subject were often resisted, and 
sometimes provoked aggressive behaviour such as hitting or foot stamping. In 
other events, inconsolable sobbing and anguish, often with wailing and pleading 
speech (such as “mum, help me, please”), were prominent (video 13.13) rather 
than fear and agitation. Notably, the central behaviours in this pattern were of 
negative emotions, either fear or anguish, with concordant facial expression, 
speech and motor behaviour.
The three behaviour patterns occurred in various combinations and sequences in 
individual events, with some hierarchy as shown schematically in Figure 13.3. 
These were broadly but not entirely congruent with the traditional 
subclassifications of NREM arousal parasomnias. The first combination (19% of 
events; Figure 13.3, panel (35% of recorded events; Figure 13.3 panel ii) often
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Figure 133 . Schematic representation o f common parasomnias. displayed as hierarchical combinations o f the three fundamental behaviour patterns on the y axis, and 
time (typically 1 -10 minutes) on the x axis. Panel (i) represents a typical confusional arousal, comprising only normal arousal behaviours but o f abnormal duration 
(19% o f recorded events); panel (ii) shows classical somnambulism with non-agitated motor behaviour, and normal arousal behaviours at onset, offset or both (35% of 
recorded events); panel (iii) represents typical sleep terrors, with predominantly negative emotional behaviour often o f sudden onset; calm motor and normal arousal 
behaviours are usually also seen during these events, either at onset or offset (26% o f events); panel (iv) is a nyxed type, but comprising waxing and waning of the four 
behaviour types (19% o f events). All events usually start in stage III or IV NREM sleep, and end either in wakefulness or lighter NREM sleep. Sometimes episodes are 
brief (solid lines) and at other times prolonged (hatched lines).
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started and ended with arousal behaviours, but non-agitated motor behaviours and 
speech predominated. Although frank sleepwalking was not seen in this series, 
these episodes appeared to represent early somnambulism. The third combination 
(26% of events; Figure 13.3 panel iii) was dominated by distressed emotional 
behaviour. These events could have an explosive onset, and would be classically 
described as ‘sleep terrors’, although fear was not the negative emotional 
behaviour in all these events. The fourth and final combination (19% of events; 
Figure 13.3 panel iv) observed was not classifiable using the classical subtypes. 
These episodes contained all four behaviour patterns, alternating in a waxing and 
waning fashion over a relatively prolonged period of several minutes (in some 
cases up to 14 minutes). Distressed emotional behaviours were the striking 
features of these events, but were interspersed with the arousal and non-agitated 
motor behaviour patterns.
Comparison with NFLE. The behavioural patterns were usually different to those 
seen in NFLE. The more elaborate behaviours of parasomnias (such as yawning 
and nose rubbing) were unusual in NFLE, as were myoclonic jerks and trembling 
or shivering (Table 13.1). While distressed emotional behaviour could be seen in 
NFLE, it was often qualitatively different to that seen in parasomnias. The fearful 
or distressed behaviours in parasomnias were usually more highly emotive, 
whereas grimacing and undirected frenetic behaviour was more common in 
NFLE; sobbing or crying were not seen in our NFLE series. However, sometimes 
the negative emotional behaviours in the two conditions could be 
indistinguishable.
Although stereotypy is a widely recognised feature of NFLE seizures, many 
parasomnias were also very similar. The behaviour patterns described were 
usually very similar within, and to some extent between, individuals. However, in 
contrast to NFLE, behaviour patterns in parasomnias did not always follow a 
consistent sequence; patterns could appear and disappear at various phases in the 
event, with the sequence varying between events, or could be ‘skipped’ entirely in 
some episodes.
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Discussion
This study, to my knowledge, represents the largest reported group of NREM 
parasomnias studied with video EEG monitoring, and the only detailed 
semiological analysis of these conditions. The landmark neurophysiological 
studies of parasomnias in the 1960s included broad clinical descriptions of the 
attacks, but were performed prior to the advent of video EEG monitoring and did 
not address semiology in detail. They were also performed prior to the 
recognition of the spectrum of clinical features seen in frontal lobe epilepsy, and 
the appreciation of NFLE as a distinct syndrome.
Rather than identifying the classic parasomnia subtypes of sleep terrors, 
somnambulism and confusional arousals, we identified four key behavioural 
patterns which could combine in a variety of forms. These comprised normal 
arousal behaviours, non-agitated motor activity, apparent fear, and distressed 
sobbing. From a diagnostic perspective, the most important findings were that 
parasomnias and NFLE usually have distinct presentations, and can be 
distinguished on the basis of objective statistical analysis. However, both 
conditions may have very similar onset patterns with non-specific arousal 
behaviours, indicating that it may not be possible to diagnose very brief events on 
the basis of semiology alone.
A. Methodological Considerations
In a study of this type the inclusion and exclusion criteria applied are critical. This 
is of particular importance for the parasomnias, which are quasi-physiological 
phenomena with no definitive biological marker to serve as a ‘gold standard’ in 
diagnosis. In addition, NFLE, is often associated with normal or non-diagnostic 
investigations; even ictal EEG is often unhelpful (Provini et al., 1999). This study, 
therefore, ran the risk of circularity -  in other words, the clinical and EEG findings 
described might simply be the features used by observers to define the groups, 
making the study self-fulfilling. We sought to avoid this through the adoption of 
stringent exclusion and inclusion criteria. NFLE cases without definite biological 
correlate (such as an ictal rhythm on EEG or a positive SPECT scan) were
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excluded, to ensure that the diagnosis in this group was indisputable; individuals 
with convulsive and diurnal seizures were also excluded, to ensure that the 
comparison group accurately reflected the NFLE seizures which cause diagnostic 
confusion in clinical practice.
While minimising the risk of misdiagnosis cases, this selection strategy raises the 
possibility (by excluding equivocal or uncertain events) of artificially separating 
NFLE and parasomnias, and thereby not reviewing the full spectrum of nocturnal 
events. The issue of isolated brief arousals from sleep is particularly relevant here 
and is discussed later.
B. Practical differences between NFLE and parasomnias on 
video EEG monitoring: useful features and potential pitfalls.
Cluster analysis, based purely on the presence or absence of elemental behaviours, 
divided these nocturnal events relatively cleanly into seizures and parasomnias. 
This indicates that there are broad behavioural differences between these 
conditions, although the fact that 15% of seizures were grouped with parasomnias 
confirms a degree of overlap. The clinical ‘decision tree’, which generates a 
diagnostic model using those features of greatest discriminatory value, is shown in 
Figure 13.2. This provides a practical framework for analysing video recordings 
of nocturnal events, and in our series correctly identified 94% of cases. Failure to 
rouse to full wakefulness, an indistinct end to the events, and a lack of dystonic 
posturing and head version were the most powerful indicators of parasomnias in 
this analysis. The algorithm may be useful in the assessment of nocturnal events 
in both the seizure monitoring laboratory and home videos, although prospective 
validation has yet to be undertaken.
Several other characteristics of the onset, progression and offset of parasomnias 
which may be useful in their positive diagnosis were also identified in this study, 
documented in detail in Table 13.1 and summarised in Table 13.2. In particular, 
clear triggers (either internal or external) at onset, elaborate features of normal 
arousal (such as nose rubbing, scratching, and yawning), clear verbal or physical
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Table 13. 2. Important quantitative and qualitative features which can be used in the positive identification of parasomnias.
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interaction, and a prolonged duration (over 2 minutes), all favour a diagnosis of 
parasomnias over NFLE.
In general, despite the variety of behaviours reported in the histories of 
parasomnia subjects, the behavioural repertoire observed in our series was 
relatively small. The abnormal and restrained environment of the video EEG 
monitoring environment may restrict expression and elaboration of more complex 
behaviours (including somnambulism) fleetingly recorded in some individuals. 
Discrepancies between the historical account and recorded events, particularly in 
terms of event severity, was a prominent feature in our parasomnia group, in 
contrast to the NFLE group in whom the history and video EEG monitoring were 
generally concordant (as recognised in previous studies (Manford, 1996)).
A number of important potential diagnostic pitfalls in the assessment of nocturnal 
events should be addressed at this point. Firstly, an important consideration is the 
diagnosis of recurrent, brief arousals from sleep. Such events are well recognised 
in NFLE, where they are typically highly stereotyped and are regarded as 
‘fragments’ of the habitual seizures (Montagna et al., 1990; Zucconi et al., 1997; 
Provini et al., 1999; Provini et al., 2000; Valenti et al., 2006). Intracerebral 
recordings have confirmed that these arousals may be associated with brief 
electrographic seizures without scalp EEG changes (Nobili et al., 2005), and that 
seizure onset in sleep may precede clinical arousal and motor behaviour by up to 
15-20 seconds (Malow and Varma, 1995). However, many other, non-epileptic 
conditions such as restless legs syndrome or obstructive sleep apnoea, may also 
cause recurrent arousals. As a result, when recurrent arousals with no 
distinguishing motor behaviours or accompanying ictal rhythms are captured, it 
can be extremely difficult to ascertain whether they have an epileptic basis. 
Because of these diagnostic difficulties, such cases were not included in this study. 
Despite this, our observations suggest that their accurate diagnosis may not be 
possible on semiological grounds alone. The brief periods of ‘normal’ arousal 
behaviours seen in both groups, which often preceded the main motor behaviour 
of the event, were indistinguishable in NFLE and parasomnias (videos 13.3,13.7) 
suggests that additional information is necessary to make an accurate diagnosis. 
Stereotypy and frequency are generally considered to be the most useful pointers
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to a possible epileptic origin when other investigations are unhelpful in such 
situations (Oldani et al., 1996; Zucconi et al., 1997; Zucconi and Ferini-Strambi, 
2000; Tinuper et al., 2004). However, our findings suggest that while marked 
stereotypy of arousals is suggestive of epilepsy, this feature does not invariably 
indicate such a diagnosis; the onset of parasomnias could be similarly stereotyped. 
Secondly, postictal behaviours, albeit usually very brief (lasting less than one 
minute), were seen in a proportion of NFLE subjects, and when present were 
strikingly similar in quality and nature to parasomnias. Staring, looking around, 
semipurposeful fumbling and partially interactive speech were all seen in this 
postictal period (video 13.6). From a practical perspective it is important to bear 
this in mind when reviewing videos, particularly home videos, in which the onset 
of a nocturnal event may not have been captured. If the entirety of the episode is 
recorded, however, a clear distinction between ictal and postictal behaviours is 
usually possible in NFLE.
Finally, it is important to fully consider the range of nocturnal events in sleep. 
While NFLE and NREM parasomnias are often the most difficult conditions to 
distinguish, other parasomnias such as REM behaviour disorder should also be 
considered in the differential diagnosis, along with non-epileptic conditions such 
as obstructive sleep apnoea, gastro-oesophageal reflux and nocturnal panic 
disorder (see literature review, Chapter 10 for full discussion).
C. Parasomnias - Broad concepts.
Although NREM arousal parasomnias are traditionally grouped into three distinct 
types (confusional arousals, sleep terrors and somnambulism), the results of this 
study only partially support this classification. Rather, they suggest that several 
basic behaviour patterns occur in parasomnias, and that individual events comprise 
a mixture of these. The patterns occur in a hierarchical fashion, with normal 
arousal behaviours being the fundamental component; almost all events contained 
these behaviours at some stage. The next level of behaviour is abnormal but non- 
agitated motor behaviour; presumably this would include somnambulism, 
although this was not recorded in this study. The third, and most abnormal, tier on
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the hierarchy is negative emotional behaviour, either fearful and agitated or 
distraught and tearful in nature. Although any one of these patterns could 
predominate, they would not occur in isolation; components from the level below 
would always be present at some stage. In other words, while an event could 
comprise arousal behaviours alone, calm motor behaviours were not seen without 
arousal features, and agitated activity was not seen without both arousal features 
and calm motor behaviours. The sequence of these behaviours could, however, 
vary significantly between individuals, and between episodes in individual 
subjects.
This hierarchy has led us to a clinical concept of parasomnias based on two axes, 
behaviour and time, shown in Figure 13.3. Although any combination within this 
framework appears possible, and different combinations could be seen within a 
single individual, 4 main combinations were observed as shown. Although these 
were broadly consistent with the recognised subclassifications of NREM arousal 
parasomnias, our findings suggest that labelling individual events as sleep terrors, 
somnambulism or confusional arousals is an oversimplification. Rather, abnormal 
arousal behaviour has three main components (prolonged normal arousal, non- 
agitated motor behaviour, and distressed emotional behaviour) the balance of 
which may vary between individual events.
D. Theoretical implications - parasomnias
Current concepts of the NREM arousal parasomnias have changed little since the 
landmark studies of Gastaut and Broughton in the 1960s (Gastaut, 1965; 
Broughton, 1968). They are broadly considered to represent a functional 
deafferentation of the cerebral cortex in which brainstem and thalamic arousal 
processes are dissociated from normal awake cortical function and consciousness 
(Broughton, 1968), and more recent work has largely supported this hypothesis 
(Bassetti et al., 2000; Balkin et al., 2002). They appear to arise through a 
combination of unusually intense slow wave sleep, which makes arousal to 
wakefulness difficult (Espa et al., 2000; Joncas et al., 2002), and sleep instability 
(Zucconi et al., 1995), possibly related to frequent arousals due to obstructive 
sleep apnoea in some individuals (Espa et al., 2002; Guilleminault et al., 2005).
258
Chapter 13. Parasomnias and NFLE -Video-EEG
The very high incidence of NREM parasomnias during childhood (Laberge et al., 
2000; Agargun et al., 2004) suggests that maturation and synchronisation of 
various central arousal mechanisms may play a role in these disorders (Sheldon, 
2000). Three observations in the current study are relevant to the pathophysiology 
of NREM parasomnias.
Firstly, the high proportion of clear triggers to events is consistent with a 
disordered response to arousal stimuli, either internal (such as coughing, snoring 
and hypnic jerks) or external (particularly sudden noises). In the normal situation 
such stimuli would be followed by full wakefulness or a return to sleep; however, 
in predisposed individuals, incomplete arousal results in a dissociated state which 
manifests clinically as a parasomnia. This initiation of parasomnias by internal 
triggers explains the emerging data that obstructive sleep apnoea may be a 
significant factor in some individuals with NREM arousal parasomnias 
(Guilleminault et al., 2005).
Furthermore, the nature of initial arousal behaviour, when present, was 
indistinguishable in parasomnias and NFLE, and impossible to differentiate from 
normal waking arousal. This suggests that such behaviours represent a common 
non-specific response to a stimulus during sleep; this stimulus can be ‘normal’ 
(e.g. a loud noise) or pathological (e.g. a subclinical seizure), but either will result 
in the same initial arousal behaviour (Figure 13.4). In the case of NFLE, a brief 
subclinical seizure may be a sufficient stimulus to generate such a non-specific 
arousal response without necessarily progressing to a clinical seizure. This 
concept would explain recent findings from intracranial electrode studies in 
NFLE, in which paroxysmal arousals associated with brief seizures were not 
highly stereotyped (Nobili et al., 2005); in these cases the seizure is apparently a 
sufficiently large stimulus to produce a non-specific arousal from sleep, but is not 
prolonged or widespread enough to produce seizure-specific behavioural 
manifestations. It might also explain occasional reports of parasomnia-like 
wandering in individuals with NFLE (Plazzi et al., 1995); it seems possible that in 
predisposed individuals, a subclinical seizure sufficient to produce a non-specific 
arousal could also trigger a parasomnia.
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F ig u re  13. 4 Schematic representation of the postulated relationship of arousal behaviour to parasomnias and nocturnal seizures. During sleep, 
physiological stimuli (external or internal) or subclinical seizure discharges can induce indistinguishable arousal behaviours. In parasomnia 
subjects, these may evolve (heavy black arrows) to a clinical parasomnia or terminate with return to sleep or full waking. In individuals with 
nocturnal epilepsy (heavy grey arrows), clinically evident seizures with distinguishing characteristic behaviours and marked stereotypy may 
occur, or the event may terminate with full waking or return to sleep.
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Secondly, the EEG findings observed in this study, as in the studies of Gastaut and 
Broughton (Gastaut, 1965), support the concept of dissociated sleep in 
parasomnias. About one quarter of individuals with parasomnias showed evidence 
of electrographic dissociation in at least one event, with a posterior dominant 
alpha rhythm coexisting with anterior light sleep patterns. While the precise 
biological foundation of this pattern is unclear, it appears to imply a state in which 
regions of the brain (including frontal, temporal and parietal cortices) are 
functionally asleep, but other areas (including the thalamocortical circuits 
involved in generating the posterior dominant rhythm) are functionally “awake”. 
This is consistent with the emerging concept that sleep, rather than being a whole- 
brain property, is in fact a fundamental property of small groups of highly 
interconnected neurons; ‘local’ brain areas independently generate sleep patterns, 
and are then synchronised through extensive regulatory networks to produce 
global sleep behaviour (Krueger, 2002). Using such a paradigm, the EEG patterns 
suggest that a failure of synchronising mechanisms may be fundamental to the 
pathophysiology of parasomnias.
Thirdly, a relatively narrow repertoire of behaviours was observed in parasomnias; 
this finding may provide clues to the mechanisms involved in generating complex 
behaviour in a brain which is, at least in terms of cortical function, ‘asleep’. The 
three patterns of behaviour seen (arousal behaviours, non-distressed motor 
activity, and distressed emotional behaviour) were broadly stereotyped within, and 
to a certain extent between, individuals. This raises the possibility that the 
behaviours are mediated via the activation of central pattern generators (CPGs).
CPGs are primitive spinal or subcortical neural networks, definitively identified in 
a number of animals, which are able to endogenously (i.e. without sensory or 
cortical input) produce patterns of behaviour (Grillner and Wallen, 1985; Hooper, 
2000). They are phylogenetically ancient; many studies of these systems have 
been conducted in the lamprey, a primitive lizard (Grillner, 2003). There is, 
however, considerable evidence that similar mechanism operate in higher animals 
including mammals, although the large number of cells in the mammalian central 
nervous system makes it more difficult to identify these networks using standard 
electrophysiological and anatomical techniques (Grillner, 2003; Kiehn, 2006).
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CPGs range from the very basic, for example those coordinating protective 
reflexes (such as coughing) or rhythmic respiratory patterns, to more complex 
patterns involved in locomotion. While some are continuously active (such those 
producing respiration) others (such as those involved in locomotion) can be turned 
on and off - in mammals the latter are largely under neocortical control (Grillner, 
2003; Tassinari et al., 2005). Although most work on CPGs has examined their 
role in relatively simple repetitive behaviours such as locomotion, there is also 
evidence that they encode more complex innate behaviours. “Sham rage” was 
first described by Bard in 1928 (Bard, 1928). This term describes apparently 
angry behaviours in cats in which both cerebral hemispheres had been removed.
In response to minimal external stimulation they would snarl, back arch and lash 
their tails; hypertension, tachycardia, piloerection and pupillary dilation were also 
observed. The presence of such behaviour in the absence of a cerebral cortex 
suggests that such innate emotional behaviours are coded in subcortical networks; 
from this finding in cats it is reasonable to hypothesise that emotional behaviours 
are encoded in a similar manner in other animal species, including humans 
(Grillner, 2003).
A possible role for CPGs in NREM arousal parasomnias has previously been 
suggested by some authors (Mahowald, 2002; Tassinari et al., 2005), but the lack 
of detailed video EEG evidence has made definite conclusions difficult. The 
finding of three main behavioural patterns in the current study, however, provides 
support for such a hypothesis; it is plausible that these patterns seen largely reflect 
innate CPG encoded behaviours which are triggered inappropriately during 
NREM sleep in these individuals. If this is this case, by what mechanism might 
this occur? The expression of many CPGs is thought to be predominantly under 
neocortical control during wakefulness, with the circuits inactive at rest but with 
the capacity to ‘turned on’ by cortical command centres (Grillner, 2003). During 
normal NREM sleep, there is reduced metabolic activity and cerebral blood flow 
in large areas of cerebral cortex (see literature review Chapter 3, pages 79-80, for 
further details), such that these CPGs are rarely activated. In a NREM arousal 
parasomnia, however, it is possible that disordered arousal is sufficient to activate 
subcortical CPGs but insufficient to produce normal waking cortical function.
The only reported functional imaging study peformed during a NREM arousal
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parasomnia supports such a mechanism, demonstrating relative hypoperfusion in 
neocortical regions with relatively increased blood flow in thalamic and cingulate 
regions (Bassetti et al., 2000). In parasomnias, therefore, CPG-encoded 
emotional, ambulatory or simple arousal behaviours may be expressed in an 
unrestricted fashion during apparent sleep, without cortical control. Apparently 
purposeful behaviours are thus simply the reflection of such uninhibited CPG 
activity, and the emotional distress observed is analogous to the “sham rage” of 
decorticate cats (Mahowald, 2002).
Evolutionary considerations arising from animal studies in sleep add an additional 
perspective to a discussion of CPGs and parasomnias. Mammals and birds, which 
diverged from a common reptilian ancestor over 310 million years ago, have been 
widely studied and every species exhibits sleep, including both NREM and REM 
sleep (Rattenborg, 2002). However, sleep is much more difficult to study in 
reptiles; these animals have no neocortex, and their EEG patterns are entirely 
unlike those of birds and mammals. As such, interpreting sleep-wake state is 
problematic, and even defining sleep (as opposed to inactivity) is not 
straightforward. Although some understandable inconsistencies therefore exist in 
descriptions of reptilian EEG, a number of studies report diffuse slow activity in 
the delta frequency range in the active reptile, and low amplitude, largely 
featureless EEG during apparent sleep (Nicolau et al., 2000). Moreover, spindles 
with a very similar appearance to human sleep spindles have been reported during 
periods of physical activity these animals (Gaztelu et al., 1991; Nicolau et al., 
2000). Taken together, these findings have led to an interesting evolutionary 
hypothesis of sleep. The concept of “advanced wakefulness” proposes that REM 
sleep in mammals is analogous to the resting or ‘asleep’ state in reptiles (Rial et 
al., 1993; Nicolau et al., 2000); the loss of endothermic control in REM sleep, as 
well as EEG patterns in reptilian sleep, is consistent with this idea. NREM sleep, 
with delta activity and sleep spindles, is considered analogous to reptilian 
wakefulness, and mammalian (or “advanced”) wakefulness is considered to be the 
most recent evolutionary adaptation. The radical concept in this theory is that 
NREM and REM sleep, rather than being evolutionary developments with specific 
adaptive functions, actually remnants from a more primitive phylogenetic era. 
These sleep states may have acquired new functions over time, such as a role in
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the consolidation of memory, although specific functions of sleep remain to be 
definitively identified. Nevertheless, if such functions exist, they may have 
evolved from the pre-existing ‘structures’ of reptilllian activity and rest -  such 
evolution of function is widespread in nature, for example the development of the 
jaw in land-based animals from the branchial arches of fish and amphibians 
(Nicolau et al., 2000).
How are such considerations relevant in terms of parasomnias? If NREM sleep is 
the evolutionary equivalent of an active state in reptiles, it is reasonable that 
primitive motor patterns such as searching behaviours and expressions of fear are 
capable of being expressed during this state; as previously discussed, such 
behaviours are likely to be encoded in subcortical CPGs. In normal sleep such 
behaviours occur infrequently, probably because profound thalamic functional 
deafferentation and relative neocortical cortical inactivity prevent their 
stimulation; in other words, CPGs are not ‘switched on’. If, however, a disordered 
arousal in NREM sleep activates the primitive CPG-encoded behaviours without 
producing normal mammalian “advanced wakefulness”, the individual will 
engaging in simple behaviours involving primitive cerebral structures, without 
cortical involvement. Their environmental interaction and behavioural responses 
can be considered, in a sense, ‘reptilian’.
E. Theoretical considerations -  parasomnias, NFLE and CPGs
Many automatisms have been described in epileptic seizures, some with 
lateralising or localising value (Loddenkemper and Kotagal, 2005). It has 
occasionally been hypothesised that CPGs may play a role in epileptic 
automatisms; oral automatisms in temporal lobe epilepsy may reflect feeding- 
related CPGs, and the bipedal automatisms of frontal lobe epilepsy may reflect 
activation of locomotor CPGs (Meletti et al., 2004; Tassinari et al., 2005). 
Tassinari and colleagues have advanced this concept, and recently suggested that 
the same mechanism may be responsible for the behaviours in parasomnias, 
although they acknowledge a lack of video EEG monitoring data to support such a 
hypothesis (Tassinari et al., 2005). These authors cite McLean’s concept of the 
“triune brain” (MacLean, 1990), an evolutionary concept which has similarities to
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the theory of “advanced wakefulness” discussed previously; in this model the 
human brain is comprised of three evolutionary strata, each based upon the layer 
before it. The “reptilian” brain is the most phylogenetically ancient, with the 
“paleomammalian” and “neomammalian” brains being more recent evolutionary 
additions. The authors suggest that fundamental behaviour patterns, encoded in 
CPGs in primitive ‘reptillian’ brain structures, are expressed in parasomnias and 
epileptic automatisms.
The finding of several broadly stereotyped categories of behaviour in this study 
supports a potential role for CPGs in parasomnias. However, if these networks are 
involved in both epileptic seizures and parasomnias, why are there clear 
qualitative and quantitative differences in the behaviour patterns observed? The 
case for CPG involvement in parasomnias has already been made; likewise, the 
repetitive and highly stereotyped automatisms seen in seizures of NFLE make it 
highly likely that such a mechanism is involved in this condition. It is possible, 
however, that the pattern of CPG activation differs in the two conditions. During 
a frontal lobe seizure, subcortical structures including the basal ganglia (which 
appear to play an important role in the regulation of CPG’s (Grillner, 2003)), are 
repetitively stimulated in an abnormal, non-physiological, manner. As a result, 
bizarre, automatisms which may comprise fragments of other normal behaviours 
encoded in this fashion (such as bicycling) are expressed; these have an unusually 
explosive, repetitive, frenetic and minimally interactive quality. In contrast, the 
abnormal arousal of parasomnias may result from a more physiologically ‘normal’ 
stimulation of these behaviour patterns; the abnormality in this situation is not so 
much the manner of stimulation of these neural circuits, but rather the fact that this 
stimulation is occurring in the context of impaired neocortical function consistent 
with a NREM sleep state.
A striking, and related, finding in this study was the marked similarity between 
parasomnias and the post-ictal behaviours observed in NFLE. Eye opening, 
looking around, searching behaviours, semipurposeful fumbling with objects and 
partial verbal interaction with individuals in attendance were common both 
postictally and during parasomnias, and were qualitatively almost identical. Two 
other recognised postictal behaviours were also prominent in the parasomnia
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group. Firstly, prominent and often vigorous nose or face wiping, a widely 
reported and often lateralising postictal behaviour in temporal lobe epilepsy 
(Hirsch et al., 1998; Geyer et al., 1999; Meletti et al., 2003), was frequently 
observed in parasomnias; this behaviour was seen infrequently in the NFLE 
comparison group, in line with previous studies of this phenomenon (Geyer et al., 
1999; Catenoix et al., 2004). Secondly, some individuals in the parasomnia series 
reacted in a resistive or aggressive fashion to comforting or restraint, behaviour 
which were not seen if the subject was left alone; this observation is concordant 
with the clinical experience that attempts to restrain individuals during sleep 
terrors or sleepwalking can lead to resistance and occasionally violence (Plazzi et 
al., 2005). Although the aggression observed on video EEG monitoring in this 
study was mild, it was qualitatively similar to the non-directed, “reactive” or 
“affective” aggression which may occasionally be seen postictally in epilepsy 
patients. Such postictal aggression appears to particularly be seen in individuals 
with frontal and temporal lobe epilepsy, and usually arises in response to restraint 
(Gerard et al., 1998; Tassinari et al, 2005). It is possible, therefore, to speculate 
that the physiological conditions in parasomnias and the postictal state 
(particularly in NFLE) are similar. While seizures in NFLE usually terminate in 
full wakefulness, a brief period of postictal behaviour is often observed, which 
presumably results from dysfunction in the epileptogenic cortical networks. The 
postictal behaviour is, therefore, occurring in the context of diffuse cortical 
dysfunction in an otherwise ‘awake’ brain. This state may be functionally 
analogous to that of parasomnias; in both conditions there are active, ‘awake’, 
brainstem and diencephalic structures, but functionally inhibited neocortex. 
Quasi-physiological stimulation of CPGs without neocortical regulation may 
occur as in parasomnias, thereby producing similar behaviours. The SPECT study 
performed during a NREM arousal parasomnia, discussed previously, also 
provides some support for this concept. This demonstrated relative reduction in 
cerebral blood flow in large areas of frontal and parietal association cortex 
consistent with NREM sleep, but increased blood flow (more consistent with 
wakefulness) in thalamus and cingulate cortex (Bassetti et al., 2000). While 
consistent with sleep-wake state dissociation between diencephalic structures and 
neocortex, this pattern is also comparable to that seen in SPECT studies of focal 
epilepsy (including FLE) in which there is a post-ictal reduction in blood flow in
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the area of seizure activity but relatively preserved blood flow elsewhere (Newton 
et al., 1992, 1995).
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CHAPTER 14 
SEVERE ADNFLE WITHOUT A KNOWN NICOTINIC 
ACETYLCHOLINE RECEPTOR MUTATION
Introduction
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a familial 
partial epilepsy syndrome characterized by frontal lobe motor seizures occurring 
predominantly during light sleep. To date, ADNFLE has been associated with 
seven mutations in the genes encoding the a4 and (32 subunits of the neuronal 
nicotinic acetylcholine receptor (nAChR). Four are in CHRNA4, the gene coding 
for the neuronal nicotinic acetylcholine receptor (three missense mutations, 
Ser248Phe, Ser252Leu, and Thr265Ile (Steinlein et al., 1995; Hirose et al., 1999; 
Leniger et al., 2003); and one insertion, 776ins3 (Steinlein et al., 1997)); and three 
missense mutations (Val287Leu, Val287Met, lle312Met) have been identified in 
CHRNB2, the gene coding for the neuronal nicotinic acetylcholine receptor (32 
subunit (De Fusco et al., 2000; Phillips et al., 2001; Bertrand et al., 2005). These 
recognized mutations account for only a minority of families with the condition 
(Combi et al., 2004). Recently, however, evidence of alternative molecular 
defects in ADNFLE has started to emerge. Two nucleotide variations in the 
promoter region of the corticotrophin-releasing hormone (CRH) gene have been 
identified which are hypothesized to play a role in the pathogenesis of ADNFLE 
(Combi et al., 2005), although the significance of this finding is not yet clear. 
Finally, a mutation of the gene coding for the a2 subunit of the nAChR was 
reported in a single large family with ADNFLE (Aridon, 2006).
Clinical descriptions of ADNFLE indicate that seizure control may be variable 
during childhood but often improves in adulthood, with seizures typically 
responsive to carbamazepine (Scheffer et al., 1995). Within families there is 
substantial variability in the severity of this condition (Scheffer et al., 1994); while 
some individuals may have severe epilepsy, a substantial proportion are often only 
mildly affected, being fully controlled on a single antiepileptic drug or never 
seeking medical attention (Scheffer et al., 1995; Phillips et al., 2001). While
268
Chapter 14. Severe ADNFLE
seizures may be very frequent in ADNFLE, status epilepticus is rare. Affected 
individuals are typically of normal intelligence, although two families with 
ADNFLE associated with mental retardation have been reported (Khatami et al., 
1998; Cho et al., 2003). Psychiatric and behavioural morbidity has occasionally 
been reported in ADNFLE, but has largely been regarded as a misdiagnosis of the 
seizures themselves (for example as hysteria or psychogenic non-epileptic 
seizures) due to the unusual seizure semiology and normal investigation findings 
(Scheffer et al., 1994; Magnusson et al., 2003). Alternatively, psychiatric features 
have been conceptualized as a consequence of delayed diagnosis of epilepsy, or 
attributed to the impact of chronic illness (McLellan et al., 2003).
Here, two families with ADNFLE are described in whom a number of atypical 
cognitive, behavioural, and psychiatric features were seen, often in association 
with frequent refractory seizures and episodes of status epilepticus. Neither 
family carries a mutation in the nicotinic acetylcholine receptor subunit genes. 
These families, while still within the spectrum of ADNFLE, represent a more 
severe phenotype than that usually described in this condition.
Subjects and Methods
Clinical information on two unrelated, non-consanguinous families containing 17 
affected individuals from Australia and the UK was obtained. Available living 
affected family members underwent detailed assessment. 1 assessed all affected 
members of both families, and collected blood samples, on at least two separate 
occasions. Assessments comprised clinical interviews (including a validated 
seizure questionnaire (Reutens et al., 1992) and physical examination) in affected 
and unaffected individuals, correspondence with professionals involved with their 
clinical management, and review of medical records and investigations, including 
EEG, video-EEG monitoring and neuroimaging. Extensive pedigrees were 
constructed and genetic analysis performed. ‘Mental retardation’ and ‘behavioural 
disorder’ in this study were defined according to the criteria for Mental 
Retardation and Attention-Deficit and Disruptive Behaviors in DSM-IV-TR 
(Association, 2000). Some members of Family A were reported in the original 
description of ADNFLE (Scheffer et al., 1994); Family B has not been previously
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reported. Previous study of the Family A pedigree also provided evidence of 
linkage to I5q24 (Scheffer et al., 1994; Phillips et al., 1998), but phenotyping was 
incomplete. The family has now been further expanded with detailed phenotyping 
undertaken in all individuals.
Molecular Genetics
Molecular genetic analysis was conducted by Ms S. Heron and A/Prof J. Mulley at 
the Department of genetic medicine, Women’s and Children’s Hospital, Adelaide, 
Australia. I was not directly involved in this analysis.
Genotyping
PCR amplification was carried out on genomic DNA using 32P dCTP as 
previously described (Phillips et al., 1995; Phillips et al., 1998). A genome-wide 
search was performed using highly polymorphic microsatellite markers, chosen 
primarily from the Genethon maps (Weissenbach et al., 1992; Gyapay et al.,
1994). Fine mapping was performed for chromosome 15q, 20q and lq.
Linkage analysis
LOD scores, between ADNFLE and 15q and lq markers, were calculated using 
MLINK. The analysis assumed autosomal dominant inheritance with 75% 
penetrance, and an affected allele frequency of 0.0001. Only affected family 
members and obligate carriers were included in linkage analysis, both in excluding 
linkage (through evidence of recombination) and in demonstrating linkage through 
LOD-score analysis, as ADNFLE is associated with incomplete (approximately 
75-80%) penetrance (Oldani et al., 1998). Observations of recombination between 
ADNFLE and intragenic CHRNA4 and markers were used to exclude linkage 
between ADNFLE and these regions. These intragenic polymorphisms have been 
described previously (Steinlein, 1995; Weiland and Steinlein, 1996; Phillips and 
Mulley, 1997).
Mutation Analysis
Mutation analysis for known mutations in CHRNA4 and CHRNAB2 was 
performed by single strand conformation analysis (SSCA) and direct DNA
270
Chapter 14. Severe ADNFLE
sequencing, using previously published primers (Phillips et al., 1998; Phillips et 
al., 2001). These genes were also screened for new mutations using SSCA.
Results
Family A is from the UK and family B from Australia. The two families are 
unrelated and non-consanguinous. Pedigrees showing the distribution of 
epilepsy, psychiatric and cognitive disorders are displayed in Figure 14.1, and the 
phenotypic features of the 17 affected individuals are shown in Table 14.1. Age 
of onset was relatively early (mean 7.8 years, median 7 years). Overall seizure 
frequency during periods of poor control was high (mean 33 seizures per night, 
median 30 ), and status epilepticus was seen in four cases (two from each family, 
24%). Individuals with an earlier age of onset tended to have more severe 
epilepsy; those with onset at seven years or younger reported a median of 40 
seizures per night compared to a median of 20 per night in those with a later onset, 
although this difference was not statistically significant. 9 individuals (53%) had 
seizures during wakefulness, coinciding with periods of poor control; in 3 
individuals, unusual daytime events with an ‘atonic’ semiology were also seen 
(described in the case reports below).
Nine individuals (53%) gave a history of a psychiatric or behavioural disorder, 
requiring at least one psychiatric admission in four cases (24%). In childhood, 
behavioural disturbance took a variety of forms. In some individuals it was 
predominantly aggressive, hostile and destructive behaviour; in others, running 
away, distractibility and overactivity were the most marked traits. In adulthood, 
the most frequent psychiatric diagnosis was depression (diagnosed in three 
individuals); in one case this may have been associated with psychotic features, 
but medical records from the time are no longer available. Two individuals have a 
personality disorder and one has been diagnosed with paranoid schizophrenia. 
Mental retardation (MR) was seen in four affected individuals (24%), with two 
individuals (one from each family) showing developmental regression in 
association with periods of poor seizure control or status epilepticus; in the more 
severe case, regression was from an active and normally developing four year old
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to a fully dependent, wheelchair bound and markedly bradyphrenic, almost mute, 
adult. In the four individuals with MR, three have mild to moderate MR and one 
has moderate to severe MR. No psychiatric or cognitive disorders were reported in 
the unaffected members of these families.
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Family and 
Pedigree 
Reference
Age at Onset Age at 
interview
Seizure types 
Nocturnal Diurnal
Refractory 
epilepsy at time 
of interview
Reported 
seizures 
per night*
Status
epilepticus
Behavioural or 
psychiatric 
disorder
Mental
retardation
Develp-
mental
regression
Neurological
abnormalities
A IM 10 76 partial . . 40-80 . depression t - - .
AIIH 17 63 partial, rare GTC - Yes 20 - depression - - -
AIV-2 13 33 partial • - Up to 40 - depression - -
A 111-3 7 57 partial, rare GTC • Yes 40+ yes Behavioural
disorderf
- -
AIV-4 10 33 Partial partial - 10 - - - -
AIV-3 7 37 Partial partial - 20 - - - -
AIV-5 7 21 Partial partial - 40 - - - -
A 111-6 14 51 Partial, GTC partial - 12 - Paranoid
schizophreniat
- -
AIII-8 4 45 Partial, ?GTC partial Yes 100+ yes yes yes yes
(hemiparesis, 
extrapyramidal 
signs, ataxia)
A 111-9 4 36 partial partial Yes 5 - - - - -
AIV-11 9 14 partial partial Yes 40 - - - - -
B 1-2 Not known partial - - infrequent • - - - -
B 11-4 2 33 partial - - 50 - Personality
disorder
- - -
B 11-5 15 45 partial, rare GTC - Yes 20 - Depression - * -
B 111-2 3 21 partial partial Yes 40-60 yes Personality
disorder!
yes yes -
B 111-6 2 6 partial partial Yes 12 yes Behavioural
disorder
yes - -
B 111-7 1 5 partial - Yes 6 * Behavioural
disorder
yes - "
Table 14. 1. Summary o f the clinical features of families A and B.
*This frequency often changes throughout an individual's lifetime; numbers quoted reflect periods when the disorder was most active, usually in 
childhood and adolescence.
flndicates at least one hospital admission for psychiatric or behavioural disorders
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Case histories
Subject A III-8. This 44 year old man was the product of a normal pregnancy 
and had normal early development. At four years, following a single daytime 
febrile convulsion in the context of an upper respiratory tract infection, he 
developed frequent nocturnal seizures characterized by screaming, dystonic 
posturing and violent thrashing. Epilepsy was very severe from the onset, with 6 
to 200 seizures every night, exclusively during sleep and without apparent aura or 
retained awareness. Rare secondarily generalized tonic-clonic seizures also 
occurred. The onset of seizures was associated with a rapid and dramatic loss of 
motor skills with loss of walking and running and he could only crawl with 
difficulty. No deterioration in speech or cognition was noted. He was seizure free 
for four months on phenytoin and phenobarbitone and slowly regained motor 
skills, including crawling and eventually walking, although these never returned to 
normal. One year after seizure onset, he had an episode of probable tonic-clonic 
status epilepticus and was left with a mild right hemiparesis. His written and 
verbal language skills remained within the normal range. However, frequent (10- 
15) nightly seizures continued and in teenage years he began to struggle at school, 
particularly in mathematics.
At 15 years, a further episode of probable tonic-clonic status epilepticus requiring 
intensive care admission occurred in the context of diabetic ketoacidosis which 
was the first presentation of type 1 diabetes mellitus. Cognitive and motor decline 
followed, with significant loss of written and verbal language skills and worsening 
of his hemiparesis, such that he was unable to walk unaided and was no longer 
able to attend school. Seizures continued on a nightly basis throughout his life 
despite numerous anticonvulsants; in recent years, identical daytime seizures have 
occurred. Periods of poor seizure control during his adult life have corresponded 
with a progressive deterioration in motor and cognitive function. He is now 
markedly bradyphrenic, and speaks only a few words. He is unable to walk 
unaided and is fully dependent on assistance for all activities of daily living. On 
neurological examination he has diffusely increased tone in an extrapyramidal 
pattern, a right hemiparesis and mild trunkal ataxia. Interictal EEGs demonstrated 
diffuse slowing but no epileptiform activity. CT brain scan at age 40 showed
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atrophic changes, primarily in the cerebellum with bilateral frontal cortical 
atrophy, and no other focal lesions.
Subject A III-6. This 5 1 year old man was the product of a normal pregnancy, 
with normal development. At 14 years, he developed episodes ‘like butterflies in 
the stomach’ during waking hours, but without impaired awareness or motor 
features. At 16 he developed nocturnal seizures characterized by an abdominal 
sensation and breathlessness, followed by generalized tonic stiffening with 
retained awareness. These lasted for around 1 minute, with up to 12 nightly. 
Occasional nocturnal generalized tonic-clonic seizures and daytime partial 
seizures were also observed, usually in association with anticonvulsant omission. 
Ambulatory EEG monitoring (4 channels only) recorded two events in which a 
clear ictal rhythm of rhythmic sharp theta activity, maximal over the left 
hemisphere, was observed. CT brain was normal. Seizures were refractory to 
multiple medications until 40 years.
With the onset of nocturnal seizures his personality and behaviour deteriorated 
abruptly, and he changed from a quiet to an aggressive and temperamental 
adolescent. He was frequently involved in arguments and fights, and was arrested 
on several occasions. He was made redundant from his electrician apprenticeship 
after less than 1 year and has not worked again. He increasingly abused alcohol 
and became socially isolated. In his 20’s, he took numerous non life-threatening 
overdoses of antiepileptic drugs. In his 30’s, he had two unprovoked episodes of 
psychosis, the second requiring a six month inpatient admission when a diagnosis 
of paranoid schizophrenia was made. These episodes were unrelated to seizure 
activity as his seizures were becoming increasingly infrequent. By 40 years, he 
was seizure-free on carbamazepine monotherapy, but remains on long-term 
antipsychotic medication to manage fluctuating psychotic delusions.
Subject B III-6 : This 6-year-old girl was the product of a normal pregnancy and 
delivery. Motor development was normal but language was delayed; she had 
single words by one year but did not put two words together until 2Vi years of age. 
Now, at 6 years, her language is at a 3-year-old level. She rarely speaks in 
sentences, but continues to make gains and no regression has been noted.
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Seizures, characterized by sudden repetitive limb thrashing, began at 2 years 9 
months of age, occurring twelve times per night. Interictal EEGs and MRI brain 
were normal, but typical frontal lobe seizures were recorded on video EEG 
monitoring, associated with diffuse EEG attenuation. Ictal SPECT demonstrated 
hyperperfusion of the right superior frontal gyrus. Her epilepsy remains severe 
and refractory to treatment with numerous antiepileptic drugs.
She has had very severe behavioural problems since from the onset of epilepsy, 
being described by her parents as ‘uncontrollable’. She is overactive, distractible 
and prone to severe tantrums, and lacks appreciation of normal social cues. She 
has a tendency to ‘run away’ to the point where her parents and teachers must 
ensure doors are locked at all times.
Recently she had 3 episodes of focal frontal lobe status epilepticus in a 1 month 
period; this worsening in seizure control was associated with significant 
behavioural deterioration. She has also recently developed occasional daytime 
seizures with an atonic component. During these episodes, which occur at any 
time of day and are not associated with an apparent aura, she suddenly becomes 
limp ‘like a rag doll’. Her head and body tend to fall to the right, her eyes roll and 
she is unresponsive for up to a minute. If standing she will collapse, and has 
sustained some minor head injuries. Postictally she makes a rapid recovery, 
although may walk with a limp for two hours.
Subject B III-2. This 21 year-old-woman was the product of a normal pregnancy, 
with normal early development. She was a well behaved child, although she 
‘never knew how to play’ like her siblings, and was socially ‘over friendly’. 
Seizures began at 3 years, occurring up to sixty times per night, with yelling out, 
gasping and prominent dystonia. Video EEG monitoring recorded stereotyped 
hypermotor seizures associated with bifrontal fast activity. Two ictal SPECT 
studies demonstrated right orbitofrontal hyperperfusion. Serial MRI scans of the 
brain were normal.
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Frequent nocturnal seizures continued throughout early childhood despite 
numerous antiepileptic drugs. She had recurrent episodes of focal status 
epilepticus, requiring hospitalization on six occasions prior to 10 years. At 5 
years, following frontal status epilepticus, she lost motor, verbal and cognitive 
skills and was unable to sit up or walk at discharge. However, she fully regained 
these skills over two weeks. She struggled academically; an intellectual 
assessment using the Wechsler Preschool and Primary Scale of Intelligence at 6 
years indicated mild intellectual disability.
She was seizure free between 10 and 11 years, but at 13 years with the onset of 
puberty, her seizure control deteriorated markedly. Sixty or more seizures 
occurred nightly, and this was associated with a sudden and severe decline in both 
her behaviour and cognitive function. She developed severe and rapid mood 
swings, with frequent violent and abusive outbursts in which she would smash 
objects, injure herself or threaten suicide. She was increasingly socially 
inappropriate, undressing in public or acting in a sexually inappropriate manner 
with males. Language and cognitive skills deteriorated, and she became 
incontinent of faeces and urine during both day and night. At age 14, she scored 
45 on IQ testing (using WISC-III), placing her in the moderate MR range. She 
could no longer be managed at home, and was placed in institutional care. She has 
subsequently required admission to inpatient psychiatric services on 10 occasions 
over the last 11 years, and has been diagnosed with a complex range of 
neurodevelopmental problems comprising an emerging personality disorder, 
anxiety, and depression with a rapidly cycling and episodic nature. Her behaviour 
has partially responded to treatment with citalopram and counseling but remains a 
significant problem. Further neuropsychological reviews have continued to place 
her in the moderate MR range. Seizures occur nightly, despite multiple 
antiepileptic drugs, and she now has daytime seizures occurring around 5 days per 
month; although these are usually identical to her nocturnal events, occasionally 
she will have “atonic” events similar to those of her sister (described above).
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Molecular genetics 
Family A
CHRNA4. Affected individual A IV-2 did not inherit a copy of CHRNA4 from her 
carrier grandmother, excluding linkage to this gene .
CNRNB2. Segregation of ADNFLE with haplotype markers for a 6.6 cM region 
on chromosome lq21 between markers D1S2343 and D1S2715; this region 
contains CNRNB2. Co-segregration of haplotypes is shown in Figure 14.2, LOD 
scores are given in Table 14.2. However, the maximum LOD score was not 
significant (LOD score 1.66 at a recombination factor of 0); the informative 
marker was D1S2715. Two individuals were sequenced for the coding exons of 
CNRNB2 and no mutations were detected. No intragenic coding SNP was 
detected in the family.
Chromosome 15g24. Family A also showed evidence of linkage to Chromosome 
15q24 as previously reported (Phillips et al., 1998). Regional localization was 
between markers D15S211 and D15S152. Co-segregration of haplotypes is shown 
in figure 14.3; LOD scores are shown in Table 14.3. Previously, the region was 
thought to include the cholinergic subunit genes CHRNA3, CHRNA5, and 
CHRNB4 (18), but the use of closely spaced Genethon markers showed that these 
genes were ouside the region.
Family B
CHRNA4. Using intragenic markers, linkage of family B to CHRNA4  cannot be 
excluded but one family member has been sequenced for exons 1-6 of CHRNA4 
and no mutations were identified.
CNRNB2. Linkage of family B to CHRNB2 was excluded through evidence of 
recombination in the region of 1 q21 involving this gene.
Chromosome 15g24. Linkage of family B to 15q24 was excluded through 
analysis of haplotype markers.
Figures of family B haplotype markers for chromosomes lq21 and 15q24, as well 
as for the AC triplet repeat marker in CHRNA4, are shown in Appendix B.
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Marker LOD score at recombination fraction (0) of:
0.0 0.01 0.05 0.1 0.2 0.3 0.4
D1S442 -2.18 -0.68 -0.03 0.21 0.36 0.34 0.21
D1S498 -1.49 0.40 0.98 1.12 1.05 0.76 0.38
D1S2343 0.98 0.96 0.89 0.79 0.56 0.31 0.09
D1S2715 1.66 1.64 1.53 1.39 1.05 0.68 0.32
D1S2777 1.34 1.32 1.23 1.11 0.81 0.46 0.14
D1S2506 -5.59 -1.42 0.17 0.25 0.45 0.36 0.18
D1S484 0.34 0.34 0.32 0.30 0.26 0.19 0.11
Table 14. 2. Two-point LOD scores fo r  chromosome lq21 markers in Family A.
Marker LOD score at recombination fraction (0) of:
0.0 0.01 0.05 0.1 0.2 0.3 0.4
D15S1023 -1.96 -1.51 -0.40 0.04 0.30 0.26 0.10
D15S211 -1.46 -1.02 0.07 0.47 0.64 0.51 0.24
D15S1041 2.72 2.67 2.48 2.22 1.64 1.00 0.40
D15S205 3.21 3.16 2.93 2.63 1.98 1.27 0.53
D15S152 2.99 2.94 2.75 2.49 1.91 1.27 0.59
D15S201 2.72 2.68 2.50 2.26 1.73 1.13 0.53
D15S1030 1.85 1.81 1.68 1.52 1.20 0.85 0.45
D15S979 -0.98 1.28 1.78 1.82 1.53 1.05 0.50
D15S963 0.85 0.84 0.80 0.74 0.60 0.43 0.24
Table 14. 3. Two-point LOD scores fo r  chromosome 15q24 markers in Family A
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Discussion
Severe ADNFLE phenotype
Two families are presented with a severe form of ADNFLE, displaying a number 
of atypical cognitive and psychiatric features, in which no mutations of nicotinic 
acetylcholine receptor genes have been identified. Affected individuals in both 
families have more severe epilepsy with early onset, very frequent seizures, status 
epilepticus and high rates of intractability into adulthood. The mean age of onset 
in these families was 7.8 years (median 7 years) compared to the reported mean of 
11.7 years (median 8 years)(Scheffer et al., 1995), and the overall seizure 
frequency per night (mean 33, median 30) is high compared to the reported 
frequency in ADNFLE (mean 7.7, median 6) (Scheffer et al., 1995). Status 
epilepticus is infrequently reported in ADNFLE, but was seen in one quarter of the 
affected individuals in these families. Half of the affected adults in these families 
are refractory to multiple AEDs, which is unusual in ADNFLE; while seizures in 
this condition often require lifelong treatment, they are usually easily controlled 
with carbamazepine. Also atypically for ADNFLE, in which marked intrafamilial 
variability in disease severity is usually seen (Scheffer et al., 1994; Oldani et al., 
1998), all affected individuals in both families are severely affected with one 
exception; a single elderly woman in family B (B 1-2) reported infrequent, 
minimally disruptive attacks, but she was very reluctant to discuss her epilepsy 
and the reliability of this history was uncertain.
Overall, while the clinical features in these families are consistent with the 
spectrum of ADNFLE, they appear to represent a more pernicious form than that 
usually reported; the epilepsy in the least severely affected individuals here is as 
severe as or worse than that of the more severely affected members of other 
ADNFLE families (Scheffer et al., 1995; Phillips et al., 2001). Moreover, a 
number of the most seriously affected individuals in these families have additional 
cognitive and affective comorbidities not usually seen in ADNFLE. Mental 
retardation, behavioural and psychiatric disorders are observed in individuals from 
both families, with definite developmental regression in two cases.
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Mental retardation, regression, and psychiatric morbidity
Mental retardation (MR) is not usually associated with ADNFLE, although it has 
been previously reported in two families. In one of these, bilineal inheritance of 
MR and ADNFLE was observed, raising the possibility that these two features 
were segregating independently through the pedigree rather arising through a 
common mechanism (Khatami et al., 1998). More recently, however, a Korean 
kindred was described with ADNFLE and MR associated with the CHRNA4 
Ser252Leu mutation (Cho et al., 2003); in this family, all individuals with epilepsy 
also had mild to moderate MR, and all but one had seizures persisting into 
adulthood despite treatment with multiple medication. MR and behavioural 
problems were also reported in some members of a Japanese family reported with 
the same mutation (Ito et al., 2000), and in a single member of a Norwegian 
family with the CHRNA4 Ser248Phe mutation (Steinlein et al., 2000). Overall, 
however, the majority of reports of ADNFLE emphasise normal intellectual 
function (Scheffer et al., 1995; Oldani et al., 1996; Nakken et al., 1999; Saenz et 
al., 1999).
While the majority of affected individuals in family A reported here have normal 
intellect, mild to moderate MR is a feature of half of the affected members of 
family B. Furthermore, in both families developmental regression was observed 
in individuals with very severe epilepsy; in the most severe example (A III-8), 
regression was from a normally developing and active 4 year old to a fully 
dependent, wheelchair bound and markedly bradyphrenic, almost mute, adult.
Both individuals had frequent, refractory seizures with early clinical onset (4 years 
or younger), and regression was temporally related to episodes of focal frontal 
lobe or tonic-clonic status epilepticus. In one, regression was associated with the 
development of focal neurological deficits without neuroimaging correlate. To 
our knowledge, developmental regression has not previously been reported in 
ADNFLE.
The other striking feature in these families is the high incidence of behavioural 
and psychiatric disorders, ranging from depression to frank psychosis. Psychiatric 
diagnoses in individuals with ADNFLE were previously considered to be largely a
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reflection of the burden of living with chronic, and often unrecognized, epilepsy; 
in some cases they represented direct misdiagnosis of the underlying condition as 
psychogenic nonepileptic seizures (Scheffer et al., 1994). Recently, however, this 
explanation has been questioned. Magnusson et al. proposed that the high rate of 
psychiatric diagnoses among patients with ADNFLE may not be an artifact, 
hypothesising that psychiatric disturbance is part of the clinical spectrum of 
ADNFLE associated with the CHRNA4 776ins3 mutation (Magnusson et al., 
2003). A phenotypic comparison of two Scottish families with mutations in 
different genes causing ADNFLE (the Ser248Phe CHRNA4 and Val287Met 
CHRNB2 mutations) also noted significant rates of psychological morbidity in 
both families, with reports of depression, low self-esteem, a hysterical gait 
disorder and school refusal (McLellan et al., 2003). Although the mean delay of 
approximately 9 years between seizure onset and diagnosis in these families may 
have contributed to the psychiatric morbidity observed, the findings raise the 
possibility that mutations causing ADNFLE also directly predispose to mental 
illness.
The high rates of behavioural and psychiatric disorders in the families A and B 
reported here support this hypothesis. In many individuals these disorders are 
highly disabling, more so than the seizures themselves, and in 4 cases (24%) have 
resulted in affected individuals requiring institutional care. Although it is possible 
that some of this psychopathology is attributable to the burden of epilepsy, this is 
unlikely to fully explain the range and severity of problems observed. 
Significantly, ADNFLE was promptly recognized and treated in family B; despite 
this, five of the six affected individuals have significant psychiatric or behavioural 
disorders, indicating that missed or delayed diagnosis was not a significant factor 
in the development of psychopathology here.
Whether MR, regression, and behavioural and psychiatric disorders are a direct 
result of the genetic abnormality, a consequence of frequent frontal lobe seizures, 
or a combination of the two, is unclear. In contrast to the report of Magnusson et 
al (Magnusson et al., 2003), in which psychiatric features appeared despite good 
seizure control, psychopathology and developmental regression in families A and 
B usually developed in the context of frequent refractory seizures or frank focal
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status epilepticus. It appears likely, therefore, that seizures play some role in the 
development of these comorbidities, even if they are not the sole cause. Such a 
hypothesis is biologically plausible. Cognitive and neurological sequelae have 
been reported following complex partial status epilepticus, albeit predominantly in 
status epilepticus of temporal lobe rather than frontal lobe origin (Krumholz et al.,
1995), and affective or behavioural disturbance is well described during periods of 
ongoing focal frontal lobe status epilepticus (Thomas et al., 1999; Takaya et al., 
2005). It has long been recognized that frontal lobe injury or dysfunction can 
result in a range of behavioural problems, including distractibility, poor attention, 
perseveration, disinhibition, irritability and aggression (Trimble, 1990). There is 
also considerable evidence of frontal lobe dysfunction in schizophrenia and 
depression (Weinberger, 1988; Trimble, 1990; Mayberg, 1994; Weinberger and 
Berman, 1996), with some clinical features of these conditions (such as including 
apathy, blunted affect, psychomotor retardation, and paucity of speech and 
spontaneous movement) being well-recognised features of frontal lobe 
dysfunction.
Taken together, these observations raise the possibility that the underlying genetic 
abnormality may confer a predisposition to such problems, but also that 
inadequate seizure control, with associated impairment of frontal lobe function, 
can precipitate a significant deterioration. This underscores the importance of 
prompt diagnosis and treatment in ADNFLE in order to minimize the development 
of these disabling features.
The role of the nAChR
ADNFLE has been definitively associated with mutations in genes coding for a4 
and (32 subunits of the nicotinic acetylcholine receptor (nAChR); recently a 
mutation of the a2 subunit was also described (Aridon, 2006), suggesting that the 
a4p2 receptor may not be the only nAChR implicated in this disorder.
Recognized mutations, however, account for only a minority of families with 
ADNFLE, and are not present in the families presented here.
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Two possibilities arise from the molecular genetic findings in these families: either 
further, as yet unrecognized, nAChR mutations are responsible; or an alternative 
genetic basis to the disorder may exist. It remains possible, though unlikely, that 
the more severe phenotype presented results from novel mutations in nAChR 
genes. In family B, linkage analysis was able to exclude CHRNB2 and the 
CHRNA3/CHRNA5/CHRNB4 cluster, but not CHRNA4; however sequencing of 
this gene identified no mutations. In family A, CHRNB2 may still be implicated 
as cosegregation of hapolotypes is consistent with linkage to lq21, although 
sequencing of this gene has failed to identify a mutation. Linkage analysis has, 
however, excluded CHRNA4 and the CHRNA3/CHRNA5/CHRNB4. The initial 
reported evidence for linkage to chromosome 15q from this family implicated a ~ 
6.3cM region, which appeared to include the CHRNA3/CHRNA5/CHRNB4 gene 
cluster (Phillips et al., 1998). The region identified here through reanalysis with 
more affected individuals, more markers and better localization of markers 
excludes this cluster, indicating that these genes are not responsible for the 
ADNFLE phenotype in this family. As this is the only reported example of 
linkage to this region, any role for the CHRNA3/CHRNA5/CHRNB4 cluster in 
ADNFLE must be questioned.
The sequencing of CHRNB2 and CHRNA4 in these families makes a mutation in 
these genes unlikely, but not impossible. Although DNA sequencing is extremely 
reliable for detecting nucleotide substitutions, it cannot always detect large 
deletions or duplications. A deletion might explain the more severe phenotype 
observed, as such mutations can have more profound consequences than 
nucleotide substitutions. A further possibility is a mutation in non-coding DNA, 
including promoter regions; these areas have occasionally been reported in 
familial diseases (Liu et al., 1999) but have not been sequenced in these families. 
Therefore although mutations in the nAChR genes previously implicated in 
ADNFLE are unlikely in these families, they cannot be firmly excluded.
Altered nAChR function is a biologically plausible mechanism for the 
comorbidities described here. The possible role of these receptors in mental 
illness has received increasing attention in recent years, stimulated by the 
substantially increased prevalence of smoking in schizophrenia (70-88%) (Hughes
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et al., 1986; Leonard et al., 2001), ADHD (42%) (Pomerleau et al., 1995) and 
depression (46%) (Poirier et al., 2002) compared to the general population (28%). 
Smoking may represent self-medicating behaviour in these conditions, a 
possibility supported by reports of symptomatic improvements with nicotine 
administration (Dalack et al., 1998; Salin-Pascual and Drucker-Colin, 1998; Ripoll 
et al., 2004). In schizophrenia, evidence from post-mortem studies suggests 
reductions in CNS nAChR density, although more predominantly in a l  than a4p2 
receptors (Freedman et al., 1995; Ripoll et al., 2004); this receptor appears to play 
an important role in auditory sensory gating, and dysfunction may be implicated in 
auditory hallucinations in this disorder (Ripoll et al., 2004).
Moreover, the nAChR (particularly the a4p2 receptor) also plays a critical role in 
synapse formation and modification of circuitry in the developing brain (Lipton 
and Kater, 1989; Pugh and Berg, 1994; Role and Berg, 1996). It is reasonable to 
hypothesise that dysfunctional nAChR in this setting could result in MR; reduced 
gene expression and post-transcriptional abnormalities of the a4p2 nAChR have 
recently been described in autism with MR (Perry et al., 2001; Lee et al., 2002; 
Martin-Ruiz et al., 2004).
Other genetic considerations
Although a mutation in a gene coding for one of the nAChR subunits may be 
responsible for the ADNFLE and associated features in these families, the 
molecular genetic analysis makes this relatively unlikely. The possibility is 
therefore raised of an alternative molecular mechanism, unrelated to the nAChR. 
This concept is supported by the recently published finding of two rare 
polymorphisms in the corticotrophin releasing hormone (CRH) promoter region in 
ADNFLE families with no nAChR mutation (Combi et al., 2005). However, this 
report is suggestive rather than conclusive; one of the polymorphisms was present 
in approximately 3.35% of normal controls, and the other, although not present in 
controls, was found in only one affected individual. Further studies are required 
before these polymorphisms can be conclusively established as a causative
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molecular defect in ADNFLE, but the concept of a non-nAChR mutation in this 
condition is interesting.
Although family B presented here is too small for linkage studies, segregation of 
haplotypes in family A is potentially consistent with linkage to both 15q24 and 
lq21. The LOD scores are significantly greater for the 15q24 locus than the lq21, 
however (Tables 14.2 and 14.3), largely because the lq21 markers are not highly 
polymorphic within Family A. As already discussed, the CHRNB2 gene on lq21 
has been sequenced and no mutation identified, and the
CHRNA3/CHRNA5/CHRNB4 cluster on 15q24 has been excluded. A number of 
possible molecular mechanisms could explain these findings. Firstly, a non- 
nAChR gene on either chromosome lq21 or 15q24 may carry the molecular defect 
in this family. Linkage as determined by the LOD score is a statistical inference. 
As with any statistical test, the possibility of false positives exists, and it is 
therefore likely that one of these two loci is correct and the other is irrelevant to 
the disorder. In addition to CHRNB2, candidate genes on chromosome lq21 
include SNX27, which is involved in endocytosis of plasma membrane receptors; 
KCNN3, a calcium-activated potassium channel, and HCN3, a cation channel. The 
localization on chromosome 15q24 also contains a number of possible candidate 
genes, including HOMER2, a gene involved with glutamate receptor function, 
AP3B2, involved in plasma membrane receptor endocytosis; and SH3GL3, which 
plays a role in CNS development.
The haplotype data in family A, however, raise the possibility that both loci are in 
fact implicated in the disease process. For example, an interaction between a 
novel, as yet unidentified mutation CHRNB2 gene on lq21 (presumably of 
borderline pathogenicity), and a mutation in a functionally related gene on 
chromosome 15q24, might be insufficient in isolation to cause ADNFLE but may 
result in the condition if inherited together. Digenic inheritance of this type has 
previously been described in a number of disorders. The first example in human 
disease was identified in families with retinitis pigmentosa, in which only 
individuals doubly heterozygous for mutations in the unlinked but functionally 
related photoreceptor-specific genes ROM1 and peripherin/RDS developed the 
condition (Kajiwara et al., 1994). Since then, convincing evidence of digenic
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inheritance has been reported in various conditions, including Bardet-Biedl 
syndrome (Katsanis et al., 2001; Fauser et al., 2003), non-syndromic deafness (del 
Castillo et al., 2002), insulin resistance (Savage et al., 2002) and early-onset 
Parkinson’s disease (Tang et al., 2006). To date, digenic inheritance has not been 
definitively identified in epilepsy, although evidence for this inheritance pattern 
from linkage studies was obtained in one family with febrile convulsions and 
temporal lobe epilepsy; no mutations has yet been reported in this family (Baulac 
et al., 2001).
Most examples of digenic inheritance show a digenic-diallelic mechanism, in 
which affected individuals are doubly heterozygous for mutations in different but 
often functionally related genes (Zheng et al., 2005; Tang et al., 2006); individuals 
with mutations in only one of the two genes are unaffected. In digenic-triallelic 
inheritance, which has been reported in a syndromic variant of Bardet-Biedl 
syndrome, two mutant alleles are required in one gene and one at another 
(Katsanis et al., 2001; Fauser et al., 2003).
In addition to the linkage data, the more severe phenotype seen in family A and B 
reported here is potentially in-keeping with digenic inheritance. A recent report of 
digenic Emery-Dreifuss syndrome was associated with an unusually severe 
disease phenotype (Muntoni et al., 2006), and a single case report of unusually 
severe Becker muscular dystrophy was associated with mutations in both the 
dystrophin and the functionally related Myf6 genes (Kerst et al., 2000). It is 
possible that such an association of two functionally-related genes, insufficient in 
isolation to produce the ADNFLE phenotype, in combination produce the more 
severe features observed in these families. While it might be anticipated that some 
mildly affected family members would carry only one of the relevant alleles, a 
finding not seen in family A, this is not necessarily the case. Indeed, in most 
conditions previously reported with digenic inheritance patterns, mutations in one 
gene only are insufficient to produce the disease phenotype. Possibly more 
difficult to explain, however, is the presence of asymptomatic obligate carriers in 
family A. If digenic inheritance is responsible for an exacerbation of the 
phenotype, intuitively it becomes more difficult to explain the presence of such 
individuals. While such concerns make the possibility of digenic inheritance less
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compelling in this family, they do not refute it entirely; however, sequencing of 
potential candidate genes and identification of causative mutations will be 
necessary to validate this hypothesis.
Conclusion
Although ADNFLE is classically described as a condition with normal 
intelligence in which behavioural and psychiatric problems are either a 
misdiagnosis of the underlying condition or a social consequence of unrecognized 
seizures, evidence is emerging that this is not always the case. Our families, in 
conjunction with some previous reports (Cho et al., 2003; Magnusson et al., 2003; 
McLellan et al., 2003) suggest that psychiatric and behavioural problems, mental 
retardation and developmental regression may be part of the spectrum of this 
disorder, particularly in those individuals with very severe epilepsy. It is possible 
that certain mutations associated with ADNFLE confer a greater genetic 
predisposition to these features than others; the absence of any recognised 
mutation in genes coding for the neuronal nicotinic acetylcholine receptor and 
linkage to two loci raises the prospect of an alternative, possibly digenic, 
mechanism in the families presented here. Recognition of behavioural and 
psychiatric conditions in families with ADNFLE, as well as intellectual disability, 
is important as these problems may be a greater cause of suffering than the 
seizures themselves. Optimization of seizure control may help to minimize the 
impact of these comorbidities and improve outcome. Ultimately, molecular 
genetics may elucidate the relationship between frontal lobe epilepsy and the 
affective and cognitive disorders observed in these families.
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CHAPTER 15 
GENERAL DISCUSSION
The work in this thesis addresses three aspects of sleep and its relationship with 
frontal lobe epilepsy. First, (Chapter 11), changes in serotonergic 
neurotransmission were examined across the human sleep-wake cycle using the 
novel PET ligand l8F-MPPF. Altered function in the neurotransmitter systems 
underlying normal human sleep may play a fundamental role in the precipitation 
of seizures in some epilepsy syndromes. The aim of this study was to look for 
measurable changes in serotonergic neurotransmission across the human sleep- 
wake cycle, and compare these observations with previously reported data from 
animal studies. The second aspect (Chapters 12 and 13) was the clinical and 
semiologial features of the NREM arousal parasomnias such as sleep terrors and 
somnambulism. These disorders may be easily confused with NFLE, and 
systematic descriptions of their historical and behavioural characteristics are 
scanty. Improving diagnostic accuracy is clearly important from a clinical 
perspective, but is also vital in genetic studies of ADNFLE -  parasomnias 
represent potential phenocopies of NFLE, and may therefore undermine linkage 
analysis in this setting. The aim of these studies was, therefore, to clarify the 
clinical features of parasomnias, and to identify those which are of greatest value 
in discrimination from frontal lobe seizures. Thirdly, a clinical and genetic 
analysis of two large families with a severe form of ADNFLE was undertaken. 
Affected individuals in these families had severe, refactory epilepsy and high rates 
of intellectual disability and psychiatric or behavioural morbidity. Molecular 
genetic studies on the larger family have been undertaken by Assistant Professor 
John Mulley’s group, based in the Department of Genetic Medicine in the 
Women’s and Children’s Hospital, Adelaide, Australia. No nAChR mutation has 
been identified at this time. While not yet conclusive, however, these studies raise 
the possibility of a novel mechanism for the severe ADNFLE phenotype observed 
here.
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18F- MPPF, serotonin and the sleep-wake cycle
Our understanding of the neurochemical basis of sleep has increased dramatically 
over the last few decades. An increasing number of neurotransmitter systems have 
been associated with sleep regulation, many of which have also been implicated in 
human disease. These neurochemical changes may be critical to the relationship 
between sleep and a variety of neurological disorders in man, including the 
epilepsies.
The current understanding of this area is, however, based almost exclusively on 
data from animal studies. From the early multilevel brainstem transactions 
studies, to more recent work using microdialysis and neurophysiological 
techniques (see literature review, Chapter 2, pages 43-50), the invasive and often 
destructive nature of the methods employed to study sleep neurochemistry 
generally precludes their use in human subjects. As specific REM and NREM 
sleep states are seen in all mammalian and avian species, mediated through 
phylogenetically preserved brainstem structures, it is usually assumed that the 
fundamental mechanisms of human sleep are similar or identical to those of other 
animals. However, direct evidence for this is limited, and such assumptions 
should be made with some caution. The development of PET ligands with 
apparent sensitivity to endogenous neurotransmitter concentration has opened new 
possibilities for studying physiological neurotransmitter flux in humans. The 
novel ligand l8F-MPPF, a competitive antagonist of the 5HT ia receptor, is the first 
serotonergic ligand which appears to demonstrate such properties.
What has been learnt
Serotonin and sleep. The experiment described in Chapter 11 examined 
serotonergic neurotransmission across the human sleep-wake cycle using l8F- 
MPPF PET. The widespread increase in 18F-MPPF binding identified in sleep 
compared to wakefulness indicates that serotoninergic 5HTia receptor availability 
is increased in sleep compared to wakefulness, although the precise interpretation 
of these findings is not straightforward. The simplest, and most intuitively 
attractive, interpretation is that serotonin release is greatest during wakefulness
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and reduced during sleep, in line with existing animal studies. However, while 
this is one possible explanation, the mechanisms regulating 18F-MPPF binding 
across the sleep-wake cycle may be more complex. A number of factors, 
including neurotransmitter release, neuroreceptor trafficking, and state-dependent 
alterations 5HT iA receptor affinity, may influence l8F-MPPF binding (see 
literature review, Chapter 3 pages 86- 87), and the precise influence of each of 
these is not yet clear. Nevertheless, the clear increase in 5HT iA receptor 
availability observed during sleep is congruent with existing animal data.
18F-M PPF PET. Although there has been compelling animal data to indicate that 
1 8 F-MPPF binding is sensitive to supraphysiological endogenous serotonin release, 
some studies have suggested that normal physiological serotonin fluctuations 
might not be detectable using 18F-MPPF PET (see literature review, Chapter 3 
pages 86-87). The findings reported here, however, indicate that this technique is 
capable of detecting physiological changes in human serotonergic 
neurotransmission in vivo.
Future directions
Serotonin and Sleep. Replication of this study in normal subjects is important to 
confirm the applicability of the findings to normal human sleep. The subjects in 
this experiment all had narcolepsy-cataplexy; these subjects were chosen to 
maximize the chances of recording sleep during the scanning period, and because 
this disorder has not been associated with primary serotonergic dysfunction. 
Narcolepsy-cataplexy arises through loss of hypocretin-containing neurons in the 
dorsolateral hypothalamus. Although the wake-promoting effects of hypocretin 
may, in part, be mediated through stimulation of serotonergic and noradrenergic 
neurons (see literature review, Chapter 2, page 49), there is no evidence that 
serotonergic function is fundamentally affected in this disorder. It is, therefore, 
likely that the changes in serotoninergic neurotransmission observed across the 
sleep-wake cycle in narcolepsy-cataplexy are similar to those in normal human 
sleep, although this requires experimental confirmation. Studies of sleep in 
normal volunteers are logistically more difficult than in individuals with
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narcolepsy. In many centres, scanning at night is impractical, but to have a 
reasonable chance of obtaining daytime sleep in normal volunteers a degree of 
prior sleep deprivation is often required. This process may itself influence 
serotonergic neurotransmission, a fact that would need to be taken into account in 
any such study.
Mechanism of altered 18F- MPPF binding. From a technical perspective, more 
work is needed to understand the mechanisms of altered 18F- MPPF binding 
observed here. At the simplest level, these changes may reflect displacement of 
i8F- MPPF by endogenous serotonin, or receptor internalization in the face of 
endogenous serotonin release. However, the possibility of more complex 
interactions, including changes in receptor affinity states with the sleep-wake 
cycle, need to be considered (see literature review, Chapter 3, pages 86-87). Such 
questions are more easily answered using animal studies, as techniques including 
microdialysis, PET and p-microprobe, and autoradiography can be employed in 
combination in this setting.
Other uses for 18F- MPPF PET. A wider role for 18F- MPPF PET in the study of 
serotonergic neurotransmission per se still requires confirmation. Clear changes 
in 18F- MPPF binding were demonstrated across the sleep-wake cycle in the 
current study, but ongoing investigations in a variety of settings are required.
There are at least two potential factors which may limit broader applicability of 
18F- MPPF PET. The first relates to the magnitude of serotonin flux being studied. 
The variation in endogenous serotonin between wakefulness and REM sleep is 
probably the largest to occur during normal physiological function; serotonergic 
neurons are active during normal wakefulness, but their activity reduces 
considerably during NREM sleep and ceases entirely during REM sleep (see 
literature review, Chapter 2, page 45-46). It is possible that such large changes in
I o
serotonin concentration are detectable using F- MPPF PET, but that smaller 
physiological, and even pathological, variations may not be. The second reason 
relates to sleep-related changes in 5HTiA receptor affinity. It has been 
hypothesized by some authors that certain states, such as anaesthesia and 
potentially sleep, may lead to changes in receptor affinity unrelated to endogenous
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serotonin release. If this is the case, such changes may be an essential component 
of the altered 18F- MPPF binding observed during sleep in the present study. 
Changes in endogenous serotonin in other settings, unrelated to sleep, might 
therefore have no detectable effect on 18F- MPPF binding. Further studies may be 
able to clarify these points. For example, a comparison of 18F- MPPF binding pre 
and post SSRI administration (with both scans performed during wakefulness) 
might be a useful experiment to address the second concern.
If the reliability and sensitivity of l8F- MPPF PET for detecting endogenous 
serotonin flux can be confirmed, it has the potential to become a valuable 
neuroimaging modality. Serotonin is believed to play a role in a wide range of 
neuropsychological functions including emotion and cognition, as well as 
neurological and psychiatric disorders including schizophrenia and depression. As 
such, any technique with the capacity to detect fluctuations in CNS serotonin in 
vivo would have extensive applications.
PET ligands, sleep and epilepsy. Finally, taking a broader view, 18F- MPPF may 
be the first of many PET ligands with the potential to shed light on neurochemical 
changes in human sleep, and the relationship of these to epilepsy and other 
neurological disorders. For example, the serotonergic system has long been
1Xsuspected of involvement in myoclonus. F- MPPF PET may be useful for 
examining relationships between serotonin, sleep and myoclonus, particularly in 
conditions such as juvenile myoclonic epilepsy in which myoclonus is common on 
waking and is exacerbated by sleep deprivation. Likewise, ligands are emerging 
for other neurotransmitter systems involved in sleep, and may be used to study 
human sleep and its relationship to disease. Particularly interesting are the 
emerging a4p2 nAChR ligands such as [18F]-F -A-85380. The recently reported 
finding of altered [18F]-F - A-85380 binding in ADNFLE, increased in brainstem 
and epithalamus but reduced in mesial frontal regions (Picard et al., 2006), is an 
example of how such studies may shed new light on the mechanisms of sleep- 
related epilepsies.
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Distinguishing parasomnias and NFLE
Distinguishing NFLE from the NREM arousal parasomnias can be difficult; both 
conditions often present with unusual and dramatic sleep-related events, and 
investigations are often unhelpful. While misdiagnosis of NFLE as parasomnias 
has been widely reported (Scheffer et al., 1994), increasing awareness of this 
condition may also result in the opposite problem, with parasomnias being 
incorrectly diagnosed as epileptic seizures. Although the clinical features of 
NFLE have been extensively studied and well described, those of the NREM 
arousal parasomnias have not. While their existence and broad behavioural 
manifestations are well known in both medical and lay communities, descriptions 
of their clinical features remain nebulous, based largely on clinical anecdote and 
traditional descriptions. The absence of any systematic analysis of the historical 
features and ictal semiology of parasomnias contributes to the diagnostic 
difficulties which may arise in this setting.
What has been learnt
Two systematic studies of NREM arousal parasomnias are presented in this thesis; 
one is a study of historical data, the other a detailed examination of electroclinical 
features as recorded on video EEG monitoring. These studies are, to my 
knowledge, the first of their kind in parasomnias, and identify the principal 
clinical features of these conditions. In addition, direct comparison with NFLE 
has identified a number of key differences and similarities between these 
disorders.
Historical features. Analysis of the clinical histories in NFLE and parasomnias 
(Chapter 12) demonstrated that these disorders can usually be distinguished on the 
basis of the history alone. Interestingly, the data indicated that many individual 
clinical features are common to both conditions, and few features, if any, are 
entirely reliable discriminators when taken in isolation. However, when these are 
reviewed in combination, the disorders rarely closely mimic one another. This is 
reflected by the validity of the scale developed here (FLEP -  Frontal lobe epilepsy 
and parasomnia scale), which predicts a diagnosis based on a composite of clinical
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features. From the data presented, a confident diagnosis of NFLE or parasomnias 
could be made on the basis of the FLEP scale in over 80% of individuals. In the 
remainder, however, a diagnosis of epilepsy was suspected but was uncertain; 
such subjects would still require video EEG monitoring. Thus although 
previously most authors have emphasized the importance of video EEG 
monitoring in the diagnosis of NFLE (see literature review, Chapter 10, page 190), 
these finding suggest that such a diagnosis can often be made or excluded with 
confidence on the basis of the history alone.
Electroclinical features. The companion study (Chapter 13) comprised a detailed 
description of the ictal semiology of parasomnias as recorded on video EEG 
monitoring, and contrasted the findings with those of NFLE. Although numerous 
studies of semiology have been conducted in epilepsy, to my knowledge this is the 
first study of its kind undertaken in parasomnias. The principal finding was of 
three main behavioural patterns, which occurred either individually or, more 
commonly, in a combination within a single parasomnias event. These patterns 
(‘normal’ arousal behaviours, non-agitated motor activity, and distressed 
emotional behaviour), were broadly stereotyped both within, and to a lesser extent 
between, individuals.
In addition to these behavioural patterns, a number of elemental semiological 
features positively favouring a diagnosis of parasomnias over NFLE were 
identified. These included an indistinct offset, failure to rouse to full wakefulness, 
physical and verbal interaction with the environment, and prominent ‘normal’ 
arousal behaviours. Many characteristic features of NFLE, including bicycling 
automatisms, dystonic posturing, grunting respiration, and a clearly defined offset 
were rare in parasomnias. However, the study also demonstrated that some 
individual behaviours were indistinguishable in NFLE and parasomnias; this was a 
particularly striking with respect to initial arousal behaviour. Both seizures and 
parasomnias could commence with identical arousal behaviour of this type, lasting 
for several seconds prior to the major motor activity of the event. As a result, it 
would appear that brief nocturnal arousals cannot be diagnosed as epileptic or 
non-epileptic on the basis of semiology alone. In the absence of clear epileptic 
behaviours or definitive EEG abnormalities, additional information (such as sleep
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stage, frequency of arousals and stereotypy) must be used to form the basis of a 
diagnosis, but these features are not entirely reliable.
In addition to the clinical applicability of these findings, the video EEG 
monitoring study also provided some clues to the underlying mechanism of 
parasomnias. The similiarity of the four main behaviour patterns within, and also 
between, individuals suggests they may be mediated by subcortical central pattern 
generators (CPGs). Such a mechansism has been invoked by several authors in 
discussions of epileptic automatisms, and it has been occasionally suggested that 
similar mechanisms may be responsible in NFLE and parasomnias (Tassinari et 
al., 2005). The findings presented in this study, however, indicate that while 
behaviour in parasomnias is very similar to postictal behaviour in NFLE, it is 
usually different to the ictal behaviour. This suggests that, although CPGs may be 
involved in both parasomnias and NFLE, the nature of their activation in these 
disorders may be quite different.
Future Directions
Although the existence of parasomnias such as somnambulism has been 
recognised for centuries, the understanding of these disorders is still limited. This 
is partly due to the rarity with which they are recorded in a monitored 
environment, and partly because, although sometimes distressing for onlookers 
and occasionally dangerous for sufferers (injury during sleepwalking is well 
described), they are generally considered to be quasi-physiological events, and not 
intrinsically pathological.
Nevertheless, parasomnias may have the potential to provide important 
information about mechanisms of arousal and sleep stage transition in the normal 
human brain. The strong family history in many subjects opens possibilities for 
genetic studies, with the potential to identify molecular mechanisms important in 
arousal. Modem imaging modalities, including fMRI and PET, may provide 
important insights into neural mechanisms of sleep and arousal, and comparisons 
of individuals with and without parasomnias may be instructive in identifying 
networks or anatomical structures involved in neuronal synchronization during
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sleep. An increased understanding of such mechanisms may ultimately also 
provide insights into sleep-related epilepsy syndromes, including ADNFLE.
Finally, the role of CPGs in epileptic automatisms and parasomnias warrants 
further investigation. The similarity between the behaviour in parasomnias and 
postictal behaviours in NFLE was a striking finding, and further comparisons of 
parasomnias with ictal and postictal automatisms in other forms of epilepsy may 
be enlightening. Designing studies to prove or disprove a role for CPGs in these 
disorders is difficult at present, as the exact nature and extent of these networks in 
normal mammalian behaviour is not well understood (Kiehn, 2006). However, 
their structure and function of central pattern generators in mammals is an active 
area of basic science research; as the anatomical and physiological arrangements 
of these neural circuits are increasingly understood, this knowledge may be 
applied to the study of parasomnias and epileptic automatisms.
Severe ADNFLE -  Clinical and genetic considerations
ADNFLE is usually considered to be a relatively mild epilepsy syndrome. While 
seizures may be difficult to control in childhood, they usually respond to 
carbarnazepine in adults; comorbidities, such as cognitive and psychiatric 
disorders, are reported infrequently. Causative mutations in ADNFLE have been 
definitively identified in genes coding for subunits of the nAChR, although these 
account for only a minority of reported cases. More recently it has been 
hypothesized that polymorphisms in the corticotrophin releasing hormone (CRH) 
may play a pathogenic role in some families without recognized nAChR mutations 
(see literature review, Chapter 9, page 158).
What has been learnt
Clinical Features. In contrast to the phenotype usually reported, two families 
with ADNFLE are described in whom epilepsy was severe, often refractory to 
multiple anti-epileptic drugs, and associated with high rates of intellectual 
disability, behavioural and psychiatric disorders (Chapter 14). In some individuals 
the disorder was devastating, with status epilepticus and severe refractory seizures
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accompanied by marked developmental regression. Psychiatric and cognitive 
comorbidities in these families were often disabling, sometimes more so than the 
seizures themselves.
Molecular Genetics. No mutation in nAChR subunit genes was identified in 
either of these families. The molecular genetics in the larger family is, however, 
complex. This family was initially identified a decade ago, although has since 
been extended. The initial molecular studies provided evidence for linkage to 
15q24. At that time, the critical region was thought to include the 
CHRNA3/CHRNA5/CHRNB4 gene cluster, but no mutation was identified 
(Phillips et al., 1998). The extended pedigree examined here again provides 
stronger evidence for linkage to 15q24 but with much better physical mapping 
data now available, the region identified now excludes the 
CHRNA3/CHRNA5/CHRNB4 cluster. In addition, the segregation of haplotypes is 
consistent with linkage to chromosome lq21 (the region including CHRNB2), 
although, LOD scores for this region fall well short of statistical significance and 
sequencing of coding exons of CHRNB2 has failed to identify any mutation. The 
significance of these 2 loci is, at this stage, unclear, and a number of possible 
explanations exist, including non-nAChR related mechanisms and even a possible 
digenic basis to the condition. While mutations in nAChR subunit genes do not 
appear to be the cause of ADNFLE in this family, they have not yet been 
definitively excluded. Molecular analysis of the regions of interest on 
chromosomes lq21 and 15q24 is ongoing, including sequencing of candidate 
genes.
Future Directions
Clincial studies. From a clinical perspective, the possibility of systematic 
neuropsychological assessment in ADNFLE should be investigated, with 
particular reference to frontal lobe functions. Although development and 
cognition is said to be normal in ADNFLE, subtle frontal lobe dysfunction may be 
easily overlooked. The high rates of intellectual disability in the families reported 
here raise the possibility that cognitive involvement, albeit to a mild degree, is 
more widespread in ADNFLE than is generally appreciated. This is a technically
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difficult area as the functions of the frontal lobes are complex, and existing 
neuropsychological tests are not always reliable at detecting mild dysfunction of 
this sort (Stuss and Levine, 2002). However, a deeper understanding of any 
neuropsychological deficits may help to identify anatomical structures involved in 
the seizures of ADNFLE, as well as potentially improving the management of 
affected individuals.
Molecular genetics. Although ADNFLE is a relatively uncommon disorder, it 
has now been reported extensively from around the world (see literature review, 
Chapter 9, page 153-4). Known mutations, however, account for only a minority 
of reported cases. The recent findings of a mutation in the a2 subunit, as well as 
possibly pathogenic polymorphisms in the corticotrophin releasing hormone 
(CRH) gene, suggest that a4p2 nAChR dysfunction is not the only molecular basis 
for this disorder. Ongoing studies of large multiplex families with ADNFLE 
should continue with the aim of further elucidating additional mechanisms. 
Findings in such families may lead to a deeper understanding not only of 
ADNFLE, but of frontal lobe epilepsy in general. Findings from more severely 
affected families such as those presented here may also provide insights into 
mechanisms of psychiatric illness and cognitive function. Moreover, they may 
shed light upon the intriguing relationship between frontal lobe epilepsy and 
NREM sleep.
Concluding remarks
The studies presented in this thesis are a small contribution to the understanding of 
sleep and its relationship to frontal lobe epilepsy; they address the neurochemical 
changes fundamental to human sleep as well as clinical, electrographic and genetic 
aspects of NREM arousal parasomnias and NFLE. Much work, however, remains. 
New technologies, such as neuroreceptor-specific ligands for PET and fMRI, will 
undoubtedly enable more sophisticated study of neurobiological changes in 
normal human sleep. Motor disorders of sleep, including parasomnias, currently 
attract only modest scientific interest but warrant more active investigation. Study 
of these disorders is important, not only to gain a deeper understanding of the 
conditions themselves, but also because of the insights into underlying sleep
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mechanisms which they may provide. Finally, although clinical and molecular 
genetic studies of ADNFLE have already profoundly influenced our understanding 
of epilepsy, this disorder may still have much to teach us. Further study of 
ADNFLE may not only shed further light on fundamental mechanisms of 
epilepsy, but may also help to unravel the relationship between sleep and epilepsy 
which has fascinated observers since the time of Aristotle.
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Appendix A. Semi-structured questionnaire for interviews 
in subjects with nocturnal events (Chapter 12)
Background
• Information obtained from (state relationship of collateral history giver to 
the subject):
•  Number of events seen by individual giving collateral history (l or 2; 3- 
10; more than 10):
• How long ago was last attack witnessed (weeks/ months/years)
• Current age of patient
Clinical History
1) Age of onset:
2) Age of offset ( if applicable)
3) Semiology of attacks
a) Give a general description of the events
b) Are the events associated with an aura? If yes, give a description
c) Does the subject ever walk during the episode? In particular, describe 
extent of wandering (do they ever walk out of the bedroom?).
d) Are there complex, directed behaviours (e.g. dressing, turning on lights etc) 
during the episodes? Give examples.
e) Is there a history of abnormal stiffening (including dystonic posturing), 
tonic extension or cramping? Give a detailed description.
0  According to the subject and witnesses, are the events highly stereotyped, 
broadly similar or variable in their manifestation? Describe further if 
necessary.
g) Has tongue biting or incontinence ever been a feature of these events? If 
so, how frequently? Give details.
h) Does the patient ever recall the events? If so, is it a detailed or a vague 
recollection? Give details of the patients reported recall, and how often it 
occurs.
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i) Does the patient vocalise during the episode? Is it shouting/ screaming, 
incoherent speech or coherent speech? Give examples of the things that 
are said.
j) If speech is a feature, does the patient recall what they have said? If there 
is recall, is it full or partial?
4) The day after the events, are their any symptoms? In particular, is headache or 
fatigue a feature?
5) How frequent are the patients ‘attack nights’? Express per week/, month or 
year. Give details.
• Maximum frequency (and duration of this period)
• ‘Average’ frequency
6) How many episodes occur in one ‘attack night’?
• Maximum number
• ‘Average’ number
7) Do the attacks tend to occur in ‘clusters’ (i.e. many for a period of days -  
weeks, then periods with very few or none). Give details.
8) Are there any factors that seem to trigger the events? In particular stress, 
fatigue or intercurrent illness.
9) Is there a pattern with respect to the most common timing of attacks during the 
night? In particular is it just as they are falling asleep (first 0.5 hour of sleep), in 
the first 2-3 hours of the sleep period, other times or no pattern? Be as explicit 
with timing as possible.
10) What is the duration of the events? Is there a lot of variability?
• Longest
• ‘Average’ or typical event
11) Additional information: is there a history of (give details):
• learning difficulties?
• behavioural disorder (e.g. ADHD) or psychiatric diagnosis?
• family history of nocturnal events?
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APPENDIX B . Haplotype markers in Family B (Chapter 14)
z
D1S206
D1S495
D1S2651
D1S2696
D1S2345
D1S305
D1S2715
D1S303
D1S506
p #
1 1 1 2
2 3 3 1
1 3 5 2
6 3 4 1
1 > 6 6
1 2 1 2
2 4 1 3
3 3 2 2
2 1 2 2. . o
o
ADNFLE
Appendix B .l. Haplotype markers for chromosome Iq2I in Family B (Chapter 14). 
Markers in this region do not cosegregate with ADNFLE
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1 3
2 2
1 4
2 4
1 3
2 2 
1 2 
1 3 
3 1
D15S1041
D15S206
D15S200
D15S1030 wm
D15S979 ■  ADNFLE
Appendix B.2. Haplotype markers for chromosome I5q24 in Family B (Chapter 14). 
Markers in this region do not cosegregate with ADNFLE
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1 1 31 1 1
AC repeat marker in CHRNA4
H  ADNFLE
Appendix B. 3. AC repeat marker in CHRNA4 in Family B (Chapter 14). Note that marker 1 
is seen in all affected individuals, thereby CHRNA4 cannot be excluded.
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